
<html lang="en"     class="pb-page"  data-request-id="0083e4a1-7241-4ee2-b959-ce456f969691"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2005.48.issue-21;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm058225d"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Designed Multiple Ligands. An Emerging Drug Discovery Paradigm" /></meta><meta name="dc.Creator" content="Richard  Morphy* and" /></meta><meta name="dc.Creator" content="Zoran  Rankovic" /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="September 24, 2005" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm058225d" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-48-21-6523" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(05)08225-7" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2005 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm058225d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm058225d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm058225d" /></link>
        
    
    

<title>Designed Multiple Ligands. An Emerging Drug Discovery Paradigm | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm058225d" /></meta><meta property="og:title" content="Designed Multiple Ligands. An Emerging Drug Discovery Paradigm" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm058225d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm058225d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm058225d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm058225d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm058225d&amp;href=/doi/10.1021/jm058225d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2005</span><span class="cit-fg-volume">, 48</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 6523-6543</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/48/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm0504555" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Designed Multiple Ligands. An Emerging Drug Discovery Paradigm</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Morphy">Richard Morphy</a></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zoran++Rankovic">Zoran Rankovic</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Medicinal Chemistry Department, Organon Laboratories, Newhouse, Lanarkshire, ML1 5SH, U.K. </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm058225d&amp;href=/doi/10.1021%2Fjm058225d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2005</span></span><span class="cit-volume">, 48</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 6523–6543</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2005</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2005</li><li><span class="item_label"><b>Published</b> online</span>24 September 2005</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 October 2005</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm058225d" title="DOI URL">https://doi.org/10.1021/jm058225d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2005 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6523%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRichard%2BMorphy%252C%2BZoran%2BRankovic%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D48%26issueNum%3D21%26contentID%3Djm058225d%26title%3DDesigned%2BMultiple%2BLigands.%2BAn%2BEmerging%2BDrug%2BDiscovery%2BParadigm%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6543%26publicationDate%3DOctober%2B2005">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm058225d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7162</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">789</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm058225d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Designed Multiple Ligands. An Emerging Drug Discovery Paradigm&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Morphy&quot;},{&quot;first_name&quot;:&quot;Zoran&quot;,&quot;last_name&quot;:&quot;Rankovic&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2005&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;48&quot;,&quot;pages&quot;:&quot;6523-6543&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm058225d&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm058225d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058225d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm058225d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058225d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm058225d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058225d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm058225d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058225d&amp;href=/doi/10.1021/jm058225d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm058225d" /></input><a href="/doi/pdf/10.1021/jm058225d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (576 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26pmid%3D16220969%26genre%3Darticle%26aulast%3DMorphy%26date%3D2005%26atitle%3DDesigned%2BMultiple%2BLigands.%2BAn%2BEmerging%2BDrug%2BDiscovery%2BParadigm%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D48%26issue%3D21%26spage%3D6523%26epage%3D6543%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/48/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm058225dAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Telephone:  +44 (0)1698 736000. Fax:  +44 (0)1698 736187. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5c2e7231332e2c34251c332e3b3d323332723f3372293772">[email protected]</a> </p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For much of the past century, drug discovery relied largely on the use of animal models of disease as the first-line screens for testing the compounds produced by medicinal chemists. This in vivo pharmacology approach had the benefit of highlighting compounds that exhibited both desirable pharmacokinetic and pharmacodynamic profiles. A major disadvantage of this approach was that an animal model was essentially a “black box”. When compounds were inactive, it was unclear whether this was because they no longer interacted with a molecular target or simply whether they had failed to reach the site of action. In many cases, the molecular target(s) driving the desired pharmacological effect had not been identified, and inevitably many older generation drugs cross-reacted with targets that caused detrimental side effects. Inexorably, the drug discovery paradigm shifted toward a reductionist “one-target, one-disease” approach that continues to dominate the pharmaceutical industry today. Many successful drugs have emerged from this strategy, and it will no doubt remain dominant for many years to come. However, despite the best efforts of drug discoverers, many diseases remain inadequately treated. There is an increasing readiness to challenge the current paradigm and to consider developing agents that modulate multiple targets simultaneously (polypharmacology), with the aim of enhancing efficacy or improving safety relative to drugs that address only a single target.<sup><a onclick="showRef(event, 'jm058225db00001 jm058225db00002 jm058225db00003'); return false;" href="javascript:void(0);" class="ref jm058225db00001 jm058225db00002 jm058225db00003">1-3</a></sup></div><div class="NLM_p">There are three possible approaches to polypharmacology (Figure 1<a data-tab="pane-pcw-Figures" href="#jm058225df00001" id="" class=" internalNav"></a>). Traditionally, clinicians have treated unresponsive patients by combining therapeutic mechanisms with cocktails of drugs. Most frequently, the cocktail is administered in the form of two or more individual tablets (scenario A).<sup><a onclick="showRef(event, 'jm058225db00004 jm058225db00005'); return false;" href="javascript:void(0);" class="ref jm058225db00004 jm058225db00005">4,5</a></sup> However, the benefits of this approach are often compromised by poor patient compliance, particularly for treating asymptomatic diseases such as hypertension.<sup><a onclick="showRef(event, 'jm058225db00006'); return false;" href="javascript:void(0);" class="ref jm058225db00006">6</a></sup> Recently, there has been a move toward multicomponent drugs whereby two or more agents are coformulated in a single tablet to make dosing regimes simpler and thereby to improve patient compliance (scenario B).<sup><a onclick="showRef(event, 'jm058225db00007 jm058225db00008'); return false;" href="javascript:void(0);" class="ref jm058225db00007 jm058225db00008">7,8</a></sup> An alternative strategy is to develop a single chemical entity that is able to modulate multiple targets simultaneously (scenario C).<sup><a onclick="showRef(event, 'jm058225db00009'); return false;" href="javascript:void(0);" class="ref jm058225db00009">9</a></sup><div id="_i2"><figure id="jm058225df00001" data-index="0" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00001.jpeg" id="_i3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Three main clinical scenarios for multitarget therapy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Across the pharmaceutical industry, scenario B is increasingly providing an attractive opportunity for enhancing R&D output. Several multicomponent drugs have recently been launched, such as Caduet<sup><a onclick="showRef(event, 'jm058225db00010'); return false;" href="javascript:void(0);" class="ref jm058225db00010">10</a></sup> (amlodipine/atorvastatin) and Vytorin<sup><a onclick="showRef(event, 'jm058225db00011'); return false;" href="javascript:void(0);" class="ref jm058225db00011">11</a></sup> (ezetimibe/simvastatin) that were approved in 2004 for the treatment of cardiovascular disease. However, there are significant risks involved in the development of multicomponent <a name="jm004802106524" id="jm004802106524"></a> drugs. There is the commercial uncertainty arising from the risk that clinicians might still prefer prescribing combinations of existing monotherapies that may offer greater dose flexibility and lower cost treatment, particularly in the case of generic drugs. Differences in the relative rates of metabolism between patients can produce highly complex pharmacokinetic (PK)/pharmacodynamic (PD) relationships for multicomponent drugs, leading to unpredictable variability between patients and necessitating extensive and expensive clinical studies. </div><div class="NLM_p">Compared to multicomponent drugs, the multiple-ligand approach (scenario C) has a profoundly different risk−benefit profile. A downside is that it is significantly more difficult to adjust the ratio of activities at the different targets. However, this increased complexity in the design and optimization of such ligands is shifted toward the earlier and therefore less expensive stages of the drug discovery process. The clinical development of multiple ligands, in terms of the risks and costs involved, is in principle no different from the development of any other single entity. Another advantage is a lower risk of drug−drug interactions compared to cocktails or multicomponent drugs.<sup><a onclick="showRef(event, 'jm058225db00012'); return false;" href="javascript:void(0);" class="ref jm058225db00012">12</a></sup></div><div class="NLM_p">While many currently marketed drugs are in essence multiple ligands, very few were rationally designed to be so. Typically, the mechanism of action was elucidated retrospectively. Recently, there has been growing interest in the deliberate, rational design of ligands acting specifically on multiple targets, and this has been reflected by an increase in the number of relevant publications. Numerous terms are currently used to describe such ligands, dual ligand, heterodimer, promiscuous drug, pan-agonist, and triple blocker being just a few of many examples. The complexity and inconsistency of this nomenclature serve to obscure developments in this field. To improve communication and awareness, the authors propose using a common term, designed multiple ligands (DMLs), to describe compounds whose multiple biological profile is rationally designed to address a particular disease, with the overall goal of enhancing efficacy and/or improving safety. Ligands that possess significant activity at irrelevant targets should not be regarded as DMLs but rather as “nonselective” ligands, since undesirable cross-reactivity frequently leads to deleterious side effects. </div><div class="NLM_p last">An example of a nonselective ligand is the atypical antipsychotic drug clozapine, which displays an extremely complex in vitro pharmacology. To reduce side effects, a number of ligands that are selective for single receptors targeted by clozapine were developed, such as D<sub>4</sub> and 5-HT<sub>2a</sub> antagonists, but these lacked sufficient efficacy in the clinic.<sup><a onclick="showRef(event, 'jm058225db00013'); return false;" href="javascript:void(0);" class="ref jm058225db00013">13</a></sup> Research then shifted toward DMLs such as dual D<sub>2</sub>/5-HT<sub>2a</sub> antagonists.<sup><a onclick="showRef(event, 'jm058225db00014 jm058225db00015'); return false;" href="javascript:void(0);" class="ref jm058225db00014 jm058225db00015">14,15</a></sup> This evolutionary process, from nonselective to selective to DML, has also been seen for other diseases. Nonselective tricyclic antidepressants such as amitryptyline were superseded by selective serotonin (5-HT) transporter inhibitors (SSRIs), which increased safety but had a slow onset of action and lacked efficacy in some patients. Dual serotonin and norepinephrine (NA) reuptake inhibitors (SNRIs) are now being developed clinically with the hope of addressing these deficiencies.<sup><a onclick="showRef(event, 'jm058225db00016'); return false;" href="javascript:void(0);" class="ref jm058225db00016">16</a></sup> Likewise, the same trend is observed in the area of nonsteroidal anti-inflammatory drugs (NSAIDs), starting from nonselective agents such as aspirin to selective cyclooxygenase-2 (COX-2) inhibitors and then to dual COX-2/5-lipoxygenase (5-LOX) inhibitors.<sup><a onclick="showRef(event, 'jm058225db00017'); return false;" href="javascript:void(0);" class="ref jm058225db00017">17</a></sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Strategies for Designing Multiple Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Conceptually, there are two quite different methods of generating chemical matter with which to commence a DML project:  <i>knowledge-based</i> approaches and <i>screening </i>approaches (Figure 2<a data-tab="pane-pcw-Figures" href="#jm058225df00002" id="" class=" internalNav"></a>). Knowledge-based approaches rely on existing biological data from old drugs or other historical compounds, from either literature or proprietary company sources. Serendipitous approaches involve the screening of either diverse or focused compound libraries. Typically, diversity-based screening involves the high-throughput screening (HTS) of large, diverse compound collections at one target, and any actives are then triaged on the basis of activity at the second target. In focused screening, compound classes that are already known to provide robust activity at one of the targets of interest, A, are screened for signs of activity at a new target, B. Even if only weak activity is observed for target B, this can provide a useful baseline for increasing that activity by incorporating structural elements from more potent selective ligands for target B. <div id="_i5"><figure id="jm058225df00002" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00002.jpeg" id="_i6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Different strategies for DML projects. In the lead generation phase, knowledge-based or screening approaches are used to provide starting compounds that may be highly selective (little or no activity at a second target), moderately selective, or nonselective (with undesired activity). The subsequent strategy involves “designing in”, “balancing”, or “designing out” activities, respectively. As well as balancing the activity ratio, lead optimization provides other major challenges, in particular adsorption, distribution, metabolism, excretion, and toxicity (ADME-T) optimization. In this schematic, activity at targets A and B is desired and activity at target C is undesired. The size of the target letter illustrates the affinity for that target.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">For both the screening or knowledge-based approaches, the identification of a lead compound with appropriate activity at both targets A and B is unlikely. In reality, a lead generation, or “hit-to-lead” phase, will be required. In one scenario, two compounds that bind with very high selectivity to their respective targets are used as the starting points. To incorporate activity at both targets into a single molecule (“designing in”), structural elements from the two selective ligands are combined. Incorporating a second activity into a compound that has no measurable affinity for that target, while retaining affinity for the original target, is not an easy task. However, many literature examples testify to the fact that it can often be achieved. Perhaps a more tractable scenario is to first identify a compound that has at least minimal activity at both targets. In this case, the activity at both targets must be modulated to achieve an optimal ratio. In a third scenario, a compound is identified that possesses activity at both targets A and B but also possesses undesirable activity at another target C. The optimization strategy must then focus on “<i>designing out</i>” this cross-reactivity. In some cases, a compound may possess more than one undesired activity, and this will inevitably increase the complexity of the task. </div><div class="NLM_p">By far the most common trajectory for generating leads is to convert a ligand with a single activity into a dual ligand. The conversion of single ligands into triple ligands is more challenging and is much rarer. As the number of targets in a profile increases, the “designing in” philosophy will become less attractive compared to the “designing out” approach starting from a nonselective ligand. </div><div class="NLM_p last">The lead candidate will usually lack the optimal ratio of in vitro activities. In lead optimization, the ratio is adjusted so that both targets are modulated to an appropriate degree in vivo at similar plasma or brain concentrations. In most examples, the aim has been to <a name="jm004802106525" id="jm004802106525"></a> obtain in vitro activities within an order of magnitude of each other, with the assumption that this will lead to similar levels of receptor occupancy in vivo. However, this may not necessarily be the case, and assuming a validated animal model is available, the testing of a lead candidate in vivo may help to clarify the required ratio of in vitro activities. Ultimately, feedback from clinical studies will be required to identify the optimal ratio that can be then be used to drive the design of “follow-up” compounds. In addition to adjusting the ratio of activities, optimizing wider selectivity against a broad panel of targets is often required. This will be particularly intricate for targets for which a large number of subtypes or isozymes exist. Many publications do not discuss the key issue of global selectivity, so it is frequently difficult to judge whether real selectivity for the disease-relevant targets has been achieved. Again, animal models and subsequent clinical studies will provide essential feedback on the level of cross-reactivity that can be tolerated. A particular challenge in lead optimization is to optimize the PK profile and to obtain physicochemical properties that are consistent with good oral absorption. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Classification of Designed Multiple Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">“Conjugates” are DMLs in which the molecular frameworks, which contain the underlying pharmacophore elements for each target, are well separated by a distinct linker group that is not found in either of the selective ligands (Figure 3<a data-tab="pane-pcw-Figures" href="#jm058225df00003" id="" class=" internalNav"></a>). Most conjugates contain a metabolically stable linker. “Cleavable conjugates” employ a linker that is designed to be metabolized to release two ligands that interact independently with each target. As the size of the linker decreases, a point is reached where the frameworks are essentially touching, and these DMLs can be regarded as “fused”. In the most common type of DML, the frameworks are “merged” by taking advantage of commonalities in the structures of the starting compounds. In reality, the degree of merger of the frameworks forms a continuum, with high molecular weight conjugates with lengthy linker groups representing one extreme. At the other extreme are examples where the frameworks, and underlying pharmacophores, are highly merged, giving rise to smaller and simpler molecules. <div id="_i8"><figure id="jm058225df00003" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00003.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 DML continuum. Ligands vary greatly in the degree of merger of the frameworks (and the underlying pharmacophores) of the selective ligands used as the starting points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Knowledge-Based “Designing In” Approaches</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Conjugates.</b> Van Boeckel et al. designed conjugate <b>1 </b>(Figure 4<a data-tab="pane-pcw-Figures" href="#jm058225df00004" id="" class=" internalNav"></a>), a high-efficacy antithrombotic that inhibited both thrombin (via NAPAP) and ATIII-mediated factor Xa (via a heparin-derived pentasaccharide fragment).<sup><a onclick="showRef(event, 'jm058225db00018'); return false;" href="javascript:void(0);" class="ref jm058225db00018">18</a></sup> A poly(ethylene glycol) linker conferred good aqueous solubility, thus making the compound suitable for parenteral administration. The crystal structure of NAPAP in thrombin was used to identify a tolerant position for attachment of the linker without affecting potency. Since the pentasaccharide demonstrated a <a name="jm004802106526" id="jm004802106526"></a> much longer half-life (13−15 h in man) than NAPAP (18 min), the authors postulated that a conjugate with NAPAP might possess improved pharmacokinetic properties. Indeed, this was confirmed, and in vivo studies revealed that <b>1</b> provided a stronger and longer-lasting antithrombotic effect compared to a cocktail of free pentasaccharide and NAPAP. <div id="_i11"><figure id="jm058225df00004" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00004.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Structures of high molecular weight DML conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The covalent linking of selective adenosine A<sub>1</sub> and A<sub>3</sub> agonists by Jacobson et al. using a rigid ethynyl-based spacer led to conjugates with the desired dual activity <b>2</b>.<sup><a onclick="showRef(event, 'jm058225db00019'); return false;" href="javascript:void(0);" class="ref jm058225db00019">19</a></sup> Evaluation of these conjugates in models of myocardial ischemia confirmed that activation of both A<sub>1</sub> and A<sub>3</sub> receptor subtypes resulted in a cardioprotective effect that is significantly greater than that induced by activation of either receptor individually. </div><div class="NLM_p">Portoghese et al. reported a range of homo- and heterodimeric conjugates with varying linker length designed to investigate pharmacodynamic and organizational features of opioid receptors.<sup><a onclick="showRef(event, 'jm058225db00020'); return false;" href="javascript:void(0);" class="ref jm058225db00020">20</a></sup> For example, recently reported heterodimeric conjugates containing δ-antagonist (naltrindole) and <i>κ</i><sub>1</sub>-agonist (ICI-199,441) pharmacophores tethered by variable-length oligoglycyl-based linkers <b>3</b> were demonstrated to possess significantly greater potency and selectivity compared to their monomer congeners, providing further evidence for the opioid receptor heterooligomerization phenomenon.<sup><a onclick="showRef(event, 'jm058225db00021'); return false;" href="javascript:void(0);" class="ref jm058225db00021">21</a></sup></div><div class="NLM_p">Most of the cleavable conjugates reported in the literature contain an ester-based linker, which is designed to be cleaved by plasma esterases to release two individual drugs that then act independently. For example, several cleavable conjugates contain a nitrous oxide releasing functionality linked via an ester group to a known drug such as NO-aspirin <b>4</b> (NCX-4016) and the ibuprofen derivative <b>5 </b>(Figure 5<a data-tab="pane-pcw-Figures" href="#jm058225df00005" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00022 jm058225db00023'); return false;" href="javascript:void(0);" class="ref jm058225db00022 jm058225db00023">22,23</a></sup><div id="_i13"><figure id="jm058225df00005" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00005.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Structures of low molecular weight nitric oxide releasing conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><b>Fused DMLs.</b> When the hydrophobic gastrin receptor pharmacophore was combined with the hydrophilic histamine H<sub>2</sub> pharmacophore, “tolerant regions” were identified by superimposing non-peptide gastrin antagonist <b>6</b> (L-365,260) onto the peptide <i>N</i>-acetyl-CCK-7 (Figure 6<a data-tab="pane-pcw-Figures" href="#jm058225df00006" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00024'); return false;" href="javascript:void(0);" class="ref jm058225db00024">24</a></sup> It was predicted that the region around the C3‘ tolyl group would be sufficiently open to accommodate functionality from the H<sub>2</sub> antagonist <b>7</b>. Indeed, <b>8</b> was found to possess balanced activity at H<sub>2</sub> and gastrin receptors, albeit with some cross-reactivity at <a name="jm004802106527" id="jm004802106527"></a> CCK-B receptors. For highly dissimilar targets, achieving multiple activities in a compact molecule in which the pharmacophores are merged may prove to be impossible. The only realistic option may be fusion of the frameworks by exploiting tolerant positions in each component, but oral absorption may then be compromised. <div id="_i15"><figure id="jm058225df00006" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00006.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 6 Structures of fused and merged DMLs (<b>8</b>, <b>12</b>, <b>15</b>) that bind to two GPCRs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><b>Merged DMLs.</b> In their quest for an opioid analgesic with reduced side effects, Montero et al. combined agonism at two G-protein-coupled receptors (GPCRs):  the μ-opioid and I<sub>2</sub>-imidazoline receptors (Figure 6).<sup><a onclick="showRef(event, 'jm058225db00025 jm058225db00026'); return false;" href="javascript:void(0);" class="ref jm058225db00025 jm058225db00026">25,26</a></sup> A guanidinium group from the I<sub>2</sub> ligand, agmatine<b> 9</b>, was incorporated into the opioid, fentanyl<b> 10</b>. The lead compound, <b>11</b>, possessed activity at both receptors, but the activity was unbalanced, having significantly higher affinity for the opioid receptor. In this example, the frameworks of the starting compounds are slightly merged with the agmatine-derived alkyl chain replacing the aniline system in fentanyl. The identification of such a “tolerant region” for both receptors is a key first step in any DML program. The compound with an eight-carbon spacer, <b>12</b>, possessed the best balance of activities. </div><div class="NLM_p">Buckholder et al. desired a dual NK<sub>1</sub>/NK<sub>2</sub> ligand because it was postulated that both SP and NK-A participated in the etiology of asthma. They started from a selective NK<sub>2</sub> ligand <b>14</b> that had weak NK<sub>1</sub> activity and then attempted to achieve balanced activity (Figure 6).<sup><a onclick="showRef(event, 'jm058225db00027'); return false;" href="javascript:void(0);" class="ref jm058225db00027">27</a></sup> An overlay of <b>14 </b>with the potent NK<sub>1</sub> ligand, <b>13</b>, showed a good overlap of the aromatic ring of the benzamide and the aromatic ring of the benzylamine, suggesting that a methoxy group on the benzamide of <b>14</b> might enhance NK<sub>1</sub> binding. Whereas the directly analogous 2-methoxy derivative was only 4-fold more active, the 3,4,5-trimethoxy derivative had much improved NK<sub>1</sub> affinity. So while the strategy was successful, the SAR around this ring in <b>15</b> was significantly different from that for <b>13</b>. Often the SAR does not transfer directly from the starting compounds to the DML possibly because of a slight shift in the mode of <a name="jm004802106528" id="jm004802106528"></a> binding. Consequently, it is important to maintain an open mind with respect to the SARs when balancing the activities of DMLs. </div><div class="NLM_p">The commonality between the P<sub>2</sub>‘ and P<sub>2</sub> requirements for matrix metalloprotease-1 (MMP-1) (<b>16</b>) and cathepsin L (Cat L) inhibitors (<b>17</b>), and the use of two warheads positioned at either end, enabled the barrier between the metalloprotease and cysteine protease families to be overcome in <b>18</b> (Figure 7<a data-tab="pane-pcw-Figures" href="#jm058225df00007" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00028'); return false;" href="javascript:void(0);" class="ref jm058225db00028">28</a></sup><div id="_i17"><figure id="jm058225df00007" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00007.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 7 Design of a DML <b>18 </b>that binds to two proteases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">It might be expected that rationally “designing in” activity for targets from fundamentally different superfamilies might be particularly difficult. However, a large number of recent examples show that spanning phylogenetically diverse targets, while still accommodating multiple pharmacophores within a single molecule, is possible. Kogen et al. describe efforts to combine acetylcholinesterase (AChE) and 5-HT transporter (SERT) inhibition for treating Alzheimer's disease. A pharmacophoric model of the active site of AChE showed that a marketed inhibitor, rivastigmine <b>19</b>, possessed three elements of the proposed AChE pharmacophore but lacked a fourth hydrophobic binding site (Figure 8<a data-tab="pane-pcw-Figures" href="#jm058225df00008" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00029'); return false;" href="javascript:void(0);" class="ref jm058225db00029">29</a></sup> It was hypothesized that a phenoxyethyl motif from the SERT blocker, <b>20 </b>fluoxetine, might provide this hydrophobic interaction, thereby improving potency relative to rivastigmine. Hybridization of the two inhibitors, followed by optimization of the carbamate and phenoxy substituents, provided a reasonably balanced inhibitor, <b>21</b>. Conformational constraint using a seven-membered ring enhanced potency, <b>22</b>. This compound facilitated both cholinergic and serotonergic transmission in the brain following oral administration. In addition to producing a potent and balanced inhibition at two diverse targets, <b>22 </b>possessed high selectivity over the targets most closely related to AChE and SERT, butyrylcholinesterase and norepinephrine/dopamine transporters (NET/DAT), respectively, as well as over monoamine GPCRs. This work also represents one of the rare examples so far published that uses biostructural information to guide the hybridization of the starting compounds. <div id="_i19"><figure id="jm058225df00008" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00008.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 8 Design of a DML <b>22</b> that binds to an enzyme, acetylcholine esterase (AChE), and the serotonin transporter (SERT).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">DMLs from Screening Approaches</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While screening relies largely on serendipity to generate a hit compound with multiple activity, the subsequent process to optimize the overall profile is carried out as rationally as for compounds derived from knowledge-based approaches. Thus, the optimized compounds, despite their screening lineage, can be regarded as DMLs. Screening can add particular value if there is a lack of selective ligands for the targets of interest and little knowledge of the individual SARs required for a more rational approach. Moreover, screening can deliver novel and unexpected chemotypes, as well as sometimes providing hits for unusual target combinations that span unrelated receptor families. For example, a diversity-based screen at UCB Pharma provided a multiple ligand with a surprising combination of activities at a peptide GPCR, the neurokinin NK<sub>1</sub> receptor, and a monoamine transporter, SERT.<sup><a onclick="showRef(event, 'jm058225db00030'); return false;" href="javascript:void(0);" class="ref jm058225db00030">30</a></sup> Although the hit <b>23</b> had only modest activity, optimization of each aromatic moiety in turn provided a more potent compound with a balanced activity at both targets <b>24 </b>(Figure 9<a data-tab="pane-pcw-Figures" href="#jm058225df00009" id="" class=" internalNav"></a>). An aryl ether moiety was introduced to reduce lipophilicity, providing physicochemical properties predictive of central nervous system (CNS) penetration following oral administration. The similarity between the initial and optimized structures illustrates the value of a methodical stepwise approach in order to satisfy two sets of stringent receptor requirements. <div id="_i22"><figure id="jm058225df00009" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00009.jpeg" id="_i23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 9 Structures of DMLs that were discovered via diversity or focused screening approaches.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">In their quest for a dual 5-HT<sub>1A</sub>/SERT blocker, van Niel et al. designed a focused library based on the 3-aryloxy-2-propanolamine scaffold found in the 5-HT<sub>1A</sub> antagonist pinadol <b>25 </b>(Figure 9).<sup><a onclick="showRef(event, 'jm058225db00031'); return false;" href="javascript:void(0);" class="ref jm058225db00031">31</a></sup> The variations at the amine and phenol positions included privileged structures, as well as fragments reported to have affinity for either 5-HT<sub>1A</sub> or SERT. The SAR around the indole region was reasonably tolerant for both targets, but the only amine group that provided reasonable SERT inhibition was a spiropiperidine <b>26</b>. This compound provided balanced inhibition and good oral exposure (<i>F</i> = 65%) and brain penetration in the rat. </div><div class="NLM_p">The potential of using “old drugs” as a starting point for a DML project has also been demonstrated. For example, the 5-HT<sub>3</sub> antagonist tropisetron <b>27</b> was found to bind with nanomolar potency to the α<sub>7</sub> nicotinic acetylcholine receptor (nAChR) by Macor et al.,<sup><a onclick="showRef(event, 'jm058225db00032'); return false;" href="javascript:void(0);" class="ref jm058225db00032">32</a></sup> and the COX-2 inhibitor celecoxib <b>28</b> was recently reported to potently inhibit carbonic anhydrases hCA II and IX but not hCA I (Figure 9).<sup><a onclick="showRef(event, 'jm058225db00033'); return false;" href="javascript:void(0);" class="ref jm058225db00033">33</a></sup></div><div class="NLM_p">While there are many literature examples of the “designing in” approach for GPCRs, transporters,<a data-tab="pane-pcw-Figures" href="#jm058225df00010" id="" class=" internalNav"></a><a name="jm004802106529" id="jm004802106529"></a> nuclear receptors, proteases, and oxidases, we have so far identified no such examples for kinases or ion channels. Almost certainly, this is due to the fact that obtaining single target ligands for these superfamilies is still a major challenge, and this step has to precede the rational “designing in” of multiple activities, driven by a knowledge of the selective ligand SARs. Kinase DMLs are usually discovered serendipitously through cross-screening ligands from selective kinase programs against a wide panel of other kinases. At the present time, the most feasible strategy for designing multiple kinase inhibitors, acting via the ATP-binding site, appears to be starting from a nonselective inhibitor and attempting to “design out” undesired kinase activities. <div id="_i24"><figure id="jm058225df00010" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00010.jpeg" id="_i25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 10 Structures of DMLs, <b>29</b> and <b>32</b>, that inhibit multiple kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00010"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The clinical effectiveness of imatinib <b>29</b> for the treatment of chronic myelogenous leukemia (CML) first validated the use of kinase inhibitors for the treatment of human disease (Figure 10). Currently there is growing interest in systematically targeting multiple kinases in order to increase efficacy in fighting diseases such as cancer.<sup><a onclick="showRef(event, 'jm058225db00034'); return false;" href="javascript:void(0);" class="ref jm058225db00034">34</a></sup> In addition to its well-known activity as an Abl kinase inhibitor, imatinib has also been found to inhibit two other kinases, PDGFR and c-KIT, that might be involved in producing clinical efficacy. Imatinib was derived from a nonselective inhibitor <b>30</b> with activity at PDGF, PKCα, and Src.<sup><a onclick="showRef(event, 'jm058225db00035'); return false;" href="javascript:void(0);" class="ref jm058225db00035">35</a></sup> The observation of Abl activity for this series was made later.<sup><a onclick="showRef(event, 'jm058225db00036'); return false;" href="javascript:void(0);" class="ref jm058225db00036">36</a></sup> During subsequent optimization, the PKCα and Src activities were “designed out” via the introduction of a “flag methyl” group on the phenylaminopyrimidine scaffold <b>31</b>. Finally a piperidine ring was added to confer good solubility to imatinib <b>29</b>. </div><div class="NLM_p">Compounds from Src kinase inhibitor programs are commonly found to possess activity at Abl, and dual Src/Abl inhibitors are currently of interest for the treatment of CML in patients who are resistant to imatinib because of mutations in the Abl gene. Boschelli et al. found a very close correlation between the Src and Abl SARs, reflecting the close homology of these kinases, and identified a high-affinity DML, <b>32 </b>(Figure 10).<sup><a onclick="showRef(event, 'jm058225db00037'); return false;" href="javascript:void(0);" class="ref jm058225db00037">37</a></sup></div><div class="NLM_p last">The “designing out” strategy has also been applied successfully to other targets with conserved binding sites such as monoamine GPCRs, where broad-spectrum activity is commonly observed. For example, Bonnert et al. successfully “designed out” adrenergic α<sub>1</sub> activity from a dual dopamine D<sub>2</sub>/adrenergic β<sub>2</sub> agonist.<sup><a onclick="showRef(event, 'jm058225db00038'); return false;" href="javascript:void(0);" class="ref jm058225db00038">38</a></sup> Atkinson et al. removed adrenergic β<sub>2</sub> activity from a 5-HT<sub>1A</sub>/SERT ligand.<sup><a onclick="showRef(event, 'jm058225db00039'); return false;" href="javascript:void(0);" class="ref jm058225db00039">39</a></sup> In the peptide GPCR area, Reichard et al. “designed out” NK<sub>3</sub> affinity from a broad-spectrum neurokinin antagonist to give a dual NK<sub>1</sub>/NK<sub>2</sub> antagonist.<sup><a onclick="showRef(event, 'jm058225db00040'); return false;" href="javascript:void(0);" class="ref jm058225db00040">40</a></sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Main Areas of Focus in DML Discovery (1990−2004)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have identified more than 300 references published in the primary medicinal chemistry journals since <a name="jm004802106530" id="jm004802106530"></a> 1990 (Figure 11<a data-tab="pane-pcw-Figures" href="#jm058225df00011" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00041'); return false;" href="javascript:void(0);" class="ref jm058225db00041">41</a></sup> While our literature survey is inevitably incomplete because of the difficulties of tracking relevant articles, we believe that it is illustrative of the activity in the field. Moreover, the primary goal of this review is to focus on state-of-the-art design strategies rather than to provide a comprehensive compendium of multiple ligands. Compounds that were described only in patents or pharmacological journals were excluded, and indeed, many of the pioneering examples of multiple ligands from the pre-1990 period were also not included because the manner of their discovery either was serendipitous or has never been reported in depth. A relatively small number of target combinations have predominated in terms of their percentage share of the total number of publications. During the 1990s, activity was dominated by the angiotensin, thromboxane A<sub>2</sub>, cyclooxygenase, and histamine target areas. More recently, new areas of focus have emerged, such as serotonin receptors, peroxisome proliferator activated receptors (PPARs), kinases, and nitric oxide releasing conjugates. <div id="_i27"><figure id="jm058225df00011" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00011.jpeg" id="_i28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 11 DML examples published in the primary medicinal chemistry literature between 1990 and 2004, classified according to the main areas of focus.<sup>41</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00011"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">5HT Transporter-Based DMLs for Depression</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There has been a long-standing hypothesis that depression is associated with reduced levels of 5-HT in the brain. First-generation tricyclic antidepressants, such as amitriptyline, were efficacious in many patients but suffered from a delayed onset of action as well as exhibiting cardiovascular side effects and toxicity in overdose. Second-generation agents, namely, the SSRIs, were considerably safer but were no better in terms of efficacy or time of onset. In an attempt to address these deficiencies, SERT inhibition has been combined with activity at a secondary monoamine target such as the GPCRs, 5HT<sub>1A</sub>, 5HT<sub>1D</sub>, α<sub>2</sub>, and NK<sub>1</sub> receptors, or the transporters, NET and DAT. </div><div class="NLM_p">The time delay for first- and second-generation drugs has been attributed to the need for the desensitization of 5-HT<sub>1A</sub> autoreceptors by sustained SERT blockade, so mimicking this desensitization by antagonizing 5-HT<sub>1A</sub> autoreceptors might accelerate the onset time. This theory is supported by clinical trials in which 5-HT<sub>1A</sub> antagonists, such as (±)-pindolol, were found to accelerate the antidepressant effect of SSRIs.<sup><a onclick="showRef(event, 'jm058225db00042'); return false;" href="javascript:void(0);" class="ref jm058225db00042">42</a></sup></div><div class="NLM_p">In one of the earliest papers in this area, Perez et al. described hybrids of the 5-HT<sub>1A</sub> antagonist, pindolol<b> 33</b>, and SERT ligands such as milnacipran<b> 34 </b>(Figure 12<a data-tab="pane-pcw-Figures" href="#jm058225df00012" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00043'); return false;" href="javascript:void(0);" class="ref jm058225db00043">43</a></sup> SERT motifs were attached to the 3-aryloxy-2-propanol framework of pindolol via a common nitrogen to give a reasonably well balanced DML <b>35</b>. However, compound <b>35</b> is not very potent, reflecting the relatively low activity of the two starting compounds. <div id="_i30"><figure id="jm058225df00012" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00012.jpeg" id="_i31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 12 Design of a SERT/5HT<sub>1A</sub> ligand <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00012"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">In contrast, Mewshaw et al. started from a template known to possess robust SERT activity <b>36 </b>and added 5-HT<sub>1A</sub> features in the form of the aryloxyethyl group found in <b>37 </b>(Figure 13<a data-tab="pane-pcw-Figures" href="#jm058225df00013" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00044'); return false;" href="javascript:void(0);" class="ref jm058225db00044">44</a></sup> The justification for this approach was that the 5-HT<sub>1A</sub> pharmacophore was particularly well understood, and so this facilitated the incorporation of 5-HT<sub>1A</sub>-conferring functionality. This illustrates an important general point in DML design; namely, that it is often wise to start with a compound for which the most difficult to optimize, or least understood, activity is closest to its required value and then to try to incorporate structural elements that seek to address the more tractable target. Once again, a basic nitrogen was the common feature that allowed the two frameworks to be merged to give <b>38</b>. In this case, it was observed that changes in the SERT derived area of the molecule influenced SERT activity more and that changes in the 5-HT<sub>1A</sub> derived area of the molecule influenced 5-HT<sub>1A</sub> activity more. However, this is by no means always the case, and often all regions of a DML are <a name="jm004802106531" id="jm004802106531"></a> found to affect all activities to a similar extent. The initial piperidine lead <b>38</b> had lower 5-HT<sub>1A</sub> activity than SERT activity and suffered from high adrenergic α<sub>1</sub> activity.<sup><a onclick="showRef(event, 'jm058225db00045'); return false;" href="javascript:void(0);" class="ref jm058225db00045">45</a></sup> By introduction of a secondary amine, there was some improvement obtained in the selectivity over α<sub>1</sub> for <b>39</b>, but cross-reactivity still remained an issue for this series. <div id="_i32"><figure id="jm058225df00013" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00013.jpeg" id="_i33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 13 Design of a SERT/5HT<sub>1A</sub> ligand <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00013"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The slow onset of SSRIs has also been ascribed to a need for the desensitization of terminal 5-HT<sub>1D</sub> receptors, so some researchers aimed for dual SERT/5-HT<sub>1D</sub> blockers, such as Timms et al. at Eli Lilly.<sup><a onclick="showRef(event, 'jm058225db00046'); return false;" href="javascript:void(0);" class="ref jm058225db00046">46</a></sup> Again, the basic nitrogen in both components, <b>40</b> and <b>41</b>, was used to merge the frameworks (Figure 14<a data-tab="pane-pcw-Figures" href="#jm058225df00014" id="" class=" internalNav"></a>). Not only was the<a data-tab="pane-pcw-Figures" href="#jm058225df00015" id="" class=" internalNav"></a> bulky biaryltetrahydropyridine group tolerated by 5-HT<sub>1D</sub>, but its incorporation gave a serendipitous shift from 5-HT<sub>1D</sub> agonism for <b>40 </b>to the desired antagonism for <b>42</b>. However, <b>42</b> suffered from a lack of balance of the two activities as well as cross-reactivity at α<sub>1</sub> and D<sub>2</sub> receptors. In a follow-on paper, Torrado et al. described modifications that significantly reduced α<sub>1</sub> and D<sub>2</sub> affinity, namely, the replacement of the indole by a naphthyl group and the introduction of a methyl group adjacent to the piperazine nitrogen.<sup><a onclick="showRef(event, 'jm058225db00047'); return false;" href="javascript:void(0);" class="ref jm058225db00047">47</a></sup> Finally the introduction of a chloride substituent at C3 gave the best overall profile, <b>43</b>. In this example, both activities were similarly influenced by changes in the thienopyran and naphthylpiperazine regions of the molecule. <div id="_i34"><figure id="jm058225df00014" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00014.jpeg" id="_i35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 14 Design of a SERT/5HT<sub>1D</sub> ligand <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00014"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00015" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00015.jpeg" id="_i36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 15 Design of a SERT/5HT<sub>1A</sub> ligand <b>46</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00015"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Most of the 5-HT examples employ knowledge-based “designing in” strategies. However, successful implementation of an HTS-based strategy was recently reported.<sup>39</sup> HTS was performed using a 5-HT<sub>1A</sub>-expressing cell line, and actives were then triaged by testing for SERT blockade. The high potency of the hit <b>44</b> at 5-HT<sub>1A</sub> might be expected because of the pindolol <b>33</b>-like substructure, so in this case HTS did not produce a novel chemotype (Figure 15). High affinity at β<sub>2</sub> receptors was also observed. It was postulated that this cross-reactivity was due to the presence of an aryloxypropanolamine moiety. The simplified analogue <b>45</b>, lacking the hydroxy and methyl groups, retained 5-HT<sub>1A</sub> and SERT activity and had much reduced β<sub>2</sub> activity. Significantly, this is one of the few examples to date of rationally “designing out” an activity using knowledge of the pharmacophore for the undesired target. To increase potency, conformational constraint was introduced in the region of the basic amine and the indole was replaced by a 5-quinolinyloxy group. Compound <b>46</b> had a good profile together with low clearance in the rat and an oral bioavailability of 45%. The 2-methyl group on the quinoline ring served to protect that position from oxidation by aldehyde oxidase. Compound <b>46</b> was profiled against a panel of other receptors and transporters, and significant activity was only observed at 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptors. </div><div class="NLM_p">Adaptive changes in adrenergic α<sub>2</sub> heteroreceptors have also been implicated in the slow onset time for SSRIs. SERT inhibition may, by increasing 5-HT concentrations, activate not only 5-HT<sub>1</sub> autoreceptors but also α<sub>2</sub> heteroreceptors indirectly by enhancing NE release.<sup><a onclick="showRef(event, 'jm058225db00048'); return false;" href="javascript:void(0);" class="ref jm058225db00048">48</a></sup> Thus, an agent that blocks both SERT and α<sub>2</sub> receptors might increase synaptic 5-HT levels above those achievable with a SSRI and produce a more rapid onset. </div><div class="NLM_p">Meyer et al. identified through screening a hit compound <b>47</b> that had high affinity for the α<sub>2</sub> receptor and modest potency at SERT (Figure 16<a data-tab="pane-pcw-Figures" href="#jm058225df00016" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00049 jm058225db00050'); return false;" href="javascript:void(0);" class="ref jm058225db00049 jm058225db00050">49,50</a></sup> Potency at SERT was increased 8-fold by incorporating the methylenedioxyphenyl group from the potent SERT blocker, paroxetine<b> 48</b>. Replacement of the methylenedioxy group in <b>49</b> by a benzofuran gave a slightly more potent compound, <b>50</b>. Crucially, both activities resided in the <i>R</i>-enantiomer. In the DML field, it is strongly preferred <a name="jm004802106532" id="jm004802106532"></a> that all activities reside in a single enantiomer because if a racemate is used, differences in metabolism between the two enantiomers may over time change the desired ratio of activities. The SAR in the region of the pendant arylethyl group was flat for both the α<sub>2</sub> receptor and the 5-HT transporter. The presence of a tolerant region that is common to both targets allows physicochemical properties, such as solubility, to be manipulated more easily. Changes to the 5-methoxy substituent on the tetralin ring affected SERT activity more than α<sub>2</sub> activity. Compound <b>50</b> is clean at a wider panel of monoamine GPCRs and transporters, except D<sub>2</sub> (<i>K</i><sub>i</sub> = 52 nM) and 5-HT<sub>2</sub> (<i>K</i><sub>i</sub> = 144 nM), and demonstrated activity in the olfactory bulbectomized rat model of depression. <div id="_i37"><figure id="jm058225df00016" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00016.jpeg" id="_i38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 16 Design of a SERT/α<sub>2</sub> ligand <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00016"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Another 5-HT-based approach for the treatment of depression was to combine SERT inhibition with activity at other monoamine transporters.<sup><a onclick="showRef(event, 'jm058225db00051'); return false;" href="javascript:void(0);" class="ref jm058225db00051">51</a></sup> For example, the dual SERT/NET blocker (SNRI), duloxetine<b> 51</b>, is being clinically evaluated as an antidepressant (Figure 17<a data-tab="pane-pcw-Figures" href="#jm058225df00017" id="" class=" internalNav"></a>). Duloxetine belongs to the same aryl benzyl ether series as fluoxetine <b>20</b>. A key difference is the presence of a naphthyl group, which is important for imparting dual activity. <div id="_i39"><figure id="jm058225df00017" data-index="16" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00017.jpeg" id="_i40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 17 Structure of the SNRI ligand, duloxetine <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00017"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Supermixed uptake blockers (SMUBs), which concurrently block the reuptake of 5-HT, NE, and DA, may possess mood-elevating properties and, provided the three potencies are appropriately balanced, may deliver better control of depression than either SSRIs or SNRIs. Axford et al. started from a mixed NE and DA reuptake inhibitor <b>52</b> and attempted to enhance SERT activity (Figure 18<a data-tab="pane-pcw-Figures" href="#jm058225df00018" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00052'); return false;" href="javascript:void(0);" class="ref jm058225db00052">52</a></sup> Pharmacophore models predicted that a bicycloaryl group could be tolerated by all three binding sites, and by introduction of a 2-naphthyl group, SERT activity was increased and NET and DAT activity was retained, <b>53</b>. The 2-(<i>S</i>),3-(<i>S</i>) isomer was active in in vivo models of 5-HT, NE, and DA function. <div id="_i41"><figure id="jm058225df00018" data-index="17" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00018.jpeg" id="_i42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 18 Design of the SMUB ligand <b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00018"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Dopamine D<sub>2</sub>-Receptor Based DMLs for Schizophrenia</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pharmacological treatment of schizophrenia has traditionally been dominated by D<sub>2</sub> antagonists such as haloperidol. While demonstrating efficacy against the positive symptoms of the disease (hallucinations, delusions), haloperidol does not address the negative symptoms (such as social withdrawal) and caused extrapyramidal side effects (EPS) such as Parkinsonism. The “atypical” antipsychotic drug clozapine addresses both positive and negative symptoms without producing EPS but in a few cases causes potentially fatal agranulocytosis. One of a number of possible explanations for this atypical profile is that clozapine has higher antagonist affinity for the 5-HT<sub>2</sub> receptor than it does for the D<sub>2</sub> receptor. This observation led to the so-called “D<sub>2</sub>/5-HT<sub>2</sub> ratio” hypothesis whereby agents with >10-fold selectivity for 5-HT<sub>2</sub> over D<sub>2</sub> were sought. Several atypical antipsychotics with low D<sub>2</sub>/5-HT<sub>2</sub> binding ratios have now been introduced onto the market, such as risperidone,<sup><a onclick="showRef(event, 'jm058225db00053'); return false;" href="javascript:void(0);" class="ref jm058225db00053">53</a></sup> quetiapine,<sup><a onclick="showRef(event, 'jm058225db00054'); return false;" href="javascript:void(0);" class="ref jm058225db00054">54</a></sup> and olanzapine.<sup><a onclick="showRef(event, 'jm058225db00055'); return false;" href="javascript:void(0);" class="ref jm058225db00055">55</a></sup></div><div class="NLM_p">A strategy employed by Lowe et al. at Pfizer was based on ideas first espoused by Ariens in the 1970s. The structure of the endogenous agonist for the D<sub>2</sub> receptor, dopamine <b>54</b>, was modified with a large lipophilic group from the 5-HT ligand <b>55</b>, which transformed the D<sub>2</sub>-agonist activity of the endogenous ligand into an antagonist (Figure 19<a data-tab="pane-pcw-Figures" href="#jm058225df00019" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00056'); return false;" href="javascript:void(0);" class="ref jm058225db00056">56</a></sup> Various heterocyclic groups were selected containing hydrogen-bonding groups that might mimic the phenolic interaction, such as the oxindole found in <b>56</b>. Further optimization involved replacing the naphthyl group by a 1,2-benzisothiazole group (<b>57</b>), which provided D<sub>2</sub> blockade comparable in potency to the typical antipsychotic haloperidol, together with a desirable D<sub>2</sub>/5-HT<sub>2</sub> ratio of 11, comparable to the atypical agent clozapine.<sup><a onclick="showRef(event, 'jm058225db00057'); return false;" href="javascript:void(0);" class="ref jm058225db00057">57</a></sup> The D<sub>2</sub>/α<sub>1</sub> ratio of 0.44 for <b>57</b> is substantially lower than that for clozapine, suggesting that the former should have less propensity to cause orthostatic hypotension. The ratio hypothesis was validated by clinical studies, and <b>57</b> (ziprasidone) was launched in 2001 by Pfizer for the treatment of schizophrenia. <div id="_i44"><figure id="jm058225df00019" data-index="18" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00019.jpeg" id="_i45" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 19 Design of the D<sub>2</sub>/5HT<sub>2A</sub> ligand ziprasidone <b>57</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00019"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">D<sub>4</sub> selective antagonists were found to be ineffective in a phase 2 trial in schizophrenics.<sup>13</sup> Thereafter, it was postulated that the unique profile of clozapine in treating psychosis may be due to a precise ratio of affinities between D<sub>2</sub> and D<sub>4</sub> receptors, with higher affinity required at D<sub>4</sub> than at D<sub>2</sub>. Zhao et al. tried to reproduce this exact ratio with the goal of obtaining D<sub>4</sub> affinity of less than 10 nM, D<sub>2</sub> affinity of less than 200 nM, and to minimize cardiovascular side effects, α<sub>1</sub> affinity above 1000 nM.<sup><a onclick="showRef(event, 'jm058225db00058'); return false;" href="javascript:void(0);" class="ref jm058225db00058">58</a></sup> They started from a nonselective D<sub>2</sub>/D<sub>4</sub>/α<sub>1</sub> compound <b>58</b> discovered via a screening approach (Figure 20<a data-tab="pane-pcw-Figures" href="#jm058225df00020" id="" class=" internalNav"></a>). Introduction of a methyl group in the 2-position of the indoline ring gave a dramatic reduction <a name="jm004802106533" id="jm004802106533"></a> in α<sub>1</sub> activity as well as a slight improvement in D<sub>2</sub><a data-tab="pane-pcw-Figures" href="#jm058225df00021" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm058225df00022" id="" class=" internalNav"></a> activity, <b>59</b>. The <i>R</i> enantiomer <b>60</b> displayed a slightly better profile than the racemate and also had good selectivity against a diverse range of other targets, with limited activity at SERT (IC<sub>50</sub> = 500 nM).<sup><a onclick="showRef(event, 'jm058225db00059'); return false;" href="javascript:void(0);" class="ref jm058225db00059">59</a></sup> It displayed activity in an in vivo test of psychosis, the inhibition of amphetamine-induced locomotor activity, and showed low activity in a catalepsy test, suggesting a low propensity to cause EPS. The behavioral data for this dual antagonist provided support for the “D<sub>2</sub>/D<sub>4</sub> ratio” hypothesis, although the approach still needs clinical validation. <div id="_i46"><figure id="jm058225df00020" data-index="19" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00020.jpeg" id="_i47" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 20 Design of the D<sub>2</sub>/D<sub>4</sub> ligand <b>60</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00020"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00021" data-index="20" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00021.jpeg" id="_i48" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 21 Design of the H<sub>1</sub>/LTD<sub>4</sub> ligand <b>63</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00021"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00022" data-index="21" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00022.jpeg" id="_i49" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 22 Design of the H<sub>1</sub>/5-LO ligand <b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00022"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Histamine H<sub>1</sub> Receptor-Based DMLs for Allergies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Histamine is a primary mediator of the immediate allergic response in humans. H<sub>1</sub> receptor antagonists have found utility in the treatment of hay fever and other allergic reactions but have been largely ineffective for the treatment of asthma.<sup><a onclick="showRef(event, 'jm058225db00060'); return false;" href="javascript:void(0);" class="ref jm058225db00060">60</a></sup> Interestingly, almost all the H<sub>1</sub> antagonists that show some efficacy against asthma are reported to possess additional activities, suggesting that other chemical mediators are also involved in its pathogenesis. As a result, various groups aimed to produce DMLs combining H<sub>1</sub> antagonism with platelet activating factor receptor (PAF), thromboxane-A<sub>2</sub> receptor (TxA<sub>2</sub>R), leukotriene D4 (LTD<sub>4</sub>), or 5-LOX activity. </div><div class="NLM_p">Clinical data had demonstrated that patients treated with a combination of an H<sub>1</sub> antagonist and an LTD<sub>4</sub> antagonist responded better than those treated with a single agent.<sup><a onclick="showRef(event, 'jm058225db00061'); return false;" href="javascript:void(0);" class="ref jm058225db00061">61</a></sup> Zhang et al. screened 22 structurally diverse H<sub>1</sub> antagonists against LTD<sub>4</sub> and found that cyproheptadine<b> 61</b> exhibited weak activity against LTD<sub>4</sub>-induced contraction of guinea pig ileum (50% inhibition at 10 μM) (Figure 21).<sup><a onclick="showRef(event, 'jm058225db00062'); return false;" href="javascript:void(0);" class="ref jm058225db00062">62</a></sup> It was reasoned that the potency could be increased by incorporating structural features from the endogenous agonist LTD<sub>4</sub><b>62</b>, since many LTD<sub>4</sub> analogues showed antagonist activity. Incorporation of an amino acid like group from LTD<sub>4</sub> at the nitrogen of cyproheptadine, a tolerant region, gave <b>63</b>, which had well balanced affinity for both GPCRs. Compound <b>63</b> was tested for inhibitory activity against the antigen-induced contraction of guinea pig trachea and was found to be more efficacious than selective H<sub>1</sub> or LTD<sub>4</sub> antagonists. </div><div class="NLM_p">Since leukotriene biosynthesis is mediated via 5-LOX, an alternative approach was to combine H<sub>1</sub> antagonism with 5-LOX inhibition. The starting points for framework combination were the selective H<sub>1</sub> antagonist <b>64</b> and the 5-LOX inhibitor <b>65 </b>(Figure 22).<sup><a onclick="showRef(event, 'jm058225db00063'); return false;" href="javascript:void(0);" class="ref jm058225db00063">63</a></sup> Once again, the strategy took advantage of the flat SAR around the basic nitrogen of the antihistamine to introduce a butynylhydroxyurea group required for 5-LOX inhibition, <b>66</b>. </div><div class="NLM_p">Ohshima et al. aimed to combine H<sub>1</sub> and TxA<sub>2</sub>R pharmacophores in a single molecule for the treatment of allergies.<sup><a onclick="showRef(event, 'jm058225db00064'); return false;" href="javascript:void(0);" class="ref jm058225db00064">64</a></sup> This endeavor was facilitated by the observation that both the selective H<sub>1</sub> antagonist <b>67</b> and the TxA<sub>2</sub>R antagonist <b>68</b> contained a common benz[<i>b</i>,<i>e</i>]oxepin scaffold (Figure 23<a data-tab="pane-pcw-Figures" href="#jm058225df00023" id="" class=" internalNav"></a>). This example illustrates that it might still be possible to obtain DMLs even for target combinations where the endogenous ligands are highly dissimilar. The tertiary amine group in <b>69</b> successfully mimicked the benzimidazole moiety that was known to be crucial for the TxA<sub>2</sub> activity of <b>68</b>. Compound <b>69</b> was active at both GPCRs, albeit with rather different binding affinities, and was selective over related GPCRs. <div id="_i51"><figure id="jm058225df00023" data-index="22" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00023.jpeg" id="_i52" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 23 Design of the H<sub>1</sub>/TxA<sub>2</sub> ligand <b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00023"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Aslanian et al. aimed for a dual H<sub>1</sub>/H<sub>3</sub> antagonist for the treatment of allergic diseases such as nasal congestion.<sup><a onclick="showRef(event, 'jm058225db00065'); return false;" href="javascript:void(0);" class="ref jm058225db00065">65</a></sup> The approach was based on the combination of structural features from the H<sub>1</sub> antagonist <b>70</b> and the alkylamine class of H<sub>3</sub> antagonists <b>71</b>, using a common nitrogen as an anchor group, <b>72 </b>(Figure 24<a data-tab="pane-pcw-Figures" href="#jm058225df00024" id="" class=" internalNav"></a>). <div id="_i53"><figure id="jm058225df00024" data-index="23" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00024.jpeg" id="_i54" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 24 Design of the H<sub>1</sub>/H<sub>3</sub> ligand <b>72</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00024"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The most advanced area of “H<sub>1</sub> plus” research from a clinical perspective has been dual H<sub>1</sub>/PAF receptor antagonism. PAF appears to act alongside HA in the pathogenesis of the allergic response. </div><div class="NLM_p"><a name="jm004802106534" id="jm004802106534"></a>Piwinski et al. observed that the H<sub>1</sub> antagonist <b>73</b> (loratidine) was a very weak PAF antagonist (Figure 25<a data-tab="pane-pcw-Figures" href="#jm058225df00025" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00066'); return false;" href="javascript:void(0);" class="ref jm058225db00066">66</a></sup> To increase the PAF activity, the ethoxycarbonyl group was replaced by a simple acetamide <b>74</b>. The SAR for PAF and H<sub>1</sub> receptors was fundamentally different, reflecting the difference in the lipophilicity of the endogenous ligands. The series was further optimized by replacing the acetamide by a 3-pyridylmethyl group <b>75</b>, which was 25-fold more active than <b>74 </b>in the H<sub>1</sub> assay and marginally less active in the PAF assay.<sup><a onclick="showRef(event, 'jm058225db00067'); return false;" href="javascript:void(0);" class="ref jm058225db00067">67</a></sup> Compound <b>75</b> (rupatidine, UR-12592) was more active than loratidine in an HA-dependent in vivo test of passive cutaneous anaphylactic shock after oral dosing and has been launched by Uriach for the treatment of allergic rhinitis. <div id="_i55"><figure id="jm058225df00025" data-index="24" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00025.jpeg" id="_i56" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 25 Design of the H<sub>1</sub>/PAF ligand <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00025"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">The possibility that combined blockade of H<sub>1</sub> and NK<sub>1</sub> receptors might produce added therapeutic benefit led to the exploration of dual inhibitors by Maynard et al<i>.</i><sup><a onclick="showRef(event, 'jm058225db00068'); return false;" href="javascript:void(0);" class="ref jm058225db00068">68</a></sup> On the basis of an understanding of the SARs for H<sub>1</sub> and NK<sub>1</sub> antagonists such as <b>76</b> and <b>77</b>, it was predicted that hybrid structures such as <b>78</b> would retain NK<sub>1</sub> affinity (Figure 26<a data-tab="pane-pcw-Figures" href="#jm058225df00026" id="" class=" internalNav"></a>). The compounds from this series were subjected to CoMFA analsis. This indicated that the benzamide end of the molecule <b>78</b> harbored the NK<sub>1</sub> activity without significantly affecting H<sub>1</sub> activity. Variations to the benzimidazole end affected H<sub>1</sub> activity much more than NK<sub>1</sub> activity. Supporting this observation, overlays of <b>78</b> with selective H<sub>1</sub> and NK<sub>1</sub> antagonists indicated little in common between them. <div id="_i57"><figure id="jm058225df00026" data-index="25" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00026.jpeg" id="_i58" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 26 Design of the H<sub>1</sub>/NK<sub>1</sub> ligand <b>78</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00026"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">DMLs Targeting the Angiotensin System for Hypertension</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiotensin converting enzyme (ACE) inhibitors, such as captopril <b>79</b>, gained wide acceptance for the treatment of hypertension and congestive heart failure (Figure 27<a data-tab="pane-pcw-Figures" href="#jm058225df00027" id="" class=" internalNav"></a>). Neutral endopeptidase (NEP) is another metallopeptidase that is responsible for the degradation of atrial natriuretic peptide (ANP), a peptide hormone with opposing actions to those of angiotensin II (AT-II), which is released by the heart in response to atrial distension and causes vasodilatation. Consequently, it has been postulated that dual ACE/NEP inhibition may produce a beneficial synergistic effect in the management of hypertension and congestive heart failure. <div id="_i60"><figure id="jm058225df00027" data-index="26" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00027.jpeg" id="_i61" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 27 Design of the ACE/NEP ligand omapatrilat <b>82</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00027"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">One of the earliest dual ACE/NEP inhibitors, dipeptide <b>80</b>, was rationally designed using the knowledge of binding requirements for both enzymes. NEP favors a hydrophobic substituent at S1‘, preferably a benzyl group such as that present in the NEP selective inhibitor <b>81</b> (SQ28603), whereas ACE is more tolerant in this region but strongly favors a proline residue at P<sub>2</sub>‘.<sup><a onclick="showRef(event, 'jm058225db00069'); return false;" href="javascript:void(0);" class="ref jm058225db00069">69</a></sup> To further improve the in vitro and in vivo potency, a group at Bristol-Myers Squibb (BMS) focused their optimization efforts on conformationally restricted dipeptide mimetics. A range of diverse constrained analogues have been designed by drawing extensively from the SAR generated for selective ACE inhibitors. One of main challenges for optimization within this series proved to be a relatively tight SAR for NEP. Fortuitously, this was counterbalanced by a remarkably flexible SAR for ACE. One of the most successful biomimetics was a series of <a name="jm004802106535" id="jm004802106535"></a> 7,6- and 7,5-fused bicyclic thiazepinones and oxazepinones. Omapatrilat<b> 82</b> displayed high ACE/NEP potency and the best pharmacokinetic profile in this series, so it was advanced into clinical development for treatment of hypertension.<sup><a onclick="showRef(event, 'jm058225db00070'); return false;" href="javascript:void(0);" class="ref jm058225db00070">70</a></sup></div><div class="NLM_p">Scientists at Marion Merrell Dow also employed a constrained dipeptide mimetic strategy for the design of dual ACE/NEP inhibitors except that instead of starting from a known inhibitor like the BMS group, they adopted a substrate-based approach. This strategy is based on the fact that the two proteases cleave similar dipeptide fragments from their natural substrates, indicating topological similarity within the prime sides of their active sites, the region to which inhibitors such as captopril and SQ 28603 bind. Therefore, a highly constrained anti phenylalanine containing dipeptide mimetic <b>83</b> was designed to mimic a postulated low-energy conformation of the His-Leu portion of angiotensin I bound to ACE and the Phe-Leu portion of Leu-enkephalin bound to NEP (Figure 28<a data-tab="pane-pcw-Figures" href="#jm058225df00028" id="" class=" internalNav"></a>). Indeed, the corresponding mercaptoacetyl derivative <b>84</b> was found to be a highly potent inhibitor of both ACE and NEP.<sup><a onclick="showRef(event, 'jm058225db00071'); return false;" href="javascript:void(0);" class="ref jm058225db00071">71</a></sup><div id="_i62"><figure id="jm058225df00028" data-index="27" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00028.jpeg" id="_i63" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 28 Design of the ACE/NEP ligand <b>84</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00028"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">One of potential limitations of the ACE/NEP dual inhibition approach is an increase in plasma levels of endothelin I (ET-1), a vasoconstricting peptide similar to angiotensin II that is degraded by NEP. This might be overcome by additionally inhibiting endothelin converting enzyme (ECE-1), a closely related zinc metallopeptidase involved in ET-1 formation that has a 51% homology to NEP in the active site region. To tackle the challenge of designing a triple inhibitor, Roques et al. synthesized noncyclic constrained compounds that interact with the S1‘ and S2‘ subsites of the three enzymes and bear a thiol group as the zinc ligand, with the general formula HSCH<sub>2</sub>CH(P1‘)CO-Trp-OH. It was reasoned that a noncyclic constraint should still lead to increased affinity by reducing the entropy loss upon binding, but unlike cyclic constraints, there would be some residual structural flexibility that would allow for adaptation at each of the three active sites. Owing to the importance of the P2‘ tryptophan residue for interacting with the S2‘ subsite of ECE-1, this group was held constant. One of the best compounds derived from this approach was the indanyl analogue <b>85</b> displaying potent triple inhibition (Figure 29<a data-tab="pane-pcw-Figures" href="#jm058225df00029" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00072'); return false;" href="javascript:void(0);" class="ref jm058225db00072">72</a></sup><div id="_i64"><figure id="jm058225df00029" data-index="28" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00029.jpeg" id="_i65" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 29 Structure of the ACE/NEP/ECE-1 ligand <b>85</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00029"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Like ACE inhibitors, AT-II receptor antagonists are clinically efficacious agents for controlling hypertension. The first agents introduced to the market, such as <a name="jm004802106536" id="jm004802106536"></a> losartan, were selective for the AT<sub>1</sub> receptor over the AT<sub>2</sub> receptor. Antagonism of the AT<sub>1</sub> receptor was found to result in an elevation of circulating angiotensin II levels, which has the potential to lead to an overstimulation of AT<sub>2</sub> receptors. Therefore, it was thought that a dual AT<sub>1</sub>/AT<sub>2</sub> ligand might have clinical advantages. </div><div class="NLM_p">Screening of a number of AT<sub>1</sub> selective quinazolinones at the AT<sub>2</sub> receptor revealed compounds with weak activity, such as <b>86 </b>(Figure 30<a data-tab="pane-pcw-Figures" href="#jm058225df00030" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm058225df00031" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00073'); return false;" href="javascript:void(0);" class="ref jm058225db00073">73</a></sup> The introduction of a propyl group in the 2-position, together with increasing the size of the 6 substituent, led to a well balanced antagonist, <b>87</b>, that was active orally in inhibiting the pressor response in normotensive rats to exogenously administered AT-II. An ex vivo binding assay using plasma samples from the dosing of normotensive rats with <b>87</b> was used to confirm that balanced AT<sub>1</sub>/AT<sub>2</sub> inhibition was maintained in vivo. Clearly, when working with DMLs, it is important to confirm that balanced activity in a simple in vitro assay translates into an appropriate balance in a whole animal. <div id="_i66"><figure id="jm058225df00030" data-index="29" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00030.jpeg" id="_i67" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 30 Design of the AT<sub>1</sub>/AT<sub>2</sub> ligand <b>87</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00030"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00031" data-index="30" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00031.jpeg" id="_i68" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 31 Design of the angiotensin/endothelin receptor ligand <b>89</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00031"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">A combination of the AT<sub>1</sub> selective antagonist losartan and the ET<sub>A</sub>/ET<sub>B</sub> selective antagonist SB-290670 produced an additive reduction in blood pressure compared to either drug alone, prompting groups at Merck and BMS to develop simultaneous blockers of AT<sub>1</sub> and ET<sub>A</sub> receptors.<sup><a onclick="showRef(event, 'jm058225db00074'); return false;" href="javascript:void(0);" class="ref jm058225db00074">74</a></sup> Fortunately, these two peptide-binding GPCRs share a number of structural and functional similarities. The aromatic-containing amino acids at positions 13 and 14 of the endothelins, as well as the C-terminal acid, are crucial for ET<sub>A</sub> binding. Conveniently, such groups are appropriately positioned in some non-peptide AT<sub>1</sub> antagonists, and this prompted Merck to conduct a focused screen of AT<sub>1</sub> ligands for ET<sub>A</sub> affinity.<sup><a onclick="showRef(event, 'jm058225db00075'); return false;" href="javascript:void(0);" class="ref jm058225db00075">75</a></sup> Compounds with weak ET<sub>A</sub> activity were identified, such as <b>88 </b>(Figure 31). Incorporation of a benzodihydrofuran and an acylsulfonamide acid isostere gave ligand <b>89</b>, which exhibited balanced activity at all four receptors. </div><div class="NLM_p">The design strategy followed by Murugesan et al. was based on the observation that both the selective AT<sub>1</sub> and ET<sub>A</sub> antagonists, <b>90</b> and <b>91</b>, respectively, contain a biaryl core (Figure 32<a data-tab="pane-pcw-Figures" href="#jm058225df00032" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00076'); return false;" href="javascript:void(0);" class="ref jm058225db00076">76</a></sup> Fortuitously the heterocycle in the 4‘-position of the biaryl, required for AT<sub>1</sub> activity, was tolerated by ET<sub>A</sub>, albeit with reduced affinity. The <a name="jm004802106537" id="jm004802106537"></a> acylsulfonamide moiety was found to be a carboxylic acid bioisostere that was suitable for both receptors. By introduction of a new substituent in the C2‘ position of the biaryl, a balanced dual activity at AT<sub>1</sub> and ET<sub>A</sub> receptors was obtained, <b>92</b>. Interestingly, unlike <b>89</b>, this compound was selective over AT<sub>2</sub> and ET<sub>B</sub> receptors. <div id="_i69"><figure id="jm058225df00032" data-index="31" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00032.jpeg" id="_i70" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 32 Design of the AT<sub>1</sub>/ET<sub>A</sub> receptor ligand <b>93</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00032"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Good oral bioavailability was observed in rats (<i>F</i> = 38%), but this compound was found to have lower oral<a data-tab="pane-pcw-Figures" href="#jm058225df00033" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm058225df00034" id="" class=" internalNav"></a> bioavailability in dogs and monkeys (<10%). Further optimization focused on reducing the molecular weight and the number of hydrogen-bonding groups and addressing a site of metabolism on the 5-aminoisoxazole ring.<sup><a onclick="showRef(event, 'jm058225db00077'); return false;" href="javascript:void(0);" class="ref jm058225db00077">77</a></sup> Incorporation of a 3-isoxazole solved this metabolism problem, and the use of a 2‘-ethoxymethyl substituent helped to lower the molecular weight. Compound <b>93</b> showed good oral bioavailability in rats, dogs, and monkeys (40%, 86%, and 21% respectively) and was superior to irbesartan in the spontaneously hypertensive rat model, demonstrating the synergy of AT<sub>1</sub> and ET<sub>A</sub> blockade. <div id="_i71"><figure id="jm058225df00033" data-index="32" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00033.jpeg" id="_i72" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 33 Structures of the COX/5-LOX ligands <b>94 </b>and <b>95</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00033"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00034" data-index="33" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00034.jpeg" id="_i73" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 34 Structures of the COX/5-LOX ligands <b>97</b>−<b>99</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00034"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Nonsteroidal Anti-Inflammatory Drugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NSAIDs exert their anti-inflammatory effect by inhibiting COX-1 and COX-2, key enzymes in prostaglandin (PG) biosynthesis from arachidonic acid.<sup><a onclick="showRef(event, 'jm058225db00078'); return false;" href="javascript:void(0);" class="ref jm058225db00078">78</a></sup> Side effects often limit their use, in particular gastrointestinal ulcerogenic activity and renal toxicity.<sup><a onclick="showRef(event, 'jm058225db00079'); return false;" href="javascript:void(0);" class="ref jm058225db00079">79</a></sup> In contrast to the “single target” strategy adopted for COX-2 inhibitors like celecoxib <b>28</b>, a number of DML approaches targeting various key proteins involved inarachidonic acid biosynthesis have been reported. These include combinations of COX/5-LOX, 5-LOX/TxA<sub>2</sub>S, and TxA<sub>2</sub>R/TxA<sub>2</sub>S. </div><div class="NLM_p">NSAID-induced gastric toxicity may involve the shunting of arachidonic acid metabolism from the COX to the 5-LOX pathway, thereby producing proinflammatory and gastrotoxic leukotrienes such as LTB<sub>4</sub>.<sup><a onclick="showRef(event, 'jm058225db00080'); return false;" href="javascript:void(0);" class="ref jm058225db00080">80</a></sup> Thus, combined inhibition of COX and 5-LOX may provide safer and more effective NSAIDs.<sup><a onclick="showRef(event, 'jm058225db00081'); return false;" href="javascript:void(0);" class="ref jm058225db00081">17,81</a></sup></div><div class="NLM_p">A hypothesis suggesting important roles for free radicals in the inflammatory process led to the serendipitous discovery of the “redox-based” class of COX/5-LOX dual inhibitors. One of the earliest such compounds was R-830, <b>94</b>, and its anti-inflammatory efficacy was attributed to antioxidant and radical scavenging properties of the phenol group (Figure 33).<sup><a onclick="showRef(event, 'jm058225db00082'); return false;" href="javascript:void(0);" class="ref jm058225db00082">82</a></sup> The 2,6-di-<i>tert</i>-butyl-1-hydroxy substitution pattern was shown to be optimal for dual inhibition and in vivo activity. Reducing the size of one of the <i>tert</i>-butyl groups had no detrimental effect on the in vitro profile, but the resulting derivatives lacked in vivo efficacy, possibly because of rapid phase II metabolism.<sup><a onclick="showRef(event, 'jm058225db00083'); return false;" href="javascript:void(0);" class="ref jm058225db00083">83</a></sup> Optimization activities therefore focused almost entirely on the 4-position, which proved to be more tolerant of change. Researchers at Parke-Davis aimed to improve the generally poor aqueous solubility of this class of compounds, with a range of ionizable groups in the 4-position. This work led to the discovery of a potent DML PD-136095, <b>95</b>, which possessed favorable physicochemical and pharmacokinetic properties.<sup><a onclick="showRef(event, 'jm058225db00084'); return false;" href="javascript:void(0);" class="ref jm058225db00084">84</a></sup></div><div class="NLM_p">Henichart et al. designed a dual COX-2/5-LOX inhibitor by fusing the tricyclic moiety present in celecoxib <b>28</b> with a aryltetrahydropyran moiety from the 5-LOX inhibitor, <b>96 </b>(ZD-23138) (Figure 34).<sup><a onclick="showRef(event, 'jm058225db00085'); return false;" href="javascript:void(0);" class="ref jm058225db00085">85</a></sup> Both starting compounds were completely inactive at the second target, but the resulting DML <b>97</b> possessed nanomolar potencies for both enzymes, as well as surprising selectivity for COX-2 over COX-1. Modeling studies revealed that the aryltetrahydropyran group actually enhanced affinity for COX-2 by interacting positively with several amino acids in its active site. </div><div class="NLM_p"><a name="jm004802106538" id="jm004802106538"></a>An observation that arachidonoyl hydroxamate is a potent inhibitor of 5-LOX,<sup><a onclick="showRef(event, 'jm058225db00086'); return false;" href="javascript:void(0);" class="ref jm058225db00086">86</a></sup> presumably because of chelation of the iron in the enzyme catalytic site, led to the development of a range of hydroxamic acid and <i>N</i>-hydroxyurea-based 5-LOX selective inhibitors.<sup><a onclick="showRef(event, 'jm058225db00087'); return false;" href="javascript:void(0);" class="ref jm058225db00087">87</a></sup> This finding has also been successfully used in the rational design of dual inhibitors such as <b>98</b>, which is a result of the combination of the tricyclic core characteristic of<a data-tab="pane-pcw-Figures" href="#jm058225df00035" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm058225df00036" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm058225df00037" id="" class=" internalNav"></a> selective COX-2 inhibitors such as celecoxib <b>28</b> and the iron-chelating hydroxamic acid of 5-LOX inhibitors.<sup><a onclick="showRef(event, 'jm058225db00088'); return false;" href="javascript:void(0);" class="ref jm058225db00088">88</a></sup><div id="_i75"><figure id="jm058225df00035" data-index="34" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00035.jpeg" id="_i76" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 35 Design of the TxA<sub>2</sub>/5-LOX ligand <b>101</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00035"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00036" data-index="35" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00036.jpeg" id="_i77" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 36 Design of the TxA<sub>2</sub>R/TxA<sub>2</sub>S ligand <b>104</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00036"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058225df00037" data-index="36" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00037.jpeg" id="_i78" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 37 Design of the TxA<sub>2</sub>R/TxA<sub>2</sub>S ligand <b>108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00037"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Licofelone <b>99</b>, first reported in 1994 by scientists at Merckle GmbH, is currently in phase III clinical studies for the potential treatment of osteoarthritis (Figure 34). Lacking an iron-chelating functionality and antioxidant properties, the compound is considered a substrate-based inhibitor. A good alignment of licofelone with a hypothetical conformation of arachidonic acid bound to COX and LOX has been achieved. The carboxylic acids overlap, and the two aromatic groups in <b>99</b> match the double bonds of arachidonic acid.<sup><a onclick="showRef(event, 'jm058225db00089'); return false;" href="javascript:void(0);" class="ref jm058225db00089">89</a></sup></div><div class="NLM_p">Arachidonic acid is converted by COX enzymes into prostaglandin H<sub>2</sub> (PGH<sub>2</sub>), which in turn is converted by TxA<sub>2</sub> synthase (TxA<sub>2</sub>S) into TxA<sub>2</sub>. Increased levels of LTB<sub>4</sub> and TxB<sub>2</sub>, the stable metabolite of TxA<sub>2</sub>, have been associated with inflammatory bowel disease, stimulating an interest in developing dual inhibitors of 5-LOX and TxA<sub>2</sub>S. Hibi et al. started from a selective 5-LOX inhibitor, E6080 <b>100</b>, into which they incorporated a pyridine moiety known for its potential to coordinate the iron atom in the enzyme catalytic site (Figure 35).<sup><a onclick="showRef(event, 'jm058225db00090'); return false;" href="javascript:void(0);" class="ref jm058225db00090">90</a></sup> Whereas the replacement of the phenylsulfonamide group in <b>100</b> with a methylene-3-pyridinyl moiety was unsuccessful, attachment of the pyridinyl substitution to the phenol portion of the molecule led to a series of compounds displaying a well balanced dual profile, of which compound <b>101</b> was most potent. </div><div class="NLM_p">TxA<sub>2</sub>R activation triggers platelet aggregation, vasoconstriction, and bronchoconstriction, so targeting the TxA<sub>2</sub> pathway is of interest for the treatment of cardiovascular, renal, and pulmonary diseases. Selective TxA<sub>2</sub>R antagonists and TxA<sub>2</sub>S inhibitors were developed as antiplatelet agents, but clinical results were disappointing. The lack of efficacy was attributed to the accumulation of PGH<sub>2</sub>, which itself is a potent agonist of TxA<sub>2</sub>R.<sup><a onclick="showRef(event, 'jm058225db00091'); return false;" href="javascript:void(0);" class="ref jm058225db00091">91</a></sup> It was therefore hypothesized that dual blockers of TxA<sub>2</sub>R and TxA<sub>2</sub>S may show improved efficacy by simultaneously blocking the actions of both TxA<sub>2</sub> and PGH<sub>2</sub> while conveniently shunting PGH<sub>2</sub> metabolism toward beneficial PGI<sub>2</sub> with its vasodilating and platelet aggregation inhibitory effects.<sup><a onclick="showRef(event, 'jm058225db00092 jm058225db00093'); return false;" href="javascript:void(0);" class="ref jm058225db00092 jm058225db00093">92,93</a></sup></div><div class="NLM_p">The essential structural features of TxA<sub>2</sub>S inhibitors such as isbogrel<b> 102</b> are a pyridine nitrogen and a carboxylic group separated by a distance range between 8.5 and 10 Å (Figure 36).<sup><a onclick="showRef(event, 'jm058225db00094'); return false;" href="javascript:void(0);" class="ref jm058225db00094">94</a></sup> Since TxA<sub>2</sub>S is a cytochrome P-450 enzyme, it was postulated that the pyridine moiety forms a complex with the heme group of the enzyme catalytic site. A key feature of TxA<sub>2</sub>R antagonists such as daltroban<b> 103</b> is a carboxylic acid separated by a nonspecific spacer from a benzenesulfonamide group. Integration of the TxA<sub>2</sub>S and TxA<sub>2</sub>R features produced compounds such as samixogrel<b> 104</b>, which showed low nanomolar activity at both targets.<sup><a onclick="showRef(event, 'jm058225db00095'); return false;" href="javascript:void(0);" class="ref jm058225db00095">95</a></sup></div><div class="NLM_p last">Adopting a similar approach, researchers at Pfizer combined structural features from the TxA<sub>2</sub>R antagonists sulotroban<b> 105</b> with an imidazole-containing TxA<sub>2</sub>S inhibitor <b>106</b> to give <b>107 </b>(Figure 37). Replacement of the imidazolyl group with a pyridinyl group resulted in increased potency at both targets, <b>108</b>.<sup><a onclick="showRef(event, 'jm058225db00096'); return false;" href="javascript:void(0);" class="ref jm058225db00096">96</a></sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">PPAR-Based DMLs for Metabolic Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a name="jm004802106539" id="jm004802106539"></a>The realization that the fibrate class of drugs used to treat dyslipidemia and the insulin-sensitizing thiazolidine-2,4-dione derivatives (glitazones) used in treatment of type 2 diabetes, exerting their effects through activation of PPARα and PPARγ, respectively, led to an explosion of research in this field and the development of selective ligands for each of the PPAR receptor subtypes. However, recent findings suggest that insulin resistance, dyslipidemia, and obesity can be seen as components of a complex mixture of abnormalities known as “metabolic syndrome”. This has stimulated interest in developing dual PPARα and PPARγ agonists.<sup><a onclick="showRef(event, 'jm058225db00097'); return false;" href="javascript:void(0);" class="ref jm058225db00097">97</a></sup> Dual agonists might be expected to show reduced PPARγ-mediated side effects, like weight gain and fluid retention. </div><div class="NLM_p">The first reported “balanced” dual agonist, KRP-297 <b>110</b>, was identified through the testing of thiazolidine (TZD) derivatives of the PPARγ selective agonist troglitazone <b>109</b> in in vivo models of hyperglycemia and hyperlipidemia in genetically obese ob/ob mice (Figure 38<a data-tab="pane-pcw-Figures" href="#jm058225df00038" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00098'); return false;" href="javascript:void(0);" class="ref jm058225db00098">98</a></sup> The compound demonstrated superior efficacy compared to troglitazone. It was only later that the compound's dual in vitro profile was established, leading the authors to conclude that the superior in vivo pharmacological effects of KRP-297 could be attributed to its activation of both subtypes. <div id="_i80"><figure id="jm058225df00038" data-index="37" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00038.jpeg" id="_i81" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 38 Design of the PPARα/γ dual agonist <b>110</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00038"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">TZD derivatives were shown to completely racemize under physiological conditions. To avoid this problem, scientists at Novo Nordisk combined structural features of TZD-containing rosiglitazone <b>111</b>, a marketed PPARγ agonist, and the alkoxypropionic acid class of insulin sensitizers known for their reduced tendency for racemization (Figure 39<a data-tab="pane-pcw-Figures" href="#jm058225df00039" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00099'); return false;" href="javascript:void(0);" class="ref jm058225db00099">99</a></sup> This approach led to identification of the initial tricyclic lead <b>112</b> showing moderate but balanced dual activity. Molecular modeling studies based on the 3D structure of rosiglitazone cocrystallized with the PPARγ ligand binding domain (LBD) suggested a preference for planar tricyclic systems in the lipophilic “tail” region, which led to the discovery of the carbazole analogue <b>113</b>, a more potent PPARα/γ dual agonist showing around 10-fold selectivity over PPARδ. <div id="_i82"><figure id="jm058225df00039" data-index="38" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00039.jpeg" id="_i83" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 39 Design of the PPARα/γ/δ triple agonist <b>115</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00039"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Following reports that PPARδ selective agonists show increased levels of HDL cholesterol and decreased levels of triglycerides in obese monkeys, the same group further elaborated <b>113</b> with the aim of building in PPARδ activity and developing ligands with a pan-agonist PPARα/γ/δ profile.<sup><a onclick="showRef(event, 'jm058225db00100'); return false;" href="javascript:void(0);" class="ref jm058225db00100">100</a></sup> They retained the acid component of the dual PPARα/γ agonist and focused on modifications to the lipophilic “tail”. Opening the carbazole central ring and replacing the nitrogen with an sp<sup>2</sup> carbon led to the biphenyl analogue <b>114</b> with balanced activity across all three subtypes. The SAR exploration around phenyl rings of <b>114</b> showed that large and lipophilic groups are preferred in this region and ultimately led to identification of bis-biphenyl derivative <b>115</b> with more potent triple activity. </div><div class="NLM_p last">An interesting combination of screening and structure-based approaches, reported by a group at Eli Lilly,<sup><a onclick="showRef(event, 'jm058225db00101'); return false;" href="javascript:void(0);" class="ref jm058225db00101">101</a></sup> resulted in the identification of carboxylic acid <b>116</b> containing a bulky lipophilic group in the α-position as a moderate dual PPARα/γ agonist (Figure 40<a data-tab="pane-pcw-Figures" href="#jm058225df00040" id="" class=" internalNav"></a>). The fact that <b>116</b> exhibited activity for both targets despite lacking the lipophilic “tail” characteristic of PPAR ligands suggested that the α-benzyl group might improve the binding affinity of <b>117</b>, a well balanced dual agonist. The α-benzyl derivative <b>118</b> indeed showed improved activity at both PPARα and PPARγ. Shifting the oxygen adjacent to the quaternary stereogenic center in <b>118</b> to the alternative benzylic position provided a significantly more potent dual agonist <b>119</b>. <div id="_i84"><figure id="jm058225df00040" data-index="39" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00040.jpeg" id="_i85" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 40 Design of the PPARα/γ dual agonist <b>119</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00040"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">The Physicochemical Challenge</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a name="jm004802106540" id="jm004802106540"></a>Given the need to satisfy two or more sets of stringent pharmacophoric requirements, it might be expected that sufficiently potent DMLs would be larger and more structurally complex than ligands that are selective for a single target. As we have previously reported, the average molecular weight for DMLs is considerably higher than that for marketed oral CNS or non-CNS drugs.<sup>9</sup> Larger, more lipophilic, and more flexible molecules are often associated with poorer oral absorption profiles, and yet this route of administration is required for most DMLs.<sup><a onclick="showRef(event, 'jm058225db00102 jm058225db00103'); return false;" href="javascript:void(0);" class="ref jm058225db00102 jm058225db00103">102,103</a></sup> So optimizing the pharmacokinetics, in addition to attaining a balanced profile, is usually the most challenging aspect of working with DMLs. Many DML lead compounds have molecular weights well above 500 and clogP values greater than 5. To improve PK profiles, a strong emphasis has often been required during lead optimization on simplifying the structures by removing functionality and rotatable bonds. As described above, Murugesan et al. successfully improved the oral bioavailability of the AT<sub>1</sub>/ET<sub>A</sub> antagonist <b>92</b>. Mah et al. simplified the structure of the NK<sub>1</sub>/NK<sub>2</sub> lead compound, <b>120</b>, to give a biaryl derivative <b>121</b> that possessed good oral bioavailability while maintaining the desired receptor profile (Figure 41<a data-tab="pane-pcw-Figures" href="#jm058225df00041" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm058225db00104'); return false;" href="javascript:void(0);" class="ref jm058225db00104">104</a></sup><div id="_i87"><figure id="jm058225df00041" data-index="40" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00041.jpeg" id="_i88" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 41 Simplification of a NK<sub>1</sub>/NK<sub>2</sub> ligand, <b>120</b>, during lead optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00041"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Where the pharmacophores are fundamentally different, it may not be possible to integrate the requirements of both binding sites into a small and compact molecule, and a higher molecular weight conjugate may be unavoidable. Inevitably, this will mean that some combinations of targets will be more difficult, if not impossible, to address with a “druglike” molecule. It is likely that rationally designing multiple ligands is most feasible where the targets are more similar, in terms of binding the same endogenous ligand or belonging to the same superfamily. While many DMLs reported in the literature thus far have the desired in vitro profile, they lack the in vivo activity and PK profile required for their further development as oral drugs. Nonetheless, such DMLs may represent useful pharmacological tools to validate particular target combinations, particularly if in vitro methods of target validation are available. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds that act at multiple targets often deliver superior efficacy against complex diseases compared to compounds with high specificity for a single target. Consequently, there is increasing interest in the identification and validation of new target combinations that are attractive from both a disease-relevance and druggability perspective. Furthermore, combining existing targets, many of which are clinically validated and druggable, is one possible way of expanding the “biological space” that is available for drug discovery and improving the productivity of the pharmaceutical industry. </div><div class="NLM_p">Our aim in this review has been to highlight the gradual emergence of an exciting new area for medicinal chemists, particularly for those working in disease areas where selective agents often lack clinical efficacy. Already, the literature contains many elegant and increasingly rational approaches to the discovery of DMLs. To address the “physicochemical challenge”, more sophisticated design strategies and computational tools will certainly be needed. Rather than simply merging predefined molecular frameworks found in selective ligands, increasingly DMLs will be designed and optimized at the level of their underlying pharmacophores. Greater application of biostructural information and pharmacophore modeling will facilitate the “designing in” of desired activities and the “designing out” of undesired cross-reactivities. Computational tools that can rapidly search for commonalities in binding sites will help predict those targets that are phylogenetically distant but still have similar surface cavities.<sup><a onclick="showRef(event, 'jm058225db00105'); return false;" href="javascript:void(0);" class="ref jm058225db00105">105</a></sup> By delineating cellular signaling networks, the emerging field of systems biology has the clear potential to identify the inherent redundancy within many biological systems that provides the opportunity for achieving higher efficacy with a DML. </div><div class="NLM_p last">Inevitably, medicinal chemists will face target combinations that are particularly compelling in terms of biological rationale but are problematical from the perspective of combining appropriately balanced in vitro and in vivo activities with acceptable oral <a name="jm004802106541" id="jm004802106541"></a> bioavailability, duration of action, and safety. In many cases, alternative formulations and routes of administration will need to be investigated. The systematic discovery of multiple ligands is a field that presents future drug discoverers with many challenges and opportunities in their quest for superior medicines. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Richard Morphy</b> completed his B.Sc. (1985) and Ph.D. at Durham University (U.K.) before becoming a medicinal chemist at Celltech in Slough (U.K.) in 1989. Since 1995, he has worked at Organon Laboratories in Scotland and is currently a Section Head in the Medicinal Chemistry Department. His work on a number of CNS-related projects has led to a keen interest in the area of designing multiple ligands. </div><div class="NLM_p last"><b>Zoran Rankovic </b>received his Ph.D. degree in organic chemistry from the University of Leeds (U.K.). In 1995 he joined Organon Laboratories in Scotland and is currently a Medicinal Chemistry Section Head with research interests in the CNS and CV fields, in particular in the design of multiple ligands. </div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Morphy</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Organon Laboratories, Newhouse, Lanarkshire, ML1 5SH, U.K. </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zoran Rankovic</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Department, Organon Laboratories, Newhouse, Lanarkshire, ML1 5SH, U.K. </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm058225d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><a name="jm004802106542" id="jm004802106542"></a></div><p class="references-count">
            This article references 105 other publications.
        </p><ol id="references" class="useLabel"><li id="jm058225db00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm058225db00001_1"><span><span class="NLM_string-ref">Roth, B. L.; Sheffler, D. J.; Kroeze, W. K. Magic shotguns versus magic bullets:  selectively non-selective drugs for mood disorders and schizophrenia. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>3</i>, 353−359.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=359&author=B.+L.+Roth&author=D.+J.+Sheffler&author=W.+K+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A%E2%80%89+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%25E2%2580%2589%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm058225db00002_1"><span><span class="NLM_string-ref">Law, M. R.; Wald, J.; Morris, J. K.; Jordan, R. E. Value of low dose combination treatment with blood pressure lowering drugs:  analysis of 354 randomised trials. <i>  Br. Med. J.</i><b>2003</b>, <i>326</i>, 1427−1431.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2003&pages=1431&author=M.+R.+Law&author=J.+Wald&author=J.+K.+Morris&author=R.+E+Jordan&title=Value+of+low+dose+combination+treatment+with+blood+pressure+lowering+drugs%3A%E2%80%89+analysis+of+354+randomised+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DM.%2BR.%26atitle%3DValue%2520of%2520low%2520dose%2520combination%2520treatment%2520with%2520blood%2520pressure%2520lowering%2520drugs%253A%25E2%2580%2589%2520analysis%2520of%2520354%2520randomised%2520trials%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2003%26volume%3D326%26spage%3D1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm058225db00003_1"><span><span class="NLM_string-ref">Keith, C. T.; Borisy, A. A.; Stockwell, B. R. Multicomponent therapeutics for networked systems. <i>  Nat. Rev. Drug Discovery</i><b>2005</b>, <i>4</i>, 1−7.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=7&author=C.+T.+Keith&author=A.+A.+Borisy&author=B.+R+Stockwell&title=Multicomponent+therapeutics+for+networked+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulticomponent%2520therapeutics%2520for%2520networked%2520systems%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm058225db00004_1"><span><span class="NLM_string-ref">Takano, H.; Sawada, K.; Sato, N.; Natoya, A.; Tarumi, T.; Hirayama, S.; Koizumi, K.; Takahashi, T A.; Sekiguchi, S.; Koike, T. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. <i>  Leuk. Lymphoma</i><b>1996</b>, <i>21</i>, 473−478.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=478&author=H.+Takano&author=K.+Sawada&author=N.+Sato&author=A.+Natoya&author=T.+Tarumi&author=S.+Hirayama&author=K.+Koizumi&author=T+A+Takahashi&author=S.+Sekiguchi&author=T+Koike&title=Mobilization+of+peripheral+blood+progenitor+cells+following+CHOP+treatment+combined+with+delayed+granulocyte+colony-stimulating+factor+administration+in+patients+with+non-Hodgkin%27s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DH.%26atitle%3DMobilization%2520of%2520peripheral%2520blood%2520progenitor%2520cells%2520following%2520CHOP%2520treatment%2520combined%2520with%2520delayed%2520granulocyte%2520colony-stimulating%2520factor%2520administration%2520in%2520patients%2520with%2520non-Hodgkin%2527s%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D1996%26volume%3D21%26spage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm058225db00005_1"><span><span class="NLM_string-ref">Larder, B. A.; Kemp, S. D.; Harrigan, P. R. Potential mechanism for sustained antiretroviral effiacy of AZT-3TC combination therapy. <i>  Science</i><b>1995</b>, <i>269</i>, 696−699.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1995&pages=699&author=B.+A.+Larder&author=S.+D.+Kemp&author=P.+R+Harrigan&title=Potential+mechanism+for+sustained+antiretroviral+effiacy+of+AZT-3TC+combination+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarder%26aufirst%3DB.%2BA.%26atitle%3DPotential%2520mechanism%2520for%2520sustained%2520antiretroviral%2520effiacy%2520of%2520AZT-3TC%2520combination%2520therapy%26jtitle%3DScience%26date%3D1995%26volume%3D269%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm058225db00006_1"><span><span class="NLM_string-ref">Eisen, S. A.; Miller, D. K.; Woodward, R. S.; Spitznagel, E.; Przybeck, T. R. The effect of prescribed daily dose frequency on patient medical compliance. <i>  Arch. Intern. Med.</i><b>1990</b>, <i>150</i>, 1881−1884.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1990&pages=1884&author=S.+A.+Eisen&author=D.+K.+Miller&author=R.+S.+Woodward&author=E.+Spitznagel&author=T.+R+Przybeck&title=The+effect+of+prescribed+daily+dose+frequency+on+patient+medical+compliance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisen%26aufirst%3DS.%2BA.%26atitle%3DThe%2520effect%2520of%2520prescribed%2520daily%2520dose%2520frequency%2520on%2520patient%2520medical%2520compliance%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1990%26volume%3D150%26spage%3D1884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm058225db00007_1"><span><span class="NLM_string-ref">Skolnik, N. S.; Beck, J. D.; Clark, M. Combination antihypertensive drugs:  Recommendations for use. <i>  Am. Fam. Physician</i><b>2000</b>, <i>61</i>, 3049−3056.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=3056&author=N.+S.+Skolnik&author=J.+D.+Beck&author=M+Clark&title=Combination+antihypertensive+drugs%3A%E2%80%89+Recommendations+for+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnik%26aufirst%3DN.%2BS.%26atitle%3DCombination%2520antihypertensive%2520drugs%253A%25E2%2580%2589%2520Recommendations%2520for%2520use%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2000%26volume%3D61%26spage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm058225db00008_1"><span><span class="NLM_string-ref">Glass, G. Cardiovascular combinations. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>3</i>, 731−732.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=732&author=G+Glass&title=Cardiovascular+combinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlass%26aufirst%3DG%26atitle%3DCardiovascular%2520combinations%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm058225db00009_1"><span><span class="NLM_string-ref">Morphy, R.; Kay, C.; Rankovic, Z. From magic bullets to designed multiple ligands. <i>  Drug Discovery Today</i><b>2004</b>, <i>9</i>, 641−651.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=651&author=R.+Morphy&author=C.+Kay&author=Z+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00010"><div class="reference"><div class="NLM_citation" id="jm058225db00010_1"><span><span class="NLM_string-ref">Frishman, W. H.; Zuckerman, A. L. Amlodipine/atorvastatin:  the first cross risk factor polypill for the prevention and treatment of cardiovascular disease. <i>  Expert Rev. Cardiovas. Ther.</i><b>2004</b>, <i>2</i>, 675−681.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=681&author=W.+H.+Frishman&author=A.+L.+Zuckerman&author=+Amlodipine&title=the+first+cross+risk+factor+polypill+for+the+prevention+and+treatment+of+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3Dthe%2520first%2520cross%2520risk%2520factor%2520polypill%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520cardiovascular%2520disease%26jtitle%3DExpert%2520Rev.%2520Cardiovas.%2520Ther.%26date%3D2004%26volume%3D2%26spage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm058225db00011_1"><span><span class="NLM_string-ref">Flores, N. A. Ezetimibe + simvastatin (Merck/Schering-Plough). <i>  Curr. Opin. </i><i>Invest. Drugs </i><b>2004</b>, <i>5</i>, 984−992.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Flores%2C+N.+A.+Ezetimibe+%2B+simvastatin+%28Merck%2FSchering-Plough%29.+Curr.+Opin.+Invest.+Drugs+2004%2C+5%2C+984%E2%88%92992.+Flores%2C+N.+A.+Ezetimibe+%2B+simvastatin+%28Merck%2FSchering-Plough%29.+Curr.+Opin.+Invest.+Drugs+2004%2C+5%2C+984%E2%88%92992."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlores%26aufirst%3DN.%2BA.%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm058225db00012_1"><span><span class="NLM_string-ref">Edwards, I. R.; Aronson, J. K. Adverse drug reactions:  Definitions, diagnosis and management. <i>  Lancet</i><b>2000</b>, <i>356</i>, 1255−1259.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2000&pages=1259&author=I.+R.+Edwards&author=J.+K+Aronson&title=Adverse+drug+reactions%3A%E2%80%89+Definitions%2C+diagnosis+and+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DI.%2BR.%26atitle%3DAdverse%2520drug%2520reactions%253A%25E2%2580%2589%2520Definitions%252C%2520diagnosis%2520and%2520management%26jtitle%3DLancet%26date%3D2000%26volume%3D356%26spage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm058225db00013_1"><span><span class="NLM_string-ref">Kramer, M. S.; Last, B.; Getson, A.; Reines, S. A. The effects of selective D<sub>4</sub> dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. <i>  Arch. Gen. Psychiatry </i><b>1997</b>, <i>54</i>, 567−572.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=572&author=M.+S.+Kramer&author=B.+Last&author=A.+Getson&author=S.+A+Reines&title=The+effects+of+selective+D4+dopamine+receptor+antagonist+%28L-745%2C870%29+in+acutely+psychotic+inpatients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DM.%2BS.%26atitle%3DThe%2520effects%2520of%2520selective%2520D4%2520dopamine%2520receptor%2520antagonist%2520%2528L-745%252C870%2529%2520in%2520acutely%2520psychotic%2520inpatients%2520with%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1997%26volume%3D54%26spage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm058225db00014_1"><span><span class="NLM_string-ref">Campiani, G.; Butini, S.; Fattorusso, C.; Catalanotti, B.; Gemma, S.; Nacci, V.; Morelli, E.; Cagnotto, A.; Mereghetti, I.; Mennini, T.; Carli, M.; Minetti, P.; Di Cesare, M. A.; Mastroianni, D.; Scafetta, N.; Galletti, B.; Stasi, M. A.; Castorina, M.; Pacifici, L.; Vertechy, M.; Di Serio, S.; Ghirardi, O.; Tinti, O.; Carminati, P<i>.</i> Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure−activity relationship studies, and identification of novel atypical antipsychotic agents <i>J. Med. Chem. </i><b>2004</b>, <i>47</i>, 143−157.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=157&author=G.+Campiani&author=S.+Butini&author=C.+Fattorusso&author=B.+Catalanotti&author=S.+Gemma&author=V.+Nacci&author=E.+Morelli&author=A.+Cagnotto&author=I.+Mereghetti&author=T.+Mennini&author=M.+Carli&author=P.+Minetti&author=M.+A.+Di+Cesare&author=D.+Mastroianni&author=N.+Scafetta&author=B.+Galletti&author=M.+A.+Stasi&author=M.+Castorina&author=L.+Pacifici&author=M.+Vertechy&author=S.+Di+Serio&author=O.+Ghirardi&author=O.+Tinti&author=P.+Carminati&author=+Pyrrolo&title=serotonin+and+dopamine+receptor+antagonists.+Molecular+modeling%2C+further+structure%E2%88%92activity+relationship+studies%2C+and+identification+of+novel+atypical+antipsychotic+agents+J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampiani%26aufirst%3DG.%26atitle%3Dserotonin%2520and%2520dopamine%2520receptor%2520antagonists.%2520Molecular%2520modeling%252C%2520further%2520structure%25E2%2588%2592activity%2520relationship%2520studies%252C%2520and%2520identification%2520of%2520novel%2520atypical%2520antipsychotic%2520agents%2520J%26jtitle%3DMed.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm058225db00015_1"><span><span class="NLM_string-ref">Jones, H. M<i>.</i>; Pilowsky, L. S. New targets for antipsychotics. <i>  Expert Rev. </i><i>Neurother.</i><b>2002</b>, <i>2</i>, 61−68.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=68&author=H.+M.+Jones&author=L.+S+Pilowsky&title=New+targets+for+antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26atitle%3DNew%2520targets%2520for%2520antipsychotics%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2002%26volume%3D2%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm058225db00016_1"><span><span class="NLM_string-ref">Stahl, S. M.; Entsuah, R.; Rudolph, R. L. Comparative Efficacy between venlafaxine and SSRIs:  A pooled analysis of patients with depression. <i>  Biol. </i><i>Psychiatry</i><b>2002</b>, <i>202</i>, 1166−1174.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2002&pages=1174&author=S.+M.+Stahl&author=R.+Entsuah&author=R.+L+Rudolph&title=Comparative+Efficacy+between+venlafaxine+and+SSRIs%3A%E2%80%89+A+pooled+analysis+of+patients+with+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26atitle%3DComparative%2520Efficacy%2520between%2520venlafaxine%2520and%2520SSRIs%253A%25E2%2580%2589%2520A%2520pooled%2520analysis%2520of%2520patients%2520with%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2002%26volume%3D202%26spage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm058225db00017_1"><span><span class="NLM_string-ref">Charlier, C.; Michaux, C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. <i>  Eur. J. Med. Chem.</i><b>2003</b>, <i>38</i>, 645−659.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=659&author=C.+Charlier&author=C+Michaux&title=Dual+inhibition+of+cyclooxygenase-2+%28COX-2%29+and+5-lipoxygenase+%285-LOX%29+as+a+new+strategy+to+provide+safer+non-steroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharlier%26aufirst%3DC.%26atitle%3DDual%2520inhibition%2520of%2520cyclooxygenase-2%2520%2528COX-2%2529%2520and%25205-lipoxygenase%2520%25285-LOX%2529%2520as%2520a%2520new%2520strategy%2520to%2520provide%2520safer%2520non-steroidal%2520anti-inflammatory%2520drugs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm058225db00018_1"><span><span class="NLM_string-ref">Buijsman, R. C.; Basten, J. E.; van Dinther, T. G.; van der Marel, G. A.; van Boeckel, C. A.; van Boom, J. H. Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying a dual antithrombotic action. <i>  Bioorg. Med. Chem. Lett. </i><b>1999</b>, <i>9</i>, 2013−2018.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2018&author=R.+C.+Buijsman&author=J.+E.+Basten&author=T.+G.+van+Dinther&author=G.+A.+van+der+Marel&author=C.+A.+van+Boeckel&author=J.+H+van+Boom&title=Design+and+synthesis+of+a+novel+synthetic+NAPAP-pentasaccharide+conjugate+displaying+a+dual+antithrombotic+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520synthetic%2520NAPAP-pentasaccharide%2520conjugate%2520displaying%2520a%2520dual%2520antithrombotic%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm058225db00019_1"><span><span class="NLM_string-ref">Jacobson, K. A.; Xie, R.; Young, L.; Chang, L.; Liang, B. T. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists. <i>  J. Biol. Chem.</i><b>2000</b>, <i>275</i>, 30272−30279.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30279&author=K.+A.+Jacobson&author=R.+Xie&author=L.+Young&author=L.+Chang&author=B.+T+Liang&title=A+novel+pharmacological+approach+to+treating+cardiac+ischemia.+Binary+conjugates+of+A1+and+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA%2520novel%2520pharmacological%2520approach%2520to%2520treating%2520cardiac%2520ischemia.%2520Binary%2520conjugates%2520of%2520A1%2520and%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00020"><div class="reference"><div class="NLM_citation" id="jm058225db00020_1"><span><span class="NLM_string-ref">Portoghese, P. S. From models to molecules:  Opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. <i>  J. Med. Chem.</i><b>2001</b>, <i>44</i>, 2259−2269.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2269&author=P.+S+Portoghese&title=From+models+to+molecules%3A%E2%80%89+Opioid+receptor+dimers%2C+bivalent+ligands%2C+and+selective+opioid+receptor+probes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPortoghese%26aufirst%3DP.%2BS%26atitle%3DFrom%2520models%2520to%2520molecules%253A%25E2%2580%2589%2520Opioid%2520receptor%2520dimers%252C%2520bivalent%2520ligands%252C%2520and%2520selective%2520opioid%2520receptor%2520probes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm058225db00021_1"><span><span class="NLM_string-ref">Daniels, D. J.; Kulkarni, A.; Xie, Z.; Bhushan, R. G.; Portoghese, P. S. A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotypes. <i>  J. Med. </i><i>Chem.</i><b>2005</b>, <i>48</i>, 1713−1716.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1716&author=D.+J.+Daniels&author=A.+Kulkarni&author=Z.+Xie&author=R.+G.+Bhushan&author=P.+S+Portoghese&title=A+bivalent+ligand+%28KDAN-18%29+containing+%CE%B4-antagonist+and+%CE%BA-agonist+pharmacophores+bridges+%CE%B42+and+%CE%BA1+opioid+receptor+phenotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DD.%2BJ.%26atitle%3DA%2520bivalent%2520ligand%2520%2528KDAN-18%2529%2520containing%2520%25CE%25B4-antagonist%2520and%2520%25CE%25BA-agonist%2520pharmacophores%2520bridges%2520%25CE%25B42%2520and%2520%25CE%25BA1%2520opioid%2520receptor%2520phenotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm058225db00022_1"><span><span class="NLM_string-ref">Di Napoli, M.; Papa, F. NCX-4016 NicOX. <i>  Curr. Opin. Invest. Drugs</i><b>2003</b>, <i>4</i>, 1126−1139.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Di+Napoli%2C+M.%3B+Papa%2C+F.+NCX-4016+NicOX.+Curr.+Opin.+Invest.+Drugs+2003%2C+4%2C+1126%E2%88%921139.+Di+Napoli%2C+M.%3B+Papa%2C+F.+NCX-4016+NicOX.+Curr.+Opin.+Invest.+Drugs2003%2C+4%2C+1126%E2%88%921139."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BNapoli%26aufirst%3DM.%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D4%26spage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm058225db00023_1"><span><span class="NLM_string-ref">Lolli, M. L.; Cena, C.; Medana, C.; Lazzarato, L.; Morini, G.; Coruzzi, G.; Manarini, S.; Fruttero, R.; Gasco, A. A new class of ibuprofen derivatives with reduced gastrotoxicity. <i>  J. Med. Chem.</i><b>2001</b>, <i>44</i>, 3463−3468.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3468&author=M.+L.+Lolli&author=C.+Cena&author=C.+Medana&author=L.+Lazzarato&author=G.+Morini&author=G.+Coruzzi&author=S.+Manarini&author=R.+Fruttero&author=A+Gasco&title=A+new+class+of+ibuprofen+derivatives+with+reduced+gastrotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DM.%2BL.%26atitle%3DA%2520new%2520class%2520of%2520ibuprofen%2520derivatives%2520with%2520reduced%2520gastrotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm058225db00024_1"><span><span class="NLM_string-ref">Kawanishi, Y.; Ishihara, S.; Tsushim, T.; Seno, K.; Miyagoshi, M.; Hagishita, S.; Ishikawa, M.; Shima, N.; Shimamura, M.; Ishihar, Y. Synthesis and pharmacological evaluation of highly potent dual histamine H<sub>2</sub> and gastrin receptor antagonists. <i>  Bioorg. Med. Chem. Lett.</i><b>1996</b>, <i>6</i>, 1427−1430.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1430&author=Y.+Kawanishi&author=S.+Ishihara&author=T.+Tsushim&author=K.+Seno&author=M.+Miyagoshi&author=S.+Hagishita&author=M.+Ishikawa&author=N.+Shima&author=M.+Shimamura&author=Y+Ishihar&title=Synthesis+and+pharmacological+evaluation+of+highly+potent+dual+histamine+H2+and+gastrin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawanishi%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520highly%2520potent%2520dual%2520histamine%2520H2%2520and%2520gastrin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm058225db00025_1"><span><span class="NLM_string-ref">Montero, A.; Goya, P.; Jagerovic, N.; Luis, F.; Callado, L.; Meana, J.; Girón, R.; Goicoechea, C.; Martín, I. Guanidinium and aminoimidazolinium derivatives of <i>N</i>-(4-piperidyl)propanamides as potential ligands for opioid and I<sub>2</sub>-imidazoline receptors:  synthesis and pharmacological screening. <i>  Bioorg. Med. Chem.</i><b>2002</b>, <i>10</i>, 1009−1018.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1018&author=A.+Montero&author=P.+Goya&author=N.+Jagerovic&author=F.+Luis&author=L.+Callado&author=J.+Meana&author=R.+Gir%C3%B3n&author=C.+Goicoechea&author=I+Mart%C3%ADn&title=Guanidinium+and+aminoimidazolinium+derivatives+of+N-%284-piperidyl%29propanamides+as+potential+ligands+for+opioid+and+I2-imidazoline+receptors%3A%E2%80%89+synthesis+and+pharmacological+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontero%26aufirst%3DA.%26atitle%3DGuanidinium%2520and%2520aminoimidazolinium%2520derivatives%2520of%2520N-%25284-piperidyl%2529propanamides%2520as%2520potential%2520ligands%2520for%2520opioid%2520and%2520I2-imidazoline%2520receptors%253A%25E2%2580%2589%2520synthesis%2520and%2520pharmacological%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm058225db00026_1"><span><span class="NLM_string-ref">Dardonville, C.; Jagerovic, N.; Callado, L.; Meana, J. Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties:  a new series of hybrid molecules with significant binding affinity for μ-opioid receptors and I<sub>2</sub>-imidazoline binding sites. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 491−493.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=493&author=C.+Dardonville&author=N.+Jagerovic&author=L.+Callado&author=J+Meana&title=Fentanyl+derivatives+bearing+aliphatic+alkaneguanidinium+moieties%3A%E2%80%89+a+new+series+of+hybrid+molecules+with+significant+binding+affinity+for+%CE%BC-opioid+receptors+and+I2-imidazoline+binding+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDardonville%26aufirst%3DC.%26atitle%3DFentanyl%2520derivatives%2520bearing%2520aliphatic%2520alkaneguanidinium%2520moieties%253A%25E2%2580%2589%2520a%2520new%2520series%2520of%2520hybrid%2520molecules%2520with%2520significant%2520binding%2520affinity%2520for%2520%25CE%25BC-opioid%2520receptors%2520and%2520I2-imidazoline%2520binding%2520sites%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm058225db00027_1"><span><span class="NLM_string-ref">Burkholder, T.; Kudlacz, E.; Le, T.-B.; Knippenberg, R.; Shatzer, S.; Maynard, G.; Webster, M.; Horgan, S. Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK<sub>1</sub> and NK<sub>2</sub> receptors. <i>  Bioorg. Med. Chem. Lett.</i><b>1996</b>, <i>6</i>, 951−956.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=956&author=T.+Burkholder&author=E.+Kudlacz&author=T.-B.+Le&author=R.+Knippenberg&author=S.+Shatzer&author=G.+Maynard&author=M.+Webster&author=S+Horgan&title=Identification+and+chemical+synthesis+of+MDL+105%2C212%2C+a+non-peptide+tachykinin+antagonist+with+high+affinity+for+NK1+and+NK2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurkholder%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520chemical%2520synthesis%2520of%2520MDL%2520105%252C212%252C%2520a%2520non-peptide%2520tachykinin%2520antagonist%2520with%2520high%2520affinity%2520for%2520NK1%2520and%2520NK2%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm058225db00028_1"><span><span class="NLM_string-ref">Yamamoto, M.; Ikeda, S.; Kondo, H.; Inoue, S. Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin<i>. Bioorg. Med. Chem. </i><i>Lett.</i><b>2002</b>, <i>12</i>, 375−378.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=378&author=M.+Yamamoto&author=S.+Ikeda&author=H.+Kondo&author=S+Inoue&title=Design+and+synthesis+of+dual+inhibitors+for+matrix+metalloproteinase+and+cathepsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dual%2520inhibitors%2520for%2520matrix%2520metalloproteinase%2520and%2520cathepsin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm058225db00029_1"><span><span class="NLM_string-ref">Toda, N.; Tago, K.; Marumoto, S.; Takami, K.; Ori, M.; Yamada, N.; Koyama, K.; Naruto, S.; Abe, K.; Yamazaki, R.; Hara, T.; Aoyagi, A.; Abe, Y.; Kaneko, T.; Kogen, H. A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease. <i>  Bioorg. Med. </i><i>Chem.</i><b>2003</b>,<i> 11</i>, 4389−4415.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4415&author=N.+Toda&author=K.+Tago&author=S.+Marumoto&author=K.+Takami&author=M.+Ori&author=N.+Yamada&author=K.+Koyama&author=S.+Naruto&author=K.+Abe&author=R.+Yamazaki&author=T.+Hara&author=A.+Aoyagi&author=Y.+Abe&author=T.+Kaneko&author=H+Kogen&title=A+conformational+restriction+approach+to+the+development+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+as+potential+agents+for+Alzheimer%27s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26atitle%3DA%2520conformational%2520restriction%2520approach%2520to%2520the%2520development%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520as%2520potential%2520agents%2520for%2520Alzheimer%2527s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00030"><div class="reference"><div class="NLM_citation" id="jm058225db00030_1"><span><span class="NLM_string-ref">Ryckmans, T.; Balançon, L.; Berton, O.; Genicot, C.; Lamberty, Y.; Lallemand, B.; Pasau, P.; Pirlot, N.; Quéré, L.; Talaga, P. First dual NK<sub>1</sub> antagonists-serotonin reuptake inhibitors:  synthesis and SAR of a new class of potential antidepressants. <i>  Bioorg. Med. Chem. Lett. </i><b>2002</b>, <i>12</i>, 261−264.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=264&author=T.+Ryckmans&author=L.+Balan%C3%A7on&author=O.+Berton&author=C.+Genicot&author=Y.+Lamberty&author=B.+Lallemand&author=P.+Pasau&author=N.+Pirlot&author=L.+Qu%C3%A9r%C3%A9&author=P+Talaga&title=First+dual+NK1+antagonists-serotonin+reuptake+inhibitors%3A%E2%80%89+synthesis+and+SAR+of+a+new+class+of+potential+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26atitle%3DFirst%2520dual%2520NK1%2520antagonists-serotonin%2520reuptake%2520inhibitors%253A%25E2%2580%2589%2520synthesis%2520and%2520SAR%2520of%2520a%2520new%2520class%2520of%2520potential%2520antidepressants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm058225db00031_1"><span><span class="NLM_string-ref">Van Niel, M.; Beer, M.; Castro, J.; Cheng, S.; Evans, D.; Heald, A.; Hitzel, L.; Hunt, P.; Mortishire-Smith, R.; O'Connor, D.; Watt, A.; MacLeod, A. Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT<sub>1A</sub> and 5-HT re-uptake ligands. <i>  Bioorg. Med. Chem. Lett. </i><b>1999</b>, <i>9</i>, 3243−3248.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=3248&author=M.+Van+Niel&author=M.+Beer&author=J.+Castro&author=S.+Cheng&author=D.+Evans&author=A.+Heald&author=L.+Hitzel&author=P.+Hunt&author=R.+Mortishire-Smith&author=D.+O%27Connor&author=A.+Watt&author=A+MacLeod&title=Parallel+synthesis+of+3-aryloxy-2-propanolamines+and+evaluation+as+dual+affinity+5-HT1A+and+5-HT+re-uptake+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BNiel%26aufirst%3DM.%26atitle%3DParallel%2520synthesis%2520of%25203-aryloxy-2-propanolamines%2520and%2520evaluation%2520as%2520dual%2520affinity%25205-HT1A%2520and%25205-HT%2520re-uptake%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm058225db00032_1"><span><span class="NLM_string-ref">Macor, J. E.; Gurley, D.; Lanthorn, T.; Loch, J.; Mack, R. A.; Mullen, G.; Tran, O.; Wright, N.; Gordon, J. C. The 5-HT<sub>3</sub> antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist. <i>  Bioorg. Med. Chem. Lett. </i><b>2001</b>, <i>11</i>, 319−321.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=321&author=J.+E.+Macor&author=D.+Gurley&author=T.+Lanthorn&author=J.+Loch&author=R.+A.+Mack&author=G.+Mullen&author=O.+Tran&author=N.+Wright&author=J.+C+Gordon&title=The+5-HT3+antagonist+tropisetron+%28ICS+205-930%29+is+a+potent+and+selective+%CE%B17+nicotinic+receptor+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DThe%25205-HT3%2520antagonist%2520tropisetron%2520%2528ICS%2520205-930%2529%2520is%2520a%2520potent%2520and%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520partial%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm058225db00033_1"><span><span class="NLM_string-ref">Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.; Scozzafava, A.; Klebe, G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:  New pharmacological opportunities due to related binding site recognition. <i>  J. Med. Chem.</i><b>2004</b>, <i>46</i>, 550−557.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=557&author=A.+Weber&author=A.+Casini&author=A.+Heine&author=D.+Kuhn&author=C.+T.+Supuran&author=A.+Scozzafava&author=G+Klebe&title=Unexpected+nanomolar+inhibition+of+carbonic+anhydrase+by+COX-2-selective+celecoxib%3A%E2%80%89+New+pharmacological+opportunities+due+to+related+binding+site+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%26atitle%3DUnexpected%2520nanomolar%2520inhibition%2520of%2520carbonic%2520anhydrase%2520by%2520COX-2-selective%2520celecoxib%253A%25E2%2580%2589%2520New%2520pharmacological%2520opportunities%2520due%2520to%2520related%2520binding%2520site%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D46%26spage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm058225db00034_1"><span><span class="NLM_string-ref">Daub, H.; Specht, K.; Ullrich, A. Strategies to overcome resistance to targeted protein kinase inhibitors. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>12</i>, 1001−1010.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1010&author=H.+Daub&author=K.+Specht&author=A+Ullrich&title=Strategies+to+overcome+resistance+to+targeted+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaub%26aufirst%3DH.%26atitle%3DStrategies%2520to%2520overcome%2520resistance%2520to%2520targeted%2520protein%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D12%26spage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm058225db00035_1"><span><span class="NLM_string-ref">Zimmermann, J.; Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N.; Traxler, P. Phenylamino-pyrimidine (PAP) derivatives:  a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>1996</b>, <i>6</i>, 1221−1226.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1226&author=J.+Zimmermann&author=E.+Buchdunger&author=H.+Mett&author=T.+Meyer&author=N.+Lydon&author=P.+Traxler&author=+Phenylamino&title=a+new+class+of+potent+and+highly+selective+PDGF-receptor+autophosphorylation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3Da%2520new%2520class%2520of%2520potent%2520and%2520highly%2520selective%2520PDGF-receptor%2520autophosphorylation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm058225db00036_1"><span><span class="NLM_string-ref">Zimmermann, J.; Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N. B. Potent and selective inhibitors of the Abl-kinase:  phenylamino-pyrimidine (PAP) derivatives. <i>  Bioorg. Med. Chem. Lett.</i><b>1997</b>, <i>7</i>, 187−192.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=192&author=J.+Zimmermann&author=E.+Buchdunger&author=H.+Mett&author=T.+Meyer&author=N.+B+Lydon&title=Potent+and+selective+inhibitors+of+the+Abl-kinase%3A%E2%80%89+phenylamino-pyrimidine+%28PAP%29+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520the%2520Abl-kinase%253A%25E2%2580%2589%2520phenylamino-pyrimidine%2520%2528PAP%2529%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm058225db00037_1"><span><span class="NLM_string-ref">Boschelli, D.; Wang, Y.; Johnson, S.; Wu, B.; Ye, F.; Sosa, A.; Golas, J.; Boschelli, F. 7-Alkoxy-4-phenylamino-3-quinolinecarbonitriles as dual inhibitors of Src and Abl kinases. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 1599−1601.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1601&author=D.+Boschelli&author=Y.+Wang&author=S.+Johnson&author=B.+Wu&author=F.+Ye&author=A.+Sosa&author=J.+Golas&author=F.+Boschelli&author=+Alkoxy&title=as+dual+inhibitors+of+Src+and+Abl+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoschelli%26aufirst%3DD.%26atitle%3Das%2520dual%2520inhibitors%2520of%2520Src%2520and%2520Abl%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm058225db00038_1"><span><span class="NLM_string-ref">Bonnert, R. V.; Brown, R. C.; Chapman, D.; Cheshire, D. R.; Dixon, J.; Ince, F.; Kinchin, E. C.; Lyons, A. J.; Davis, A. M.; Hallam, C.; Harper, S. T.; Unitt, J. F.; Dougall, I. G.; Jackson, D. M.; McKechnie, K.; Young, A.; Simpson, W. T. Dual D<sub>2</sub>-receptor and b<sub>2</sub>-adrenoreceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues. <i>  J. </i><i>Med. Chem.</i><b>1998</b>, <i>41</i>, 4915−4917.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4917&author=R.+V.+Bonnert&author=R.+C.+Brown&author=D.+Chapman&author=D.+R.+Cheshire&author=J.+Dixon&author=F.+Ince&author=E.+C.+Kinchin&author=A.+J.+Lyons&author=A.+M.+Davis&author=C.+Hallam&author=S.+T.+Harper&author=J.+F.+Unitt&author=I.+G.+Dougall&author=D.+M.+Jackson&author=K.+McKechnie&author=A.+Young&author=W.+T.+Simpson&author=+Dual&title=agonists+for+the+treatment+of+airway+diseases.+1.+Discovery+and+biological+evaluation+of+some+7-%282-aminoethyl%29-4-hydroxybenzothiazol-2%283H%29-one+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonnert%26aufirst%3DR.%2BV.%26atitle%3Dagonists%2520for%2520the%2520treatment%2520of%2520airway%2520diseases.%25201.%2520Discovery%2520and%2520biological%2520evaluation%2520of%2520some%25207-%25282-aminoethyl%2529-4-hydroxybenzothiazol-2%25283H%2529-one%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm058225db00039_1"><span><span class="NLM_string-ref">Atkinson, P.; Bromidge, S.; Duxon, M.; Laramie, M.; Gaster, L.; Hadley, M.; Hammond, B.; Johnson, C.; Middlemiss, D.; North, S.; Price, G.; Rami, H.; Riley, J.; Scott, C.; Shaw, T.; Starr, K.; Stemp, G.; Thewlis, K.; Thomas, D.; Thompson, M.; Vong, A.; Watson, J. 3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity. <i>  Bioorg. Med. Chem. Lett. </i><b>2005</b>, <i>15</i>, 737−741.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=741&author=P.+Atkinson&author=S.+Bromidge&author=M.+Duxon&author=M.+Laramie&author=L.+Gaster&author=M.+Hadley&author=B.+Hammond&author=C.+Johnson&author=D.+Middlemiss&author=S.+North&author=G.+Price&author=H.+Rami&author=J.+Riley&author=C.+Scott&author=T.+Shaw&author=K.+Starr&author=G.+Stemp&author=K.+Thewlis&author=D.+Thomas&author=M.+Thompson&author=A.+Vong&author=J.+Watson&author=A+Dihydro&title=receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%26atitle%3Dreceptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00040"><div class="reference"><div class="NLM_citation" id="jm058225db00040_1"><span><span class="NLM_string-ref">Reichard, G. A.; Grice, C. A.; Shih, N. Y.; Spitler, J.; Majmundar, S.; Wang, S. D.; Paliwal, S.; Anthes, J. C.; Piwinski, J. J. Preparation of oxime dual NK<sub>1</sub>/NK<sub>2</sub> antagonists with reduced NK<sub>3</sub> affinity. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2355−2358.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2358&author=G.+A.+Reichard&author=C.+A.+Grice&author=N.+Y.+Shih&author=J.+Spitler&author=S.+Majmundar&author=S.+D.+Wang&author=S.+Paliwal&author=J.+C.+Anthes&author=J.+J+Piwinski&title=Preparation+of+oxime+dual+NK1%2FNK2+antagonists+with+reduced+NK3+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReichard%26aufirst%3DG.%2BA.%26atitle%3DPreparation%2520of%2520oxime%2520dual%2520NK1%252FNK2%2520antagonists%2520with%2520reduced%2520NK3%2520affinity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00041"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00041'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="jm058225db00041_1"><span><span class="NLM_string-ref">The medicinal chemistry journals covered were <i>Bioorg. Med. Chem. Lett.</i>, <i>Bioorg. Med. Chem.</i>, <i>J. Med. Chem.</i>, and <i>Eur. J. Med. Chem</i>.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+medicinal+chemistry+journals+covered+were+Bioorg.+Med.+Chem.+Lett.%2C+Bioorg.+Med.+Chem.%2C+J.+Med.+Chem.%2C+and+Eur.+J.+Med.+Chem.+The+medicinal+chemistry+journals+covered+were+Bioorg.+Med.+Chem.+Lett.%2C+Bioorg.+Med.+Chem.%2C+J.+Med.+Chem.%2C+and+Eur.+J.+Med.+Chem."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520medicinal%2520chemistry%2520journals%2520covered%2520were%2520Bioorg%26jtitle%3DMed.%2520Chem.%2520Lett.%252C%2520Bioorg.%2520Med.%2520Chem.%252C%2520J.%2520Med.%2520Chem.%252C%2520and%2520Eur.%2520J.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00042"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00042'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="jm058225db00042_1"><span><span class="NLM_string-ref">Romero, L.; Hervás, I.; Artigas, F. The 5-HT<sub>1A</sub> antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. <i>  Neurosci. </i><i>Lett.</i><b>1996</b>, <i>219</i>, 123−126.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1996&pages=126&author=L.+Romero&author=I.+Herv%C3%A1s&author=F+Artigas&title=The+5-HT1A+antagonist+WAY-100635+selectively+potentiates+the+presynaptic+effects+of+serotonergic+antidepressants+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26atitle%3DThe%25205-HT1A%2520antagonist%2520WAY-100635%2520selectively%2520potentiates%2520the%2520presynaptic%2520effects%2520of%2520serotonergic%2520antidepressants%2520in%2520rat%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1996%26volume%3D219%26spage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00043"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00043'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="jm058225db00043_1"><span><span class="NLM_string-ref">Perez, M.; Pauwelsb, P.; Pallard-Sigogneaua, I.; Fourriera, C.; Chopinc, P.; Palmierb, C.; Colovrayd, V.; Halazy, S. Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>1998</b>, <i>8</i>, 3423−3428.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=3428&author=M.+Perez&author=P.+Pauwelsb&author=I.+Pallard-Sigogneaua&author=C.+Fourriera&author=P.+Chopinc&author=C.+Palmierb&author=V.+Colovrayd&author=S+Halazy&title=Design+and+synthesis+of+new+potent%2C+silent+5-HT1A+antagonists+by+covalent+coupling+of+aminopropanol+derivatives+with+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520potent%252C%2520silent%25205-HT1A%2520antagonists%2520by%2520covalent%2520coupling%2520of%2520aminopropanol%2520derivatives%2520with%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00044"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00044'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="jm058225db00044_1"><span><span class="NLM_string-ref">Mewshaw, R.; Meagher, K.; Zhou, P.; Zhou, D.; Shi, X.; Scerni, R.; Smith, D.; Schechter, L.; Andree, T. Studies toward the discovery of the next generation of antidepressants. Part 2:  Incorporating a 5-HT1A antagonist component into a class of serotonin reuptake inhibitors. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>2002</b>, <i>12</i>, 307−310.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=310&author=R.+Mewshaw&author=K.+Meagher&author=P.+Zhou&author=D.+Zhou&author=X.+Shi&author=R.+Scerni&author=D.+Smith&author=L.+Schechter&author=T+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+Part+2%3A%E2%80%89+Incorporating+a+5-HT1A+antagonist+component+into+a+class+of+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%2520Part%25202%253A%25E2%2580%2589%2520Incorporating%2520a%25205-HT1A%2520antagonist%2520component%2520into%2520a%2520class%2520of%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00045"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00045'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="jm058225db00045_1"><span><span class="NLM_string-ref">Mewshaw, R.; Zhou, D.; Zhou, P.; Shi, X.; Hornby, G.; Spangler, T.; Scerni, R.; Smith, D.; Schechter, L.; Andree, T. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of <i>N</i>-aryloxyethylindolylalkylamines. <i>  J. </i><i>Med. Chem.</i><b>2004</b>, <i>47</i>, 3823−3842.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3842&author=R.+Mewshaw&author=D.+Zhou&author=P.+Zhou&author=X.+Shi&author=G.+Hornby&author=T.+Spangler&author=R.+Scerni&author=D.+Smith&author=L.+Schechter&author=T+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+3.+Dual+5-HT1A+and+serotonin+transporter+affinity+within+a+class+of+N-aryloxyethylindolylalkylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%25203.%2520Dual%25205-HT1A%2520and%2520serotonin%2520transporter%2520affinity%2520within%2520a%2520class%2520of%2520N-aryloxyethylindolylalkylamines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00046"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00046'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="jm058225db00046_1"><span><span class="NLM_string-ref">Timms, G.; Boot, J.; Broadmore, R.; Carney, S.; Cooper, J.; Findlay, J.; Gilmore, J.; Mitchell, S.; Moore, N.; Pullar, I.; Sanger, G.; Tomlinson, R.; Tree, B.; Wedley, S. SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 2469−2472.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2472&author=G.+Timms&author=J.+Boot&author=R.+Broadmore&author=S.+Carney&author=J.+Cooper&author=J.+Findlay&author=J.+Gilmore&author=S.+Mitchell&author=N.+Moore&author=I.+Pullar&author=G.+Sanger&author=R.+Tomlinson&author=B.+Tree&author=S+Wedley&title=SAR+development+of+a+selective+5-HT1D+antagonist%2Fserotonin+reuptake+inhibitor+lead+using+rapid+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00046_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimms%26aufirst%3DG.%26atitle%3DSAR%2520development%2520of%2520a%2520selective%25205-HT1D%2520antagonist%252Fserotonin%2520reuptake%2520inhibitor%2520lead%2520using%2520rapid%2520parallel%2520synthesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00047"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00047'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="jm058225db00047_1"><span><span class="NLM_string-ref">Torrado, A.; Lamas, C.; Agejas, J.; Jiménez, A.; D×c6ìaza, N.; Gilmore, J.; Boot, J.; Findlay, J.; Hayhurst, L.; Wallace, L.; Broadmore, R.; Tomlinson, R. Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity:  chemistry and pharmacological evaluation of a series of thienopyran derivatives. <i>  Bioorg. Med. Chem.</i><b>2004</b>, <i>12</i>, 5277−5295.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5295&author=A.+Torrado&author=C.+Lamas&author=J.+Agejas&author=A.+Jim%C3%A9nez&author=+D%C3%97c&author=J.+Gilmore&author=J.+Boot&author=J.+Findlay&author=L.+Hayhurst&author=L.+Wallace&author=R.+Broadmore&author=R+Tomlinson&title=Novel+selective+and+potent+5-HT+reuptake+inhibitors+with+5-HT1D+antagonist+activity%3A%E2%80%89+chemistry+and+pharmacological+evaluation+of+a+series+of+thienopyran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00047_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorrado%26aufirst%3DA.%26atitle%3DNovel%2520selective%2520and%2520potent%25205-HT%2520reuptake%2520inhibitors%2520with%25205-HT1D%2520antagonist%2520activity%253A%25E2%2580%2589%2520chemistry%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520series%2520of%2520thienopyran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00048"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00048'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="jm058225db00048_1"><span><span class="NLM_string-ref">Feuerstein, T. H.; Hertting, G. Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release:  Evidence for facilitatory 5-HT receptors within the CNS. <i>  Naunyn-Schmiedeberg</i><i>'</i><i>s Arch. Pharmacol.</i><b>1986</b>, <i>333</i>, 191−197.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1986&pages=197&author=T.+H.+Feuerstein&author=G.+Hertting&author=+Serotonin&title=enhances+hippocampal+noradrenaline+%28NA%29+release%3A%E2%80%89+Evidence+for+facilitatory+5-HT+receptors+within+the+CNS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00048_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeuerstein%26aufirst%3DT.%2BH.%26atitle%3Denhances%2520hippocampal%2520noradrenaline%2520%2528NA%2529%2520release%253A%25E2%2580%2589%2520Evidence%2520for%2520facilitatory%25205-HT%2520receptors%2520within%2520the%2520CNS%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1986%26volume%3D333%26spage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00049"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00049'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="jm058225db00049_1"><span><span class="NLM_string-ref">Meyer, M. D.; Hancock, A. A.; Tietje, K.; Sippy, K. B.; Prasad, R.; Stout, D. M.; Arendsen, D. L.; Donner, B. G.; Carroll, W. A. Structure−activity studies for a novel series of <i>N</i>-(arylethyl)-<i>N</i>-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-<i>N</i>-methylamines possessing dual 5-HT uptake inhibiting and α<sub>2</sub>-antagonistic activities. <i>  J. </i><i>Med. Chem.</i><b> 1997</b>, <i>40</i>, 1049−1062.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1062&author=M.+D.+Meyer&author=A.+A.+Hancock&author=K.+Tietje&author=K.+B.+Sippy&author=R.+Prasad&author=D.+M.+Stout&author=D.+L.+Arendsen&author=B.+G.+Donner&author=W.+A+Carroll&title=Structure%E2%88%92activity+studies+for+a+novel+series+of+N-%28arylethyl%29-N-%281%2C2%2C3%2C4-tetrahydronaphthalen-1-ylmethyl%29-N-methylamines+possessing+dual+5-HT+uptake+inhibiting+and+%CE%B12-antagonistic+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00049_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DStructure%25E2%2588%2592activity%2520studies%2520for%2520a%2520novel%2520series%2520of%2520N-%2528arylethyl%2529-N-%25281%252C2%252C3%252C4-tetrahydronaphthalen-1-ylmethyl%2529-N-methylamines%2520possessing%2520dual%25205-HT%2520uptake%2520inhibiting%2520and%2520%25CE%25B12-antagonistic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00050"><div class="reference"><div class="NLM_citation" id="jm058225db00050_1"><span><span class="NLM_string-ref">Meyer, M.; Hancock, A.; Tietje, K.; Sippy, K.; Giardina, W.; Kerwin, J. Synthesis and pharmacological characterization of A-80426:  A putative novel antidepressant combining alpha-2 antagonism with 5-HT uptake inhibition. <i>  Bioorg. Med. Chem. Lett.</i><b>1995</b>, <i>5</i>, 2287−2292.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2292&author=M.+Meyer&author=A.+Hancock&author=K.+Tietje&author=K.+Sippy&author=W.+Giardina&author=J+Kerwin&title=Synthesis+and+pharmacological+characterization+of+A-80426%3A%E2%80%89+A+putative+novel+antidepressant+combining+alpha-2+antagonism+with+5-HT+uptake+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00050_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520A-80426%253A%25E2%2580%2589%2520A%2520putative%2520novel%2520antidepressant%2520combining%2520alpha-2%2520antagonism%2520with%25205-HT%2520uptake%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D2292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00051"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00051'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="jm058225db00051_1"><span><span class="NLM_string-ref">Bymaster, F.; Beedle, E.; Findlay, J.; Gallagher, P.; Krushinski, J.; Mitchell, S.; Robertson, D.; Thompson, D.; Wallace, L.; Wong, D. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 4477−4480.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4480&author=F.+Bymaster&author=E.+Beedle&author=J.+Findlay&author=P.+Gallagher&author=J.+Krushinski&author=S.+Mitchell&author=D.+Robertson&author=D.+Thompson&author=L.+Wallace&author=D.+Wong&author=+Duloxetine&title=a+dual+inhibitor+of+serotonin+and+norepinephrine+reuptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00051_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBymaster%26aufirst%3DF.%26atitle%3Da%2520dual%2520inhibitor%2520of%2520serotonin%2520and%2520norepinephrine%2520reuptake%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00052"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00052'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="jm058225db00052_1"><span><span class="NLM_string-ref">Axford, L.; Boot, J.; Hotten, T.; Keenan, M.; Martin, F.; Milutinovic, S.; Moore, N.; O'Neill, M.; Pullar, I.; Tupper, D.; Van Belle, K.; Vivien, V. Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 3277−3280.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3280&author=L.+Axford&author=J.+Boot&author=T.+Hotten&author=M.+Keenan&author=F.+Martin&author=S.+Milutinovic&author=N.+Moore&author=M.+O%27Neill&author=I.+Pullar&author=D.+Tupper&author=K.+Van+Belle&author=V.+Vivien&author=+Bicyclo&title=as+novel+triple+re-uptake+inhibitors+for+the+treatment+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00052_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxford%26aufirst%3DL.%26atitle%3Das%2520novel%2520triple%2520re-uptake%2520inhibitors%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00053"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00053'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="jm058225db00053_1"><span><span class="NLM_string-ref">One of the earliest marketed drugs that possessed dual D<sub>2</sub>/5HT<sub>2</sub> activity was risperidone:  Janssen, P. A.; Niemegeers, C. J.; Awouters, F.; Schellekens, K. H.; Megens, A. A.; Meert, T. F. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. <i>  J. Pharmacol. Exp. Ther.</i><b>1988</b>, <i>244</i>, 685−693.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=+One&author=C.+J.+Niemegeers&author=F.+Awouters&author=K.+H.+Schellekens&author=A.+A.+Megens&author=T.+F.+Meert&title=Pharmacology+of+risperidone+%28R+64+766%29%2C+a+new+antipsychotic+with+serotonin-S2+and+dopamine-D2+antagonistic+properties.+J.+Pharmacol.+Exp.+Ther"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00053_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOne%26btitle%3DPharmacology%2520of%2520risperidone%2520%2528R%252064%2520766%2529%252C%2520a%2520new%2520antipsychotic%2520with%2520serotonin-S2%2520and%2520dopamine-D2%2520antagonistic%2520properties.%2520J.%2520Pharmacol.%2520Exp.%2520Ther%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00054"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00054'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="jm058225db00054_1"><span><span class="NLM_string-ref">Gray, R. Quetiapine:  a new atypical antipsychotic for the treatment of schizophrenia. <i>  Ment. Health Care </i><b>1998</b>, <i>1</i>, 163−164.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1998&pages=164&author=R.+Gray&author=+Quetiapine&title=a+new+atypical+antipsychotic+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00054_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DR.%26atitle%3Da%2520new%2520atypical%2520antipsychotic%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DMent.%2520Health%2520Care%26date%3D1998%26volume%3D1%26spage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00055"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00055'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="jm058225db00055_1"><span><span class="NLM_string-ref">Fuller, R. W.; Snoddy, H. D. Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate. <i>  Res. Commun. Chem. Pathol. Pharmacol. </i><b>1992</b>, <i>77</i>, 87−93.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1992&pages=93&author=R.+W.+Fuller&author=H.+D+Snoddy&title=Neuroendocrine+evidence+for+antagonism+of+serotonin+and+dopamine+receptors+by+olanzapine+%28LY170053%29%2C+an+antipsychotic+drug+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00055_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DR.%2BW.%26atitle%3DNeuroendocrine%2520evidence%2520for%2520antagonism%2520of%2520serotonin%2520and%2520dopamine%2520receptors%2520by%2520olanzapine%2520%2528LY170053%2529%252C%2520an%2520antipsychotic%2520drug%2520candidate%26jtitle%3DRes.%2520Commun.%2520Chem.%2520Pathol.%2520Pharmacol.%26date%3D1992%26volume%3D77%26spage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00056"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00056'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="jm058225db00056_1"><span><span class="NLM_string-ref">Lowe, J.; Seeger, T.; Nagel, A.; Howard, H.; Seymour, P.; Heym, J.; Ewing, F.; Newman, M.; Schmidt, A. 1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents. <i>  J. Med. Chem. </i><b>1991</b>, <i>34</i>, 1860−1866.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1866&author=J.+Lowe&author=T.+Seeger&author=A.+Nagel&author=H.+Howard&author=P.+Seymour&author=J.+Heym&author=F.+Ewing&author=M.+Newman&author=A+Schmidt&title=1-Naphthylpiperazine+derivatives+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00056_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%26atitle%3D1-Naphthylpiperazine%2520derivatives%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00057"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00057'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="jm058225db00057_1"><span><span class="NLM_string-ref">Howard, H.; Lowe, J.; Seeger, T.; Seymour, P.; Zorn, S.; Maloney, P.; Ewing, F.; Newman, M.; Schmidt, A.; Furman, J.; Robinson, G.; Jackson, E.; Johnson, C.; Morrone J. 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 143−148.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=148&author=H.+Howard&author=J.+Lowe&author=T.+Seeger&author=P.+Seymour&author=S.+Zorn&author=P.+Maloney&author=F.+Ewing&author=M.+Newman&author=A.+Schmidt&author=J.+Furman&author=G.+Robinson&author=E.+Jackson&author=C.+Johnson&author=J+Morrone&title=3-Benzisothiazolylpiperazine+derivatives+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00057_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DH.%26atitle%3D3-Benzisothiazolylpiperazine%2520derivatives%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00058"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00058'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="jm058225db00058_1"><span><span class="NLM_string-ref">Zhao, H.; Thurkauf, A.; He, X.; Hodgetts, K.; Zhang, X.; Rachwal, S.; Kover, R.; Hutchison, A.; Peterson, J.; Kieltyka, A.; Brodbeck, R.; Primus, R.; Wasley, J. Indoline and piperazine containing derivatives as a novel class of mixed D<sub>2</sub>/D<sub>4</sub> receptor antagonists. Part 1:  Identification and structure−activity relationships. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 3105−3109.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3109&author=H.+Zhao&author=A.+Thurkauf&author=X.+He&author=K.+Hodgetts&author=X.+Zhang&author=S.+Rachwal&author=R.+Kover&author=A.+Hutchison&author=J.+Peterson&author=A.+Kieltyka&author=R.+Brodbeck&author=R.+Primus&author=J+Wasley&title=Indoline+and+piperazine+containing+derivatives+as+a+novel+class+of+mixed+D2%2FD4+receptor+antagonists.+Part+1%3A%E2%80%89+Identification+and+structure%E2%88%92activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00058_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DIndoline%2520and%2520piperazine%2520containing%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520mixed%2520D2%252FD4%2520receptor%2520antagonists.%2520Part%25201%253A%25E2%2580%2589%2520Identification%2520and%2520structure%25E2%2588%2592activity%2520relationships%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00059"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00059'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="jm058225db00059_1"><span><span class="NLM_string-ref">Zhao, H.; He, X.; Thurkauf, A.; Hoffman, D.; Kieltyka, A.; Brodbeck, R.; Primus, R.; Wasley, J. Indoline and piperazine containing derivatives as a novel class of mixed D<sub>2</sub>/D<sub>4</sub> receptor antagonists. Part 2:  Asymmetric synthesis and biological evaluation. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 3111−3115.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3115&author=H.+Zhao&author=X.+He&author=A.+Thurkauf&author=D.+Hoffman&author=A.+Kieltyka&author=R.+Brodbeck&author=R.+Primus&author=J+Wasley&title=Indoline+and+piperazine+containing+derivatives+as+a+novel+class+of+mixed+D2%2FD4+receptor+antagonists.+Part+2%3A%E2%80%89+Asymmetric+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00059_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DIndoline%2520and%2520piperazine%2520containing%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520mixed%2520D2%252FD4%2520receptor%2520antagonists.%2520Part%25202%253A%25E2%2580%2589%2520Asymmetric%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00060"><div class="reference"><div class="NLM_citation" id="jm058225db00060_1"><span><span class="NLM_string-ref">Eiser, N. Histamine antagonists and asthma. <i>  Phar</i><i>macol. </i><i>Ther</i>. <b>1982</b>, <i>17</i>, 239−250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1982&pages=250&author=N+Eiser&title=Histamine+antagonists+and+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00060_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEiser%26aufirst%3DN%26atitle%3DHistamine%2520antagonists%2520and%2520asthma%26jtitle%3DPharmacol.%2520Ther.%26date%3D1982%26volume%3D17%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00061"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00061'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="jm058225db00061_1"><span><span class="NLM_string-ref">Roquet, A.; Dahlen, B.; Kumlin, M.; Ihre, E.; Gudrun, A.; S. Binks, S. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. <i>  Am. J. Respir. Crit. Care Med.</i><b>1997</b>, <i>155</i>, 1856.</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=jm058225db00061/jm058225db00061_1&amp;dbid=16&amp;doi=10.1021%2Fjm058225d&amp;key=10.1164%2Fajrccm.155.6.9196086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=jm058225db00061/jm058225db00061_1&amp;dbid=8&amp;doi=10.1021%2Fjm058225d&amp;key=9196086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=jm058225db00061/jm058225db00061_1&amp;dbid=32&amp;doi=10.1021%2Fjm058225d&amp;key=1%3ACAS%3A280%3ADyaK2szjvFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1997&pages=1856&author=A.+Roquet&author=B.+Dahlen&author=M.+Kumlin&author=E.+Ihre&author=A.+Gudrun&author=S+Binks&title=Combined+antagonism+of+leukotrienes+and+histamine+produces+predominant+inhibition+of+allergen-induced+early+and+late+phase+airway+obstruction+in+asthmatics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_jm058225db00061_1R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics</span></div><div class="casAuthors">Roquet A; Dahlen B; Kumlin M; Ihre E; Anstren G; Binks S; Dahlen S E</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1856-63</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">We defined the contribution of histamine and leukotrienes to allergen-induced airway obstruction in asthmatics; 12 subjects with allergic asthma underwent identical allergen bronchoprovocations on four occasions.  At a control session, all subjects displayed early (EAR) and late asthmatic (LAR) reactions.  The mean (+/- SE) drop in FEV1 during EAR (0-2 h) and LAR (2-12 h) was 29 +/- 2% and 28 +/- 4%, respectively.  Thereafter, the influence of 1 wk randomized pretreatment with the leukotriene receptor antagonist zafirlukast (Accolate) (80 mg twice daily), the antihistamine loratadine (10 mg twice daily), and the combination of both antagonists was assessed.  Expressed as AUC FEV1 in percent of the control reaction, zafirlukast reduced the response during EAR and LAR by 62 +/- 11% and 55 +/- 12%, respectively (p < 0.05 versus control).  Loratadine inhibited EAR and LAR by 25 +/- 14% and 40 +/- 16%, respectively (p < 0.05 versus control).  Zafirlukast was significantly more effective than loratadine during EAR but not during LAR.  The combination of zafirlukast and loratadine reduced the AUC FEV1 during EAR and LAR further, by 75 +/- 8% and 74 +/- 14%, respectively (p < 0.05 versus control).  The combination was significantly (p < 0.05) more effective than either drug alone during the LAR.  The findings indicate that leukotrienes and histamine together mediate the major part of both the EAR and the LAR following exposure of asthmatics to allergen.  Combination of leukotriene antagonism and antihistamines may represent a new strategy for treatment of airway obstruction in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7uWM2JdA5ucve_zCu79I8fW6udTcc2eYCGSstxoXMdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szjvFCrtQ%253D%253D&md5=2700b325cf4f1badd2372a28fbadf7f9</span></div><a href="/servlet/linkout?suffix=jm058225db00061_1&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.155.6.9196086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.155.6.9196086%26sid%3Dliteratum%253Aachs%26aulast%3DRoquet%26aufirst%3DA.%26atitle%3DCombined%2520antagonism%2520of%2520leukotrienes%2520and%2520histamine%2520produces%2520predominant%2520inhibition%2520of%2520allergen-induced%2520early%2520and%2520late%2520phase%2520airway%2520obstruction%2520in%2520asthmatics%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1997%26volume%3D155%26spage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00062"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00062'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="jm058225db00062_1"><span><span class="NLM_string-ref">Zhang, M.; van de Stolpe, A.; Zuiderveld, O.; Timmerman, H. Synthesis and pharmacological evaluation of some amino-acid-containing cyproheptadine derivatives as dual antagonists of histamine H<sub>1</sub>- and leukotriene D<sub>4</sub>-receptors. <i>  Eur. J. Med. Chem.</i><b>1997</b>, <i>32</i>, 95−102.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=102&author=M.+Zhang&author=A.+van+de+Stolpe&author=O.+Zuiderveld&author=H+Timmerman&title=Synthesis+and+pharmacological+evaluation+of+some+amino-acid-containing+cyproheptadine+derivatives+as+dual+antagonists+of+histamine+H1-+and+leukotriene+D4-receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00062_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520some%2520amino-acid-containing%2520cyproheptadine%2520derivatives%2520as%2520dual%2520antagonists%2520of%2520histamine%2520H1-%2520and%2520leukotriene%2520D4-receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00063"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00063'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="jm058225db00063_1"><span><span class="NLM_string-ref">Lewis, T.; Bayless, L.; Eckman, J.; Ellis, J.; Grewal, G.; Libertine, L.; Nicolas, J.; Scannell, R.; Wels, B.; Wenberg, K.; Wypij, D. 5-Lipoxygenase inhibitors with histamine H1 receptor antagonist activity. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>2004</b>, <i>14</i>, 2265−2268.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2268&author=T.+Lewis&author=L.+Bayless&author=J.+Eckman&author=J.+Ellis&author=G.+Grewal&author=L.+Libertine&author=J.+Nicolas&author=R.+Scannell&author=B.+Wels&author=K.+Wenberg&author=D+Wypij&title=5-Lipoxygenase+inhibitors+with+histamine+H1+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00063_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DT.%26atitle%3D5-Lipoxygenase%2520inhibitors%2520with%2520histamine%2520H1%2520receptor%2520antagonist%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00064"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00064'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="jm058225db00064_1"><span><span class="NLM_string-ref">Ohshima, E.; Takami, H.; Harakawa, H.; Sato, H.; Obase, H.; Miki, I.; Ishii, A.; Ishii, H.; Sasaki, Y. Dibenz[<i>b</i>,<i>e</i>]oxepin derivatives:  novel antiallergic agents possessing thromboxane A<sub>2</sub> and histamine H<sub>1</sub> dual antagonizing activity. 1.<i> J. Med. Chem. </i><b>1993</b>,<i> 36</i>, 417−420.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=420&author=E.+Ohshima&author=H.+Takami&author=H.+Harakawa&author=H.+Sato&author=H.+Obase&author=I.+Miki&author=A.+Ishii&author=H.+Ishii&author=Y.+Sasaki&author=+Dibenz&title=novel+antiallergic+agents+possessing+thromboxane+A2+and+histamine+H1+dual+antagonizing+activity.+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00064_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhshima%26aufirst%3DE.%26atitle%3Dnovel%2520antiallergic%2520agents%2520possessing%2520thromboxane%2520A2%2520and%2520histamine%2520H1%2520dual%2520antagonizing%2520activity.%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00065"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00065'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="jm058225db00065_1"><span><span class="NLM_string-ref">Aslanian, R.; Mutahi, M.; Shih, N.; Piwinski, J.; West, R.; Williams, S.; She, S.; Wu, R.; Hey, J. Identification of a dual histamine H<sub>1</sub>/H<sub>3</sub> receptor ligand based on the H<sub>1</sub> antagonist chlorpheniramine. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 1959−1961.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1961&author=R.+Aslanian&author=M.+Mutahi&author=N.+Shih&author=J.+Piwinski&author=R.+West&author=S.+Williams&author=S.+She&author=R.+Wu&author=J+Hey&title=Identification+of+a+dual+histamine+H1%2FH3+receptor+ligand+based+on+the+H1+antagonist+chlorpheniramine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00065_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAslanian%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520a%2520dual%2520histamine%2520H1%252FH3%2520receptor%2520ligand%2520based%2520on%2520the%2520H1%2520antagonist%2520chlorpheniramine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00066"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00066'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="jm058225db00066_1"><span><span class="NLM_string-ref">Piwinski, J.; Wong, J.; Green, M.; Ganguly, A.; Billah, M.; West, R.; Kreutner, W. Dual antagonists of platelet-activating factor and histamine. Identification of structural requirements for dual activity of <i>N</i>-acyl-4-(5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidines. <i>  J. Med. Chem. </i><b>1991</b>,<i> 34</i>, 457−461.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=461&author=J.+Piwinski&author=J.+Wong&author=M.+Green&author=A.+Ganguly&author=M.+Billah&author=R.+West&author=W+Kreutner&title=Dual+antagonists+of+platelet-activating+factor+and+histamine.+Identification+of+structural+requirements+for+dual+activity+of+N-acyl-4-%285%2C6-dihydro-11H-benzo%5B5%2C6%5Dcyclohepta%5B1%2C2-b%5Dpyridin-11-ylidene%29piperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00066_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiwinski%26aufirst%3DJ.%26atitle%3DDual%2520antagonists%2520of%2520platelet-activating%2520factor%2520and%2520histamine.%2520Identification%2520of%2520structural%2520requirements%2520for%2520dual%2520activity%2520of%2520N-acyl-4-%25285%252C6-dihydro-11H-benzo%255B5%252C6%255Dcyclohepta%255B1%252C2-b%255Dpyridin-11-ylidene%2529piperidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00067"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00067'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="jm058225db00067_1"><span><span class="NLM_string-ref">Carceller, E.; Merlos, M.; Giral, M.; Balsa, D.; Almansa, C.; Bartroli, J.; Garcia-Rafanell, J.; Forn, J. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine. <i>  J. Med. Chem. </i><b>1994</b>,<i> 37</i>, 2697−2703.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2703&author=E.+Carceller&author=M.+Merlos&author=M.+Giral&author=D.+Balsa&author=C.+Almansa&author=J.+Bartroli&author=J.+Garcia-Rafanell&author=J.+Forn&author=+Pyridylalkyl&title=derivatives+as+dual+antagonists+of+PAF+and+histamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00067_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarceller%26aufirst%3DE.%26atitle%3Dderivatives%2520as%2520dual%2520antagonists%2520of%2520PAF%2520and%2520histamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00068"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00068'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="jm058225db00068_1"><span><span class="NLM_string-ref">Maynard, G.; Bratton, L.; Kane, J.; Burkholder, T.; Santiago, B.; Stewart, K.; Kudlacz, E.; Shatzer, S.; Knippenberg, R.; Farrell, A.; Logan, D. Synthesis and SAR of 4-(1<i>H</i>-benzimidazole-2-carbonyl)piperidines with dual histamine H1/tachykinin NK1 receptor antagonist activity. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>1997</b>, <i>7</i>, 2819−2824.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2824&author=G.+Maynard&author=L.+Bratton&author=J.+Kane&author=T.+Burkholder&author=B.+Santiago&author=K.+Stewart&author=E.+Kudlacz&author=S.+Shatzer&author=R.+Knippenberg&author=A.+Farrell&author=D+Logan&title=Synthesis+and+SAR+of+4-%281H-benzimidazole-2-carbonyl%29piperidines+with+dual+histamine+H1%2Ftachykinin+NK1+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00068_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaynard%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25281H-benzimidazole-2-carbonyl%2529piperidines%2520with%2520dual%2520histamine%2520H1%252Ftachykinin%2520NK1%2520receptor%2520antagonist%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00069"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00069'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="jm058225db00069_1"><span><span class="NLM_string-ref">Robl, J.; Sieber-McMaster, E.; Asaad, M. M.; Bird, J. E.; Delaney, N. G.; Barrish, J. C.; Neubeck, R.; Natarajan, S.; Cohen, M.; Rovnyak, G. C.; Huber, G.; Murugesan, N.; Girotra, R.; Cheung, H. S.; Waldron, T.; Petrillo, E. W. Mercaptoacyl dipeptides as dual inhibitors of angiotensin converting enzyme and neutral peptidase. Preliminary structure−activity studies. <i>  Bioorg. Med. Chem. Lett.</i><b>1994</b>, <i>4</i>, 1783−1789.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=1789&author=J.+Robl&author=E.+Sieber-McMaster&author=M.+M.+Asaad&author=J.+E.+Bird&author=N.+G.+Delaney&author=J.+C.+Barrish&author=R.+Neubeck&author=S.+Natarajan&author=M.+Cohen&author=G.+C.+Rovnyak&author=G.+Huber&author=N.+Murugesan&author=R.+Girotra&author=H.+S.+Cheung&author=T.+Waldron&author=E.+W+Petrillo&title=Mercaptoacyl+dipeptides+as+dual+inhibitors+of+angiotensin+converting+enzyme+and+neutral+peptidase.+Preliminary+structure%E2%88%92activity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00069_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobl%26aufirst%3DJ.%26atitle%3DMercaptoacyl%2520dipeptides%2520as%2520dual%2520inhibitors%2520of%2520angiotensin%2520converting%2520enzyme%2520and%2520neutral%2520peptidase.%2520Preliminary%2520structure%25E2%2588%2592activity%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00070"><div class="reference"><div class="NLM_citation" id="jm058225db00070_1"><span><span class="NLM_string-ref">Robl, J. A.; Sun, C.-Q.; Stevenson, J.; Ryono, D. E.; Simpkins, L. M.; Cimarusti, M. P.; Dejneka, T.; Slusarchuk, W. A.; Chao, S.; Stratton, L.; Misra, R. N.; Bednarz, M. S.; Asaad, M. M.; Cheung, H. S.; Abboa-Offei, B. E.; Smith, P. L.; Mathers, P. D.;  6543  Fox, M.; Schaeffer, T. R.; Seymour, A. A.; Trippodo, N. C. Dual metalloprotease inhibitors:  mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. <i>  J. Med. Chem.</i><b>1997</b>, <i>40</i>, 1570−1577.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1577&author=J.+A.+Robl&author=C.-Q.+Sun&author=J.+Stevenson&author=D.+E.+Ryono&author=L.+M.+Simpkins&author=M.+P.+Cimarusti&author=T.+Dejneka&author=W.+A.+Slusarchuk&author=S.+Chao&author=L.+Stratton&author=R.+N.+Misra&author=M.+S.+Bednarz&author=M.+M.+Asaad&author=H.+S.+Cheung&author=B.+E.+Abboa-Offei&author=P.+L.+Smith&author=P.+D.+Mathers&author=M.+Fox&author=T.+R.+Schaeffer&author=A.+A.+Seymour&author=N.+C+Trippodo&title=Dual+metalloprotease+inhibitors%3A%E2%80%89+mercaptoacetyl-based+fused+heterocyclic+dipeptide+mimetics+as+inhibitors+of+angiotensin-converting+enzyme+and+neutral+endopeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00070_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDual%2520metalloprotease%2520inhibitors%253A%25E2%2580%2589%2520mercaptoacetyl-based%2520fused%2520heterocyclic%2520dipeptide%2520mimetics%2520as%2520inhibitors%2520of%2520angiotensin-converting%2520enzyme%2520and%2520neutral%2520endopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00071"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00071'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="jm058225db00071_1"><span><span class="NLM_string-ref">Flynn, G. A.; Beight, D. W.; Mehdi, S.; Koehl, J. R.; Giroux, E. L.; French, J. F.; Hake, P. W.; Dage, R. C. Application of conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensinI converting enzyme and neutral endopeptidase 24.11. <i>  J. Med. </i><i>Chem.</i><b>1993</b>, <i>36</i>, 2420−2430.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2430&author=G.+A.+Flynn&author=D.+W.+Beight&author=S.+Mehdi&author=J.+R.+Koehl&author=E.+L.+Giroux&author=J.+F.+French&author=P.+W.+Hake&author=R.+C+Dage&title=Application+of+conformationally+restricted+Phe-Leu+dipeptide+mimetic+to+the+design+of+a+combined+inhibitor+of+angiotensinI+converting+enzyme+and+neutral+endopeptidase+24.11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00071_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DG.%2BA.%26atitle%3DApplication%2520of%2520conformationally%2520restricted%2520Phe-Leu%2520dipeptide%2520mimetic%2520to%2520the%2520design%2520of%2520a%2520combined%2520inhibitor%2520of%2520angiotensinI%2520converting%2520enzyme%2520and%2520neutral%2520endopeptidase%252024.11%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00072"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00072'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="jm058225db00072_1"><span><span class="NLM_string-ref">Inguimbert, N.; Poras, H.; Meudal, H.; Teffo, F.; Beslot, F.; Selkti, M.; Tomas, A.; Scalbert, E.; Bennejean, C.; Renard, P.; Fournie-Zaluski, M.-C.; Roques, B. P. <i>  N</i>-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidase (NEP, ACE, ECE):  in vitro and in vivo activities. <i>Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2001−2005.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Inguimbert%2C+N.%3B+Poras%2C+H.%3B+Meudal%2C+H.%3B+Teffo%2C+F.%3B+Beslot%2C+F.%3B+Selkti%2C+M.%3B+Tomas%2C+A.%3B+Scalbert%2C+E.%3B+Bennejean%2C+C.%3B+Renard%2C+P.%3B+Fournie-Zaluski%2C+M.-C.%3B+Roques%2C+B.+P.+N-%5B2-%28Indan-1-yl%29-3-mercapto-propionyl%5D+amino+acids+as+highly+potent+inhibitors+of+the+three+vasopeptidase+%28NEP%2C+ACE%2C+ECE%29%3A%E2%80%89+in+vitro+and+in+vivo+activities.+Bioorg.+Med.+Chem.+Lett.+2002%2C+12%2C+2001%E2%88%922005.+Inguimbert%2C+N.%3B+Poras%2C+H.%3B+Meudal%2C+H.%3B+Teffo%2C+F.%3B+Beslot%2C+F.%3B+Selkti%2C+M.%3B+Tomas%2C+A.%3B+Scalbert%2C+E.%3B+Bennejean%2C+C.%3B+Renard%2C+P.%3B+Fournie-Zaluski%2C+M.-C.%3B+Roques%2C+B.+P.+N-%5B2-%28Indan-1-yl%29-3-mercapto-propionyl%5D+amino+acids+as+highly+potent+inhibitors+of+the+three+vasopeptidase+%28NEP%2C+ACE%2C+ECE%29%3A%E2%80%89+in+vitro+and+in+vivo+activities.+Bioorg.+Med.+Chem.+Lett.2002%2C+12%2C+2001%E2%88%922005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00072_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInguimbert%26aufirst%3DN.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00073"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00073'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="jm058225db00073_1"><span><span class="NLM_string-ref">Laszlo, S.; Quagliato, C.; Greenlee, W.; Patchett, A.; Chang, R.; Lotti, V.; Chen, T.; Scheck, S.; Faust, K. A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor. <i>  J. Med. Chem. </i><b>1993</b>,<i> 36</i>, 3207−3210.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3210&author=S.+Laszlo&author=C.+Quagliato&author=W.+Greenlee&author=A.+Patchett&author=R.+Chang&author=V.+Lotti&author=T.+Chen&author=S.+Scheck&author=K+Faust&title=A+potent%2C+orally+active%2C+balanced+affinity+angiotensin+II+AT1+antagonist+and+AT2+binding+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00073_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaszlo%26aufirst%3DS.%26atitle%3DA%2520potent%252C%2520orally%2520active%252C%2520balanced%2520affinity%2520angiotensin%2520II%2520AT1%2520antagonist%2520and%2520AT2%2520binding%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00074"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00074'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="jm058225db00074_1"><span><span class="NLM_string-ref">Gardiner, S. M.; March, J. E.; Kemp, P. A.; Mullins, J. J.; Bennett, T. Hemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. <i>  Br. J. </i><i>Pharmacol. </i><b>1995</b>, <i>116</i>, 2237−2244.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&conference=SB+209670&author=S.+M.+Gardiner&author=J.+E.+March&author=P.+A.+Kemp&author=J.+J.+Mullins&author=T.+Bennett&title=Hemodynamic+effects+of+losartan+and+the+endothelin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00074_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DGardiner%26aufirst%3DS.%2BM.%26atitle%3DHemodynamic%2520effects%2520of%2520losartan%2520and%2520the%2520endothelin%2520antagonist%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00075"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00075'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="jm058225db00075_1"><span><span class="NLM_string-ref">Walsh, T.; Fitch, K.; Williams, D.; Murphy, K.; Nolan, N.; Pettibone, D.; Chang, R.; O'Malley, S.; Clineschmidt, B.; Veber, D.; Greenlee, W. Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III). <i>  Bioorg. Med. Chem. Lett.</i><b>1995</b>, <i>5</i>, 1155−1158.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=1158&author=T.+Walsh&author=K.+Fitch&author=D.+Williams&author=K.+Murphy&author=N.+Nolan&author=D.+Pettibone&author=R.+Chang&author=S.+O%27Malley&author=B.+Clineschmidt&author=D.+Veber&author=W+Greenlee&title=Potent+dual+antagonists+of+endothelin+and+angiotensin+II+receptors+derived+from+%CE%B1-phenoxyphenylacetic+acids+%28Part+III%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00075_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%26atitle%3DPotent%2520dual%2520antagonists%2520of%2520endothelin%2520and%2520angiotensin%2520II%2520receptors%2520derived%2520from%2520%25CE%25B1-phenoxyphenylacetic%2520acids%2520%2528Part%2520III%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00076"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00076'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="jm058225db00076_1"><span><span class="NLM_string-ref">Murugesan, N.; Tellew, J.; Gu, Z.; Kunst, B.; Fadnis, L.; Cornelius, L.; Baska, R.; Yang, Y.; Beyer, S.; Monshizadegan, H.; Dickinson, K.; Panchal, B.; Valentine, M.; Chong, S.; Morrison, R.; Carlson, K.; Powell, J.; Moreland, S.; Barrish, J.; Kowala, M.; Macor, J. Discovery of <i>N</i>-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. <i>  J. Med. Chem. </i><b>2002</b>,<i> 45</i>, 3829−3835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3835&author=N.+Murugesan&author=J.+Tellew&author=Z.+Gu&author=B.+Kunst&author=L.+Fadnis&author=L.+Cornelius&author=R.+Baska&author=Y.+Yang&author=S.+Beyer&author=H.+Monshizadegan&author=K.+Dickinson&author=B.+Panchal&author=M.+Valentine&author=S.+Chong&author=R.+Morrison&author=K.+Carlson&author=J.+Powell&author=S.+Moreland&author=J.+Barrish&author=M.+Kowala&author=J+Macor&title=Discovery+of+N-isoxazolyl+biphenylsulfonamides+as+potent+dual+angiotensin+II+and+endothelin+A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00076_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurugesan%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520N-isoxazolyl%2520biphenylsulfonamides%2520as%2520potent%2520dual%2520angiotensin%2520II%2520and%2520endothelin%2520A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00077"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00077'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="jm058225db00077_1"><span><span class="NLM_string-ref">Murugesan, N.; Gu, Z.; Fadnis, L.; Tellew, J.; Baska, R.; Yang, Y.; Beyer, S.; Monshizadegan, H.; Dickinson, K.; Valentine, M.; Humphreys, W.; Lan, S.; Ewing, W.; Carlson, K.; Kowala, M.; Zahler, R.; Macor, J. Dual angiotensin II and endothelin A receptor antagonists:  Synthesis of 2‘-substituted <i>N</i>-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics. <i>  J. Med. Chem. </i><b>2005</b>,<i> 48</i>, 171−179.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=179&author=N.+Murugesan&author=Z.+Gu&author=L.+Fadnis&author=J.+Tellew&author=R.+Baska&author=Y.+Yang&author=S.+Beyer&author=H.+Monshizadegan&author=K.+Dickinson&author=M.+Valentine&author=W.+Humphreys&author=S.+Lan&author=W.+Ewing&author=K.+Carlson&author=M.+Kowala&author=R.+Zahler&author=J+Macor&title=Dual+angiotensin+II+and+endothelin+A+receptor+antagonists%3A%E2%80%89+Synthesis+of+2%E2%80%98-substituted+N-3-isoxazolyl+biphenylsulfonamides+with+improved+potency+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00077_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurugesan%26aufirst%3DN.%26atitle%3DDual%2520angiotensin%2520II%2520and%2520endothelin%2520A%2520receptor%2520antagonists%253A%25E2%2580%2589%2520Synthesis%2520of%25202%25E2%2580%2598-substituted%2520N-3-isoxazolyl%2520biphenylsulfonamides%2520with%2520improved%2520potency%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00078"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00078'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="jm058225db00078_1"><span><span class="NLM_string-ref">Vane, J. R. <i>  Nat. New Biol.</i><b>1971</b>, 232−235. Dannhard, G.; Kiefer, W. Cyclooxygenase inhibitorscurrent status and future prospects. <i>Eur. J. </i><i>Med. Chem.</i><b>2001</b>, <i>36</i>, 109−126.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Vane%2C+J.+R.+Nat.+New+Biol.+1971%2C+232%E2%88%92235.+Dannhard%2C+G.%3B+Kiefer%2C+W.+Cyclooxygenase+inhibitorscurrent+status+and+future+prospects.+Eur.+J.+Med.+Chem.+2001%2C+36%2C+109%E2%88%92126.+Vane%2C+J.+R.+Nat.+New+Biol.1971%2C+232%E2%88%92235.+Dannhard%2C+G.%3B+Kiefer%2C+W.+Cyclooxygenase+inhibitorscurrent+status+and+future+prospects.+Eur.+J.+Med.+Chem.2001%2C+36%2C+109%E2%88%92126."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00078_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVane%26aufirst%3DJ.%2BR.%26jtitle%3DNat.%2520New%2520Biol.%26date%3D1971%26volume%3D232%26spage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00079"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00079'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="jm058225db00079_1"><span><span class="NLM_string-ref">Fosslien, E. Adverse effects of nonsteroidal antiinflammatory drugs on the gastrointestinal system. <i>  Ann. Clin. Lab. Sci.</i><b>1998</b>, <i>28</i>, 67−81.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=81&author=E+Fosslien&title=Adverse+effects+of+nonsteroidal+antiinflammatory+drugs+on+the+gastrointestinal+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00079_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFosslien%26aufirst%3DE%26atitle%3DAdverse%2520effects%2520of%2520nonsteroidal%2520antiinflammatory%2520drugs%2520on%2520the%2520gastrointestinal%2520system%26jtitle%3DAnn.%2520Clin.%2520Lab.%2520Sci.%26date%3D1998%26volume%3D28%26spage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00080"><div class="reference"><div class="NLM_citation" id="jm058225db00080_1"><span><span class="NLM_string-ref">Gilroy, D. W.; Tomlinson, A.; Willoughby, D. A. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. <i>  Eur. J. Pharmacol.</i><b>1998</b>, <i>355</i>, 211−217.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1998&pages=217&author=D.+W.+Gilroy&author=A.+Tomlinson&author=D.+A+Willoughby&title=Differential+effects+of+inhibitors+of+cyclooxygenase+%28cyclooxygenase+1+and+cyclooxygenase+2%29+in+acute+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00080_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilroy%26aufirst%3DD.%2BW.%26atitle%3DDifferential%2520effects%2520of%2520inhibitors%2520of%2520cyclooxygenase%2520%2528cyclooxygenase%25201%2520and%2520cyclooxygenase%25202%2529%2520in%2520acute%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D355%26spage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00081"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00081'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="jm058225db00081_1"><span><span class="NLM_string-ref">Fiorucci, S.; Meli, R.; Bucci, M.; Cirino, G. Dual inhibitors of COX and 5-LOX. A new avenue in anti-inflammatory therapy. <i>  Biochem. Pharmacol.</i><b>2001</b>, <i>62</i>, 1433−1438. De Leval, X.; Julemont, F.; Delarge, J.; Pirotte, B.; Dogne, J. M. New trends in dual 5-LOX/COX inhibition. <i>Curr. Med. </i><i>Chem.</i><b>2002</b>, <i>9</i>, 941−962. Charlier, C.; Michaux, C. Dual inhibition of COX-2 and 5-LOX as a new strategy to provide safer non-steroidal anti-inflammatory drugs. <i>Eur. J. Med. Chem.</i><b>2003</b>, <i>38</i>, 645−659.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1438&author=S.+Fiorucci&author=R.+Meli&author=M.+Bucci&author=G+Cirino&title=Dual+inhibitors+of+COX+and+5-LOX.+A+new+avenue+in+anti-inflammatory+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00081_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiorucci%26aufirst%3DS.%26atitle%3DDual%2520inhibitors%2520of%2520COX%2520and%25205-LOX.%2520A%2520new%2520avenue%2520in%2520anti-inflammatory%2520therapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D62%26spage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00082"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00082'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="jm058225db00082_1"><span><span class="NLM_string-ref">Swingle, K. F.; Moore, G. G. I. 2,6-Di-tert-4(2‘-thenoyl)phenol(R-830):  A novel nonsteroidal anti-inflammatory agent with antioxidant properties. <i>  Agents Actions</i><b>1982</b>, <i>12</i>, 674−683.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1982&pages=683&author=K.+F.+Swingle&author=G.+G.+I.+Moore&author=A+Di&title=novel+nonsteroidal+anti-inflammatory+agent+with+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00082_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DK.%2BF.%26atitle%3Dnovel%2520nonsteroidal%2520anti-inflammatory%2520agent%2520with%2520antioxidant%2520properties%26jtitle%3DAgents%2520Actions%26date%3D1982%26volume%3D12%26spage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00083"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00083'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="jm058225db00083_1"><span><span class="NLM_string-ref">Lazer, E. S.; Wong, H.-C.; Possanza, G. J.; Graham, A. G.; Farina, P. R. Anti-inflammatory 2,6-di-<i>tert</i>-butyl-4(2-arylethenyl)phenols. <i>  J. Med. </i><i>Chem.</i><b>1989</b>, <i>32</i>, 100−104.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Lazer%2C+E.+S.%3B+Wong%2C+H.-C.%3B+Possanza%2C+G.+J.%3B+Graham%2C+A.+G.%3B+Farina%2C+P.+R.+Anti-inflammatory+2%2C6-di-tert-butyl-4%282-arylethenyl%29phenols.+J.+Med.+Chem.+1989%2C+32%2C+100%E2%88%92104.+Lazer%2C+E.+S.%3B+Wong%2C+H.-C.%3B+Possanza%2C+G.+J.%3B+Graham%2C+A.+G.%3B+Farina%2C+P.+R.+Anti-inflammatory+2%2C6-di-tert-butyl-4%282-arylethenyl%29phenols.+J.+Med.+Chem.1989%2C+32%2C+100%E2%88%92104."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00083_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLazer%26aufirst%3DE.%2BS.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00084"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00084'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="jm058225db00084_1"><span><span class="NLM_string-ref">Unangst, P. C.; Connor, D. T.; Cetenko, W. A.; Sorenson, R. J.; Kostlan, C. R.; Sircar, J. C.; Wright, C. D.; Schrier, D. J.; Dyer, R. D. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethyl)-4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles:  Novel dual 5-LOX and COX inhibitors with anti-inflamatory activity. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 322−328.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=328&author=P.+C.+Unangst&author=D.+T.+Connor&author=W.+A.+Cetenko&author=R.+J.+Sorenson&author=C.+R.+Kostlan&author=J.+C.+Sircar&author=C.+D.+Wright&author=D.+J.+Schrier&author=R.+D+Dyer&title=Synthesis+and+biological+evaluation+of+5-%5B%5B3%2C5-bis%281%2C1-dimethyl%29-4-hydroxyphenyl%5Dmethylene%5Doxazoles%2C+-thiazoles%2C+and+-imidazoles%3A%E2%80%89+Novel+dual+5-LOX+and+COX+inhibitors+with+anti-inflamatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00084_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25205-%255B%255B3%252C5-bis%25281%252C1-dimethyl%2529-4-hydroxyphenyl%255Dmethylene%255Doxazoles%252C%2520-thiazoles%252C%2520and%2520-imidazoles%253A%25E2%2580%2589%2520Novel%2520dual%25205-LOX%2520and%2520COX%2520inhibitors%2520with%2520anti-inflamatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00085"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00085'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="jm058225db00085_1"><span><span class="NLM_string-ref">Barbey, S.; Goossens, L.; Taverne, T.; Cornet, J.; Choesmel, V.; Rouaud, C.; Gimeno, G.; Yannic-Arnoult, S.; Michaux, C.; Charlier, C.; Houssin, R.; Henichart, J. P. Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 779−782.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=782&author=S.+Barbey&author=L.+Goossens&author=T.+Taverne&author=J.+Cornet&author=V.+Choesmel&author=C.+Rouaud&author=G.+Gimeno&author=S.+Yannic-Arnoult&author=C.+Michaux&author=C.+Charlier&author=R.+Houssin&author=J.+P+Henichart&title=Synthesis+and+activity+of+a+new+methoxytetrahydropyran+derivative+as+dual+cyclooxygenase-2%2F5-lipoxygenase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00085_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbey%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520a%2520new%2520methoxytetrahydropyran%2520derivative%2520as%2520dual%2520cyclooxygenase-2%252F5-lipoxygenase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00086"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00086'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="jm058225db00086_1"><span><span class="NLM_string-ref">Corey, E. J.; Cashman, J. R.; Kantner, S. S.; Wright, S. W. <i>  J. Am. Chem. Soc.</i><b>1984</b>, <i>106</i>, 1503.</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00317a064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Corey%2C+E.+J.%3B+Cashman%2C+J.+R.%3B+Kantner%2C+S.+S.%3B+Wright%2C+S.+W.+J.+Am.+Chem.+Soc.+1984%2C+106%2C+1503.+Corey%2C+E.+J.%3B+Cashman%2C+J.+R.%3B+Kantner%2C+S.+S.%3B+Wright%2C+S.+W.+J.+Am.+Chem.+Soc.1984%2C+106%2C+1503."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00086_1&amp;dbid=16384&amp;doi=10.1021%2Fja00317a064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00317a064%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1984%26volume%3D106%26spage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00087"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00087'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="jm058225db00087_1"><span><span class="NLM_string-ref">Carter, G. W.; Young, P. R.; Albert, D. H.; Bouska, J.; Dyer, R.; Bell, R. L.; Summers, J. B.; Brooks, D. W. 5-LOX inhibitory activity of zileuton. <i>  J. </i><i>Pharmacol. Exp. Ther.</i><b>1991</b>, <i>256</i>, 929−937.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1991&pages=937&author=G.+W.+Carter&author=P.+R.+Young&author=D.+H.+Albert&author=J.+Bouska&author=R.+Dyer&author=R.+L.+Bell&author=J.+B.+Summers&author=D.+W+Brooks&title=5-LOX+inhibitory+activity+of+zileuton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00087_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DG.%2BW.%26atitle%3D5-LOX%2520inhibitory%2520activity%2520of%2520zileuton%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1991%26volume%3D256%26spage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00088"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00088'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="jm058225db00088_1"><span><span class="NLM_string-ref">Brooks, C. D. W.; Stewart, A. O.; Basha, A.; Bhatia, P.; Ratajczyk, J. D.; Martin, J. G.; Craig, R. A.; Kolasa, T.; Bouska, J. B.; Lanni, C.; Harris, R. R.; Malo, P. E.; Carter, G. W.; Bell, R. L. <i>  J. Med. Chem.</i><b>1995</b>, <i>38</i>, 4768.</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00024a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Brooks%2C+C.+D.+W.%3B+Stewart%2C+A.+O.%3B+Basha%2C+A.%3B+Bhatia%2C+P.%3B+Ratajczyk%2C+J.+D.%3B+Martin%2C+J.+G.%3B+Craig%2C+R.+A.%3B+Kolasa%2C+T.%3B+Bouska%2C+J.+B.%3B+Lanni%2C+C.%3B+Harris%2C+R.+R.%3B+Malo%2C+P.+E.%3B+Carter%2C+G.+W.%3B+Bell%2C+R.+L.+J.+Med.+Chem.+1995%2C+38%2C+4768.+Brooks%2C+C.+D.+W.%3B+Stewart%2C+A.+O.%3B+Basha%2C+A.%3B+Bhatia%2C+P.%3B+Ratajczyk%2C+J.+D.%3B+Martin%2C+J.+G.%3B+Craig%2C+R.+A.%3B+Kolasa%2C+T.%3B+Bouska%2C+J.+B.%3B+Lanni%2C+C.%3B+Harris%2C+R.+R.%3B+Malo%2C+P.+E.%3B+Carter%2C+G.+W.%3B+Bell%2C+R.+L.+J.+Med.+Chem.1995%2C+38%2C+4768."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00088_1&amp;dbid=16384&amp;doi=10.1021%2Fjm00024a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00024a004%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DC.%2BD.%2BW.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00089"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00089'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="jm058225db00089_1"><span><span class="NLM_string-ref">Laufer, S. A.; Augustin, J.; Dannhardt, G.; Kiefer, W. (6,7-Diarylhydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 1894−1897.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1897&author=S.+A.+Laufer&author=J.+Augustin&author=G.+Dannhardt&author=W.+Kiefer&author=+Diarylhydropyrrolizin&title=a+novel+class+of+potent+dual+inhibitors+of+both+cyclooxygenase+and+5-lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00089_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3Da%2520novel%2520class%2520of%2520potent%2520dual%2520inhibitors%2520of%2520both%2520cyclooxygenase%2520and%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00090"><div class="reference"><div class="NLM_citation" id="jm058225db00090_1"><span><span class="NLM_string-ref">Hibi, S.; Okamoto, Y.; Tagami, K.; Numata, H.; Kobayashi, N.; Shinoda, M.; Kawahara, T.; Murakami, M.; Oketani, K.; Inoue, T.; Shibata, H.; Yamatsu, I. Novel dual inhibitors of 5-LOX and TxA2S:  Synthesis and structure−activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 3062−3070.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3070&author=S.+Hibi&author=Y.+Okamoto&author=K.+Tagami&author=H.+Numata&author=N.+Kobayashi&author=M.+Shinoda&author=T.+Kawahara&author=M.+Murakami&author=K.+Oketani&author=T.+Inoue&author=H.+Shibata&author=I+Yamatsu&title=Novel+dual+inhibitors+of+5-LOX+and+TxA2S%3A%E2%80%89+Synthesis+and+structure%E2%88%92activity+relationships+of+3-pyridylmethyl-substituted+2-amino-6-hydroxybenzothiazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00090_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHibi%26aufirst%3DS.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%25205-LOX%2520and%2520TxA2S%253A%25E2%2580%2589%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25203-pyridylmethyl-substituted%25202-amino-6-hydroxybenzothiazole%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00091"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00091'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="jm058225db00091_1"><span><span class="NLM_string-ref">Fitzgerald, G. A.; Reilly, I. A. G.; Pederson, A. K. The biochemical pharmacology of thromboxane synthase inhibition in man. <i>  Circulation</i><b>1985</b>, <i>72</i>, 1194−1201.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1985&pages=1201&author=G.+A.+Fitzgerald&author=I.+A.+G.+Reilly&author=A.+K+Pederson&title=The+biochemical+pharmacology+of+thromboxane+synthase+inhibition+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00091_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DG.%2BA.%26atitle%3DThe%2520biochemical%2520pharmacology%2520of%2520thromboxane%2520synthase%2520inhibition%2520in%2520man%26jtitle%3DCirculation%26date%3D1985%26volume%3D72%26spage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00092"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00092'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="jm058225db00092_1"><span><span class="NLM_string-ref">Gresele, P.; van Houte, E.; Arnout, J.; Deckmyn, H.; Vermylen, J. Thromboxane synthase inhibition combined with thromboxane receptor blockade:  a step forward in antithrombotic strategy? <i>Thromb. Haemostasis</i><b>1984</b>, <i>52</i>, 364.</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=jm058225db00092/jm058225db00092_1&amp;dbid=8&amp;doi=10.1021%2Fjm058225d&amp;key=6099616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=jm058225db00092/jm058225db00092_1&amp;dbid=32&amp;doi=10.1021%2Fjm058225d&amp;key=1%3ACAS%3A528%3ADyaL2MXhsVaqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1984&pages=364&author=P.+Gresele&author=E.+van+Houte&author=J.+Arnout&author=H.+Deckmyn&author=J+Vermylen&title=Thromboxane+synthase+inhibition+combined+with+thromboxane+receptor+blockade%3A%E2%80%89+a+step+forward+in+antithrombotic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_jm058225db00092_1R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Thromboxane synthase inhibition combined with thromboxane receptor blockade:  a step forward in antithrombotic strategy?</span></div><div class="casAuthors">Gresele, Paolo; Van Houtte, Elisabeth; Arnout, Jef; Deckmyn, Hans; Vermylen, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">364</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    </div><div class="casAbstract">At a relatively high concn. (5 μg/mL), the thromboxane synthetase  [61276-89-9] inhibitor dazoxiben  [78218-09-4] alone did not inhibit, and the thromboxane receptor blocker BM 13.177  [72131-33-0] only slightly inhibited, platelet aggregation in whole blood.  The combination, however, was significantly more inhibitory than either drug by itself.  Aspirin-treated endothelial cells produced prostacyclin  [35121-78-9] when challenged with dazoxiben- or dazoxiben plus BM 13.177-treated platelets activated by collagen.  This indicates that BM 13.177 does not interfere with the property of dazoxiben of redirecting the platelet endoperoxide metab. towards prostacyclin in the presence of a source of prostacyclin synthase (endothelial cells, leukocytes).  To the extent that the combination of a thromboxane synthase inhibitor and a thromboxane receptor blocker results in activation of platelet adenylate cyclase selectively at the site of vascular injury, this assocn. would have major antithrombotic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmbE1rJCcG37Vg90H21EOLACvtfcHk0li7fFMsTxQuFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhsVaqtro%253D&md5=fc08189e6d487a01400eae10abbe1815</span></div><a href="/servlet/linkout?suffix=jm058225db00092_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGresele%26aufirst%3DP.%26atitle%3DThromboxane%2520synthase%2520inhibition%2520combined%2520with%2520thromboxane%2520receptor%2520blockade%253A%25E2%2580%2589%2520a%2520step%2520forward%2520in%2520antithrombotic%2520strategy%26jtitle%3DThromb.%2520Haemostasis%26date%3D1984%26volume%3D52%26spage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00093"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00093'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="jm058225db00093_1"><span><span class="NLM_string-ref">De Clerck, F.; Beetens, J.; Van de Water, A.; Vercammen, E.; Janssen, P. A. R 68 070:  thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule. II. Pharmacological effects in vivo and ex vivo. <i>  Thromb. Haemostasis</i><b>1989</b>, <i>61</i>, 43−49.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1989&pages=49&author=F.+De+Clerck&author=J.+Beetens&author=A.+Van+de+Water&author=E.+Vercammen&author=P.+A.+Janssen&title=synthetase+inhibition+and+thromboxane+A2%2Fprostaglandin+endoperoxide+receptor+blockade+combined+in+one+molecule.+II.+Pharmacological+effects+in+vivo+and+ex+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00093_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClerck%26aufirst%3DF.%26atitle%3Dsynthetase%2520inhibition%2520and%2520thromboxane%2520A2%252Fprostaglandin%2520endoperoxide%2520receptor%2520blockade%2520combined%2520in%2520one%2520molecule.%2520II.%2520Pharmacological%2520effects%2520in%2520vivo%2520and%2520ex%2520vivo%26jtitle%3DThromb.%2520Haemostasis%26date%3D1989%26volume%3D61%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00094"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00094'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="jm058225db00094_1"><span><span class="NLM_string-ref">Kato, K.; Ohkawa, S.; Terao, S.; Terashita, Z. I.; Nishikava, K. Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of ω-pyridylalkenoic acids. <i>  J. Med. Chem.</i><b>1985</b>, <i>28</i>, 287−294.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=294&author=K.+Kato&author=S.+Ohkawa&author=S.+Terao&author=Z.+I.+Terashita&author=K+Nishikava&title=Thromboxane+synthetase+inhibitors+%28TXSI%29.+Design%2C+synthesis%2C+and+evaluation+of+a+novel+series+of+%CF%89-pyridylalkenoic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00094_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26atitle%3DThromboxane%2520synthetase%2520inhibitors%2520%2528TXSI%2529.%2520Design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520%25CF%2589-pyridylalkenoic%2520acids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00095"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00095'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="jm058225db00095_1"><span><span class="NLM_string-ref">Soyka, R.; Heckel, A.; Nickl, J.; Eisert, W.; Muller, T. H.; Weisenberger, H. 6,6-Disubstituted hex-5-enoic acid derivatives as combined thromboxane A2 receptor and synthetase inhibitors. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 26−39.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=39&author=R.+Soyka&author=A.+Heckel&author=J.+Nickl&author=W.+Eisert&author=T.+H.+Muller&author=H.+Weisenberger&author=+Disubstituted&title=acid+derivatives+as+combined+thromboxane+A2+receptor+and+synthetase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00095_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoyka%26aufirst%3DR.%26atitle%3Dacid%2520derivatives%2520as%2520combined%2520thromboxane%2520A2%2520receptor%2520and%2520synthetase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00096"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00096'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="jm058225db00096_1"><span><span class="NLM_string-ref">Dickinson, R. P.; Dack, K. N.; Steele, J. Tromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonist. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>1995</b>, <i>5</i>, 3017−3022.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=3022&author=R.+P.+Dickinson&author=K.+N.+Dack&author=J+Steele&title=Tromboxane+modulating+agents.+1.+Design+of+1-%5B%28arylsulfonyl%29amino%5D+alkylindole+derivatives+as+dual+thromboxane+synthase+inhibitor%2Fthromboxane+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00096_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DR.%2BP.%26atitle%3DTromboxane%2520modulating%2520agents.%25201.%2520Design%2520of%25201-%255B%2528arylsulfonyl%2529amino%255D%2520alkylindole%2520derivatives%2520as%2520dual%2520thromboxane%2520synthase%2520inhibitor%252Fthromboxane%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00097"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00097'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="jm058225db00097_1"><span><span class="NLM_string-ref">Henke, B. Peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 4118−4127.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4127&author=B+Henke&title=Peroxisome+proliferator-activated+receptor+%CE%B1%2F%CE%B3+dual+agonists+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00097_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenke%26aufirst%3DB%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%252F%25CE%25B3%2520dual%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00098"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00098'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="jm058225db00098_1"><span><span class="NLM_string-ref">Nomua, M.; Kinoshita, S.; Satoh, H.; Maeda, T.; Murakami, K.; Tsunoda, M.; Miyachi, H.; Awano, K. (3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents. <i>  Bioorg.</i><i>Med. Chem. Lett.</i><b>1999</b>, <i>9</i>, 533−538.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=538&author=M.+Nomua&author=S.+Kinoshita&author=H.+Satoh&author=T.+Maeda&author=K.+Murakami&author=M.+Tsunoda&author=H.+Miyachi&author=K.+Awano&author=+Substituted&title=as+structurally+new+antihyperglycemic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00098_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNomua%26aufirst%3DM.%26atitle%3Das%2520structurally%2520new%2520antihyperglycemic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00099"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058225db00099'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="jm058225db00099_1"><span><span class="NLM_string-ref">Oliver, W. R.; Shenk, J. L.; Snaith, M. R.; Russell, C. S.; Kelli, D.; Plunket, K. D.; Bodkin, N. L.; Lewis, M. C.; Winegar, D. A.; Sznaidman, M. L.; Lambert, M. H.; Xu, H. E.; Sternbach, D. D.; Kliewer, S. A.; Hansen, B. C.; Willson, T. M. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. <i>  Proc. Natl. Acad. Sci.</i><i>U.S.A.</i><b>2001</b>, <i>98</i>, 5306−5311.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=5311&author=W.+R.+Oliver&author=J.+L.+Shenk&author=M.+R.+Snaith&author=C.+S.+Russell&author=D.+Kelli&author=K.+D.+Plunket&author=N.+L.+Bodkin&author=M.+C.+Lewis&author=D.+A.+Winegar&author=M.+L.+Sznaidman&author=M.+H.+Lambert&author=H.+E.+Xu&author=D.+D.+Sternbach&author=S.+A.+Kliewer&author=B.+C.+Hansen&author=T.+M+Willson&title=A+selective+peroxisome+proliferator-activated+receptor+%CE%B4+agonist+promotes+reverse+cholesterol+transport"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00099_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DW.%2BR.%26atitle%3DA%2520selective%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B4%2520agonist%2520promotes%2520reverse%2520cholesterol%2520transport%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D5311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00100"><div class="reference"><div class="NLM_citation" id="jm058225db00100_1"><span><span class="NLM_string-ref">Mogensen, J. P.; Jeppesen, L.; Bury, P. S. Design and synthesis of novel PPARα/γ/δ triple activators using known PPARα/γ dual activator as structural template. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 257−260.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=260&author=J.+P.+Mogensen&author=L.+Jeppesen&author=P.+S+Bury&title=Design+and+synthesis+of+novel+PPAR%CE%B1%2F%CE%B3%2F%CE%B4+triple+activators+using+known+PPAR%CE%B1%2F%CE%B3+dual+activator+as+structural+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00100_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMogensen%26aufirst%3DJ.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520PPAR%25CE%25B1%252F%25CE%25B3%252F%25CE%25B4%2520triple%2520activators%2520using%2520known%2520PPAR%25CE%25B1%252F%25CE%25B3%2520dual%2520activator%2520as%2520structural%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00101"><div class="reference"><div class="NLM_citation" id="jm058225db00101_1"><span><span class="NLM_string-ref">Xu, Y.; Rito, C. J.; Etgen, G. J.; Ardecky, R. J.; Bean, S. J.; Bensch, W. R.; Bosley, J. R.; Broderick, C. L.; Brooks, D. A.; Dominianni, S. J.; Hahn, P. J.; Dale, S. L.; Mais, D. E.; Montrose-Rafizadeh, C.; Ogilvie, K. M.; Oldham, B. A.; Peters, M.; Rungta, D. K.; Shuker, A. J.; Stephenson, G. A.; Tripp, A. E.; Wilson, S. B.; Winneroski, L. L.; Zink, R.; Kauffman, R. K.; McCarthy, J. R. Design and synthesis of α-aryloxy-α-methylhydrocinnamic acids:  a novel class of dual peroxisome proliferator-activated receptor α/γ agonists. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 2422−2425.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2425&author=Y.+Xu&author=C.+J.+Rito&author=G.+J.+Etgen&author=R.+J.+Ardecky&author=S.+J.+Bean&author=W.+R.+Bensch&author=J.+R.+Bosley&author=C.+L.+Broderick&author=D.+A.+Brooks&author=S.+J.+Dominianni&author=P.+J.+Hahn&author=S.+L.+Dale&author=D.+E.+Mais&author=C.+Montrose-Rafizadeh&author=K.+M.+Ogilvie&author=B.+A.+Oldham&author=M.+Peters&author=D.+K.+Rungta&author=A.+J.+Shuker&author=G.+A.+Stephenson&author=A.+E.+Tripp&author=S.+B.+Wilson&author=L.+L.+Winneroski&author=R.+Zink&author=R.+K.+Kauffman&author=J.+R+McCarthy&title=Design+and+synthesis+of+%CE%B1-aryloxy-%CE%B1-methylhydrocinnamic+acids%3A%E2%80%89+a+novel+class+of+dual+peroxisome+proliferator-activated+receptor+%CE%B1%2F%CE%B3+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00101_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B1-aryloxy-%25CE%25B1-methylhydrocinnamic%2520acids%253A%25E2%2580%2589%2520a%2520novel%2520class%2520of%2520dual%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%252F%25CE%25B3%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00102"><div class="reference"><div class="NLM_citation" id="jm058225db00102_1"><span><span class="NLM_string-ref">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. <i>  Adv.</i><i>Drug Delivery Rev.</i><b>1997</b>, <i>23</i>, 3−25.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=25&author=C.+A.+Lipinski&author=F.+Lombardo&author=B.+W.+Dominy&author=P.+J+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00102_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00103"><div class="reference"><div class="NLM_citation" id="jm058225db00103_1"><span><span class="NLM_string-ref">Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 2615−2623.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2623&author=D.+F.+Veber&author=S.+R.+Johnson&author=H.+Y.+Cheng&author=B.+R.+Smith&author=K.+W.+Ward&author=K.+D+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00103_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00104"><div class="reference"><div class="NLM_citation" id="jm058225db00104_1"><span><span class="NLM_string-ref">Mah, R.; Gerspacher, M.; von Sprecher, A.; Stutzb, S.; Tschinke, V.; Anderson, G.; Bertrand, C.; Subramanian, N.; Ball, H. Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2065−2068.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2068&author=R.+Mah&author=M.+Gerspacher&author=A.+von+Sprecher&author=S.+Stutzb&author=V.+Tschinke&author=G.+Anderson&author=C.+Bertrand&author=N.+Subramanian&author=H+Ball&title=Biphenyl+derivatives+as+novel+dual+NK1%2FNK2-receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00104_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMah%26aufirst%3DR.%26atitle%3DBiphenyl%2520derivatives%2520as%2520novel%2520dual%2520NK1%252FNK2-receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058225db00105"><div class="reference"><div class="NLM_citation" id="jm058225db00105_1"><span><span class="NLM_string-ref">Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.; Scozzafava, A.; Klebe, G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:  New pharmacological opportunities due to related binding site recognition. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 550−557.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=557&author=A.+Weber&author=A.+Casini&author=A.+Heine&author=D.+Kuhn&author=C.+T.+Supuran&author=A.+Scozzafava&author=G+Klebe&title=Unexpected+nanomolar+inhibition+of+carbonic+anhydrase+by+COX-2-selective+celecoxib%3A%E2%80%89+New+pharmacological+opportunities+due+to+related+binding+site+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00105_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%26atitle%3DUnexpected%2520nanomolar%2520inhibition%2520of%2520carbonic%2520anhydrase%2520by%2520COX-2-selective%2520celecoxib%253A%25E2%2580%2589%2520New%2520pharmacological%2520opportunities%2520due%2520to%2520related%2520binding%2520site%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm058225db00001':['jm058225db00001_1'],'jm058225db00002':['jm058225db00002_1'],'jm058225db00003':['jm058225db00003_1'],'jm058225db00004':['jm058225db00004_1'],'jm058225db00005':['jm058225db00005_1'],'jm058225db00006':['jm058225db00006_1'],'jm058225db00007':['jm058225db00007_1'],'jm058225db00008':['jm058225db00008_1'],'jm058225db00009':['jm058225db00009_1'],'jm058225db00010':['jm058225db00010_1'],'jm058225db00011':['jm058225db00011_1'],'jm058225db00012':['jm058225db00012_1'],'jm058225db00013':['jm058225db00013_1'],'jm058225db00014':['jm058225db00014_1'],'jm058225db00015':['jm058225db00015_1'],'jm058225db00016':['jm058225db00016_1'],'jm058225db00017':['jm058225db00017_1'],'jm058225db00018':['jm058225db00018_1'],'jm058225db00019':['jm058225db00019_1'],'jm058225db00020':['jm058225db00020_1'],'jm058225db00021':['jm058225db00021_1'],'jm058225db00022':['jm058225db00022_1'],'jm058225db00023':['jm058225db00023_1'],'jm058225db00024':['jm058225db00024_1'],'jm058225db00025':['jm058225db00025_1'],'jm058225db00026':['jm058225db00026_1'],'jm058225db00027':['jm058225db00027_1'],'jm058225db00028':['jm058225db00028_1'],'jm058225db00029':['jm058225db00029_1'],'jm058225db00030':['jm058225db00030_1'],'jm058225db00031':['jm058225db00031_1'],'jm058225db00032':['jm058225db00032_1'],'jm058225db00033':['jm058225db00033_1'],'jm058225db00034':['jm058225db00034_1'],'jm058225db00035':['jm058225db00035_1'],'jm058225db00036':['jm058225db00036_1'],'jm058225db00037':['jm058225db00037_1'],'jm058225db00038':['jm058225db00038_1'],'jm058225db00039':['jm058225db00039_1'],'jm058225db00040':['jm058225db00040_1'],'jm058225db00041':['jm058225db00041_1'],'jm058225db00042':['jm058225db00042_1'],'jm058225db00043':['jm058225db00043_1'],'jm058225db00044':['jm058225db00044_1'],'jm058225db00045':['jm058225db00045_1'],'jm058225db00046':['jm058225db00046_1'],'jm058225db00047':['jm058225db00047_1'],'jm058225db00048':['jm058225db00048_1'],'jm058225db00049':['jm058225db00049_1'],'jm058225db00050':['jm058225db00050_1'],'jm058225db00051':['jm058225db00051_1'],'jm058225db00052':['jm058225db00052_1'],'jm058225db00053':['jm058225db00053_1'],'jm058225db00054':['jm058225db00054_1'],'jm058225db00055':['jm058225db00055_1'],'jm058225db00056':['jm058225db00056_1'],'jm058225db00057':['jm058225db00057_1'],'jm058225db00058':['jm058225db00058_1'],'jm058225db00059':['jm058225db00059_1'],'jm058225db00060':['jm058225db00060_1'],'jm058225db00061':['jm058225db00061_1'],'jm058225db00062':['jm058225db00062_1'],'jm058225db00063':['jm058225db00063_1'],'jm058225db00064':['jm058225db00064_1'],'jm058225db00065':['jm058225db00065_1'],'jm058225db00066':['jm058225db00066_1'],'jm058225db00067':['jm058225db00067_1'],'jm058225db00068':['jm058225db00068_1'],'jm058225db00069':['jm058225db00069_1'],'jm058225db00070':['jm058225db00070_1'],'jm058225db00071':['jm058225db00071_1'],'jm058225db00072':['jm058225db00072_1'],'jm058225db00073':['jm058225db00073_1'],'jm058225db00074':['jm058225db00074_1'],'jm058225db00075':['jm058225db00075_1'],'jm058225db00076':['jm058225db00076_1'],'jm058225db00077':['jm058225db00077_1'],'jm058225db00078':['jm058225db00078_1'],'jm058225db00079':['jm058225db00079_1'],'jm058225db00080':['jm058225db00080_1'],'jm058225db00081':['jm058225db00081_1'],'jm058225db00082':['jm058225db00082_1'],'jm058225db00083':['jm058225db00083_1'],'jm058225db00084':['jm058225db00084_1'],'jm058225db00085':['jm058225db00085_1'],'jm058225db00086':['jm058225db00086_1'],'jm058225db00087':['jm058225db00087_1'],'jm058225db00088':['jm058225db00088_1'],'jm058225db00089':['jm058225db00089_1'],'jm058225db00090':['jm058225db00090_1'],'jm058225db00091':['jm058225db00091_1'],'jm058225db00092':['jm058225db00092_1'],'jm058225db00093':['jm058225db00093_1'],'jm058225db00094':['jm058225db00094_1'],'jm058225db00095':['jm058225db00095_1'],'jm058225db00096':['jm058225db00096_1'],'jm058225db00097':['jm058225db00097_1'],'jm058225db00098':['jm058225db00098_1'],'jm058225db00099':['jm058225db00099_1'],'jm058225db00100':['jm058225db00100_1'],'jm058225db00101':['jm058225db00101_1'],'jm058225db00102':['jm058225db00102_1'],'jm058225db00103':['jm058225db00103_1'],'jm058225db00104':['jm058225db00104_1'],'jm058225db00105':['jm058225db00105_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 789 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mónica García, Virginia Llorente, Lourdes Garriga, Ute Christmann, Sergi Rodríguez-Escrich, Marina Virgili, Begoña Fernández, Magda Bordas, Eva Ayet, Javier Burgueño, Marta Pujol, Albert Dordal, Enrique Portillo-Salido, Georgia Gris, José Miguel Vela, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Almansa</span>. </span><span class="cited-content_cbyCitation_article-title">Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10139-10154. <a href="https://doi.org/10.1021/acs.jmedchem.1c00417" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPropionamide%252BDerivatives%252Bas%252BDual%252B%2525CE%2525BC-Opioid%252BReceptor%252BAgonists%252Band%252B%2525CF%2525831%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM%25C3%25B3nica%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D08072021%26volume%3D64%26issue%3D14%26spage%3D10139%26epage%3D10154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenquan Xuan, Xinmei Gu, Sicheng Yan, Yanfei Xie, Yiying Zhou, Hui Zhang, Haibo Jin, Shengquan Hu, Marvin S. H. Mak, Dongsheng Zhou, Karl Wah Keung Tsim, Paul R. Carlier, Yifan Han, <span class="NLM_string-name hlFld-ContribAuthor">Wei Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (13)
                                     , 2462-2477. <a href="https://doi.org/10.1021/acschemneuro.1c00182" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00182%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDimeric%252BTacrine%25252810%252529-hupyridone%252Bas%252Ba%252BMultitarget-Directed%252BLigand%252BTo%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DXuan%26aufirst%3DZhenquan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26032021%26date%3D09062021%26date%3D22062021%26volume%3D12%26issue%3D13%26spage%3D2462%26epage%3D2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wen Shuai, Guan Wang, Yiwen Zhang, Faqian Bu, Sicheng Zhang, Duane D. Miller, Wei Li, Liang Ouyang, <span class="NLM_string-name hlFld-ContribAuthor">Yuxi Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7963-7990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bon%252BTubulin%252BInhibitors%252Bwith%252BDual%252BTargeting%252BCapabilities%252Bfor%252BCancer%252BTherapy%26aulast%3DShuai%26aufirst%3DWen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19012021%26date%3D08062021%26volume%3D64%26issue%3D12%26spage%3D7963%26epage%3D7990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kalpana Tilekar, Jessica D. Hess, Neha Upadhyay, Alessandra Lo Bianco, Markus Schweipert, Antonio Laghezza, Fulvio Loiodice, Franz-Josef Meyer-Almes, Renato J. Aguilera, Antonio Lavecchia, <span class="NLM_string-name hlFld-ContribAuthor">Ramaa C S</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazolidinedione “Magic Bullets” Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6949-6971. <a href="https://doi.org/10.1021/acs.jmedchem.1c00491" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00491%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThiazolidinedione%252B%2525E2%252580%25259CMagic%252BBullets%2525E2%252580%25259D%252BSimultaneously%252BTargeting%252BPPAR%2525CE%2525B3%252Band%252BHDACs%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BInvestigations%252Bof%252Btheir%252BIn%252BVitro%252Band%252BIn%252BVivo%252BAntitumor%252BEffects%26aulast%3DTilekar%26aufirst%3DKalpana%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18032021%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6949%26epage%3D6971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michele Rossi, Michela Freschi, Luciana de Camargo Nascente, Alessandra Salerno, Sarah de Melo Viana Teixeira, Florian Nachon, Fabien Chantegreil, Ondrej Soukup, Lukáš Prchal, Marco Malaguti, Christian Bergamini, Manuela Bartolini, Cristina Angeloni, Silvana Hrelia, Luiz Antonio Soares Romeiro, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4972-4990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00048" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00048%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSustainable%252BDrug%252BDiscovery%252Bof%252BMulti-Target-Directed%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRossi%26aufirst%3DMichele%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11012021%26date%3D08042021%26volume%3D64%26issue%3D8%26spage%3D4972%26epage%3D4990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">José Luis Díaz, Félix Cuevas, Gonzalo Pazos, Paula Álvarez-Bercedo, Ana I. Oliva, M. Ángeles Sarmentero, Daniel Font, Agustín Jiménez-Aquino, María Morón, Adriana Port, Rosalía Pascual, Albert Dordal, Enrique Portillo-Salido, Raquel F. Reinoso, José Miguel Vela, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Almansa</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels and the Norepinephrine Transporter. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2167-2185. <a href="https://doi.org/10.1021/acs.jmedchem.0c01867" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01867%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBicyclic%252BDiazepinones%252Bas%252BDual%252BLigands%252Bof%252Bthe%252B%2525CE%2525B12%2525CE%2525B4-1%252BSubunit%252Bof%252BVoltage-Gated%252BCalcium%252BChannels%252Band%252Bthe%252BNorepinephrine%252BTransporter%26aulast%3DD%25C3%25ADaz%26aufirst%3DJos%25C3%25A9%2BLuis%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28102020%26date%3D16022021%26volume%3D64%26issue%3D4%26spage%3D2167%26epage%3D2185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hafiza Rabia Afzal, Najm ul Hassan Khan, Kishwar Sultana, Aisha Mobashar, Aqsa Lareb, Ayesha Khan, Abrashim Gull, Hasan Afzaal, Muhammad Tariq Khan, Muhammad Rizwan, <span class="NLM_string-name hlFld-ContribAuthor">Muhammad Imran</span>. </span><span class="cited-content_cbyCitation_article-title">Schiff Bases of Pioglitazone Provide Better Antidiabetic and Potent Antioxidant Effect in a Streptozotocin–Nicotinamide-Induced Diabetic Rodent Model. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (6)
                                     , 4470-4479. <a href="https://doi.org/10.1021/acsomega.0c06064" title="DOI URL">https://doi.org/10.1021/acsomega.0c06064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c06064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c06064%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSchiff%252BBases%252Bof%252BPioglitazone%252BProvide%252BBetter%252BAntidiabetic%252Band%252BPotent%252BAntioxidant%252BEffect%252Bin%252Ba%252BStreptozotocin%2525E2%252580%252593Nicotinamide-Induced%252BDiabetic%252BRodent%252BModel%26aulast%3DAfzal%26aufirst%3DHafiza%2BRabia%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13122020%26date%3D25012021%26date%3D03022021%26volume%3D6%26issue%3D6%26spage%3D4470%26epage%3D4479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuewu Liang, Shuai Tang, Xuyi Liu, Yingluo Liu, Qifu Xu, Xiaomin Wang, Abdusaid Saidahmatov, Chunpu Li, Jiang Wang, Yu Zhou, Yingjie Zhang, Meiyu Geng, Min Huang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02111%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine-based%252BDerivatives%252Bas%252BPotent%252BJAK%25252FHDAC%252BDual%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BRefractory%252BSolid%252BTumors%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2021%26date%3D2020%26date%3D07122020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander A. Titov, Maxim S. Kobzev, Marco Catto, Modesto de Candia, Nicola Gambacorta, Nunzio Denora, Leonardo Pisani, Orazio Nicolotti, Tatiana N. Borisova, Alexey V. Varlamov, Leonid G. Voskressensky, <span class="NLM_string-name hlFld-ContribAuthor">Cosimo D. Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Away from Flatness: Unprecedented Nitrogen-Bridged Cyclopenta[a]indene Derivatives as Novel Anti-Alzheimer Multitarget Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 340-353. <a href="https://doi.org/10.1021/acschemneuro.0c00706" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00706%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DAway%252Bfrom%252BFlatness%25253A%252BUnprecedented%252BNitrogen-Bridged%252BCyclopenta%25255Ba%25255Dindene%252BDerivatives%252Bas%252BNovel%252BAnti-Alzheimer%252BMultitarget%252BAgents%26aulast%3DTitov%26aufirst%3DAlexander%2BA.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D02112020%26date%3D21122020%26date%3D04012021%26volume%3D12%26issue%3D2%26spage%3D340%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Milelli</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 26-41. <a href="https://doi.org/10.1021/acs.jmedchem.0c00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%25253A%252BA%252BNew%252BGold%252BRush%252Bin%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BMultitarget%252BDrug%252BDiscovery%25253F%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D21122020%26volume%3D64%26issue%3D1%26spage%3D26%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mónica García, Marina Virgili, Mònica Alonso, Carles Alegret, Joan Farran, Begoña Fernández, Magda Bordas, Rosalia Pascual, Javier Burgueño, Alba Vidal-Torres, Antonio R. Fernández de Henestrosa, Eva Ayet, Manuel Merlos, Jose Miguel Vela, Carlos R. Plata-Salamán, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Almansa</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15508-15526. <a href="https://doi.org/10.1021/acs.jmedchem.0c01127" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01127%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BEST73502%25252C%252Ba%252BDual%252B%2525CE%2525BC-Opioid%252BReceptor%252BAgonist%252Band%252B%2525CF%2525831%252BReceptor%252BAntagonist%252BClinical%252BCandidate%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM%25C3%25B3nica%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01072020%26date%3D16102020%26volume%3D63%26issue%3D24%26spage%3D15508%26epage%3D15526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mengna Zhang, Biao Xu, Ning Li, Hui Liu, Xuerui Shi, Qinqin Zhang, Yanbin Shi, Kangtai Xu, Jian Xiao, Dan Chen, Hanwen Zhu, Yulong Sun, Ting Zhang, Run Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Quan Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15709-15725. <a href="https://doi.org/10.1021/acs.jmedchem.0c01367" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01367%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BCharacterization%252Bof%252BCyclic%252BDisulfide-Containing%252BPeptide%252BAnalogs%252Bof%252Bthe%252BMultifunctional%252BOpioid%25252FNeuropeptide%252BFF%252BReceptor%252BAgonists%252BThat%252BProduce%252BLong-Lasting%252Band%252BNontolerant%252BAntinociception%26aulast%3DZhang%26aufirst%3DMengna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05082020%26date%3D03122020%26volume%3D63%26issue%3D24%26spage%3D15709%26epage%3D15725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Simon Gonzalez, Maria Dumitrascuta, Emilie Eiselt, Stevany Louis, Linda Kunze, Annalisa Blasiol, Mélanie Vivancos, Santo Previti, Elke Dewolf, Charlotte Martin, Dirk Tourwé, Florine Cavelier, Louis Gendron, Philippe Sarret, Mariana Spetea, <span class="NLM_string-name hlFld-ContribAuthor">Steven Ballet</span>. </span><span class="cited-content_cbyCitation_article-title">Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure–Activity Relationship Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12929-12941. <a href="https://doi.org/10.1021/acs.jmedchem.0c01376" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01376%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimized%252BOpioid-Neurotensin%252BMultitarget%252BPeptides%25253A%252BFrom%252BDesign%252Bto%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%26aulast%3DGonzalez%26aufirst%3DSimon%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05082020%26date%3D23092020%26date%3D09092020%26volume%3D63%26issue%3D21%26spage%3D12929%26epage%3D12941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaodi Dong, Zhishun Tang, Ling Ye, Zhichuan Shi, Zhigang Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Xuefeng Li</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Dihydrofuranoindoles via the Friedel–Crafts Alkylation/Annulation Cascade Process. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (18)
                                     , 11607-11617. <a href="https://doi.org/10.1021/acs.joc.0c00444" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00444%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Bof%252BDihydrofuranoindoles%252Bvia%252Bthe%252BFriedel%2525E2%252580%252593Crafts%252BAlkylation%25252FAnnulation%252BCascade%252BProcess%26aulast%3DDong%26aufirst%3DXiaodi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20022020%26date%3D03092020%26date%3D24082020%26volume%3D85%26issue%3D18%26spage%3D11607%26epage%3D11617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michał Abram, Anna Rapacz, Szczepan Mogilski, Gniewomir Latacz, Annamaria Lubelska, Rafał M. Kamiński, <span class="NLM_string-name hlFld-ContribAuthor">Krzysztof Kamiński</span>. </span><span class="cited-content_cbyCitation_article-title">Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (13)
                                     , 1996-2008. <a href="https://doi.org/10.1021/acschemneuro.0c00257" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00257%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitargeted%252BCompounds%252BDerived%252Bfrom%252B%2525282%25252C5-Dioxopyrrolidin-1-yl%252529%252528phenyl%252529-Acetamides%252Bas%252BCandidates%252Bfor%252BEffective%252BAnticonvulsant%252Band%252BAntinociceptive%252BAgents%26aulast%3DAbram%26aufirst%3DMicha%25C5%2582%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01052020%26date%3D01062020%26date%3D17062020%26date%3D01062020%26volume%3D11%26issue%3D13%26spage%3D1996%26epage%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lena Hefke, Kerstin Hiesinger, W. Felix Zhu, Jan S. Kramer, <span class="NLM_string-name hlFld-ContribAuthor">Ewgenij Proschak</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1244-1249. <a href="https://doi.org/10.1021/acsmedchemlett.0c00102" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00102%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComputer-Aided%252BFragment%252BGrowing%252BStrategies%252Bto%252BDesign%252BDual%252BInhibitors%252Bof%252BSoluble%252BEpoxide%252BHydrolase%252Band%252BLTA4%252BHydrolase%26aulast%3DHefke%26aufirst%3DLena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D08042020%26date%3D11052020%26date%3D08042020%26volume%3D11%26issue%3D6%26spage%3D1244%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhou, Xiaoting Liu, Junxin Xue, Lulu Liu, Tao Liang, Wen Li, Xinying Yang, Xuben Hou, <span class="NLM_string-name hlFld-ContribAuthor">Hao Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4701-4715. <a href="https://doi.org/10.1021/acs.jmedchem.9b02161" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPeptide%252BBoronate%252BDerivatives%252Bas%252BHistone%252BDeacetylase%252Band%252BProteasome%252BDual%252BInhibitors%252Bfor%252BOvercoming%252BBortezomib%252BResistance%252Bof%252BMultiple%252BMyeloma%26aulast%3DZhou%26aufirst%3DYi%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D24122019%26date%3D23042020%26date%3D08042020%26volume%3D63%26issue%3D9%26spage%3D4701%26epage%3D4715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ashish Thakur, Gregory J. Tawa, Mark J. Henderson, Carina Danchik, Suiyang Liu, Pranav Shah, Amy Q. Wang, Garrett Dunn, Md Kabir, Elias C. Padilha, Xin Xu, Anton Simeonov, Surender Kharbanda, Richard Stone, <span class="NLM_string-name hlFld-ContribAuthor">Gurmit Grewal</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 4256-4292. <a href="https://doi.org/10.1021/acs.jmedchem.0c00193" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00193%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BQuinazolin-4-one-Based%252BHydroxamic%252BAcids%252Bas%252BDual%252BPI3K%25252FHDAC%252BInhibitors%26aulast%3DThakur%26aufirst%3DAshish%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D08042020%26date%3D26032020%26volume%3D63%26issue%3D8%26spage%3D4256%26epage%3D4292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sofiane Hocine, Gilles Berger, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Backbone-Fused, Conformationally Constrained Morpholine-Proline Chimeras. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (6)
                                     , 4237-4247. <a href="https://doi.org/10.1021/acs.joc.9b03413" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03413%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBackbone-Fused%25252C%252BConformationally%252BConstrained%252BMorpholine-Proline%252BChimeras%26aulast%3DHocine%26aufirst%3DSofiane%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18122019%26date%3D05032020%26volume%3D85%26issue%3D6%26spage%3D4237%26epage%3D4247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mónica García, Marina Virgili, Mònica Alonso, Carles Alegret, Begoña Fernández, Adriana Port, Rosalía Pascual, Xavier Monroy, Alba Vidal-Torres, María-Teresa Serafini, José Miguel Vela, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Almansa</span>. </span><span class="cited-content_cbyCitation_article-title">4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2434-2454. <a href="https://doi.org/10.1021/acs.jmedchem.9b01256" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01256%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Aryl-1-oxa-4%25252C9-diazaspiro%25255B5.5%25255Dundecane%252BDerivatives%252Bas%252BDual%252B%2525CE%2525BC-Opioid%252BReceptor%252BAgonists%252Band%252B%2525CF%2525831%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM%25C3%25B3nica%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D27082019%26date%3D05122019%26date%3D19112019%26volume%3D63%26issue%3D5%26spage%3D2434%26epage%3D2454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Žiga Skok, Nace Zidar, Danijel Kikelj, <span class="NLM_string-name hlFld-ContribAuthor">Janez Ilaš</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 884-904. <a href="https://doi.org/10.1021/acs.jmedchem.9b00726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BInhibitors%252Bof%252BHuman%252BDNA%252BTopoisomerase%252BII%252Band%252BOther%252BCancer-Related%252BTargets%26aulast%3DSkok%26aufirst%3D%25C5%25BDiga%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D03052019%26date%3D21102019%26date%3D08102019%26volume%3D63%26issue%3D3%26spage%3D884%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junwei Wang, Hui Li, Guangchao He, Zhaoxing Chu, Kewen Peng, Yiran Ge, Qihua Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Yungen Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 122-139. <a href="https://doi.org/10.1021/acs.jmedchem.9b00622" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00622%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BDual%252BPoly%252528ADP-ribose%252529polymerase%252Band%252BPhosphoinositide%252B3-Kinase%252BInhibitors%252Bas%252Ba%252BPromising%252BStrategy%252Bfor%252BCancer%252BTherapy%26aulast%3DWang%26aufirst%3DJunwei%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11042019%26date%3D27122019%26date%3D17122019%26volume%3D63%26issue%3D1%26spage%3D122%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Scheiner, Dominik Dolles, Sandra Gunesch, Matthias Hoffmann, Massimo Nabissi, Oliviero Marinelli, Marina Naldi, Manuela Bartolini, Sabrina Petralla, Eleonora Poeta, Barbara Monti, Christina Falkeis, Michael Vieth, Harald Hübner, Peter Gmeiner, Rangan Maitra, Tangui Maurice, <span class="NLM_string-name hlFld-ContribAuthor">Michael Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9078-9102. <a href="https://doi.org/10.1021/acs.jmedchem.9b00623" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-Acting%252BCholinesterase%2525E2%252580%252593Human%252BCannabinoid%252BReceptor%252B2%252BLigands%252BShow%252BPronounced%252BNeuroprotection%252Bin%252BVitro%252Band%252BOveradditive%252Band%252BDisease-Modifying%252BNeuroprotective%252BEffects%252Bin%252BVivo%26aulast%3DScheiner%26aufirst%3DMatthias%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30042019%26date%3D14102019%26volume%3D62%26issue%3D20%26spage%3D9078%26epage%3D9102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Da Shi, Feroz Khan, <span class="NLM_string-name hlFld-ContribAuthor">Ruben Abagyan</span>. </span><span class="cited-content_cbyCitation_article-title">Extended Multitarget Pharmacology of Anticancer Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (6)
                                     , 3006-3017. <a href="https://doi.org/10.1021/acs.jcim.9b00031" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExtended%252BMultitarget%252BPharmacology%252Bof%252BAnticancer%252BDrugs%26aulast%3DShi%26aufirst%3DDa%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07012019%26date%3D03052019%26date%3D26042019%26volume%3D59%26issue%3D6%26spage%3D3006%26epage%3D3017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuewu Liang, Jie Zang, Xiaoyang Li, Shuai Tang, Min Huang, Meiyu Geng, C. James Chou, Chunpu Li, Yichun Cao, Wenfang Xu, Hong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Yingjie Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 3898-3923. <a href="https://doi.org/10.1021/acs.jmedchem.8b01597" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01597%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BJanus%252BKinase%252B%252528JAK%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHematological%252BMalignancies%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D14102018%26date%3D03042019%26date%3D22032019%26volume%3D62%26issue%3D8%26spage%3D3898%26epage%3D3923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yepeng Luan, Jerry Li, Jean A. Bernatchez, <span class="NLM_string-name hlFld-ContribAuthor">Rongshi Li</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3171-3183. <a href="https://doi.org/10.1021/acs.jmedchem.8b00189" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00189%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Band%252BHistone%252BDeacetylase%252BHybrid%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DLuan%26aufirst%3DYepeng%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05022018%26date%3D16112018%26date%3D12112018%26volume%3D62%26issue%3D7%26spage%3D3171%26epage%3D3183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Erik Gilberg, <span class="NLM_string-name hlFld-ContribAuthor">Jürgen Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in Structure-Based Evaluation of Compound Promiscuity. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 2758-2765. <a href="https://doi.org/10.1021/acsomega.8b03639" title="DOI URL">https://doi.org/10.1021/acsomega.8b03639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b03639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b03639%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DRecent%252BProgress%252Bin%252BStructure-Based%252BEvaluation%252Bof%252BCompound%252BPromiscuity%26aulast%3DGilberg%26aufirst%3DErik%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27122018%26date%3D29012019%26volume%3D4%26issue%3D2%26spage%3D2758%26epage%3D2765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Erik Gilberg, Michael Gütschow, <span class="NLM_string-name hlFld-ContribAuthor">Jürgen Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     , 1729-1737. <a href="https://doi.org/10.1021/acsomega.8b03481" title="DOI URL">https://doi.org/10.1021/acsomega.8b03481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b03481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b03481%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPromiscuous%252BLigands%252Bfrom%252BExperimentally%252BDetermined%252BStructures%25252C%252BBinding%252BConformations%25252C%252Band%252BProtein%252BFamily-Dependent%252BInteraction%252BHotspots%26aulast%3DGilberg%26aufirst%3DErik%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D12122018%26date%3D10012019%26volume%3D4%26issue%3D1%26spage%3D1729%26epage%3D1737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ewgenij Proschak, Holger Stark, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Merk</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 420-444. <a href="https://doi.org/10.1021/acs.jmedchem.8b00760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%252Bby%252BDesign%25253A%252BA%252BMedicinal%252BChemist%2525E2%252580%252599s%252BPerspective%252Bon%252BMultitargeting%252BCompounds%26aulast%3DProschak%26aufirst%3DEwgenij%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11052018%26date%3D03082018%26date%3D23072018%26volume%3D62%26issue%3D2%26spage%3D420%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lisa Vieider, Erik Romp, Veronika Temml, Jana Fischer, Christian Kretzer, Martin Schoenthaler, Abdulla Taha, Victor Hernández-Olmos, Sonja Sturm, Daniela Schuster, Oliver Werz, Ulrike Garscha, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Matuszczak</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Evaluation and Structure–Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 62-66. <a href="https://doi.org/10.1021/acsmedchemlett.8b00415" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00415%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252BBiological%252BEvaluation%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BDiflapolin%252BAnalogues%252Bas%252BDual%252BsEH%25252FFLAP%252BInhibitors%26aulast%3DVieider%26aufirst%3DLisa%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11092018%26date%3D29112018%26date%3D07122018%26date%3D29112018%26volume%3D10%26issue%3D1%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">R. Murray McKinnell, Paul Fatheree, Seok-Ki Choi, Roland Gendron, Keith Jendza, Brooke Olson Blair, Joe Budman, Craig M. Hill, Laxminarayan G. Hegde, Cecile Yu, Donavon McConn, Sharath S. Hegde, Daniel G. Marquess, <span class="NLM_string-name hlFld-ContribAuthor">Uwe Klein</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 86-91. <a href="https://doi.org/10.1021/acsmedchemlett.8b00462" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00462%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BTD-0212%25252C%252Ban%252BOrally%252BActive%252BDual%252BPharmacology%252BAT1%252BAntagonist%252Band%252BNeprilysin%252BInhibitor%252B%252528ARNI%252529%26aulast%3DMcKinnell%26aufirst%3DR.%2BMurray%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04102018%26date%3D03122018%26date%3D06122018%26date%3D03122018%26volume%3D10%26issue%3D1%26spage%3D86%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Leonard G. Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">The Chimera That Curbs Appetite. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11037-11038. <a href="https://doi.org/10.1021/acs.jmedchem.8b01809" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01809%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BChimera%252BThat%252BCurbs%252BAppetite%26aulast%3DLuyt%26aufirst%3DLeonard%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19112018%26date%3D03122018%26volume%3D61%26issue%3D24%26spage%3D11037%26epage%3D11038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elham Bidram, Adrian Sulistio, Hyun-Jung Cho, Abbas Amini, Trudi Harris, Ali Zarrabi, Greg Qiao, Alastair Stewart, <span class="NLM_string-name hlFld-ContribAuthor">Dave E. Dunstan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Graphene Oxide Networks: Cytotoxicity and Synergy with Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2018,</strong> <em>10 </em>
                                    (50)
                                     , 43523-43532. <a href="https://doi.org/10.1021/acsami.8b17531" title="DOI URL">https://doi.org/10.1021/acsami.8b17531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.8b17531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.8b17531%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DTargeted%252BGraphene%252BOxide%252BNetworks%25253A%252BCytotoxicity%252Band%252BSynergy%252Bwith%252BAnticancer%252BAgents%26aulast%3DBidram%26aufirst%3DElham%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17102018%26date%3D29112018%26date%3D07122018%26date%3D29112018%26volume%3D10%26issue%3D50%26spage%3D43523%26epage%3D43532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Guisen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10017-10039. <a href="https://doi.org/10.1021/acs.jmedchem.8b01096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFused%252BTricyclic%252BHeterocycle%252BPiperazine%252B%252528Piperidine%252529%252BDerivatives%252BAs%252BPotential%252BMultireceptor%252BAtypical%252BAntipsychotics%26aulast%3DCao%26aufirst%3DXudong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D09112018%26date%3D01112018%26volume%3D61%26issue%3D22%26spage%3D10017%26epage%3D10039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuma Kato, Yuko Suzuki, Kota Suzuki, Ryosuke Haraguchi, <span class="NLM_string-name hlFld-ContribAuthor">Shin-ichi Fukuzawa</span>. </span><span class="cited-content_cbyCitation_article-title">Silver-Catalyzed Diastereo- and Enantioselective Michael Addition and 1,3-Dipolar Cycloaddition Reactions of Imino Esters to 3-Methyl-4-nitro-5-styrylisoxazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (22)
                                     , 13965-13972. <a href="https://doi.org/10.1021/acs.joc.8b02309" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02309%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSilver-Catalyzed%252BDiastereo-%252Band%252BEnantioselective%252BMichael%252BAddition%252Band%252B1%25252C3-Dipolar%252BCycloaddition%252BReactions%252Bof%252BImino%252BEsters%252Bto%252B3-Methyl-4-nitro-5-styrylisoxazoles%26aulast%3DKato%26aufirst%3DShuma%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06092018%26date%3D02112018%26date%3D26102018%26volume%3D83%26issue%3D22%26spage%3D13965%26epage%3D13972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diana Lamaa, Hsin-Ping Lin, Lena Zig, Cyril Bauvais, Guillaume Bollot, Jérôme Bignon, Helene Levaique, Olivier Pamlard, Joelle Dubois, Mehdi Ouaissi, Martin Souce, Athena Kasselouri, François Saller, Delphine Borgel, Chantal Jayat-Vignoles, Hazar Al-Mouhammad, Jean Feuillard, Karim Benihoud, Mouad Alami, <span class="NLM_string-name hlFld-ContribAuthor">Abdallah Hamze</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6574-6591. <a href="https://doi.org/10.1021/acs.jmedchem.8b00050" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BTubulin%252Band%252BHistone%252BDeacetylase%252BInhibitor%252BBased%252Bon%252Biso-Combretastatin%252BA-4%26aulast%3DLamaa%26aufirst%3DDiana%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12012018%26date%3D26072018%26date%3D13072018%26volume%3D61%26issue%3D15%26spage%3D6574%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie Zang, Xuewu Liang, Yongxue Huang, Yuping Jia, Xiaoyang Li, Wenfang Xu, C. James Chou, <span class="NLM_string-name hlFld-ContribAuthor">Yingjie Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5304-5322. <a href="https://doi.org/10.1021/acs.jmedchem.8b00384" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00384%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPazopanib-Based%252BHDAC%252Band%252BVEGFR%252BDual%252BInhibitors%252BTargeting%252BCancer%252BEpigenetics%252Band%252BAngiogenesis%252BSimultaneously%26aulast%3DZang%26aufirst%3DJie%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09032018%26date%3D07062018%26date%3D22052018%26volume%3D61%26issue%3D12%26spage%3D5304%26epage%3D5322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Więckowska, Tomasz Wichur, Justyna Godyń, Adam Bucki, Monika Marcinkowska, Agata Siwek, Krzysztof Więckowski, Paula Zaręba, Damijan Knez, Monika Głuch-Lutwin, Grzegorz Kazek, Gniewomir Latacz, Kamil Mika, Marcin Kołaczkowski, Jan Korabecny, Ondrej Soukup, Marketa Benkova, Katarzyna Kieć-Kononowicz, Stanislav Gobec, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 1195-1214. <a href="https://doi.org/10.1021/acschemneuro.8b00024" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00024%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMultitarget-Directed%252BLigands%252BAiming%252Bat%252BSymptoms%252Band%252BCauses%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWi%25C4%2599ckowska%26aufirst%3DAnna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18012018%26date%3D31012018%26date%3D13022018%26date%3D31012018%26volume%3D9%26issue%3D5%26spage%3D1195%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">María
Jesús Oset-Gasque, <span class="NLM_string-name hlFld-ContribAuthor">José Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 401-403. <a href="https://doi.org/10.1021/acschemneuro.8b00069" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00069%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bthe%252B%2525E2%252580%25259COne-Molecule%25252C%252BOne-Target%2525E2%252580%25259D%252BParadigm%25252C%252Band%252Bthe%252BMultitarget%252BDirected%252BLigand%252BApproach%26aulast%3DOset-Gasque%26aufirst%3DMar%25C3%25ADa%2BJes%25C3%25BAs%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13022018%26date%3D14022018%26date%3D21022018%26volume%3D9%26issue%3D3%26spage%3D401%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Dolles</span>, <span class="hlFld-ContribAuthor ">Matthias  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Sandra  Gunesch</span>, <span class="hlFld-ContribAuthor ">Oliviero  Marinelli</span>, <span class="hlFld-ContribAuthor ">Jan  Möller</span>, <span class="hlFld-ContribAuthor ">Giorgio  Santoni</span>, <span class="hlFld-ContribAuthor ">Arnaud  Chatonnet</span>, <span class="hlFld-ContribAuthor ">Martin J.  Lohse</span>, <span class="hlFld-ContribAuthor ">Hans-Joachim  Wittmann</span>, <span class="hlFld-ContribAuthor ">Andrea  Strasser</span>, <span class="hlFld-ContribAuthor ">Massimo  Nabissi</span>, <span class="hlFld-ContribAuthor ">Tangui  Maurice</span>, and <span class="hlFld-ContribAuthor ">Michael  Decker</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1646-1663. <a href="https://doi.org/10.1021/acs.jmedchem.7b01760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BComputational%252BInvestigations%252Binto%252Bthe%252BDevelopment%252Bof%252BPotent%252Band%252BBalanced%252BDual-Acting%252BButyrylcholinesterase%252BInhibitors%252Band%252BHuman%252BCannabinoid%252BReceptor%252B2%252BLigands%252Bwith%252BPro-Cognitive%252Bin%252BVivo%252BProfiles%26aulast%3DDolles%26aufirst%3DDominik%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29112017%26date%3D05022018%26date%3D22022018%26volume%3D61%26issue%3D4%26spage%3D1646%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michał  Abram</span>, <span class="hlFld-ContribAuthor ">Mirosław  Zagaja</span>, <span class="hlFld-ContribAuthor ">Szczepan  Mogilski</span>, <span class="hlFld-ContribAuthor ">Marta  Andres-Mach</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Sebastian  Baś</span>, <span class="hlFld-ContribAuthor ">Jarogniew J.  Łuszczki</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>, and <span class="hlFld-ContribAuthor ">Krzysztof  Kamiński</span>  . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Hybrid Compounds Derived from 2-(2,5-Dioxopyrrolidin-1-yl)-3-methoxypropanamides with Anticonvulsant and Antinociceptive Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8565-8579. <a href="https://doi.org/10.1021/acs.jmedchem.7b01114" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultifunctional%252BHybrid%252BCompounds%252BDerived%252Bfrom%252B2-%2525282%25252C5-Dioxopyrrolidin-1-yl%252529-3-methoxypropanamides%252Bwith%252BAnticonvulsant%252Band%252BAntinociceptive%252BProperties%26aulast%3DAbram%26aufirst%3DMicha%25C5%2582%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30072017%26date%3D04102017%26date%3D26102017%26date%3D21092017%26volume%3D60%26issue%3D20%26spage%3D8565%26epage%3D8579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Xinglin  Yang</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 7965-7983. <a href="https://doi.org/10.1021/acs.jmedchem.7b00467" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00467%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BInhibitors%252BSimultaneously%252BTargeting%252BCancer%252BMetabolism%252Band%252BEpigenetics%25253A%252BDiscovery%252Bof%252BNovel%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual%252BInhibitors%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27032017%26date%3D21092017%26date%3D12102017%26date%3D08092017%26volume%3D60%26issue%3D19%26spage%3D7965%26epage%3D7983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jurema  Schmidt</span>, <span class="hlFld-ContribAuthor ">Marco  Rotter</span>, <span class="hlFld-ContribAuthor ">Tim  Weiser</span>, <span class="hlFld-ContribAuthor ">Sandra  Wittmann</span>, <span class="hlFld-ContribAuthor ">Lilia  Weizel</span>, <span class="hlFld-ContribAuthor ">Astrid  Kaiser</span>, <span class="hlFld-ContribAuthor ">Jan  Heering</span>, <span class="hlFld-ContribAuthor ">Tamara  Goebel</span>, <span class="hlFld-ContribAuthor ">Carlo  Angioni</span>, <span class="hlFld-ContribAuthor ">Mario  Wurglics</span>, <span class="hlFld-ContribAuthor ">Alexander  Paulke</span>, <span class="hlFld-ContribAuthor ">Gerd  Geisslinger</span>, <span class="hlFld-ContribAuthor ">Astrid  Kahnt</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, and <span class="hlFld-ContribAuthor ">Daniel  Merk</span>  . </span><span class="cited-content_cbyCitation_article-title">A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7703-7724. <a href="https://doi.org/10.1021/acs.jmedchem.7b00398" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00398%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BDual%252BModulator%252Bof%252BFarnesoid%252BX%252BReceptor%252Band%252BSoluble%252BEpoxide%252BHydrolase%252BTo%252BCounter%252BNonalcoholic%252BSteatohepatitis%26aulast%3DSchmidt%26aufirst%3DJurema%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14032017%26date%3D08092017%26date%3D28092017%26date%3D28082017%26volume%3D60%26issue%3D18%26spage%3D7703%26epage%3D7724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Juan  Yan</span>, <span class="hlFld-ContribAuthor ">Lang  Wang</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Limin  Zeng</span>, <span class="hlFld-ContribAuthor ">Minmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenwen  Duan</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Jingchen  Cao</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Aijun  Shen</span>, and <span class="hlFld-ContribAuthor ">Youhong  Hu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 830-834. <a href="https://doi.org/10.1021/acsmedchemlett.7b00172" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00172%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252Bthe%252BFirst%252Bc-Met%25252FHDAC%252BInhibitors%252BBased%252Bon%252BPyridazinone%252BDerivatives%26aulast%3DLu%26aufirst%3DDong%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22042017%26date%3D18072017%26date%3D19072017%26date%3D10082017%26date%3D18072017%26volume%3D8%26issue%3D8%26spage%3D830%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Pascal  Heitel</span>, <span class="hlFld-ContribAuthor ">Lena  Kalinowsky</span>, and <span class="hlFld-ContribAuthor ">Daniel  Merk</span>  . </span><span class="cited-content_cbyCitation_article-title">Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5235-5266. <a href="https://doi.org/10.1021/acs.jmedchem.6b01287" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01287%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Band%252BChallenges%252Bfor%252BFatty%252BAcid%252BMimetics%252Bin%252BDrug%252BDiscovery%26aulast%3DProschak%26aufirst%3DEwgenij%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D25082016%26date%3D27032017%26date%3D13072017%26date%3D02032017%26volume%3D60%26issue%3D13%26spage%3D5235%26epage%3D5266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgios  Drakakis</span>, <span class="hlFld-ContribAuthor ">Keith A.  Wafford</span>, <span class="hlFld-ContribAuthor ">Suzanne C.  Brewerton</span>, <span class="hlFld-ContribAuthor ">Michael J.  Bodkin</span>, <span class="hlFld-ContribAuthor ">David A.  Evans</span>, and <span class="hlFld-ContribAuthor ">Andreas  Bender</span>  . </span><span class="cited-content_cbyCitation_article-title">Polypharmacological in Silico Bioactivity Profiling and Experimental Validation Uncovers Sedative-Hypnotic Effects of Approved and Experimental Drugs in Rat. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (6)
                                     , 1593-1602. <a href="https://doi.org/10.1021/acschembio.7b00209" title="DOI URL">https://doi.org/10.1021/acschembio.7b00209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00209%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DPolypharmacological%252Bin%252BSilico%252BBioactivity%252BProfiling%252Band%252BExperimental%252BValidation%252BUncovers%252BSedative-Hypnotic%252BEffects%252Bof%252BApproved%252Band%252BExperimental%252BDrugs%252Bin%252BRat%26aulast%3DDrakakis%26aufirst%3DGeorgios%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08032017%26date%3D17042017%26date%3D01052017%26date%3D16062017%26date%3D17042017%26volume%3D12%26issue%3D6%26spage%3D1593%26epage%3D1602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Salah</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Abdelsamie</span>, and <span class="hlFld-ContribAuthor ">Martin  Frotscher</span>  . </span><span class="cited-content_cbyCitation_article-title">First Dual Inhibitors of Steroid Sulfatase (STS) and 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4086-4092. <a href="https://doi.org/10.1021/acs.jmedchem.7b00062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00062%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BDual%252BInhibitors%252Bof%252BSteroid%252BSulfatase%252B%252528STS%252529%252Band%252B17%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%252B1%252B%25252817%2525CE%2525B2-HSD1%252529%25253A%252BDesigned%252BMultiple%252BLigands%252Bas%252BNovel%252BPotential%252BTherapeutics%252Bfor%252BEstrogen-Dependent%252BDiseases%26aulast%3DSalah%26aufirst%3DMohamed%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13012017%26date%3D27042017%26date%3D11052017%26date%3D13042017%26volume%3D60%26issue%3D9%26spage%3D4086%26epage%3D4092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Almansa</span>, <span class="hlFld-ContribAuthor ">Ramon  Mercè</span>, <span class="hlFld-ContribAuthor ">Nicolas  Tesson</span>, <span class="hlFld-ContribAuthor ">Joan  Farran</span>, <span class="hlFld-ContribAuthor ">Jaume  Tomàs</span>, and <span class="hlFld-ContribAuthor ">Carlos R.  Plata-Salamán</span>  . </span><span class="cited-content_cbyCitation_article-title">Co-crystal of Tramadol Hydrochloride–Celecoxib (ctc): A Novel API–API Co-crystal for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2017,</strong> <em>17 </em>
                                    (4)
                                     , 1884-1892. <a href="https://doi.org/10.1021/acs.cgd.6b01848" title="DOI URL">https://doi.org/10.1021/acs.cgd.6b01848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.6b01848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.6b01848%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DCo-crystal%252Bof%252BTramadol%252BHydrochloride%2525E2%252580%252593Celecoxib%252B%252528ctc%252529%25253A%252BA%252BNovel%252BAPI%2525E2%252580%252593API%252BCo-crystal%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DAlmansa%26aufirst%3DCarmen%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2017%26date%3D16122016%26date%3D14022017%26date%3D20032017%26date%3D05042017%26date%3D06032017%26volume%3D17%26issue%3D4%26spage%3D1884%26epage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weilin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Multitarget Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (3)
                                     , 403-412. <a href="https://doi.org/10.1021/acs.jcim.6b00491" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00491%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BMultitarget%252BDrug%252BDesign%26aulast%3DZhang%26aufirst%3DWeilin%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D19082016%26date%3D23022017%26date%3D27032017%26date%3D06022017%26volume%3D57%26issue%3D3%26spage%3D403%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Li  Ng</span>, <span class="hlFld-ContribAuthor ">Xiang  Ma</span>, <span class="hlFld-ContribAuthor ">Eng-Hui  Chew</span>, and <span class="hlFld-ContribAuthor ">Wai-Keung  Chui</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1734-1745. <a href="https://doi.org/10.1021/acs.jmedchem.6b01253" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01253%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BCoupled%252BBioactive%252BScaffolds%252Bas%252BPotential%252BAnticancer%252BAgents%252Bfor%252BDual%252BTargeting%252Bof%252BDihydrofolate%252BReductase%252Band%252BThioredoxin%252BReductase%26aulast%3DNg%26aufirst%3DHui-Li%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D18082016%26date%3D24022017%26date%3D09032017%26date%3D08022017%26volume%3D60%26issue%3D5%26spage%3D1734%26epage%3D1745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, and <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>  . </span><span class="cited-content_cbyCitation_article-title">Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 527-553. <a href="https://doi.org/10.1021/acs.jmedchem.6b00935" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00935%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdiopathic%252BPulmonary%252BFibrosis%25253A%252BCurrent%252BStatus%25252C%252BRecent%252BProgress%25252C%252Band%252BEmerging%252BTargets%26aulast%3DLiu%26aufirst%3DYi-Min%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D22062016%26date%3D29112016%26date%3D26012017%26date%3D14112016%26volume%3D60%26issue%3D2%26spage%3D527%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Van der Poorten</span>, <span class="hlFld-ContribAuthor ">Astrid  Knuhtsen</span>, <span class="hlFld-ContribAuthor ">Daniel  Sejer Pedersen</span>, <span class="hlFld-ContribAuthor ">Steven  Ballet</span>, and <span class="hlFld-ContribAuthor ">Dirk  Tourwé</span>  . </span><span class="cited-content_cbyCitation_article-title">Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10865-10890. <a href="https://doi.org/10.1021/acs.jmedchem.6b01029" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSide%252BChain%252BCyclized%252BAromatic%252BAmino%252BAcids%25253A%252BGreat%252BTools%252Bas%252BLocal%252BConstraints%252Bin%252BPeptide%252Band%252BPeptidomimetic%252BDesign%26aulast%3DVan%2Bder%2BPoorten%26aufirst%3DOlivier%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12072016%26date%3D12102016%26date%3D22122016%26date%3D03102016%26volume%3D59%26issue%3D24%26spage%3D10865%26epage%3D10890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew P.  Degnan</span>, <span class="hlFld-ContribAuthor ">George O.  Tora</span>, <span class="hlFld-ContribAuthor ">Hong  Huang</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, <span class="hlFld-ContribAuthor ">Carl D.  Davis</span>, <span class="hlFld-ContribAuthor ">Umesh M.  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Hou</span>, <span class="hlFld-ContribAuthor ">Yi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Joanna  Hu</span>, <span class="hlFld-ContribAuthor ">Rudolph  Krause</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Li</span>, <span class="hlFld-ContribAuthor ">Amy E.  Newton</span>, <span class="hlFld-ContribAuthor ">Rick L.  Pieschl</span>, <span class="hlFld-ContribAuthor ">Joseph  Raybon</span>, <span class="hlFld-ContribAuthor ">Thorsten  Rosner</span>, <span class="hlFld-ContribAuthor ">Jung-Hui  Sun</span>, <span class="hlFld-ContribAuthor ">Matthew T.  Taber</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Taylor</span>, <span class="hlFld-ContribAuthor ">Michael K.  Wong</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lodge</span>, <span class="hlFld-ContribAuthor ">Joanne J.  Bronson</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, and <span class="hlFld-ContribAuthor ">Kevin W.  Gillman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (12)
                                     , 1635-1640. <a href="https://doi.org/10.1021/acschemneuro.6b00337" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00337%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Bof%252BIndazoles%252Bas%252BPotent%25252C%252BOrally%252BActive%252BDual%252BNeurokinin%252B1%252BReceptor%252BAntagonists%252Band%252BSerotonin%252BTransporter%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BDepression%26aulast%3DDegnan%26aufirst%3DAndrew%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03102016%26date%3D16102016%26date%3D18102016%26date%3D21122016%26date%3D17102016%26volume%3D7%26issue%3D12%26spage%3D1635%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Czodrowski</span> and <span class="hlFld-ContribAuthor ">Wolf-Guido  Bolick</span>  . </span><span class="cited-content_cbyCitation_article-title">OCEAN: Optimized Cross rEActivity estimatioN. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (10)
                                     , 2013-2023. <a href="https://doi.org/10.1021/acs.jcim.6b00067" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DOCEAN%25253A%252BOptimized%252BCross%252BrEActivity%252BestimatioN%26aulast%3DCzodrowski%26aufirst%3DPaul%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11022016%26date%3D26092016%26date%3D24102016%26volume%3D56%26issue%3D10%26spage%3D2013%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Nurulhuda  Mustafa</span>, <span class="hlFld-ContribAuthor ">Eng Chong  Tan</span>, <span class="hlFld-ContribAuthor ">Anders  Poulsen</span>, <span class="hlFld-ContribAuthor ">Pondy Murugappan  Ramanujulu</span>, <span class="hlFld-ContribAuthor ">Wee Joo  Chng</span>, <span class="hlFld-ContribAuthor ">Jeffrey J. Y.  Yen</span>, and <span class="hlFld-ContribAuthor ">Brian W.  Dymock</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8233-8262. <a href="https://doi.org/10.1021/acs.jmedchem.6b00157" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00157%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BJanus%252BKinase%252B2%252B%252528JAK2%252529%252Band%252BHistone%252BDeacetlyase%252B%252528HDAC%252529%252BBispecific%252BInhibitors%252BBased%252Bon%252BPacritinib%252Band%252BEvidence%252Bof%252BDual%252BPathway%252BInhibition%252Bin%252BHematological%252BCell%252BLines%26aulast%3DYang%26aufirst%3DEugene%2BGuorong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D08092016%26date%3D22092016%26date%3D19082016%26volume%3D59%26issue%3D18%26spage%3D8233%26epage%3D8262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Liao</span>, <span class="hlFld-ContribAuthor ">Xiaojia  Niu</span>, <span class="hlFld-ContribAuthor ">Bailing  Chen</span>, <span class="hlFld-ContribAuthor ">Holly  Edwards</span>, <span class="hlFld-ContribAuthor ">Liping  Xu</span>, <span class="hlFld-ContribAuthor ">Chengzhi  Xie</span>, <span class="hlFld-ContribAuthor ">Hai  Lin</span>, <span class="hlFld-ContribAuthor ">Lisa  Polin</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Taub</span>, <span class="hlFld-ContribAuthor ">Yubin  Ge</span>, and <span class="hlFld-ContribAuthor ">Zhihui  Qin</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antileukemic Activities of Piperlongumine and HDAC Inhibitor Hybrids against Acute Myeloid Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 7974-7990. <a href="https://doi.org/10.1021/acs.jmedchem.6b00772" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00772%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAntileukemic%252BActivities%252Bof%252BPiperlongumine%252Band%252BHDAC%252BInhibitor%252BHybrids%252Bagainst%252BAcute%252BMyeloid%252BLeukemia%252BCells%26aulast%3DLiao%26aufirst%3DYi%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20052016%26date%3D24082016%26date%3D08092016%26date%3D09082016%26volume%3D59%26issue%3D17%26spage%3D7974%26epage%3D7990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aubrie A.  Harland</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>, <span class="hlFld-ContribAuthor ">Nicholas W.  Griggs</span>, <span class="hlFld-ContribAuthor ">Chao  Gao</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">Irina D.  Pogozheva</span>, <span class="hlFld-ContribAuthor ">John R.  Traynor</span>, <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>, and <span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4985-4998. <a href="https://doi.org/10.1021/acs.jmedchem.6b00308" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00308%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffects%252Bof%252BN-Substitutions%252Bon%252Bthe%252BTetrahydroquinoline%252B%252528THQ%252529%252BCore%252Bof%252BMixed-Efficacy%252B%2525CE%2525BC-Opioid%252BReceptor%252B%252528MOR%252529%25252F%2525CE%2525B4-Opioid%252BReceptor%252B%252528DOR%252529%252BLigands%26aulast%3DHarland%26aufirst%3DAubrie%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D16052016%26date%3D26052016%26date%3D05052016%26volume%3D59%26issue%3D10%26spage%3D4985%26epage%3D4998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karel  Guillemyn</span>, <span class="hlFld-ContribAuthor ">Joanna  Starnowska</span>, <span class="hlFld-ContribAuthor ">Camille  Lagard</span>, <span class="hlFld-ContribAuthor ">Jolanta  Dyniewicz</span>, <span class="hlFld-ContribAuthor ">Ewelina  Rojewska</span>, <span class="hlFld-ContribAuthor ">Joanna  Mika</span>, <span class="hlFld-ContribAuthor ">Nga N.  Chung</span>, <span class="hlFld-ContribAuthor ">Valérie  Utard</span>, <span class="hlFld-ContribAuthor ">Piotr  Kosson</span>, <span class="hlFld-ContribAuthor ">Andrzej W.  Lipkowski</span>, <span class="hlFld-ContribAuthor ">Lucie  Chevillard</span>, <span class="hlFld-ContribAuthor ">Pol  Arranz-Gibert</span>, <span class="hlFld-ContribAuthor ">Meritxell  Teixidó</span>, <span class="hlFld-ContribAuthor ">Bruno  Megarbane</span>, <span class="hlFld-ContribAuthor ">Dirk  Tourwé</span>, <span class="hlFld-ContribAuthor ">Frédéric  Simonin</span>, <span class="hlFld-ContribAuthor ">Barbara  Przewlocka</span>, <span class="hlFld-ContribAuthor ">Peter W.  Schiller</span>, and <span class="hlFld-ContribAuthor ">Steven  Ballet</span>  . </span><span class="cited-content_cbyCitation_article-title">Bifunctional Peptide-Based Opioid Agonist–Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3777-3792. <a href="https://doi.org/10.1021/acs.jmedchem.5b01976" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01976%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252BPeptide-Based%252BOpioid%252BAgonist%2525E2%252580%252593Nociceptin%252BAntagonist%252BLigands%252Bfor%252BDual%252BTreatment%252Bof%252BAcute%252Band%252BNeuropathic%252BPain%26aulast%3DGuillemyn%26aufirst%3DKarel%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D21122015%26date%3D14042016%26date%3D28042016%26date%3D01042016%26volume%3D59%26issue%3D8%26spage%3D3777%26epage%3D3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">René  Blöcher</span>, <span class="hlFld-ContribAuthor ">Christina  Lamers</span>, <span class="hlFld-ContribAuthor ">Sandra K.  Wittmann</span>, <span class="hlFld-ContribAuthor ">Daniel  Merk</span>, <span class="hlFld-ContribAuthor ">Markus  Hartmann</span>, <span class="hlFld-ContribAuthor ">Lilia  Weizel</span>, <span class="hlFld-ContribAuthor ">Olaf  Diehl</span>, <span class="hlFld-ContribAuthor ">Astrid  Brüggerhoff</span>, <span class="hlFld-ContribAuthor ">Marcel  Boß</span>, <span class="hlFld-ContribAuthor ">Astrid  Kaiser</span>, <span class="hlFld-ContribAuthor ">Tim  Schader</span>, <span class="hlFld-ContribAuthor ">Tamara  Göbel</span>, <span class="hlFld-ContribAuthor ">Manuel  Grundmann</span>, <span class="hlFld-ContribAuthor ">Carlo  Angioni</span>, <span class="hlFld-ContribAuthor ">Jan  Heering</span>, <span class="hlFld-ContribAuthor ">Gerd  Geisslinger</span>, <span class="hlFld-ContribAuthor ">Mario  Wurglics</span>, <span class="hlFld-ContribAuthor ">Evi  Kostenis</span>, <span class="hlFld-ContribAuthor ">Bernhard  Brüne</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>, <span class="hlFld-ContribAuthor ">Astrid S.  Kahnt</span>, and <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>  . </span><span class="cited-content_cbyCitation_article-title">N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 61-81. <a href="https://doi.org/10.1021/acs.jmedchem.5b01239" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01239%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Benzylbenzamides%25253A%252BA%252BNovel%252BMerged%252BScaffold%252Bfor%252BOrally%252BAvailable%252BDual%252BSoluble%252BEpoxide%252BHydrolase%25252FPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B3%252BModulators%26aulast%3DBl%25C3%25B6cher%26aufirst%3DRen%25C3%25A9%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D02042015%26date%3D25122015%26date%3D14012016%26date%3D23112015%26volume%3D59%26issue%3D1%26spage%3D61%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aubrie A.  Harland</span>, <span class="hlFld-ContribAuthor ">Larisa  Yeomans</span>, <span class="hlFld-ContribAuthor ">Nicholas W.  Griggs</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">Irina D.  Pogozheva</span>, <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>, <span class="hlFld-ContribAuthor ">John R.  Traynor</span>, and <span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (22)
                                     , 8952-8969. <a href="https://doi.org/10.1021/acs.jmedchem.5b01270" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01270%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurther%252BOptimization%252Band%252BEvaluation%252Bof%252BBioavailable%25252C%252BMixed-Efficacy%252B%2525CE%2525BC-Opioid%252BReceptor%252B%252528MOR%252529%252BAgonists%25252F%2525CE%2525B4-Opioid%252BReceptor%252B%252528DOR%252529%252BAntagonists%25253A%252BBalancing%252BMOR%252Band%252BDOR%252BAffinities%26aulast%3DHarland%26aufirst%3DAubrie%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D12082015%26date%3D13112015%26date%3D25112015%26date%3D02112015%26volume%3D58%26issue%3D22%26spage%3D8952%26epage%3D8969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter W.  Schiller</span>, <span class="hlFld-ContribAuthor ">Thi M.-D.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Amy  Saray</span>, <span class="hlFld-ContribAuthor ">Annie Wing Hoi  Poon</span>, <span class="hlFld-ContribAuthor ">André  Laferrière</span>, and <span class="hlFld-ContribAuthor ">Terence J.  Coderre</span>  . </span><span class="cited-content_cbyCitation_article-title">The Bifunctional μ Opioid Agonist/Antioxidant [Dmt1]DALDA Is a Superior Analgesic in an Animal Model of Complex Regional Pain Syndrome-Type I.. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 1789-1793. <a href="https://doi.org/10.1021/acschemneuro.5b00228" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00228%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DThe%252BBifunctional%252B%2525CE%2525BC%252BOpioid%252BAgonist%25252FAntioxidant%252B%25255BDmt1%25255DDALDA%252BIs%252Ba%252BSuperior%252BAnalgesic%252Bin%252Ban%252BAnimal%252BModel%252Bof%252BComplex%252BRegional%252BPain%252BSyndrome-Type%252BI.%26aulast%3DSchiller%26aufirst%3DPeter%2BW.%26date%3D2015%26date%3D2015%26date%3D09092015%26date%3D14092015%26date%3D18112015%26date%3D09092015%26volume%3D6%26issue%3D11%26spage%3D1789%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lien  Nguyen</span>, <span class="hlFld-ContribAuthor ">Long M.  Luu</span>, <span class="hlFld-ContribAuthor ">Shaohong  Peng</span>, <span class="hlFld-ContribAuthor ">Julio F.  Serrano</span>, <span class="hlFld-ContribAuthor ">H. Y. Edwin  Chan</span>, and <span class="hlFld-ContribAuthor ">Steven C.  Zimmerman</span>  . </span><span class="cited-content_cbyCitation_article-title">Rationally Designed Small Molecules That Target Both the DNA and RNA Causing Myotonic Dystrophy Type 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (44)
                                     , 14180-14189. <a href="https://doi.org/10.1021/jacs.5b09266" title="DOI URL">https://doi.org/10.1021/jacs.5b09266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.5b09266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.5b09266%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DRationally%252BDesigned%252BSmall%252BMolecules%252BThat%252BTarget%252BBoth%252Bthe%252BDNA%252Band%252BRNA%252BCausing%252BMyotonic%252BDystrophy%252BType%252B1%26aulast%3DNguyen%26aufirst%3DLien%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05092015%26date%3D03112015%26date%3D11112015%26date%3D16102015%26volume%3D137%26issue%3D44%26spage%3D14180%26epage%3D14189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Maria  Summa</span>, <span class="hlFld-ContribAuthor ">Daniela  Pizzirani</span>, <span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>, <span class="hlFld-ContribAuthor ">Sine Mandrup  Bertozzi</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Ana  Perez-Castillo</span>, <span class="hlFld-ContribAuthor ">Barbara  Monti</span>, <span class="hlFld-ContribAuthor ">Francesca  Massenzio</span>, <span class="hlFld-ContribAuthor ">Letizia  Polito</span>, <span class="hlFld-ContribAuthor ">Marco  Racchi</span>, <span class="hlFld-ContribAuthor ">Piera  Sabatino</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>  . </span><span class="cited-content_cbyCitation_article-title">3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , 1665-1682. <a href="https://doi.org/10.1021/acschemneuro.5b00121" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00121%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D3%25252C4-Dihydro-1%25252C3%25252C5-triazin-2%2525281H%252529-ones%252Bas%252Bthe%252BFirst%252BDual%252BBACE-1%25252FGSK-3%2525CE%2525B2%252BFragment%252BHits%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21042015%26date%3D14072015%26date%3D03082015%26date%3D21102015%26date%3D14072015%26volume%3D6%26issue%3D10%26spage%3D1665%26epage%3D1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hu  Meng</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Diverse Ways of Perturbing the Human Arachidonic Acid Metabolic Network To Control Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2015,</strong> <em>48 </em>
                                    (8)
                                     , 2242-2250. <a href="https://doi.org/10.1021/acs.accounts.5b00226" title="DOI URL">https://doi.org/10.1021/acs.accounts.5b00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.5b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.5b00226%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDiverse%252BWays%252Bof%252BPerturbing%252Bthe%252BHuman%252BArachidonic%252BAcid%252BMetabolic%252BNetwork%252BTo%252BControl%252BInflammation%26aulast%3DMeng%26aufirst%3DHu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D22042015%26date%3D03082015%26date%3D18082015%26volume%3D48%26issue%3D8%26spage%3D2242%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzysztof  Kamiński</span>, <span class="hlFld-ContribAuthor ">Mirosław  Zagaja</span>, <span class="hlFld-ContribAuthor ">Jarogniew J.  Łuszczki</span>, <span class="hlFld-ContribAuthor ">Anna  Rapacz</span>, <span class="hlFld-ContribAuthor ">Marta  Andres-Mach</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, and <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Anticonvulsant Activity of New Hybrid Compounds Derived from 2-(2,5-Dioxopyrrolidin-1-yl)propanamides and 2-(2,5-Dioxopyrrolidin-1-yl)butanamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (13)
                                     , 5274-5286. <a href="https://doi.org/10.1021/acs.jmedchem.5b00578" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00578%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAnticonvulsant%252BActivity%252Bof%252BNew%252BHybrid%252BCompounds%252BDerived%252Bfrom%252B2-%2525282%25252C5-Dioxopyrrolidin-1-yl%252529propanamides%252Band%252B2-%2525282%25252C5-Dioxopyrrolidin-1-yl%252529butanamides%26aulast%3DKami%25C5%2584ski%26aufirst%3DKrzysztof%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13042015%26date%3D23062015%26date%3D09072015%26date%3D08062015%26volume%3D58%26issue%3D13%26spage%3D5274%26epage%3D5286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Florence  Gaven</span>, <span class="hlFld-ContribAuthor ">Patrizia  Giannoni</span>, <span class="hlFld-ContribAuthor ">Katia  Hamidouche</span>, <span class="hlFld-ContribAuthor ">Damien  Hedou</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Dubost</span>, <span class="hlFld-ContribAuthor ">David  Genest</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Valentine  Bouet</span>, <span class="hlFld-ContribAuthor ">François  Dauphin</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Céline  Ballandonne</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>, <span class="hlFld-ContribAuthor ">Remi  Legay</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, and <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 3172-3187. <a href="https://doi.org/10.1021/acs.jmedchem.5b00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BMultitarget-Directed%252BLigands%252B%252528MTDLs%252529%252Bwith%252BAcetylcholinesterase%252B%252528AChE%252529%252BInhibitory%252Band%252BSerotonergic%252BSubtype%252B4%252BReceptor%252B%2525285-HT4R%252529%252BAgonist%252BActivities%252BAs%252BPotential%252BAgents%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BThe%252BDesign%252Bof%252BDonecopride%26aulast%3DRochais%26aufirst%3DChristophe%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21012015%26date%3D31032015%26date%3D09042015%26date%3D20032015%26volume%3D58%26issue%3D7%26spage%3D3172%26epage%3D3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam D.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Sharath S.  Hegde</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Jasper</span>, <span class="hlFld-ContribAuthor ">Sarah  Jaw-Tsai</span>, <span class="hlFld-ContribAuthor ">Tae-Weon  Lee</span>, <span class="hlFld-ContribAuthor ">Alexander  McNamara</span>, <span class="hlFld-ContribAuthor ">M. Teresa  Pulido-Rios</span>, <span class="hlFld-ContribAuthor ">Tod  Steinfeld</span>, and <span class="hlFld-ContribAuthor ">Mathai  Mammen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1′-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and β2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2609-2622. <a href="https://doi.org/10.1021/jm501915g" title="DOI URL">https://doi.org/10.1021/jm501915g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501915g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501915g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%252529-1-%2525283-%252528%2525282-Chloro-4-%252528%252528%2525282-hydroxy-2-%2525288-hydroxy-2-oxo-1%25252C2-dihydroquinolin-5-yl%252529ethyl%252529amino%252529methyl%252529-5-methoxyphenyl%252529amino%252529-3-oxopropyl%252529piperidin-4-yl%252B%25255B1%25252C1%2525E2%252580%2525B2-Biphenyl%25255D-2-ylcarbamate%252B%252528TD-5959%25252C%252BGSK961081%25252C%252BBatefenterol%252529%25253A%252BFirst-in-Class%252BDual%252BPharmacology%252BMultivalent%252BMuscarinic%252BAntagonist%252Band%252B%2525CE%2525B22%252BAgonist%252B%252528MABA%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BObstructive%252BPulmonary%252BDisease%252B%252528COPD%252529%26aulast%3DHughes%26aufirst%3DAdam%2BD.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D10122014%26date%3D09022015%26date%3D26032015%26date%3D28012015%26volume%3D58%26issue%3D6%26spage%3D2609%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Anighoro</span>, <span class="hlFld-ContribAuthor ">Dagmar  Stumpfe</span>, <span class="hlFld-ContribAuthor ">Kathrin  Heikamp</span>, <span class="hlFld-ContribAuthor ">Kristin  Beebe</span>, <span class="hlFld-ContribAuthor ">Leonard M.  Neckers</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, and <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Polypharmacology Analysis of the Heat Shock Protein 90 Interactome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (3)
                                     , 676-686. <a href="https://doi.org/10.1021/ci5006959" title="DOI URL">https://doi.org/10.1021/ci5006959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5006959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5006959%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BPolypharmacology%252BAnalysis%252Bof%252Bthe%252BHeat%252BShock%252BProtein%252B90%252BInteractome%26aulast%3DAnighoro%26aufirst%3DAndrew%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D21112014%26date%3D23022015%26date%3D23032015%26date%3D16022015%26volume%3D55%26issue%3D3%26spage%3D676%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niamh M.  O’Boyle</span>, <span class="hlFld-ContribAuthor ">Jade K.  Pollock</span>, <span class="hlFld-ContribAuthor ">Miriam  Carr</span>, <span class="hlFld-ContribAuthor ">Andrew J. S.  Knox</span>, <span class="hlFld-ContribAuthor ">Seema M.  Nathwani</span>, <span class="hlFld-ContribAuthor ">Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Laura  Caboni</span>, <span class="hlFld-ContribAuthor ">Daniela M.  Zisterer</span>, and <span class="hlFld-ContribAuthor ">Mary J.  Meegan</span>  . </span><span class="cited-content_cbyCitation_article-title">β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (22)
                                     , 9370-9382. <a href="https://doi.org/10.1021/jm500670d" title="DOI URL">https://doi.org/10.1021/jm500670d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500670d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500670d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Lactam%252BEstrogen%252BReceptor%252BAntagonists%252Band%252Ba%252BDual-Targeting%252BEstrogen%252BReceptor%25252FTubulin%252BLigand%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DNiamh%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D29042014%26date%3D17112014%26date%3D26112014%26date%3D04112014%26volume%3D57%26issue%3D22%26spage%3D9370%26epage%3D9382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Anighoro</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, and <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Polypharmacology: Challenges and Opportunities in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (19)
                                     , 7874-7887. <a href="https://doi.org/10.1021/jm5006463" title="DOI URL">https://doi.org/10.1021/jm5006463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5006463%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%25253A%252BChallenges%252Band%252BOpportunities%252Bin%252BDrug%252BDiscovery%26aulast%3DAnighoro%26aufirst%3DAndrew%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25042014%26date%3D25062014%26date%3D09102014%26date%3D19062014%26volume%3D57%26issue%3D19%26spage%3D7874%26epage%3D7887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>, <span class="hlFld-ContribAuthor ">Ram K.  Modukuri</span>, <span class="hlFld-ContribAuthor ">Pooja  Jadiya</span>, <span class="hlFld-ContribAuthor ">K. Bhaskara  Rao</span>, <span class="hlFld-ContribAuthor ">Tanuj  Sharma</span>, <span class="hlFld-ContribAuthor ">Rizwanul  Haque</span>, <span class="hlFld-ContribAuthor ">Deependra Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Dibyendu  Banerjee</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>, and <span class="hlFld-ContribAuthor ">Aamir  Nazir</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1099-1103. <a href="https://doi.org/10.1021/ml500222g" title="DOI URL">https://doi.org/10.1021/ml500222g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500222g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500222g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3-Arylcoumarin-tetracyclic%252BTacrine%252BHybrids%252Bas%252BMultifunctional%252BAgents%252Bagainst%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DSashidhara%26aufirst%3DKoneni%2BV.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28052014%26date%3D20082014%26date%3D25082014%26date%3D09102014%26date%3D20082014%26volume%3D5%26issue%3D10%26spage%3D1099%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, <span class="hlFld-ContribAuthor ">Ning  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Ma</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Systems Biology Brings New Dimensions for Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (33)
                                     , 11556-11565. <a href="https://doi.org/10.1021/ja504810z" title="DOI URL">https://doi.org/10.1021/ja504810z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja504810z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja504810z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSystems%252BBiology%252BBrings%252BNew%252BDimensions%252Bfor%252BStructure-Based%252BDrug%252BDesign%26aulast%3DPei%26aufirst%3DJianfeng%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D14052014%26date%3D06082014%26date%3D20082014%26date%3D25072014%26volume%3D136%26issue%3D33%26spage%3D11556%26epage%3D11565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonne  Krautscheid</span>, <span class="hlFld-ContribAuthor ">Carl Johann Åke  Senning</span>, <span class="hlFld-ContribAuthor ">Simone B.  Sartori</span>, <span class="hlFld-ContribAuthor ">Nicolas  Singewald</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>, and <span class="hlFld-ContribAuthor ">Hermann  Stuppner</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling, Virtual Screening, and in Vitro Testing Reveal Haloperidol, Eprazinone, and Fenbutrazate as Neurokinin Receptors Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (6)
                                     , 1747-1757. <a href="https://doi.org/10.1021/ci500106z" title="DOI URL">https://doi.org/10.1021/ci500106z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500106z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500106z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPharmacophore%252BModeling%25252C%252BVirtual%252BScreening%25252C%252Band%252Bin%252BVitro%252BTesting%252BReveal%252BHaloperidol%25252C%252BEprazinone%25252C%252Band%252BFenbutrazate%252Bas%252BNeurokinin%252BReceptors%252BLigands%26aulast%3DKrautscheid%26aufirst%3DYvonne%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D20022014%26date%3D12062014%26date%3D23062014%26date%3D21052014%26volume%3D54%26issue%3D6%26spage%3D1747%26epage%3D1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Mitka</span>, <span class="hlFld-ContribAuthor ">Jolanta  Jaśkowska</span>, <span class="hlFld-ContribAuthor ">Piotr  Kowalski</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Anna  Wasik</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, and <span class="hlFld-ContribAuthor ">Przemyslaw  Bienkowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4543-4557. <a href="https://doi.org/10.1021/jm401895u" title="DOI URL">https://doi.org/10.1021/jm401895u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401895u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401895u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BArylsulfonamide%252BDerivatives%252Bwith%252B5-HT6%25252F5-HT7%252BReceptor%252BAntagonism%252BTargeting%252BBehavioral%252Band%252BPsychological%252BSymptoms%252Bof%252BDementia%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DMarcin%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D10122013%26date%3D23052014%26date%3D12062014%26date%3D07052014%26volume%3D57%26issue%3D11%26spage%3D4543%26epage%3D4557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Perrey</span>, <span class="hlFld-ContribAuthor ">Brian P.  Gilmour</span>, <span class="hlFld-ContribAuthor ">Brian F.  Thomas</span>, and <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (6)
                                     , 634-638. <a href="https://doi.org/10.1021/ml4004759" title="DOI URL">https://doi.org/10.1021/ml4004759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4004759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4004759%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DToward%252Bthe%252BDevelopment%252Bof%252BBivalent%252BLigand%252BProbes%252Bof%252BCannabinoid%252BCB1%252Band%252BOrexin%252BOX1%252BReceptor%252BHeterodimers%26aulast%3DPerrey%26aufirst%3DDavid%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D19112013%26date%3D25032014%26date%3D27032014%26date%3D12062014%26date%3D25032014%26volume%3D5%26issue%3D6%26spage%3D634%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz  López-Iglesias</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Sandra  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, and <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (9)
                                     , 3773-3785. <a href="https://doi.org/10.1021/jm5000613" title="DOI URL">https://doi.org/10.1021/jm5000613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5000613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5000613%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BMelatonin%2525E2%252580%252593N%25252CN-Dibenzyl%252528N-methyl%252529amine%252BHybrids%25253A%252BPotent%252BNeurogenic%252BAgents%252Bwith%252BAntioxidant%25252C%252BCholinergic%25252C%252Band%252BNeuroprotective%252BProperties%252Bas%252BInnovative%252BDrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DL%25C3%25B3pez-Iglesias%26aufirst%3DBeatriz%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13012014%26date%3D28042014%26date%3D08052014%26date%3D16042014%26volume%3D57%26issue%3D9%26spage%3D3773%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erchang  Shang</span>, <span class="hlFld-ContribAuthor ">Yaxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Xinyi  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (4)
                                     , 1235-1241. <a href="https://doi.org/10.1021/ci500021v" title="DOI URL">https://doi.org/10.1021/ci500021v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500021v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500021v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDe%252BNovo%252BDesign%252Bof%252BMultitarget%252BLigands%252Bwith%252Ban%252BIterative%252BFragment-Growing%252BStrategy%26aulast%3DShang%26aufirst%3DErchang%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11012014%26date%3D18032014%26date%3D28042014%26date%3D10032014%26volume%3D54%26issue%3D4%26spage%3D1235%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>, <span class="hlFld-ContribAuthor ">Larisa  Yeomans</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">Vanessa  Porter</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Sobczyk-Kojiro</span>, <span class="hlFld-ContribAuthor ">John R.  Traynor</span>, and <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (7)
                                     , 3148-3153. <a href="https://doi.org/10.1021/jm5002088" title="DOI URL">https://doi.org/10.1021/jm5002088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5002088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5002088%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BBioavailable%252B%2525CE%2525BC%252BOpioid%252BReceptor%252B%252528MOPr%252529%252BAgonist%25252C%252B%2525CE%2525B4%252BOpioid%252BReceptor%252B%252528DOPr%252529%252BAntagonist%252BPeptide%252BThat%252BEvokes%252BAntinociception%252Bwithout%252BDevelopment%252Bof%252BAcute%252BTolerance%26aulast%3DMosberg%26aufirst%3DHenry%2BI.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07022014%26date%3D26032014%26date%3D10042014%26date%3D18032014%26volume%3D57%26issue%3D7%26spage%3D3148%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel E.  Beck</span>, <span class="hlFld-ContribAuthor ">Keli  Agama</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Adel  Chergui</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, and <span class="hlFld-ContribAuthor ">Mark  Cushman</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of New Carbohydrate-Substituted Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan (LMP776). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1495-1512. <a href="https://doi.org/10.1021/jm401814y" title="DOI URL">https://doi.org/10.1021/jm401814y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401814y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401814y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252BCarbohydrate-Substituted%252BIndenoisoquinoline%252BTopoisomerase%252BI%252BInhibitors%252Band%252BImproved%252BSyntheses%252Bof%252Bthe%252BExperimental%252BAnticancer%252BAgents%252BIndotecan%252B%252528LMP400%252529%252Band%252BIndimitecan%252B%252528LMP776%252529%26aulast%3DBeck%26aufirst%3DDaniel%2BE.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D23112013%26date%3D11022014%26date%3D27022014%26volume%3D57%26issue%3D4%26spage%3D1495%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Stefano  Tomassi</span>, <span class="hlFld-ContribAuthor ">Mariarosaria  Conte</span>, <span class="hlFld-ContribAuthor ">Rosaria  Benedetti</span>, <span class="hlFld-ContribAuthor ">Marcello  Tortorici</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Ciossani</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Biagina  Marrocco</span>, <span class="hlFld-ContribAuthor ">Donatella  Labella</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Andrea  Mattevi</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>, <span class="hlFld-ContribAuthor ">Anthony  Tumber</span>, <span class="hlFld-ContribAuthor ">Clarence  Yapp</span>, <span class="hlFld-ContribAuthor ">Oliver N. F.  King</span>, <span class="hlFld-ContribAuthor ">Richard J.  Hopkinson</span>, <span class="hlFld-ContribAuthor ">Akane  Kawamura</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, and <span class="hlFld-ContribAuthor ">Antonello  Mai</span>  . </span><span class="cited-content_cbyCitation_article-title">Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 42-55. <a href="https://doi.org/10.1021/jm4012802" title="DOI URL">https://doi.org/10.1021/jm4012802</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4012802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4012802%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPan-Histone%252BDemethylase%252BInhibitors%252BSimultaneously%252BTargeting%252BJumonji%252BC%252Band%252BLysine-Specific%252BDemethylases%252BDisplay%252BHigh%252BAnticancer%252BActivities%26aulast%3DRotili%26aufirst%3DDante%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D19082013%26date%3D19122013%26date%3D09012014%26date%3D10122013%26volume%3D57%26issue%3D1%26spage%3D42%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janosch  Achenbach</span>, <span class="hlFld-ContribAuthor ">Franca-Maria  Klingler</span>, <span class="hlFld-ContribAuthor ">René  Blöcher</span>, <span class="hlFld-ContribAuthor ">Daniel  Moser</span>, <span class="hlFld-ContribAuthor ">Ann-Kathrin  Häfner</span>, <span class="hlFld-ContribAuthor ">Carmen B.  Rödl</span>, <span class="hlFld-ContribAuthor ">Simon  Kretschmer</span>, <span class="hlFld-ContribAuthor ">Björn  Krüger</span>, <span class="hlFld-ContribAuthor ">Frank  Löhr</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Bettina  Hofmann</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, and <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring the Chemical Space of Multitarget Ligands Using Aligned Self-Organizing Maps. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (12)
                                     , 1169-1172. <a href="https://doi.org/10.1021/ml4002562" title="DOI URL">https://doi.org/10.1021/ml4002562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002562%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExploring%252Bthe%252BChemical%252BSpace%252Bof%252BMultitarget%252BLigands%252BUsing%252BAligned%252BSelf-Organizing%252BMaps%26aulast%3DAchenbach%26aufirst%3DJanosch%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D09072013%26date%3D23102013%26date%3D30102013%26date%3D12122013%26date%3D23102013%26volume%3D4%26issue%3D12%26spage%3D1169%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens-Uwe  Peters</span>  . </span><span class="cited-content_cbyCitation_article-title">Polypharmacology – Foe or Friend?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (22)
                                     , 8955-8971. <a href="https://doi.org/10.1021/jm400856t" title="DOI URL">https://doi.org/10.1021/jm400856t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400856t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%252B%2525E2%252580%252593%252BFoe%252Bor%252BFriend%25253F%26aulast%3DPeters%26aufirst%3DJens-Uwe%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11062013%26date%3D22082013%26date%3D27112013%26date%3D06082013%26volume%3D56%26issue%3D22%26spage%3D8955%26epage%3D8971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikołaj  Chromiński</span>, <span class="hlFld-ContribAuthor ">Łukasz  Banach</span>, <span class="hlFld-ContribAuthor ">Maksymilian  Karczewski</span>, <span class="hlFld-ContribAuthor ">Keith  ó Proinsias</span>, <span class="hlFld-ContribAuthor ">Iraida  Sharina</span>, <span class="hlFld-ContribAuthor ">Dorota  Gryko</span>, and <span class="hlFld-ContribAuthor ">Emil  Martin</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Bifunctional sGC Regulators: Optimization of a Connecting Linker. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (18)
                                     , 7260-7277. <a href="https://doi.org/10.1021/jm400715h" title="DOI URL">https://doi.org/10.1021/jm400715h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400715h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400715h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BBifunctional%252BsGC%252BRegulators%25253A%252BOptimization%252Bof%252Ba%252BConnecting%252BLinker%26aulast%3DChromi%25C5%2584ski%26aufirst%3DMiko%25C5%2582aj%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D14052013%26date%3D10092013%26date%3D26092013%26date%3D20082013%26volume%3D56%26issue%3D18%26spage%3D7260%26epage%3D7277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason R.  Healy</span>, <span class="hlFld-ContribAuthor ">Padmavani  Bezawada</span>, <span class="hlFld-ContribAuthor ">Jihyun  Shim</span>, <span class="hlFld-ContribAuthor ">Jace W.  Jones</span>, <span class="hlFld-ContribAuthor ">Maureen A.  Kane</span>, <span class="hlFld-ContribAuthor ">Alexander D.  MacKerell, Jr.</span>, <span class="hlFld-ContribAuthor ">Andrew  Coop</span>, and <span class="hlFld-ContribAuthor ">Rae R.  Matsumoto</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Modeling, and Pharmacological Evaluation of UMB 425, a Mixed μ Agonist/δ Antagonist Opioid Analgesic with Reduced Tolerance Liabilities. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (9)
                                     , 1256-1266. <a href="https://doi.org/10.1021/cn4000428" title="DOI URL">https://doi.org/10.1021/cn4000428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn4000428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn4000428%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%25252C%252BModeling%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BUMB%252B425%25252C%252Ba%252BMixed%252B%2525CE%2525BC%252BAgonist%25252F%2525CE%2525B4%252BAntagonist%252BOpioid%252BAnalgesic%252Bwith%252BReduced%252BTolerance%252BLiabilities%26aulast%3DHealy%26aufirst%3DJason%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08022013%26date%3D28052013%26date%3D11062013%26date%3D18092013%26date%3D28052013%26volume%3D4%26issue%3D9%26spage%3D1256%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Njogu</span>, <span class="hlFld-ContribAuthor ">Jiri  Gut</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, and <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Antiplasmodial Activity of Hybrid Compounds Based on (2R,3S)-N-Benzoyl-3-phenylisoserine. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (7)
                                     , 637-641. <a href="https://doi.org/10.1021/ml400164t" title="DOI URL">https://doi.org/10.1021/ml400164t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400164t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400164t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAntiplasmodial%252BActivity%252Bof%252BHybrid%252BCompounds%252BBased%252Bon%252B%2525282R%25252C3S%252529-N-Benzoyl-3-phenylisoserine%26aulast%3DNjogu%26aufirst%3DPeter%2BM.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D01052013%26date%3D22052013%26date%3D29052013%26date%3D11072013%26date%3D22052013%26volume%3D4%26issue%3D7%26spage%3D637%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Stößel</span>, <span class="hlFld-ContribAuthor ">Miriam  Schlenk</span>, <span class="hlFld-ContribAuthor ">Sonja  Hinz</span>, <span class="hlFld-ContribAuthor ">Petra  Küppers</span>, <span class="hlFld-ContribAuthor ">Jag  Heer</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, and <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4580-4596. <a href="https://doi.org/10.1021/jm400336x" title="DOI URL">https://doi.org/10.1021/jm400336x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400336x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400336x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BTargeting%252Bof%252BAdenosine%252BA2A%252BReceptors%252Band%252BMonoamine%252BOxidase%252BB%252Bby%252B4H-3%25252C1-Benzothiazin-4-ones%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DAnne%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D05032013%26date%3D30052013%26date%3D13062013%26date%3D30042013%26volume%3D56%26issue%3D11%26spage%3D4580%26epage%3D4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tyler C.  Broussard</span>, <span class="hlFld-ContribAuthor ">Amanda E.  Price</span>, <span class="hlFld-ContribAuthor ">Susan M.  Laborde</span>, and <span class="hlFld-ContribAuthor ">Grover L.  Waldrop</span>  . </span><span class="cited-content_cbyCitation_article-title">Complex Formation and Regulation of Escherichia coli Acetyl-CoA Carboxylase. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (19)
                                     , 3346-3357. <a href="https://doi.org/10.1021/bi4000707" title="DOI URL">https://doi.org/10.1021/bi4000707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi4000707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi4000707%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DComplex%252BFormation%252Band%252BRegulation%252Bof%252BEscherichia%252Bcoli%252BAcetyl-CoA%252BCarboxylase%26aulast%3DBroussard%26aufirst%3DTyler%2BC.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18012013%26date%3D15042013%26date%3D01052013%26date%3D14052013%26date%3D17042013%26volume%3D52%26issue%3D19%26spage%3D3346%26epage%3D3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jhih-Bin  Chen</span>, <span class="hlFld-ContribAuthor ">Ting-Rong  Chern</span>, <span class="hlFld-ContribAuthor ">Tzu-Tang  Wei</span>, <span class="hlFld-ContribAuthor ">Ching-Chow  Chen</span>, <span class="hlFld-ContribAuthor ">Jung-Hsin  Lin</span>, and <span class="hlFld-ContribAuthor ">Jim-Min  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Dual-Action Inhibitors Targeting Histone Deacetylases and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (9)
                                     , 3645-3655. <a href="https://doi.org/10.1021/jm400179b" title="DOI URL">https://doi.org/10.1021/jm400179b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400179b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400179b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BDual-Action%252BInhibitors%252BTargeting%252BHistone%252BDeacetylases%252Band%252B3-Hydroxy-3-methylglutaryl%252BCoenzyme%252BA%252BReductase%252Bfor%252BCancer%252BTreatment%26aulast%3DChen%26aufirst%3DJhih-Bin%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03022013%26date%3D22042013%26date%3D09052013%26date%3D09042013%26volume%3D56%26issue%3D9%26spage%3D3645%26epage%3D3655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Ladopoulou</span>, <span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, and <span class="hlFld-ContribAuthor ">Angeliki P.  Kourounakis</span>  . </span><span class="cited-content_cbyCitation_article-title">New Multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine Derivatives with Antioxidant, Antihyperlipidemic, and Antidiabetic Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (8)
                                     , 3330-3338. <a href="https://doi.org/10.1021/jm400101e" title="DOI URL">https://doi.org/10.1021/jm400101e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400101e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400101e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BMultifunctional%252BDi-tert-butylphenoloctahydro%252528pyrido%25252Fbenz%252529oxazine%252BDerivatives%252Bwith%252BAntioxidant%25252C%252BAntihyperlipidemic%25252C%252Band%252BAntidiabetic%252BAction%26aulast%3DLadopoulou%26aufirst%3DEleni%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22012013%26date%3D12042013%26date%3D25042013%26date%3D27032013%26volume%3D56%26issue%3D8%26spage%3D3330%26epage%3D3338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santhosh Kumar  Alla</span>, <span class="hlFld-ContribAuthor ">Rapolu Kiran  Kumar</span>, <span class="hlFld-ContribAuthor ">Pradeep  Sadhu</span>, and <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>  . </span><span class="cited-content_cbyCitation_article-title">Iodobenzene Catalyzed C–H Amination of N-Substituted Amidines Using m-Chloroperbenzoic Acid. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (6)
                                     , 1334-1337. <a href="https://doi.org/10.1021/ol400274f" title="DOI URL">https://doi.org/10.1021/ol400274f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol400274f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol400274f%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIodobenzene%252BCatalyzed%252BC%2525E2%252580%252593H%252BAmination%252Bof%252BN-Substituted%252BAmidines%252BUsing%252Bm-Chloroperbenzoic%252BAcid%26aulast%3DAlla%26aufirst%3DSanthosh%2BKumar%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D30012013%26date%3D27022013%26date%3D15032013%26volume%3D15%26issue%3D6%26spage%3D1334%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>, <span class="hlFld-ContribAuthor ">Larisa  Yeomans</span>, <span class="hlFld-ContribAuthor ">Aubrie A.  Harland</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Sobczyk-Kojiro</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">Mary J.  Clark</span>, <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>, and <span class="hlFld-ContribAuthor ">John R.  Traynor</span>  . </span><span class="cited-content_cbyCitation_article-title">Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (5)
                                     , 2139-2149. <a href="https://doi.org/10.1021/jm400050y" title="DOI URL">https://doi.org/10.1021/jm400050y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400050y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400050y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpioid%252BPeptidomimetics%25253A%252BLeads%252Bfor%252Bthe%252BDesign%252Bof%252BBioavailable%252BMixed%252BEfficacy%252B%2525CE%2525BC%252BOpioid%252BReceptor%252B%252528MOR%252529%252BAgonist%25252F%2525CE%2525B4%252BOpioid%252BReceptor%252B%252528DOR%252529%252BAntagonist%252BLigands%26aulast%3DMosberg%26aufirst%3DHenry%2BI.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D10012013%26date%3D27022013%26date%3D14032013%26date%3D18022013%26volume%3D56%26issue%3D5%26spage%3D2139%26epage%3D2149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karin  Meirer</span>, <span class="hlFld-ContribAuthor ">Carmen B.  Rödl</span>, <span class="hlFld-ContribAuthor ">Joanna M.  Wisniewska</span>, <span class="hlFld-ContribAuthor ">Sven  George</span>, <span class="hlFld-ContribAuthor ">Ann-Kathrin  Häfner</span>, <span class="hlFld-ContribAuthor ">Estel·la  Buscató</span>, <span class="hlFld-ContribAuthor ">Franca-Maria  Klingler</span>, <span class="hlFld-ContribAuthor ">Steffen  Hahn</span>, <span class="hlFld-ContribAuthor ">Dirk  Berressem</span>, <span class="hlFld-ContribAuthor ">Sandra K.  Wittmann</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Bettina  Hofmann</span>, and <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship Studies of Novel Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (4)
                                     , 1777-1781. <a href="https://doi.org/10.1021/jm301617j" title="DOI URL">https://doi.org/10.1021/jm301617j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301617j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301617j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252BNovel%252BDual%252BInhibitors%252Bof%252BSoluble%252BEpoxide%252BHydrolase%252Band%252B5-Lipoxygenase%26aulast%3DMeirer%26aufirst%3DKarin%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D02112012%26date%3D07022013%26date%3D28022013%26date%3D28012013%26volume%3D56%26issue%3D4%26spage%3D1777%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravi  Chaniyara</span>, <span class="hlFld-ContribAuthor ">Satishkumar  Tala</span>, <span class="hlFld-ContribAuthor ">Chi-Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiuguo  Zang</span>, <span class="hlFld-ContribAuthor ">Rajesh  Kakadiya</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Lin</span>, <span class="hlFld-ContribAuthor ">Ching-Huang  Chen</span>, <span class="hlFld-ContribAuthor ">Shin-I  Chien</span>, <span class="hlFld-ContribAuthor ">Ting-Chao  Chou</span>, <span class="hlFld-ContribAuthor ">Tung-Hu  Tsai</span>, <span class="hlFld-ContribAuthor ">Te-Chang  Lee</span>, <span class="hlFld-ContribAuthor ">Anamik  Shah</span>, and <span class="hlFld-ContribAuthor ">Tsann-Long  Su</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Antitumor Indolizino[6,7-b]indoles with Multiple Modes of Action: DNA Cross-Linking and Topoisomerase I and II Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (4)
                                     , 1544-1563. <a href="https://doi.org/10.1021/jm301788a" title="DOI URL">https://doi.org/10.1021/jm301788a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301788a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301788a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BAntitumor%252BIndolizino%25255B6%25252C7-b%25255Dindoles%252Bwith%252BMultiple%252BModes%252Bof%252BAction%25253A%252BDNA%252BCross-Linking%252Band%252BTopoisomerase%252BI%252Band%252BII%252BInhibition%26aulast%3DChaniyara%26aufirst%3DRavi%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D19092012%26date%3D14022013%26date%3D28022013%26date%3D29012013%26volume%3D56%26issue%3D4%26spage%3D1544%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Veloso</span>, <span class="hlFld-ContribAuthor ">Devjani  Dhar</span>, <span class="hlFld-ContribAuthor ">Ari M.  Chow</span>, <span class="hlFld-ContribAuthor ">Biao  Zhang</span>, <span class="hlFld-ContribAuthor ">Derek W. F.  Tang</span>, <span class="hlFld-ContribAuthor ">Hashwin V. S.  Ganesh</span>, <span class="hlFld-ContribAuthor ">Svetlana  Mikhaylichenko</span>, <span class="hlFld-ContribAuthor ">Ian R.  Brown</span>, and <span class="hlFld-ContribAuthor ">Kagan  Kerman</span>  . </span><span class="cited-content_cbyCitation_article-title">sym-Triazines for Directed Multitarget Modulation of Cholinesterases and Amyloid-β in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 339-349. <a href="https://doi.org/10.1021/cn300171c" title="DOI URL">https://doi.org/10.1021/cn300171c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300171c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300171c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3Dsym-Triazines%252Bfor%252BDirected%252BMultitarget%252BModulation%252Bof%252BCholinesterases%252Band%252BAmyloid-%2525CE%2525B2%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DVeloso%26aufirst%3DAnthony%2BJ.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02102012%26date%3D30102012%26date%3D20112012%26date%3D20022013%26date%3D30102012%26volume%3D4%26issue%3D2%26spage%3D339%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina  Yin</span>, <span class="hlFld-ContribAuthor ">Qingzhong  Hu</span>, and <span class="hlFld-ContribAuthor ">Rolf W.  Hartmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (2)
                                     , 460-470. <a href="https://doi.org/10.1021/jm301408t" title="DOI URL">https://doi.org/10.1021/jm301408t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301408t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301408t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTetrahydropyrroloquinolinone%252BType%252BDual%252BInhibitors%252Bof%252BAromatase%25252FAldosterone%252BSynthase%252Bas%252Ba%252BNovel%252BStrategy%252Bfor%252BBreast%252BCancer%252BPatients%252Bwith%252BElevated%252BCardiovascular%252BRisks%26aulast%3DYin%26aufirst%3DLina%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D27092012%26date%3D03012013%26date%3D24012013%26volume%3D56%26issue%3D2%26spage%3D460%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Riganti</span>, <span class="hlFld-ContribAuthor ">Barbara  Rolando</span>, <span class="hlFld-ContribAuthor ">Joanna  Kopecka</span>, <span class="hlFld-ContribAuthor ">Ivana  Campia</span>, <span class="hlFld-ContribAuthor ">Konstantin  Chegaev</span>, <span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Antonella  Federico</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, and <span class="hlFld-ContribAuthor ">Dario  Ghigo</span>  . </span><span class="cited-content_cbyCitation_article-title">Mitochondrial-Targeting Nitrooxy-doxorubicin: A New Approach To Overcome Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2013,</strong> <em>10 </em>
                                    (1)
                                     , 161-174. <a href="https://doi.org/10.1021/mp300311b" title="DOI URL">https://doi.org/10.1021/mp300311b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp300311b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp300311b%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DMitochondrial-Targeting%252BNitrooxy-doxorubicin%25253A%252BA%252BNew%252BApproach%252BTo%252BOvercome%252BDrug%252BResistance%26aulast%3DRiganti%26aufirst%3DChiara%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07062012%26date%3D27112012%26date%3D16112012%26date%3D07122012%26date%3D07012013%26date%3D27112012%26volume%3D10%26issue%3D1%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Nurulain T.    Zaveri </span><span class="hlFld-ContribAuthor "> Dennis    Yasuda </span><span class="hlFld-ContribAuthor "> Blair V.    Journigan </span><span class="hlFld-ContribAuthor "> Pankaj R.    Daga </span><span class="hlFld-ContribAuthor "> Faming    Jiang </span><span class="hlFld-ContribAuthor "> Cris    Olsen </span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships of Nociceptin Receptor (NOP) Ligands and the Design of Bifunctional NOP/Mu Opioid Receptor-Targeted Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 145-160. <a href="https://doi.org/10.1021/bk-2013-1131.ch008" title="DOI URL">https://doi.org/10.1021/bk-2013-1131.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2013-1131.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2013-1131.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DStructure-Activity%252BRelationships%252Bof%252BNociceptin%252BReceptor%252B%252528NOP%252529%252BLigands%252Band%252Bthe%252BDesign%252Bof%252BBifunctional%252BNOP%25252FMu%252BOpioid%252BReceptor-Targeted%252BLigands%26aulast%3DZaveri%26aufirst%3DNurulain%2BT.%26date%3D2013%26date%3D2013%26spage%3D145%26epage%3D160%26atitle%3DResearch%252Band%252BDevelopment%252Bof%252BOpioid-Related%252BLigands%26aulast%3DKo%26aufirst%3DMei-Chuan%26date%3D2013%26date%3D2013%26volume%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Pereira</span>, <span class="hlFld-ContribAuthor ">Rosaria  Benedetti</span>, <span class="hlFld-ContribAuthor ">Santiago  Pérez-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Angela  Nebbioso</span>, <span class="hlFld-ContribAuthor ">José  García-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Carafa</span>, <span class="hlFld-ContribAuthor ">Mayra  Stuhldreier</span>, <span class="hlFld-ContribAuthor ">Mariarosaria  Conte</span>, <span class="hlFld-ContribAuthor ">Fátima  Rodríguez-Barrios</span>, <span class="hlFld-ContribAuthor ">Hendrik G.  Stunnenberg</span>, <span class="hlFld-ContribAuthor ">Hinrich  Gronemeyer</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>, and <span class="hlFld-ContribAuthor ">Ángel R.  de Lera</span>  . </span><span class="cited-content_cbyCitation_article-title">Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9467-9491. <a href="https://doi.org/10.1021/jm300618u" title="DOI URL">https://doi.org/10.1021/jm300618u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300618u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300618u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndole-Derived%252BPsammaplin%252BA%252BAnalogues%252Bas%252BEpigenetic%252BModulators%252Bwith%252BMultiple%252BInhibitory%252BActivities%26aulast%3DPereira%26aufirst%3DRaquel%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D03052012%26date%3D17102012%26date%3D26112012%26date%3D03102012%26volume%3D55%26issue%3D22%26spage%3D9467%26epage%3D9491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James  Pease</span> and <span class="hlFld-ContribAuthor ">Richard  Horuk</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemokine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9363-9392. <a href="https://doi.org/10.1021/jm300682j" title="DOI URL">https://doi.org/10.1021/jm300682j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300682j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300682j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemokine%252BReceptor%252BAntagonists%26aulast%3DPease%26aufirst%3DJames%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15052012%26date%3D24092012%26date%3D26112012%26date%3D29082012%26volume%3D55%26issue%3D22%26spage%3D9363%26epage%3D9392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm058225d&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2005.48.issue-21%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm058225d&amp;citedByCount=789&amp;pagesCount=6&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="jm058225df00001" data-index="0" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00001.jpeg" id="rightTab-_i3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Three main clinical scenarios for multitarget therapy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00002" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00002.jpeg" id="rightTab-_i6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Different strategies for DML projects. In the lead generation phase, knowledge-based or screening approaches are used to provide starting compounds that may be highly selective (little or no activity at a second target), moderately selective, or nonselective (with undesired activity). The subsequent strategy involves “designing in”, “balancing”, or “designing out” activities, respectively. As well as balancing the activity ratio, lead optimization provides other major challenges, in particular adsorption, distribution, metabolism, excretion, and toxicity (ADME-T) optimization. In this schematic, activity at targets A and B is desired and activity at target C is undesired. The size of the target letter illustrates the affinity for that target.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00003" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00003.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 DML continuum. Ligands vary greatly in the degree of merger of the frameworks (and the underlying pharmacophores) of the selective ligands used as the starting points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00004" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00004.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Structures of high molecular weight DML conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00005" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00005.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Structures of low molecular weight nitric oxide releasing conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00006" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00006.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 6 Structures of fused and merged DMLs (<b>8</b>, <b>12</b>, <b>15</b>) that bind to two GPCRs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00007" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00007.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 7 Design of a DML <b>18 </b>that binds to two proteases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00008" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00008.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 8 Design of a DML <b>22</b> that binds to an enzyme, acetylcholine esterase (AChE), and the serotonin transporter (SERT).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00009" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00009.jpeg" id="rightTab-_i23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 9 Structures of DMLs that were discovered via diversity or focused screening approaches.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00010" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00010.jpeg" id="rightTab-_i25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 10 Structures of DMLs, <b>29</b> and <b>32</b>, that inhibit multiple kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00010"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00011" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00011.jpeg" id="rightTab-_i28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 11 DML examples published in the primary medicinal chemistry literature between 1990 and 2004, classified according to the main areas of focus.<sup>41</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00011"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00012" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00012.jpeg" id="rightTab-_i31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 12 Design of a SERT/5HT<sub>1A</sub> ligand <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00012"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00013" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00013.jpeg" id="rightTab-_i33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 13 Design of a SERT/5HT<sub>1A</sub> ligand <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00013"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00014" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00014.jpeg" id="rightTab-_i35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 14 Design of a SERT/5HT<sub>1D</sub> ligand <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00014"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00015" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00015.jpeg" id="rightTab-_i36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 15 Design of a SERT/5HT<sub>1A</sub> ligand <b>46</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00015"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00016" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00016.jpeg" id="rightTab-_i38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 16 Design of a SERT/α<sub>2</sub> ligand <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00016"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00017" data-index="16" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00017.jpeg" id="rightTab-_i40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 17 Structure of the SNRI ligand, duloxetine <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00017"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00018" data-index="17" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00018.jpeg" id="rightTab-_i42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 18 Design of the SMUB ligand <b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00018"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00019" data-index="18" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00019.jpeg" id="rightTab-_i45" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 19 Design of the D<sub>2</sub>/5HT<sub>2A</sub> ligand ziprasidone <b>57</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00019"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00020" data-index="19" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00020.jpeg" id="rightTab-_i47" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 20 Design of the D<sub>2</sub>/D<sub>4</sub> ligand <b>60</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00020"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00021" data-index="20" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00021.jpeg" id="rightTab-_i48" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 21 Design of the H<sub>1</sub>/LTD<sub>4</sub> ligand <b>63</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00021"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00022" data-index="21" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00022.jpeg" id="rightTab-_i49" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 22 Design of the H<sub>1</sub>/5-LO ligand <b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00022"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00023" data-index="22" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00023.jpeg" id="rightTab-_i52" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 23 Design of the H<sub>1</sub>/TxA<sub>2</sub> ligand <b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00023"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00024" data-index="23" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00024.jpeg" id="rightTab-_i54" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 24 Design of the H<sub>1</sub>/H<sub>3</sub> ligand <b>72</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00024"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00025" data-index="24" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00025.jpeg" id="rightTab-_i56" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 25 Design of the H<sub>1</sub>/PAF ligand <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00025"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00026" data-index="25" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00026.jpeg" id="rightTab-_i58" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 26 Design of the H<sub>1</sub>/NK<sub>1</sub> ligand <b>78</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00026"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00027" data-index="26" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00027.jpeg" id="rightTab-_i61" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 27 Design of the ACE/NEP ligand omapatrilat <b>82</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00027"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00028" data-index="27" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00028.jpeg" id="rightTab-_i63" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 28 Design of the ACE/NEP ligand <b>84</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00028"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00029" data-index="28" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00029.jpeg" id="rightTab-_i65" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 29 Structure of the ACE/NEP/ECE-1 ligand <b>85</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00029"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00030" data-index="29" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00030.jpeg" id="rightTab-_i67" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 30 Design of the AT<sub>1</sub>/AT<sub>2</sub> ligand <b>87</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00030"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00031" data-index="30" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00031.jpeg" id="rightTab-_i68" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 31 Design of the angiotensin/endothelin receptor ligand <b>89</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00031"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00032" data-index="31" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00032.jpeg" id="rightTab-_i70" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 32 Design of the AT<sub>1</sub>/ET<sub>A</sub> receptor ligand <b>93</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00032"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00033" data-index="32" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00033.jpeg" id="rightTab-_i72" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 33 Structures of the COX/5-LOX ligands <b>94 </b>and <b>95</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00033"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00034" data-index="33" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00034.jpeg" id="rightTab-_i73" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 34 Structures of the COX/5-LOX ligands <b>97</b>−<b>99</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00034"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00035" data-index="34" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00035.jpeg" id="rightTab-_i76" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 35 Design of the TxA<sub>2</sub>/5-LOX ligand <b>101</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00035"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00036" data-index="35" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00036.jpeg" id="rightTab-_i77" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 36 Design of the TxA<sub>2</sub>R/TxA<sub>2</sub>S ligand <b>104</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00036"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00037" data-index="36" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00037.jpeg" id="rightTab-_i78" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 37 Design of the TxA<sub>2</sub>R/TxA<sub>2</sub>S ligand <b>108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00037"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00038" data-index="37" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00038.jpeg" id="rightTab-_i81" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 38 Design of the PPARα/γ dual agonist <b>110</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00038"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00039" data-index="38" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00039.jpeg" id="rightTab-_i83" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 39 Design of the PPARα/γ/δ triple agonist <b>115</b>. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00039"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00040" data-index="39" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00040.jpeg" id="rightTab-_i85" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 40 Design of the PPARα/γ dual agonist <b>119</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00040"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058225df00041" data-index="40" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/medium/jm058225df00041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00041.jpeg" id="rightTab-_i88" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 41 Simplification of a NK<sub>1</sub>/NK<sub>2</sub> ligand, <b>120</b>, during lead optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-21/jm058225d/production/images/large/jm058225df00041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058225d&amp;id=jm058225df00041"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004802106542" id="jm004802106542"></a></div><p class="rightTab-references-count">
            This article references 105 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm058225db00001"><div class="reference"><strong class="refLabel"><a href="#jm058225db00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm058225db00001_1"><span><span class="NLM_string-ref">Roth, B. L.; Sheffler, D. J.; Kroeze, W. K. Magic shotguns versus magic bullets:  selectively non-selective drugs for mood disorders and schizophrenia. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>3</i>, 353−359.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=359&author=B.+L.+Roth&author=D.+J.+Sheffler&author=W.+K+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A%E2%80%89+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%25E2%2580%2589%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00002"><div class="reference"><strong class="refLabel"><a href="#jm058225db00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm058225db00002_1"><span><span class="NLM_string-ref">Law, M. R.; Wald, J.; Morris, J. K.; Jordan, R. E. Value of low dose combination treatment with blood pressure lowering drugs:  analysis of 354 randomised trials. <i>  Br. Med. J.</i><b>2003</b>, <i>326</i>, 1427−1431.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2003&pages=1431&author=M.+R.+Law&author=J.+Wald&author=J.+K.+Morris&author=R.+E+Jordan&title=Value+of+low+dose+combination+treatment+with+blood+pressure+lowering+drugs%3A%E2%80%89+analysis+of+354+randomised+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DM.%2BR.%26atitle%3DValue%2520of%2520low%2520dose%2520combination%2520treatment%2520with%2520blood%2520pressure%2520lowering%2520drugs%253A%25E2%2580%2589%2520analysis%2520of%2520354%2520randomised%2520trials%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2003%26volume%3D326%26spage%3D1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00003"><div class="reference"><strong class="refLabel"><a href="#jm058225db00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm058225db00003_1"><span><span class="NLM_string-ref">Keith, C. T.; Borisy, A. A.; Stockwell, B. R. Multicomponent therapeutics for networked systems. <i>  Nat. Rev. Drug Discovery</i><b>2005</b>, <i>4</i>, 1−7.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=7&author=C.+T.+Keith&author=A.+A.+Borisy&author=B.+R+Stockwell&title=Multicomponent+therapeutics+for+networked+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulticomponent%2520therapeutics%2520for%2520networked%2520systems%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00004"><div class="reference"><strong class="refLabel"><a href="#jm058225db00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm058225db00004_1"><span><span class="NLM_string-ref">Takano, H.; Sawada, K.; Sato, N.; Natoya, A.; Tarumi, T.; Hirayama, S.; Koizumi, K.; Takahashi, T A.; Sekiguchi, S.; Koike, T. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. <i>  Leuk. Lymphoma</i><b>1996</b>, <i>21</i>, 473−478.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=478&author=H.+Takano&author=K.+Sawada&author=N.+Sato&author=A.+Natoya&author=T.+Tarumi&author=S.+Hirayama&author=K.+Koizumi&author=T+A+Takahashi&author=S.+Sekiguchi&author=T+Koike&title=Mobilization+of+peripheral+blood+progenitor+cells+following+CHOP+treatment+combined+with+delayed+granulocyte+colony-stimulating+factor+administration+in+patients+with+non-Hodgkin%27s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DH.%26atitle%3DMobilization%2520of%2520peripheral%2520blood%2520progenitor%2520cells%2520following%2520CHOP%2520treatment%2520combined%2520with%2520delayed%2520granulocyte%2520colony-stimulating%2520factor%2520administration%2520in%2520patients%2520with%2520non-Hodgkin%2527s%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D1996%26volume%3D21%26spage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00005"><div class="reference"><strong class="refLabel"><a href="#jm058225db00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm058225db00005_1"><span><span class="NLM_string-ref">Larder, B. A.; Kemp, S. D.; Harrigan, P. R. Potential mechanism for sustained antiretroviral effiacy of AZT-3TC combination therapy. <i>  Science</i><b>1995</b>, <i>269</i>, 696−699.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1995&pages=699&author=B.+A.+Larder&author=S.+D.+Kemp&author=P.+R+Harrigan&title=Potential+mechanism+for+sustained+antiretroviral+effiacy+of+AZT-3TC+combination+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarder%26aufirst%3DB.%2BA.%26atitle%3DPotential%2520mechanism%2520for%2520sustained%2520antiretroviral%2520effiacy%2520of%2520AZT-3TC%2520combination%2520therapy%26jtitle%3DScience%26date%3D1995%26volume%3D269%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00006"><div class="reference"><strong class="refLabel"><a href="#jm058225db00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm058225db00006_1"><span><span class="NLM_string-ref">Eisen, S. A.; Miller, D. K.; Woodward, R. S.; Spitznagel, E.; Przybeck, T. R. The effect of prescribed daily dose frequency on patient medical compliance. <i>  Arch. Intern. Med.</i><b>1990</b>, <i>150</i>, 1881−1884.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1990&pages=1884&author=S.+A.+Eisen&author=D.+K.+Miller&author=R.+S.+Woodward&author=E.+Spitznagel&author=T.+R+Przybeck&title=The+effect+of+prescribed+daily+dose+frequency+on+patient+medical+compliance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisen%26aufirst%3DS.%2BA.%26atitle%3DThe%2520effect%2520of%2520prescribed%2520daily%2520dose%2520frequency%2520on%2520patient%2520medical%2520compliance%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1990%26volume%3D150%26spage%3D1884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00007"><div class="reference"><strong class="refLabel"><a href="#jm058225db00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm058225db00007_1"><span><span class="NLM_string-ref">Skolnik, N. S.; Beck, J. D.; Clark, M. Combination antihypertensive drugs:  Recommendations for use. <i>  Am. Fam. Physician</i><b>2000</b>, <i>61</i>, 3049−3056.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=3056&author=N.+S.+Skolnik&author=J.+D.+Beck&author=M+Clark&title=Combination+antihypertensive+drugs%3A%E2%80%89+Recommendations+for+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnik%26aufirst%3DN.%2BS.%26atitle%3DCombination%2520antihypertensive%2520drugs%253A%25E2%2580%2589%2520Recommendations%2520for%2520use%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2000%26volume%3D61%26spage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00008"><div class="reference"><strong class="refLabel"><a href="#jm058225db00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm058225db00008_1"><span><span class="NLM_string-ref">Glass, G. Cardiovascular combinations. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>3</i>, 731−732.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=732&author=G+Glass&title=Cardiovascular+combinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlass%26aufirst%3DG%26atitle%3DCardiovascular%2520combinations%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00009"><div class="reference"><strong class="refLabel"><a href="#jm058225db00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm058225db00009_1"><span><span class="NLM_string-ref">Morphy, R.; Kay, C.; Rankovic, Z. From magic bullets to designed multiple ligands. <i>  Drug Discovery Today</i><b>2004</b>, <i>9</i>, 641−651.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=651&author=R.+Morphy&author=C.+Kay&author=Z+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00010_1"><span><span class="NLM_string-ref">Frishman, W. H.; Zuckerman, A. L. Amlodipine/atorvastatin:  the first cross risk factor polypill for the prevention and treatment of cardiovascular disease. <i>  Expert Rev. Cardiovas. Ther.</i><b>2004</b>, <i>2</i>, 675−681.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=681&author=W.+H.+Frishman&author=A.+L.+Zuckerman&author=+Amlodipine&title=the+first+cross+risk+factor+polypill+for+the+prevention+and+treatment+of+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3Dthe%2520first%2520cross%2520risk%2520factor%2520polypill%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520cardiovascular%2520disease%26jtitle%3DExpert%2520Rev.%2520Cardiovas.%2520Ther.%26date%3D2004%26volume%3D2%26spage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00011"><div class="reference"><strong class="refLabel"><a href="#jm058225db00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm058225db00011_1"><span><span class="NLM_string-ref">Flores, N. A. Ezetimibe + simvastatin (Merck/Schering-Plough). <i>  Curr. Opin. </i><i>Invest. Drugs </i><b>2004</b>, <i>5</i>, 984−992.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Flores%2C+N.+A.+Ezetimibe+%2B+simvastatin+%28Merck%2FSchering-Plough%29.+Curr.+Opin.+Invest.+Drugs+2004%2C+5%2C+984%E2%88%92992.+Flores%2C+N.+A.+Ezetimibe+%2B+simvastatin+%28Merck%2FSchering-Plough%29.+Curr.+Opin.+Invest.+Drugs+2004%2C+5%2C+984%E2%88%92992."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlores%26aufirst%3DN.%2BA.%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00012"><div class="reference"><strong class="refLabel"><a href="#jm058225db00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm058225db00012_1"><span><span class="NLM_string-ref">Edwards, I. R.; Aronson, J. K. Adverse drug reactions:  Definitions, diagnosis and management. <i>  Lancet</i><b>2000</b>, <i>356</i>, 1255−1259.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2000&pages=1259&author=I.+R.+Edwards&author=J.+K+Aronson&title=Adverse+drug+reactions%3A%E2%80%89+Definitions%2C+diagnosis+and+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DI.%2BR.%26atitle%3DAdverse%2520drug%2520reactions%253A%25E2%2580%2589%2520Definitions%252C%2520diagnosis%2520and%2520management%26jtitle%3DLancet%26date%3D2000%26volume%3D356%26spage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00013"><div class="reference"><strong class="refLabel"><a href="#jm058225db00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm058225db00013_1"><span><span class="NLM_string-ref">Kramer, M. S.; Last, B.; Getson, A.; Reines, S. A. The effects of selective D<sub>4</sub> dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. <i>  Arch. Gen. Psychiatry </i><b>1997</b>, <i>54</i>, 567−572.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=572&author=M.+S.+Kramer&author=B.+Last&author=A.+Getson&author=S.+A+Reines&title=The+effects+of+selective+D4+dopamine+receptor+antagonist+%28L-745%2C870%29+in+acutely+psychotic+inpatients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DM.%2BS.%26atitle%3DThe%2520effects%2520of%2520selective%2520D4%2520dopamine%2520receptor%2520antagonist%2520%2528L-745%252C870%2529%2520in%2520acutely%2520psychotic%2520inpatients%2520with%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1997%26volume%3D54%26spage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00014"><div class="reference"><strong class="refLabel"><a href="#jm058225db00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm058225db00014_1"><span><span class="NLM_string-ref">Campiani, G.; Butini, S.; Fattorusso, C.; Catalanotti, B.; Gemma, S.; Nacci, V.; Morelli, E.; Cagnotto, A.; Mereghetti, I.; Mennini, T.; Carli, M.; Minetti, P.; Di Cesare, M. A.; Mastroianni, D.; Scafetta, N.; Galletti, B.; Stasi, M. A.; Castorina, M.; Pacifici, L.; Vertechy, M.; Di Serio, S.; Ghirardi, O.; Tinti, O.; Carminati, P<i>.</i> Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure−activity relationship studies, and identification of novel atypical antipsychotic agents <i>J. Med. Chem. </i><b>2004</b>, <i>47</i>, 143−157.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=157&author=G.+Campiani&author=S.+Butini&author=C.+Fattorusso&author=B.+Catalanotti&author=S.+Gemma&author=V.+Nacci&author=E.+Morelli&author=A.+Cagnotto&author=I.+Mereghetti&author=T.+Mennini&author=M.+Carli&author=P.+Minetti&author=M.+A.+Di+Cesare&author=D.+Mastroianni&author=N.+Scafetta&author=B.+Galletti&author=M.+A.+Stasi&author=M.+Castorina&author=L.+Pacifici&author=M.+Vertechy&author=S.+Di+Serio&author=O.+Ghirardi&author=O.+Tinti&author=P.+Carminati&author=+Pyrrolo&title=serotonin+and+dopamine+receptor+antagonists.+Molecular+modeling%2C+further+structure%E2%88%92activity+relationship+studies%2C+and+identification+of+novel+atypical+antipsychotic+agents+J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampiani%26aufirst%3DG.%26atitle%3Dserotonin%2520and%2520dopamine%2520receptor%2520antagonists.%2520Molecular%2520modeling%252C%2520further%2520structure%25E2%2588%2592activity%2520relationship%2520studies%252C%2520and%2520identification%2520of%2520novel%2520atypical%2520antipsychotic%2520agents%2520J%26jtitle%3DMed.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00015"><div class="reference"><strong class="refLabel"><a href="#jm058225db00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm058225db00015_1"><span><span class="NLM_string-ref">Jones, H. M<i>.</i>; Pilowsky, L. S. New targets for antipsychotics. <i>  Expert Rev. </i><i>Neurother.</i><b>2002</b>, <i>2</i>, 61−68.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=68&author=H.+M.+Jones&author=L.+S+Pilowsky&title=New+targets+for+antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26atitle%3DNew%2520targets%2520for%2520antipsychotics%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2002%26volume%3D2%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00016"><div class="reference"><strong class="refLabel"><a href="#jm058225db00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm058225db00016_1"><span><span class="NLM_string-ref">Stahl, S. M.; Entsuah, R.; Rudolph, R. L. Comparative Efficacy between venlafaxine and SSRIs:  A pooled analysis of patients with depression. <i>  Biol. </i><i>Psychiatry</i><b>2002</b>, <i>202</i>, 1166−1174.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2002&pages=1174&author=S.+M.+Stahl&author=R.+Entsuah&author=R.+L+Rudolph&title=Comparative+Efficacy+between+venlafaxine+and+SSRIs%3A%E2%80%89+A+pooled+analysis+of+patients+with+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26atitle%3DComparative%2520Efficacy%2520between%2520venlafaxine%2520and%2520SSRIs%253A%25E2%2580%2589%2520A%2520pooled%2520analysis%2520of%2520patients%2520with%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2002%26volume%3D202%26spage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00017"><div class="reference"><strong class="refLabel"><a href="#jm058225db00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm058225db00017_1"><span><span class="NLM_string-ref">Charlier, C.; Michaux, C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. <i>  Eur. J. Med. Chem.</i><b>2003</b>, <i>38</i>, 645−659.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=659&author=C.+Charlier&author=C+Michaux&title=Dual+inhibition+of+cyclooxygenase-2+%28COX-2%29+and+5-lipoxygenase+%285-LOX%29+as+a+new+strategy+to+provide+safer+non-steroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharlier%26aufirst%3DC.%26atitle%3DDual%2520inhibition%2520of%2520cyclooxygenase-2%2520%2528COX-2%2529%2520and%25205-lipoxygenase%2520%25285-LOX%2529%2520as%2520a%2520new%2520strategy%2520to%2520provide%2520safer%2520non-steroidal%2520anti-inflammatory%2520drugs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00018"><div class="reference"><strong class="refLabel"><a href="#jm058225db00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm058225db00018_1"><span><span class="NLM_string-ref">Buijsman, R. C.; Basten, J. E.; van Dinther, T. G.; van der Marel, G. A.; van Boeckel, C. A.; van Boom, J. H. Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying a dual antithrombotic action. <i>  Bioorg. Med. Chem. Lett. </i><b>1999</b>, <i>9</i>, 2013−2018.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2018&author=R.+C.+Buijsman&author=J.+E.+Basten&author=T.+G.+van+Dinther&author=G.+A.+van+der+Marel&author=C.+A.+van+Boeckel&author=J.+H+van+Boom&title=Design+and+synthesis+of+a+novel+synthetic+NAPAP-pentasaccharide+conjugate+displaying+a+dual+antithrombotic+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520synthetic%2520NAPAP-pentasaccharide%2520conjugate%2520displaying%2520a%2520dual%2520antithrombotic%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00019"><div class="reference"><strong class="refLabel"><a href="#jm058225db00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm058225db00019_1"><span><span class="NLM_string-ref">Jacobson, K. A.; Xie, R.; Young, L.; Chang, L.; Liang, B. T. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists. <i>  J. Biol. Chem.</i><b>2000</b>, <i>275</i>, 30272−30279.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30279&author=K.+A.+Jacobson&author=R.+Xie&author=L.+Young&author=L.+Chang&author=B.+T+Liang&title=A+novel+pharmacological+approach+to+treating+cardiac+ischemia.+Binary+conjugates+of+A1+and+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA%2520novel%2520pharmacological%2520approach%2520to%2520treating%2520cardiac%2520ischemia.%2520Binary%2520conjugates%2520of%2520A1%2520and%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00020_1"><span><span class="NLM_string-ref">Portoghese, P. S. From models to molecules:  Opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. <i>  J. Med. Chem.</i><b>2001</b>, <i>44</i>, 2259−2269.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2269&author=P.+S+Portoghese&title=From+models+to+molecules%3A%E2%80%89+Opioid+receptor+dimers%2C+bivalent+ligands%2C+and+selective+opioid+receptor+probes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPortoghese%26aufirst%3DP.%2BS%26atitle%3DFrom%2520models%2520to%2520molecules%253A%25E2%2580%2589%2520Opioid%2520receptor%2520dimers%252C%2520bivalent%2520ligands%252C%2520and%2520selective%2520opioid%2520receptor%2520probes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00021"><div class="reference"><strong class="refLabel"><a href="#jm058225db00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm058225db00021_1"><span><span class="NLM_string-ref">Daniels, D. J.; Kulkarni, A.; Xie, Z.; Bhushan, R. G.; Portoghese, P. S. A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotypes. <i>  J. Med. </i><i>Chem.</i><b>2005</b>, <i>48</i>, 1713−1716.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1716&author=D.+J.+Daniels&author=A.+Kulkarni&author=Z.+Xie&author=R.+G.+Bhushan&author=P.+S+Portoghese&title=A+bivalent+ligand+%28KDAN-18%29+containing+%CE%B4-antagonist+and+%CE%BA-agonist+pharmacophores+bridges+%CE%B42+and+%CE%BA1+opioid+receptor+phenotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DD.%2BJ.%26atitle%3DA%2520bivalent%2520ligand%2520%2528KDAN-18%2529%2520containing%2520%25CE%25B4-antagonist%2520and%2520%25CE%25BA-agonist%2520pharmacophores%2520bridges%2520%25CE%25B42%2520and%2520%25CE%25BA1%2520opioid%2520receptor%2520phenotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00022"><div class="reference"><strong class="refLabel"><a href="#jm058225db00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm058225db00022_1"><span><span class="NLM_string-ref">Di Napoli, M.; Papa, F. NCX-4016 NicOX. <i>  Curr. Opin. Invest. Drugs</i><b>2003</b>, <i>4</i>, 1126−1139.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Di+Napoli%2C+M.%3B+Papa%2C+F.+NCX-4016+NicOX.+Curr.+Opin.+Invest.+Drugs+2003%2C+4%2C+1126%E2%88%921139.+Di+Napoli%2C+M.%3B+Papa%2C+F.+NCX-4016+NicOX.+Curr.+Opin.+Invest.+Drugs2003%2C+4%2C+1126%E2%88%921139."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BNapoli%26aufirst%3DM.%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D4%26spage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00023"><div class="reference"><strong class="refLabel"><a href="#jm058225db00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm058225db00023_1"><span><span class="NLM_string-ref">Lolli, M. L.; Cena, C.; Medana, C.; Lazzarato, L.; Morini, G.; Coruzzi, G.; Manarini, S.; Fruttero, R.; Gasco, A. A new class of ibuprofen derivatives with reduced gastrotoxicity. <i>  J. Med. Chem.</i><b>2001</b>, <i>44</i>, 3463−3468.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3468&author=M.+L.+Lolli&author=C.+Cena&author=C.+Medana&author=L.+Lazzarato&author=G.+Morini&author=G.+Coruzzi&author=S.+Manarini&author=R.+Fruttero&author=A+Gasco&title=A+new+class+of+ibuprofen+derivatives+with+reduced+gastrotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DM.%2BL.%26atitle%3DA%2520new%2520class%2520of%2520ibuprofen%2520derivatives%2520with%2520reduced%2520gastrotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00024"><div class="reference"><strong class="refLabel"><a href="#jm058225db00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm058225db00024_1"><span><span class="NLM_string-ref">Kawanishi, Y.; Ishihara, S.; Tsushim, T.; Seno, K.; Miyagoshi, M.; Hagishita, S.; Ishikawa, M.; Shima, N.; Shimamura, M.; Ishihar, Y. Synthesis and pharmacological evaluation of highly potent dual histamine H<sub>2</sub> and gastrin receptor antagonists. <i>  Bioorg. Med. Chem. Lett.</i><b>1996</b>, <i>6</i>, 1427−1430.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1430&author=Y.+Kawanishi&author=S.+Ishihara&author=T.+Tsushim&author=K.+Seno&author=M.+Miyagoshi&author=S.+Hagishita&author=M.+Ishikawa&author=N.+Shima&author=M.+Shimamura&author=Y+Ishihar&title=Synthesis+and+pharmacological+evaluation+of+highly+potent+dual+histamine+H2+and+gastrin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawanishi%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520highly%2520potent%2520dual%2520histamine%2520H2%2520and%2520gastrin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00025"><div class="reference"><strong class="refLabel"><a href="#jm058225db00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm058225db00025_1"><span><span class="NLM_string-ref">Montero, A.; Goya, P.; Jagerovic, N.; Luis, F.; Callado, L.; Meana, J.; Girón, R.; Goicoechea, C.; Martín, I. Guanidinium and aminoimidazolinium derivatives of <i>N</i>-(4-piperidyl)propanamides as potential ligands for opioid and I<sub>2</sub>-imidazoline receptors:  synthesis and pharmacological screening. <i>  Bioorg. Med. Chem.</i><b>2002</b>, <i>10</i>, 1009−1018.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1018&author=A.+Montero&author=P.+Goya&author=N.+Jagerovic&author=F.+Luis&author=L.+Callado&author=J.+Meana&author=R.+Gir%C3%B3n&author=C.+Goicoechea&author=I+Mart%C3%ADn&title=Guanidinium+and+aminoimidazolinium+derivatives+of+N-%284-piperidyl%29propanamides+as+potential+ligands+for+opioid+and+I2-imidazoline+receptors%3A%E2%80%89+synthesis+and+pharmacological+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontero%26aufirst%3DA.%26atitle%3DGuanidinium%2520and%2520aminoimidazolinium%2520derivatives%2520of%2520N-%25284-piperidyl%2529propanamides%2520as%2520potential%2520ligands%2520for%2520opioid%2520and%2520I2-imidazoline%2520receptors%253A%25E2%2580%2589%2520synthesis%2520and%2520pharmacological%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00026"><div class="reference"><strong class="refLabel"><a href="#jm058225db00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm058225db00026_1"><span><span class="NLM_string-ref">Dardonville, C.; Jagerovic, N.; Callado, L.; Meana, J. Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties:  a new series of hybrid molecules with significant binding affinity for μ-opioid receptors and I<sub>2</sub>-imidazoline binding sites. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 491−493.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=493&author=C.+Dardonville&author=N.+Jagerovic&author=L.+Callado&author=J+Meana&title=Fentanyl+derivatives+bearing+aliphatic+alkaneguanidinium+moieties%3A%E2%80%89+a+new+series+of+hybrid+molecules+with+significant+binding+affinity+for+%CE%BC-opioid+receptors+and+I2-imidazoline+binding+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDardonville%26aufirst%3DC.%26atitle%3DFentanyl%2520derivatives%2520bearing%2520aliphatic%2520alkaneguanidinium%2520moieties%253A%25E2%2580%2589%2520a%2520new%2520series%2520of%2520hybrid%2520molecules%2520with%2520significant%2520binding%2520affinity%2520for%2520%25CE%25BC-opioid%2520receptors%2520and%2520I2-imidazoline%2520binding%2520sites%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00027"><div class="reference"><strong class="refLabel"><a href="#jm058225db00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm058225db00027_1"><span><span class="NLM_string-ref">Burkholder, T.; Kudlacz, E.; Le, T.-B.; Knippenberg, R.; Shatzer, S.; Maynard, G.; Webster, M.; Horgan, S. Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK<sub>1</sub> and NK<sub>2</sub> receptors. <i>  Bioorg. Med. Chem. Lett.</i><b>1996</b>, <i>6</i>, 951−956.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=956&author=T.+Burkholder&author=E.+Kudlacz&author=T.-B.+Le&author=R.+Knippenberg&author=S.+Shatzer&author=G.+Maynard&author=M.+Webster&author=S+Horgan&title=Identification+and+chemical+synthesis+of+MDL+105%2C212%2C+a+non-peptide+tachykinin+antagonist+with+high+affinity+for+NK1+and+NK2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurkholder%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520chemical%2520synthesis%2520of%2520MDL%2520105%252C212%252C%2520a%2520non-peptide%2520tachykinin%2520antagonist%2520with%2520high%2520affinity%2520for%2520NK1%2520and%2520NK2%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00028"><div class="reference"><strong class="refLabel"><a href="#jm058225db00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm058225db00028_1"><span><span class="NLM_string-ref">Yamamoto, M.; Ikeda, S.; Kondo, H.; Inoue, S. Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin<i>. Bioorg. Med. Chem. </i><i>Lett.</i><b>2002</b>, <i>12</i>, 375−378.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=378&author=M.+Yamamoto&author=S.+Ikeda&author=H.+Kondo&author=S+Inoue&title=Design+and+synthesis+of+dual+inhibitors+for+matrix+metalloproteinase+and+cathepsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dual%2520inhibitors%2520for%2520matrix%2520metalloproteinase%2520and%2520cathepsin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00029"><div class="reference"><strong class="refLabel"><a href="#jm058225db00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm058225db00029_1"><span><span class="NLM_string-ref">Toda, N.; Tago, K.; Marumoto, S.; Takami, K.; Ori, M.; Yamada, N.; Koyama, K.; Naruto, S.; Abe, K.; Yamazaki, R.; Hara, T.; Aoyagi, A.; Abe, Y.; Kaneko, T.; Kogen, H. A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease. <i>  Bioorg. Med. </i><i>Chem.</i><b>2003</b>,<i> 11</i>, 4389−4415.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4415&author=N.+Toda&author=K.+Tago&author=S.+Marumoto&author=K.+Takami&author=M.+Ori&author=N.+Yamada&author=K.+Koyama&author=S.+Naruto&author=K.+Abe&author=R.+Yamazaki&author=T.+Hara&author=A.+Aoyagi&author=Y.+Abe&author=T.+Kaneko&author=H+Kogen&title=A+conformational+restriction+approach+to+the+development+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+as+potential+agents+for+Alzheimer%27s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26atitle%3DA%2520conformational%2520restriction%2520approach%2520to%2520the%2520development%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520as%2520potential%2520agents%2520for%2520Alzheimer%2527s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00030_1"><span><span class="NLM_string-ref">Ryckmans, T.; Balançon, L.; Berton, O.; Genicot, C.; Lamberty, Y.; Lallemand, B.; Pasau, P.; Pirlot, N.; Quéré, L.; Talaga, P. First dual NK<sub>1</sub> antagonists-serotonin reuptake inhibitors:  synthesis and SAR of a new class of potential antidepressants. <i>  Bioorg. Med. Chem. Lett. </i><b>2002</b>, <i>12</i>, 261−264.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=264&author=T.+Ryckmans&author=L.+Balan%C3%A7on&author=O.+Berton&author=C.+Genicot&author=Y.+Lamberty&author=B.+Lallemand&author=P.+Pasau&author=N.+Pirlot&author=L.+Qu%C3%A9r%C3%A9&author=P+Talaga&title=First+dual+NK1+antagonists-serotonin+reuptake+inhibitors%3A%E2%80%89+synthesis+and+SAR+of+a+new+class+of+potential+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26atitle%3DFirst%2520dual%2520NK1%2520antagonists-serotonin%2520reuptake%2520inhibitors%253A%25E2%2580%2589%2520synthesis%2520and%2520SAR%2520of%2520a%2520new%2520class%2520of%2520potential%2520antidepressants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00031"><div class="reference"><strong class="refLabel"><a href="#jm058225db00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm058225db00031_1"><span><span class="NLM_string-ref">Van Niel, M.; Beer, M.; Castro, J.; Cheng, S.; Evans, D.; Heald, A.; Hitzel, L.; Hunt, P.; Mortishire-Smith, R.; O'Connor, D.; Watt, A.; MacLeod, A. Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT<sub>1A</sub> and 5-HT re-uptake ligands. <i>  Bioorg. Med. Chem. Lett. </i><b>1999</b>, <i>9</i>, 3243−3248.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=3248&author=M.+Van+Niel&author=M.+Beer&author=J.+Castro&author=S.+Cheng&author=D.+Evans&author=A.+Heald&author=L.+Hitzel&author=P.+Hunt&author=R.+Mortishire-Smith&author=D.+O%27Connor&author=A.+Watt&author=A+MacLeod&title=Parallel+synthesis+of+3-aryloxy-2-propanolamines+and+evaluation+as+dual+affinity+5-HT1A+and+5-HT+re-uptake+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BNiel%26aufirst%3DM.%26atitle%3DParallel%2520synthesis%2520of%25203-aryloxy-2-propanolamines%2520and%2520evaluation%2520as%2520dual%2520affinity%25205-HT1A%2520and%25205-HT%2520re-uptake%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00032"><div class="reference"><strong class="refLabel"><a href="#jm058225db00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm058225db00032_1"><span><span class="NLM_string-ref">Macor, J. E.; Gurley, D.; Lanthorn, T.; Loch, J.; Mack, R. A.; Mullen, G.; Tran, O.; Wright, N.; Gordon, J. C. The 5-HT<sub>3</sub> antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist. <i>  Bioorg. Med. Chem. Lett. </i><b>2001</b>, <i>11</i>, 319−321.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=321&author=J.+E.+Macor&author=D.+Gurley&author=T.+Lanthorn&author=J.+Loch&author=R.+A.+Mack&author=G.+Mullen&author=O.+Tran&author=N.+Wright&author=J.+C+Gordon&title=The+5-HT3+antagonist+tropisetron+%28ICS+205-930%29+is+a+potent+and+selective+%CE%B17+nicotinic+receptor+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DThe%25205-HT3%2520antagonist%2520tropisetron%2520%2528ICS%2520205-930%2529%2520is%2520a%2520potent%2520and%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520partial%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00033"><div class="reference"><strong class="refLabel"><a href="#jm058225db00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm058225db00033_1"><span><span class="NLM_string-ref">Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.; Scozzafava, A.; Klebe, G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:  New pharmacological opportunities due to related binding site recognition. <i>  J. Med. Chem.</i><b>2004</b>, <i>46</i>, 550−557.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=557&author=A.+Weber&author=A.+Casini&author=A.+Heine&author=D.+Kuhn&author=C.+T.+Supuran&author=A.+Scozzafava&author=G+Klebe&title=Unexpected+nanomolar+inhibition+of+carbonic+anhydrase+by+COX-2-selective+celecoxib%3A%E2%80%89+New+pharmacological+opportunities+due+to+related+binding+site+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%26atitle%3DUnexpected%2520nanomolar%2520inhibition%2520of%2520carbonic%2520anhydrase%2520by%2520COX-2-selective%2520celecoxib%253A%25E2%2580%2589%2520New%2520pharmacological%2520opportunities%2520due%2520to%2520related%2520binding%2520site%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D46%26spage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00034"><div class="reference"><strong class="refLabel"><a href="#jm058225db00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm058225db00034_1"><span><span class="NLM_string-ref">Daub, H.; Specht, K.; Ullrich, A. Strategies to overcome resistance to targeted protein kinase inhibitors. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>12</i>, 1001−1010.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1010&author=H.+Daub&author=K.+Specht&author=A+Ullrich&title=Strategies+to+overcome+resistance+to+targeted+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaub%26aufirst%3DH.%26atitle%3DStrategies%2520to%2520overcome%2520resistance%2520to%2520targeted%2520protein%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D12%26spage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00035"><div class="reference"><strong class="refLabel"><a href="#jm058225db00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm058225db00035_1"><span><span class="NLM_string-ref">Zimmermann, J.; Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N.; Traxler, P. Phenylamino-pyrimidine (PAP) derivatives:  a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>1996</b>, <i>6</i>, 1221−1226.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1226&author=J.+Zimmermann&author=E.+Buchdunger&author=H.+Mett&author=T.+Meyer&author=N.+Lydon&author=P.+Traxler&author=+Phenylamino&title=a+new+class+of+potent+and+highly+selective+PDGF-receptor+autophosphorylation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3Da%2520new%2520class%2520of%2520potent%2520and%2520highly%2520selective%2520PDGF-receptor%2520autophosphorylation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00036"><div class="reference"><strong class="refLabel"><a href="#jm058225db00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm058225db00036_1"><span><span class="NLM_string-ref">Zimmermann, J.; Buchdunger, E.; Mett, H.; Meyer, T.; Lydon, N. B. Potent and selective inhibitors of the Abl-kinase:  phenylamino-pyrimidine (PAP) derivatives. <i>  Bioorg. Med. Chem. Lett.</i><b>1997</b>, <i>7</i>, 187−192.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=192&author=J.+Zimmermann&author=E.+Buchdunger&author=H.+Mett&author=T.+Meyer&author=N.+B+Lydon&title=Potent+and+selective+inhibitors+of+the+Abl-kinase%3A%E2%80%89+phenylamino-pyrimidine+%28PAP%29+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520the%2520Abl-kinase%253A%25E2%2580%2589%2520phenylamino-pyrimidine%2520%2528PAP%2529%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00037"><div class="reference"><strong class="refLabel"><a href="#jm058225db00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm058225db00037_1"><span><span class="NLM_string-ref">Boschelli, D.; Wang, Y.; Johnson, S.; Wu, B.; Ye, F.; Sosa, A.; Golas, J.; Boschelli, F. 7-Alkoxy-4-phenylamino-3-quinolinecarbonitriles as dual inhibitors of Src and Abl kinases. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 1599−1601.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1601&author=D.+Boschelli&author=Y.+Wang&author=S.+Johnson&author=B.+Wu&author=F.+Ye&author=A.+Sosa&author=J.+Golas&author=F.+Boschelli&author=+Alkoxy&title=as+dual+inhibitors+of+Src+and+Abl+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoschelli%26aufirst%3DD.%26atitle%3Das%2520dual%2520inhibitors%2520of%2520Src%2520and%2520Abl%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00038"><div class="reference"><strong class="refLabel"><a href="#jm058225db00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm058225db00038_1"><span><span class="NLM_string-ref">Bonnert, R. V.; Brown, R. C.; Chapman, D.; Cheshire, D. R.; Dixon, J.; Ince, F.; Kinchin, E. C.; Lyons, A. J.; Davis, A. M.; Hallam, C.; Harper, S. T.; Unitt, J. F.; Dougall, I. G.; Jackson, D. M.; McKechnie, K.; Young, A.; Simpson, W. T. Dual D<sub>2</sub>-receptor and b<sub>2</sub>-adrenoreceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues. <i>  J. </i><i>Med. Chem.</i><b>1998</b>, <i>41</i>, 4915−4917.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4917&author=R.+V.+Bonnert&author=R.+C.+Brown&author=D.+Chapman&author=D.+R.+Cheshire&author=J.+Dixon&author=F.+Ince&author=E.+C.+Kinchin&author=A.+J.+Lyons&author=A.+M.+Davis&author=C.+Hallam&author=S.+T.+Harper&author=J.+F.+Unitt&author=I.+G.+Dougall&author=D.+M.+Jackson&author=K.+McKechnie&author=A.+Young&author=W.+T.+Simpson&author=+Dual&title=agonists+for+the+treatment+of+airway+diseases.+1.+Discovery+and+biological+evaluation+of+some+7-%282-aminoethyl%29-4-hydroxybenzothiazol-2%283H%29-one+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonnert%26aufirst%3DR.%2BV.%26atitle%3Dagonists%2520for%2520the%2520treatment%2520of%2520airway%2520diseases.%25201.%2520Discovery%2520and%2520biological%2520evaluation%2520of%2520some%25207-%25282-aminoethyl%2529-4-hydroxybenzothiazol-2%25283H%2529-one%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00039"><div class="reference"><strong class="refLabel"><a href="#jm058225db00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm058225db00039_1"><span><span class="NLM_string-ref">Atkinson, P.; Bromidge, S.; Duxon, M.; Laramie, M.; Gaster, L.; Hadley, M.; Hammond, B.; Johnson, C.; Middlemiss, D.; North, S.; Price, G.; Rami, H.; Riley, J.; Scott, C.; Shaw, T.; Starr, K.; Stemp, G.; Thewlis, K.; Thomas, D.; Thompson, M.; Vong, A.; Watson, J. 3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity. <i>  Bioorg. Med. Chem. Lett. </i><b>2005</b>, <i>15</i>, 737−741.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=741&author=P.+Atkinson&author=S.+Bromidge&author=M.+Duxon&author=M.+Laramie&author=L.+Gaster&author=M.+Hadley&author=B.+Hammond&author=C.+Johnson&author=D.+Middlemiss&author=S.+North&author=G.+Price&author=H.+Rami&author=J.+Riley&author=C.+Scott&author=T.+Shaw&author=K.+Starr&author=G.+Stemp&author=K.+Thewlis&author=D.+Thomas&author=M.+Thompson&author=A.+Vong&author=J.+Watson&author=A+Dihydro&title=receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%26atitle%3Dreceptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00040"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00040_1"><span><span class="NLM_string-ref">Reichard, G. A.; Grice, C. A.; Shih, N. Y.; Spitler, J.; Majmundar, S.; Wang, S. D.; Paliwal, S.; Anthes, J. C.; Piwinski, J. J. Preparation of oxime dual NK<sub>1</sub>/NK<sub>2</sub> antagonists with reduced NK<sub>3</sub> affinity. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2355−2358.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2358&author=G.+A.+Reichard&author=C.+A.+Grice&author=N.+Y.+Shih&author=J.+Spitler&author=S.+Majmundar&author=S.+D.+Wang&author=S.+Paliwal&author=J.+C.+Anthes&author=J.+J+Piwinski&title=Preparation+of+oxime+dual+NK1%2FNK2+antagonists+with+reduced+NK3+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReichard%26aufirst%3DG.%2BA.%26atitle%3DPreparation%2520of%2520oxime%2520dual%2520NK1%252FNK2%2520antagonists%2520with%2520reduced%2520NK3%2520affinity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00041"><div class="reference"><strong class="refLabel"><a href="#jm058225db00041" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-jm058225db00041_1"><span><span class="NLM_string-ref">The medicinal chemistry journals covered were <i>Bioorg. Med. Chem. Lett.</i>, <i>Bioorg. Med. Chem.</i>, <i>J. Med. Chem.</i>, and <i>Eur. J. Med. Chem</i>.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+medicinal+chemistry+journals+covered+were+Bioorg.+Med.+Chem.+Lett.%2C+Bioorg.+Med.+Chem.%2C+J.+Med.+Chem.%2C+and+Eur.+J.+Med.+Chem.+The+medicinal+chemistry+journals+covered+were+Bioorg.+Med.+Chem.+Lett.%2C+Bioorg.+Med.+Chem.%2C+J.+Med.+Chem.%2C+and+Eur.+J.+Med.+Chem."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520medicinal%2520chemistry%2520journals%2520covered%2520were%2520Bioorg%26jtitle%3DMed.%2520Chem.%2520Lett.%252C%2520Bioorg.%2520Med.%2520Chem.%252C%2520J.%2520Med.%2520Chem.%252C%2520and%2520Eur.%2520J.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00042"><div class="reference"><strong class="refLabel"><a href="#jm058225db00042" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-jm058225db00042_1"><span><span class="NLM_string-ref">Romero, L.; Hervás, I.; Artigas, F. The 5-HT<sub>1A</sub> antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. <i>  Neurosci. </i><i>Lett.</i><b>1996</b>, <i>219</i>, 123−126.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1996&pages=126&author=L.+Romero&author=I.+Herv%C3%A1s&author=F+Artigas&title=The+5-HT1A+antagonist+WAY-100635+selectively+potentiates+the+presynaptic+effects+of+serotonergic+antidepressants+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26atitle%3DThe%25205-HT1A%2520antagonist%2520WAY-100635%2520selectively%2520potentiates%2520the%2520presynaptic%2520effects%2520of%2520serotonergic%2520antidepressants%2520in%2520rat%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1996%26volume%3D219%26spage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00043"><div class="reference"><strong class="refLabel"><a href="#jm058225db00043" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-jm058225db00043_1"><span><span class="NLM_string-ref">Perez, M.; Pauwelsb, P.; Pallard-Sigogneaua, I.; Fourriera, C.; Chopinc, P.; Palmierb, C.; Colovrayd, V.; Halazy, S. Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>1998</b>, <i>8</i>, 3423−3428.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=3428&author=M.+Perez&author=P.+Pauwelsb&author=I.+Pallard-Sigogneaua&author=C.+Fourriera&author=P.+Chopinc&author=C.+Palmierb&author=V.+Colovrayd&author=S+Halazy&title=Design+and+synthesis+of+new+potent%2C+silent+5-HT1A+antagonists+by+covalent+coupling+of+aminopropanol+derivatives+with+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520potent%252C%2520silent%25205-HT1A%2520antagonists%2520by%2520covalent%2520coupling%2520of%2520aminopropanol%2520derivatives%2520with%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00044"><div class="reference"><strong class="refLabel"><a href="#jm058225db00044" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-jm058225db00044_1"><span><span class="NLM_string-ref">Mewshaw, R.; Meagher, K.; Zhou, P.; Zhou, D.; Shi, X.; Scerni, R.; Smith, D.; Schechter, L.; Andree, T. Studies toward the discovery of the next generation of antidepressants. Part 2:  Incorporating a 5-HT1A antagonist component into a class of serotonin reuptake inhibitors. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>2002</b>, <i>12</i>, 307−310.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=310&author=R.+Mewshaw&author=K.+Meagher&author=P.+Zhou&author=D.+Zhou&author=X.+Shi&author=R.+Scerni&author=D.+Smith&author=L.+Schechter&author=T+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+Part+2%3A%E2%80%89+Incorporating+a+5-HT1A+antagonist+component+into+a+class+of+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%2520Part%25202%253A%25E2%2580%2589%2520Incorporating%2520a%25205-HT1A%2520antagonist%2520component%2520into%2520a%2520class%2520of%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00045"><div class="reference"><strong class="refLabel"><a href="#jm058225db00045" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-jm058225db00045_1"><span><span class="NLM_string-ref">Mewshaw, R.; Zhou, D.; Zhou, P.; Shi, X.; Hornby, G.; Spangler, T.; Scerni, R.; Smith, D.; Schechter, L.; Andree, T. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of <i>N</i>-aryloxyethylindolylalkylamines. <i>  J. </i><i>Med. Chem.</i><b>2004</b>, <i>47</i>, 3823−3842.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3842&author=R.+Mewshaw&author=D.+Zhou&author=P.+Zhou&author=X.+Shi&author=G.+Hornby&author=T.+Spangler&author=R.+Scerni&author=D.+Smith&author=L.+Schechter&author=T+Andree&title=Studies+toward+the+discovery+of+the+next+generation+of+antidepressants.+3.+Dual+5-HT1A+and+serotonin+transporter+affinity+within+a+class+of+N-aryloxyethylindolylalkylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%26atitle%3DStudies%2520toward%2520the%2520discovery%2520of%2520the%2520next%2520generation%2520of%2520antidepressants.%25203.%2520Dual%25205-HT1A%2520and%2520serotonin%2520transporter%2520affinity%2520within%2520a%2520class%2520of%2520N-aryloxyethylindolylalkylamines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00046"><div class="reference"><strong class="refLabel"><a href="#jm058225db00046" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-jm058225db00046_1"><span><span class="NLM_string-ref">Timms, G.; Boot, J.; Broadmore, R.; Carney, S.; Cooper, J.; Findlay, J.; Gilmore, J.; Mitchell, S.; Moore, N.; Pullar, I.; Sanger, G.; Tomlinson, R.; Tree, B.; Wedley, S. SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 2469−2472.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2472&author=G.+Timms&author=J.+Boot&author=R.+Broadmore&author=S.+Carney&author=J.+Cooper&author=J.+Findlay&author=J.+Gilmore&author=S.+Mitchell&author=N.+Moore&author=I.+Pullar&author=G.+Sanger&author=R.+Tomlinson&author=B.+Tree&author=S+Wedley&title=SAR+development+of+a+selective+5-HT1D+antagonist%2Fserotonin+reuptake+inhibitor+lead+using+rapid+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00046_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimms%26aufirst%3DG.%26atitle%3DSAR%2520development%2520of%2520a%2520selective%25205-HT1D%2520antagonist%252Fserotonin%2520reuptake%2520inhibitor%2520lead%2520using%2520rapid%2520parallel%2520synthesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00047"><div class="reference"><strong class="refLabel"><a href="#jm058225db00047" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-jm058225db00047_1"><span><span class="NLM_string-ref">Torrado, A.; Lamas, C.; Agejas, J.; Jiménez, A.; D×c6ìaza, N.; Gilmore, J.; Boot, J.; Findlay, J.; Hayhurst, L.; Wallace, L.; Broadmore, R.; Tomlinson, R. Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity:  chemistry and pharmacological evaluation of a series of thienopyran derivatives. <i>  Bioorg. Med. Chem.</i><b>2004</b>, <i>12</i>, 5277−5295.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5295&author=A.+Torrado&author=C.+Lamas&author=J.+Agejas&author=A.+Jim%C3%A9nez&author=+D%C3%97c&author=J.+Gilmore&author=J.+Boot&author=J.+Findlay&author=L.+Hayhurst&author=L.+Wallace&author=R.+Broadmore&author=R+Tomlinson&title=Novel+selective+and+potent+5-HT+reuptake+inhibitors+with+5-HT1D+antagonist+activity%3A%E2%80%89+chemistry+and+pharmacological+evaluation+of+a+series+of+thienopyran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00047_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorrado%26aufirst%3DA.%26atitle%3DNovel%2520selective%2520and%2520potent%25205-HT%2520reuptake%2520inhibitors%2520with%25205-HT1D%2520antagonist%2520activity%253A%25E2%2580%2589%2520chemistry%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520series%2520of%2520thienopyran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00048"><div class="reference"><strong class="refLabel"><a href="#jm058225db00048" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-jm058225db00048_1"><span><span class="NLM_string-ref">Feuerstein, T. H.; Hertting, G. Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release:  Evidence for facilitatory 5-HT receptors within the CNS. <i>  Naunyn-Schmiedeberg</i><i>'</i><i>s Arch. Pharmacol.</i><b>1986</b>, <i>333</i>, 191−197.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1986&pages=197&author=T.+H.+Feuerstein&author=G.+Hertting&author=+Serotonin&title=enhances+hippocampal+noradrenaline+%28NA%29+release%3A%E2%80%89+Evidence+for+facilitatory+5-HT+receptors+within+the+CNS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00048_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeuerstein%26aufirst%3DT.%2BH.%26atitle%3Denhances%2520hippocampal%2520noradrenaline%2520%2528NA%2529%2520release%253A%25E2%2580%2589%2520Evidence%2520for%2520facilitatory%25205-HT%2520receptors%2520within%2520the%2520CNS%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1986%26volume%3D333%26spage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00049"><div class="reference"><strong class="refLabel"><a href="#jm058225db00049" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-jm058225db00049_1"><span><span class="NLM_string-ref">Meyer, M. D.; Hancock, A. A.; Tietje, K.; Sippy, K. B.; Prasad, R.; Stout, D. M.; Arendsen, D. L.; Donner, B. G.; Carroll, W. A. Structure−activity studies for a novel series of <i>N</i>-(arylethyl)-<i>N</i>-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-<i>N</i>-methylamines possessing dual 5-HT uptake inhibiting and α<sub>2</sub>-antagonistic activities. <i>  J. </i><i>Med. Chem.</i><b> 1997</b>, <i>40</i>, 1049−1062.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1062&author=M.+D.+Meyer&author=A.+A.+Hancock&author=K.+Tietje&author=K.+B.+Sippy&author=R.+Prasad&author=D.+M.+Stout&author=D.+L.+Arendsen&author=B.+G.+Donner&author=W.+A+Carroll&title=Structure%E2%88%92activity+studies+for+a+novel+series+of+N-%28arylethyl%29-N-%281%2C2%2C3%2C4-tetrahydronaphthalen-1-ylmethyl%29-N-methylamines+possessing+dual+5-HT+uptake+inhibiting+and+%CE%B12-antagonistic+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00049_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DStructure%25E2%2588%2592activity%2520studies%2520for%2520a%2520novel%2520series%2520of%2520N-%2528arylethyl%2529-N-%25281%252C2%252C3%252C4-tetrahydronaphthalen-1-ylmethyl%2529-N-methylamines%2520possessing%2520dual%25205-HT%2520uptake%2520inhibiting%2520and%2520%25CE%25B12-antagonistic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00050"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00050_1"><span><span class="NLM_string-ref">Meyer, M.; Hancock, A.; Tietje, K.; Sippy, K.; Giardina, W.; Kerwin, J. Synthesis and pharmacological characterization of A-80426:  A putative novel antidepressant combining alpha-2 antagonism with 5-HT uptake inhibition. <i>  Bioorg. Med. Chem. Lett.</i><b>1995</b>, <i>5</i>, 2287−2292.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2292&author=M.+Meyer&author=A.+Hancock&author=K.+Tietje&author=K.+Sippy&author=W.+Giardina&author=J+Kerwin&title=Synthesis+and+pharmacological+characterization+of+A-80426%3A%E2%80%89+A+putative+novel+antidepressant+combining+alpha-2+antagonism+with+5-HT+uptake+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00050_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520A-80426%253A%25E2%2580%2589%2520A%2520putative%2520novel%2520antidepressant%2520combining%2520alpha-2%2520antagonism%2520with%25205-HT%2520uptake%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D2292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00051"><div class="reference"><strong class="refLabel"><a href="#jm058225db00051" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-jm058225db00051_1"><span><span class="NLM_string-ref">Bymaster, F.; Beedle, E.; Findlay, J.; Gallagher, P.; Krushinski, J.; Mitchell, S.; Robertson, D.; Thompson, D.; Wallace, L.; Wong, D. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 4477−4480.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4480&author=F.+Bymaster&author=E.+Beedle&author=J.+Findlay&author=P.+Gallagher&author=J.+Krushinski&author=S.+Mitchell&author=D.+Robertson&author=D.+Thompson&author=L.+Wallace&author=D.+Wong&author=+Duloxetine&title=a+dual+inhibitor+of+serotonin+and+norepinephrine+reuptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00051_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBymaster%26aufirst%3DF.%26atitle%3Da%2520dual%2520inhibitor%2520of%2520serotonin%2520and%2520norepinephrine%2520reuptake%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00052"><div class="reference"><strong class="refLabel"><a href="#jm058225db00052" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-jm058225db00052_1"><span><span class="NLM_string-ref">Axford, L.; Boot, J.; Hotten, T.; Keenan, M.; Martin, F.; Milutinovic, S.; Moore, N.; O'Neill, M.; Pullar, I.; Tupper, D.; Van Belle, K.; Vivien, V. Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 3277−3280.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3280&author=L.+Axford&author=J.+Boot&author=T.+Hotten&author=M.+Keenan&author=F.+Martin&author=S.+Milutinovic&author=N.+Moore&author=M.+O%27Neill&author=I.+Pullar&author=D.+Tupper&author=K.+Van+Belle&author=V.+Vivien&author=+Bicyclo&title=as+novel+triple+re-uptake+inhibitors+for+the+treatment+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00052_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxford%26aufirst%3DL.%26atitle%3Das%2520novel%2520triple%2520re-uptake%2520inhibitors%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00053"><div class="reference"><strong class="refLabel"><a href="#jm058225db00053" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-jm058225db00053_1"><span><span class="NLM_string-ref">One of the earliest marketed drugs that possessed dual D<sub>2</sub>/5HT<sub>2</sub> activity was risperidone:  Janssen, P. A.; Niemegeers, C. J.; Awouters, F.; Schellekens, K. H.; Megens, A. A.; Meert, T. F. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. <i>  J. Pharmacol. Exp. Ther.</i><b>1988</b>, <i>244</i>, 685−693.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=+One&author=C.+J.+Niemegeers&author=F.+Awouters&author=K.+H.+Schellekens&author=A.+A.+Megens&author=T.+F.+Meert&title=Pharmacology+of+risperidone+%28R+64+766%29%2C+a+new+antipsychotic+with+serotonin-S2+and+dopamine-D2+antagonistic+properties.+J.+Pharmacol.+Exp.+Ther"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00053_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOne%26btitle%3DPharmacology%2520of%2520risperidone%2520%2528R%252064%2520766%2529%252C%2520a%2520new%2520antipsychotic%2520with%2520serotonin-S2%2520and%2520dopamine-D2%2520antagonistic%2520properties.%2520J.%2520Pharmacol.%2520Exp.%2520Ther%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00054"><div class="reference"><strong class="refLabel"><a href="#jm058225db00054" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-jm058225db00054_1"><span><span class="NLM_string-ref">Gray, R. Quetiapine:  a new atypical antipsychotic for the treatment of schizophrenia. <i>  Ment. Health Care </i><b>1998</b>, <i>1</i>, 163−164.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1998&pages=164&author=R.+Gray&author=+Quetiapine&title=a+new+atypical+antipsychotic+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00054_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DR.%26atitle%3Da%2520new%2520atypical%2520antipsychotic%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DMent.%2520Health%2520Care%26date%3D1998%26volume%3D1%26spage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00055"><div class="reference"><strong class="refLabel"><a href="#jm058225db00055" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-jm058225db00055_1"><span><span class="NLM_string-ref">Fuller, R. W.; Snoddy, H. D. Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate. <i>  Res. Commun. Chem. Pathol. Pharmacol. </i><b>1992</b>, <i>77</i>, 87−93.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1992&pages=93&author=R.+W.+Fuller&author=H.+D+Snoddy&title=Neuroendocrine+evidence+for+antagonism+of+serotonin+and+dopamine+receptors+by+olanzapine+%28LY170053%29%2C+an+antipsychotic+drug+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00055_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DR.%2BW.%26atitle%3DNeuroendocrine%2520evidence%2520for%2520antagonism%2520of%2520serotonin%2520and%2520dopamine%2520receptors%2520by%2520olanzapine%2520%2528LY170053%2529%252C%2520an%2520antipsychotic%2520drug%2520candidate%26jtitle%3DRes.%2520Commun.%2520Chem.%2520Pathol.%2520Pharmacol.%26date%3D1992%26volume%3D77%26spage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00056"><div class="reference"><strong class="refLabel"><a href="#jm058225db00056" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-jm058225db00056_1"><span><span class="NLM_string-ref">Lowe, J.; Seeger, T.; Nagel, A.; Howard, H.; Seymour, P.; Heym, J.; Ewing, F.; Newman, M.; Schmidt, A. 1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents. <i>  J. Med. Chem. </i><b>1991</b>, <i>34</i>, 1860−1866.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1866&author=J.+Lowe&author=T.+Seeger&author=A.+Nagel&author=H.+Howard&author=P.+Seymour&author=J.+Heym&author=F.+Ewing&author=M.+Newman&author=A+Schmidt&title=1-Naphthylpiperazine+derivatives+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00056_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%26atitle%3D1-Naphthylpiperazine%2520derivatives%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00057"><div class="reference"><strong class="refLabel"><a href="#jm058225db00057" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-jm058225db00057_1"><span><span class="NLM_string-ref">Howard, H.; Lowe, J.; Seeger, T.; Seymour, P.; Zorn, S.; Maloney, P.; Ewing, F.; Newman, M.; Schmidt, A.; Furman, J.; Robinson, G.; Jackson, E.; Johnson, C.; Morrone J. 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 143−148.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=148&author=H.+Howard&author=J.+Lowe&author=T.+Seeger&author=P.+Seymour&author=S.+Zorn&author=P.+Maloney&author=F.+Ewing&author=M.+Newman&author=A.+Schmidt&author=J.+Furman&author=G.+Robinson&author=E.+Jackson&author=C.+Johnson&author=J+Morrone&title=3-Benzisothiazolylpiperazine+derivatives+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00057_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DH.%26atitle%3D3-Benzisothiazolylpiperazine%2520derivatives%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00058"><div class="reference"><strong class="refLabel"><a href="#jm058225db00058" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-jm058225db00058_1"><span><span class="NLM_string-ref">Zhao, H.; Thurkauf, A.; He, X.; Hodgetts, K.; Zhang, X.; Rachwal, S.; Kover, R.; Hutchison, A.; Peterson, J.; Kieltyka, A.; Brodbeck, R.; Primus, R.; Wasley, J. Indoline and piperazine containing derivatives as a novel class of mixed D<sub>2</sub>/D<sub>4</sub> receptor antagonists. Part 1:  Identification and structure−activity relationships. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 3105−3109.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3109&author=H.+Zhao&author=A.+Thurkauf&author=X.+He&author=K.+Hodgetts&author=X.+Zhang&author=S.+Rachwal&author=R.+Kover&author=A.+Hutchison&author=J.+Peterson&author=A.+Kieltyka&author=R.+Brodbeck&author=R.+Primus&author=J+Wasley&title=Indoline+and+piperazine+containing+derivatives+as+a+novel+class+of+mixed+D2%2FD4+receptor+antagonists.+Part+1%3A%E2%80%89+Identification+and+structure%E2%88%92activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00058_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DIndoline%2520and%2520piperazine%2520containing%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520mixed%2520D2%252FD4%2520receptor%2520antagonists.%2520Part%25201%253A%25E2%2580%2589%2520Identification%2520and%2520structure%25E2%2588%2592activity%2520relationships%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00059"><div class="reference"><strong class="refLabel"><a href="#jm058225db00059" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-jm058225db00059_1"><span><span class="NLM_string-ref">Zhao, H.; He, X.; Thurkauf, A.; Hoffman, D.; Kieltyka, A.; Brodbeck, R.; Primus, R.; Wasley, J. Indoline and piperazine containing derivatives as a novel class of mixed D<sub>2</sub>/D<sub>4</sub> receptor antagonists. Part 2:  Asymmetric synthesis and biological evaluation. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 3111−3115.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3115&author=H.+Zhao&author=X.+He&author=A.+Thurkauf&author=D.+Hoffman&author=A.+Kieltyka&author=R.+Brodbeck&author=R.+Primus&author=J+Wasley&title=Indoline+and+piperazine+containing+derivatives+as+a+novel+class+of+mixed+D2%2FD4+receptor+antagonists.+Part+2%3A%E2%80%89+Asymmetric+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00059_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DIndoline%2520and%2520piperazine%2520containing%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520mixed%2520D2%252FD4%2520receptor%2520antagonists.%2520Part%25202%253A%25E2%2580%2589%2520Asymmetric%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00060"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00060_1"><span><span class="NLM_string-ref">Eiser, N. Histamine antagonists and asthma. <i>  Phar</i><i>macol. </i><i>Ther</i>. <b>1982</b>, <i>17</i>, 239−250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1982&pages=250&author=N+Eiser&title=Histamine+antagonists+and+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00060_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEiser%26aufirst%3DN%26atitle%3DHistamine%2520antagonists%2520and%2520asthma%26jtitle%3DPharmacol.%2520Ther.%26date%3D1982%26volume%3D17%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00061"><div class="reference"><strong class="refLabel"><a href="#jm058225db00061" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-jm058225db00061_1"><span><span class="NLM_string-ref">Roquet, A.; Dahlen, B.; Kumlin, M.; Ihre, E.; Gudrun, A.; S. Binks, S. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. <i>  Am. J. Respir. Crit. Care Med.</i><b>1997</b>, <i>155</i>, 1856.</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=jm058225db00061/jm058225db00061_1&amp;dbid=16&amp;doi=10.1021%2Fjm058225d&amp;key=10.1164%2Fajrccm.155.6.9196086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=jm058225db00061/jm058225db00061_1&amp;dbid=8&amp;doi=10.1021%2Fjm058225d&amp;key=9196086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=jm058225db00061/jm058225db00061_1&amp;dbid=32&amp;doi=10.1021%2Fjm058225d&amp;key=1%3ACAS%3A280%3ADyaK2szjvFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1997&pages=1856&author=A.+Roquet&author=B.+Dahlen&author=M.+Kumlin&author=E.+Ihre&author=A.+Gudrun&author=S+Binks&title=Combined+antagonism+of+leukotrienes+and+histamine+produces+predominant+inhibition+of+allergen-induced+early+and+late+phase+airway+obstruction+in+asthmatics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_jm058225db00061_1R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics</span></div><div class="casAuthors">Roquet A; Dahlen B; Kumlin M; Ihre E; Anstren G; Binks S; Dahlen S E</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1856-63</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">We defined the contribution of histamine and leukotrienes to allergen-induced airway obstruction in asthmatics; 12 subjects with allergic asthma underwent identical allergen bronchoprovocations on four occasions.  At a control session, all subjects displayed early (EAR) and late asthmatic (LAR) reactions.  The mean (+/- SE) drop in FEV1 during EAR (0-2 h) and LAR (2-12 h) was 29 +/- 2% and 28 +/- 4%, respectively.  Thereafter, the influence of 1 wk randomized pretreatment with the leukotriene receptor antagonist zafirlukast (Accolate) (80 mg twice daily), the antihistamine loratadine (10 mg twice daily), and the combination of both antagonists was assessed.  Expressed as AUC FEV1 in percent of the control reaction, zafirlukast reduced the response during EAR and LAR by 62 +/- 11% and 55 +/- 12%, respectively (p < 0.05 versus control).  Loratadine inhibited EAR and LAR by 25 +/- 14% and 40 +/- 16%, respectively (p < 0.05 versus control).  Zafirlukast was significantly more effective than loratadine during EAR but not during LAR.  The combination of zafirlukast and loratadine reduced the AUC FEV1 during EAR and LAR further, by 75 +/- 8% and 74 +/- 14%, respectively (p < 0.05 versus control).  The combination was significantly (p < 0.05) more effective than either drug alone during the LAR.  The findings indicate that leukotrienes and histamine together mediate the major part of both the EAR and the LAR following exposure of asthmatics to allergen.  Combination of leukotriene antagonism and antihistamines may represent a new strategy for treatment of airway obstruction in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7uWM2JdA5ucve_zCu79I8fW6udTcc2eaugyyr1d47Prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szjvFCrtQ%253D%253D&md5=2700b325cf4f1badd2372a28fbadf7f9</span></div><a href="/servlet/linkout?suffix=jm058225db00061_1&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.155.6.9196086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.155.6.9196086%26sid%3Dliteratum%253Aachs%26aulast%3DRoquet%26aufirst%3DA.%26atitle%3DCombined%2520antagonism%2520of%2520leukotrienes%2520and%2520histamine%2520produces%2520predominant%2520inhibition%2520of%2520allergen-induced%2520early%2520and%2520late%2520phase%2520airway%2520obstruction%2520in%2520asthmatics%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1997%26volume%3D155%26spage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00062"><div class="reference"><strong class="refLabel"><a href="#jm058225db00062" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-jm058225db00062_1"><span><span class="NLM_string-ref">Zhang, M.; van de Stolpe, A.; Zuiderveld, O.; Timmerman, H. Synthesis and pharmacological evaluation of some amino-acid-containing cyproheptadine derivatives as dual antagonists of histamine H<sub>1</sub>- and leukotriene D<sub>4</sub>-receptors. <i>  Eur. J. Med. Chem.</i><b>1997</b>, <i>32</i>, 95−102.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=102&author=M.+Zhang&author=A.+van+de+Stolpe&author=O.+Zuiderveld&author=H+Timmerman&title=Synthesis+and+pharmacological+evaluation+of+some+amino-acid-containing+cyproheptadine+derivatives+as+dual+antagonists+of+histamine+H1-+and+leukotriene+D4-receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00062_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520some%2520amino-acid-containing%2520cyproheptadine%2520derivatives%2520as%2520dual%2520antagonists%2520of%2520histamine%2520H1-%2520and%2520leukotriene%2520D4-receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00063"><div class="reference"><strong class="refLabel"><a href="#jm058225db00063" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-jm058225db00063_1"><span><span class="NLM_string-ref">Lewis, T.; Bayless, L.; Eckman, J.; Ellis, J.; Grewal, G.; Libertine, L.; Nicolas, J.; Scannell, R.; Wels, B.; Wenberg, K.; Wypij, D. 5-Lipoxygenase inhibitors with histamine H1 receptor antagonist activity. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>2004</b>, <i>14</i>, 2265−2268.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2268&author=T.+Lewis&author=L.+Bayless&author=J.+Eckman&author=J.+Ellis&author=G.+Grewal&author=L.+Libertine&author=J.+Nicolas&author=R.+Scannell&author=B.+Wels&author=K.+Wenberg&author=D+Wypij&title=5-Lipoxygenase+inhibitors+with+histamine+H1+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00063_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DT.%26atitle%3D5-Lipoxygenase%2520inhibitors%2520with%2520histamine%2520H1%2520receptor%2520antagonist%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00064"><div class="reference"><strong class="refLabel"><a href="#jm058225db00064" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-jm058225db00064_1"><span><span class="NLM_string-ref">Ohshima, E.; Takami, H.; Harakawa, H.; Sato, H.; Obase, H.; Miki, I.; Ishii, A.; Ishii, H.; Sasaki, Y. Dibenz[<i>b</i>,<i>e</i>]oxepin derivatives:  novel antiallergic agents possessing thromboxane A<sub>2</sub> and histamine H<sub>1</sub> dual antagonizing activity. 1.<i> J. Med. Chem. </i><b>1993</b>,<i> 36</i>, 417−420.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=420&author=E.+Ohshima&author=H.+Takami&author=H.+Harakawa&author=H.+Sato&author=H.+Obase&author=I.+Miki&author=A.+Ishii&author=H.+Ishii&author=Y.+Sasaki&author=+Dibenz&title=novel+antiallergic+agents+possessing+thromboxane+A2+and+histamine+H1+dual+antagonizing+activity.+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00064_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhshima%26aufirst%3DE.%26atitle%3Dnovel%2520antiallergic%2520agents%2520possessing%2520thromboxane%2520A2%2520and%2520histamine%2520H1%2520dual%2520antagonizing%2520activity.%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00065"><div class="reference"><strong class="refLabel"><a href="#jm058225db00065" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-jm058225db00065_1"><span><span class="NLM_string-ref">Aslanian, R.; Mutahi, M.; Shih, N.; Piwinski, J.; West, R.; Williams, S.; She, S.; Wu, R.; Hey, J. Identification of a dual histamine H<sub>1</sub>/H<sub>3</sub> receptor ligand based on the H<sub>1</sub> antagonist chlorpheniramine. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 1959−1961.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1961&author=R.+Aslanian&author=M.+Mutahi&author=N.+Shih&author=J.+Piwinski&author=R.+West&author=S.+Williams&author=S.+She&author=R.+Wu&author=J+Hey&title=Identification+of+a+dual+histamine+H1%2FH3+receptor+ligand+based+on+the+H1+antagonist+chlorpheniramine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00065_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAslanian%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520a%2520dual%2520histamine%2520H1%252FH3%2520receptor%2520ligand%2520based%2520on%2520the%2520H1%2520antagonist%2520chlorpheniramine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00066"><div class="reference"><strong class="refLabel"><a href="#jm058225db00066" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-jm058225db00066_1"><span><span class="NLM_string-ref">Piwinski, J.; Wong, J.; Green, M.; Ganguly, A.; Billah, M.; West, R.; Kreutner, W. Dual antagonists of platelet-activating factor and histamine. Identification of structural requirements for dual activity of <i>N</i>-acyl-4-(5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidines. <i>  J. Med. Chem. </i><b>1991</b>,<i> 34</i>, 457−461.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=461&author=J.+Piwinski&author=J.+Wong&author=M.+Green&author=A.+Ganguly&author=M.+Billah&author=R.+West&author=W+Kreutner&title=Dual+antagonists+of+platelet-activating+factor+and+histamine.+Identification+of+structural+requirements+for+dual+activity+of+N-acyl-4-%285%2C6-dihydro-11H-benzo%5B5%2C6%5Dcyclohepta%5B1%2C2-b%5Dpyridin-11-ylidene%29piperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00066_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiwinski%26aufirst%3DJ.%26atitle%3DDual%2520antagonists%2520of%2520platelet-activating%2520factor%2520and%2520histamine.%2520Identification%2520of%2520structural%2520requirements%2520for%2520dual%2520activity%2520of%2520N-acyl-4-%25285%252C6-dihydro-11H-benzo%255B5%252C6%255Dcyclohepta%255B1%252C2-b%255Dpyridin-11-ylidene%2529piperidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00067"><div class="reference"><strong class="refLabel"><a href="#jm058225db00067" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-jm058225db00067_1"><span><span class="NLM_string-ref">Carceller, E.; Merlos, M.; Giral, M.; Balsa, D.; Almansa, C.; Bartroli, J.; Garcia-Rafanell, J.; Forn, J. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine. <i>  J. Med. Chem. </i><b>1994</b>,<i> 37</i>, 2697−2703.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2703&author=E.+Carceller&author=M.+Merlos&author=M.+Giral&author=D.+Balsa&author=C.+Almansa&author=J.+Bartroli&author=J.+Garcia-Rafanell&author=J.+Forn&author=+Pyridylalkyl&title=derivatives+as+dual+antagonists+of+PAF+and+histamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00067_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarceller%26aufirst%3DE.%26atitle%3Dderivatives%2520as%2520dual%2520antagonists%2520of%2520PAF%2520and%2520histamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00068"><div class="reference"><strong class="refLabel"><a href="#jm058225db00068" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-jm058225db00068_1"><span><span class="NLM_string-ref">Maynard, G.; Bratton, L.; Kane, J.; Burkholder, T.; Santiago, B.; Stewart, K.; Kudlacz, E.; Shatzer, S.; Knippenberg, R.; Farrell, A.; Logan, D. Synthesis and SAR of 4-(1<i>H</i>-benzimidazole-2-carbonyl)piperidines with dual histamine H1/tachykinin NK1 receptor antagonist activity. <i>  Bioorg. Med. </i><i>Chem. Lett.</i><b>1997</b>, <i>7</i>, 2819−2824.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2824&author=G.+Maynard&author=L.+Bratton&author=J.+Kane&author=T.+Burkholder&author=B.+Santiago&author=K.+Stewart&author=E.+Kudlacz&author=S.+Shatzer&author=R.+Knippenberg&author=A.+Farrell&author=D+Logan&title=Synthesis+and+SAR+of+4-%281H-benzimidazole-2-carbonyl%29piperidines+with+dual+histamine+H1%2Ftachykinin+NK1+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00068_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaynard%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25281H-benzimidazole-2-carbonyl%2529piperidines%2520with%2520dual%2520histamine%2520H1%252Ftachykinin%2520NK1%2520receptor%2520antagonist%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00069"><div class="reference"><strong class="refLabel"><a href="#jm058225db00069" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-jm058225db00069_1"><span><span class="NLM_string-ref">Robl, J.; Sieber-McMaster, E.; Asaad, M. M.; Bird, J. E.; Delaney, N. G.; Barrish, J. C.; Neubeck, R.; Natarajan, S.; Cohen, M.; Rovnyak, G. C.; Huber, G.; Murugesan, N.; Girotra, R.; Cheung, H. S.; Waldron, T.; Petrillo, E. W. Mercaptoacyl dipeptides as dual inhibitors of angiotensin converting enzyme and neutral peptidase. Preliminary structure−activity studies. <i>  Bioorg. Med. Chem. Lett.</i><b>1994</b>, <i>4</i>, 1783−1789.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=1789&author=J.+Robl&author=E.+Sieber-McMaster&author=M.+M.+Asaad&author=J.+E.+Bird&author=N.+G.+Delaney&author=J.+C.+Barrish&author=R.+Neubeck&author=S.+Natarajan&author=M.+Cohen&author=G.+C.+Rovnyak&author=G.+Huber&author=N.+Murugesan&author=R.+Girotra&author=H.+S.+Cheung&author=T.+Waldron&author=E.+W+Petrillo&title=Mercaptoacyl+dipeptides+as+dual+inhibitors+of+angiotensin+converting+enzyme+and+neutral+peptidase.+Preliminary+structure%E2%88%92activity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00069_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobl%26aufirst%3DJ.%26atitle%3DMercaptoacyl%2520dipeptides%2520as%2520dual%2520inhibitors%2520of%2520angiotensin%2520converting%2520enzyme%2520and%2520neutral%2520peptidase.%2520Preliminary%2520structure%25E2%2588%2592activity%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00070"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00070_1"><span><span class="NLM_string-ref">Robl, J. A.; Sun, C.-Q.; Stevenson, J.; Ryono, D. E.; Simpkins, L. M.; Cimarusti, M. P.; Dejneka, T.; Slusarchuk, W. A.; Chao, S.; Stratton, L.; Misra, R. N.; Bednarz, M. S.; Asaad, M. M.; Cheung, H. S.; Abboa-Offei, B. E.; Smith, P. L.; Mathers, P. D.;  6543  Fox, M.; Schaeffer, T. R.; Seymour, A. A.; Trippodo, N. C. Dual metalloprotease inhibitors:  mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. <i>  J. Med. Chem.</i><b>1997</b>, <i>40</i>, 1570−1577.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1577&author=J.+A.+Robl&author=C.-Q.+Sun&author=J.+Stevenson&author=D.+E.+Ryono&author=L.+M.+Simpkins&author=M.+P.+Cimarusti&author=T.+Dejneka&author=W.+A.+Slusarchuk&author=S.+Chao&author=L.+Stratton&author=R.+N.+Misra&author=M.+S.+Bednarz&author=M.+M.+Asaad&author=H.+S.+Cheung&author=B.+E.+Abboa-Offei&author=P.+L.+Smith&author=P.+D.+Mathers&author=M.+Fox&author=T.+R.+Schaeffer&author=A.+A.+Seymour&author=N.+C+Trippodo&title=Dual+metalloprotease+inhibitors%3A%E2%80%89+mercaptoacetyl-based+fused+heterocyclic+dipeptide+mimetics+as+inhibitors+of+angiotensin-converting+enzyme+and+neutral+endopeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00070_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDual%2520metalloprotease%2520inhibitors%253A%25E2%2580%2589%2520mercaptoacetyl-based%2520fused%2520heterocyclic%2520dipeptide%2520mimetics%2520as%2520inhibitors%2520of%2520angiotensin-converting%2520enzyme%2520and%2520neutral%2520endopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00071"><div class="reference"><strong class="refLabel"><a href="#jm058225db00071" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-jm058225db00071_1"><span><span class="NLM_string-ref">Flynn, G. A.; Beight, D. W.; Mehdi, S.; Koehl, J. R.; Giroux, E. L.; French, J. F.; Hake, P. W.; Dage, R. C. Application of conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensinI converting enzyme and neutral endopeptidase 24.11. <i>  J. Med. </i><i>Chem.</i><b>1993</b>, <i>36</i>, 2420−2430.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2430&author=G.+A.+Flynn&author=D.+W.+Beight&author=S.+Mehdi&author=J.+R.+Koehl&author=E.+L.+Giroux&author=J.+F.+French&author=P.+W.+Hake&author=R.+C+Dage&title=Application+of+conformationally+restricted+Phe-Leu+dipeptide+mimetic+to+the+design+of+a+combined+inhibitor+of+angiotensinI+converting+enzyme+and+neutral+endopeptidase+24.11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00071_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DG.%2BA.%26atitle%3DApplication%2520of%2520conformationally%2520restricted%2520Phe-Leu%2520dipeptide%2520mimetic%2520to%2520the%2520design%2520of%2520a%2520combined%2520inhibitor%2520of%2520angiotensinI%2520converting%2520enzyme%2520and%2520neutral%2520endopeptidase%252024.11%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00072"><div class="reference"><strong class="refLabel"><a href="#jm058225db00072" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-jm058225db00072_1"><span><span class="NLM_string-ref">Inguimbert, N.; Poras, H.; Meudal, H.; Teffo, F.; Beslot, F.; Selkti, M.; Tomas, A.; Scalbert, E.; Bennejean, C.; Renard, P.; Fournie-Zaluski, M.-C.; Roques, B. P. <i>  N</i>-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidase (NEP, ACE, ECE):  in vitro and in vivo activities. <i>Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2001−2005.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Inguimbert%2C+N.%3B+Poras%2C+H.%3B+Meudal%2C+H.%3B+Teffo%2C+F.%3B+Beslot%2C+F.%3B+Selkti%2C+M.%3B+Tomas%2C+A.%3B+Scalbert%2C+E.%3B+Bennejean%2C+C.%3B+Renard%2C+P.%3B+Fournie-Zaluski%2C+M.-C.%3B+Roques%2C+B.+P.+N-%5B2-%28Indan-1-yl%29-3-mercapto-propionyl%5D+amino+acids+as+highly+potent+inhibitors+of+the+three+vasopeptidase+%28NEP%2C+ACE%2C+ECE%29%3A%E2%80%89+in+vitro+and+in+vivo+activities.+Bioorg.+Med.+Chem.+Lett.+2002%2C+12%2C+2001%E2%88%922005.+Inguimbert%2C+N.%3B+Poras%2C+H.%3B+Meudal%2C+H.%3B+Teffo%2C+F.%3B+Beslot%2C+F.%3B+Selkti%2C+M.%3B+Tomas%2C+A.%3B+Scalbert%2C+E.%3B+Bennejean%2C+C.%3B+Renard%2C+P.%3B+Fournie-Zaluski%2C+M.-C.%3B+Roques%2C+B.+P.+N-%5B2-%28Indan-1-yl%29-3-mercapto-propionyl%5D+amino+acids+as+highly+potent+inhibitors+of+the+three+vasopeptidase+%28NEP%2C+ACE%2C+ECE%29%3A%E2%80%89+in+vitro+and+in+vivo+activities.+Bioorg.+Med.+Chem.+Lett.2002%2C+12%2C+2001%E2%88%922005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00072_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInguimbert%26aufirst%3DN.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00073"><div class="reference"><strong class="refLabel"><a href="#jm058225db00073" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-jm058225db00073_1"><span><span class="NLM_string-ref">Laszlo, S.; Quagliato, C.; Greenlee, W.; Patchett, A.; Chang, R.; Lotti, V.; Chen, T.; Scheck, S.; Faust, K. A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor. <i>  J. Med. Chem. </i><b>1993</b>,<i> 36</i>, 3207−3210.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3210&author=S.+Laszlo&author=C.+Quagliato&author=W.+Greenlee&author=A.+Patchett&author=R.+Chang&author=V.+Lotti&author=T.+Chen&author=S.+Scheck&author=K+Faust&title=A+potent%2C+orally+active%2C+balanced+affinity+angiotensin+II+AT1+antagonist+and+AT2+binding+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00073_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaszlo%26aufirst%3DS.%26atitle%3DA%2520potent%252C%2520orally%2520active%252C%2520balanced%2520affinity%2520angiotensin%2520II%2520AT1%2520antagonist%2520and%2520AT2%2520binding%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00074"><div class="reference"><strong class="refLabel"><a href="#jm058225db00074" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-jm058225db00074_1"><span><span class="NLM_string-ref">Gardiner, S. M.; March, J. E.; Kemp, P. A.; Mullins, J. J.; Bennett, T. Hemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. <i>  Br. J. </i><i>Pharmacol. </i><b>1995</b>, <i>116</i>, 2237−2244.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&conference=SB+209670&author=S.+M.+Gardiner&author=J.+E.+March&author=P.+A.+Kemp&author=J.+J.+Mullins&author=T.+Bennett&title=Hemodynamic+effects+of+losartan+and+the+endothelin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00074_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DGardiner%26aufirst%3DS.%2BM.%26atitle%3DHemodynamic%2520effects%2520of%2520losartan%2520and%2520the%2520endothelin%2520antagonist%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00075"><div class="reference"><strong class="refLabel"><a href="#jm058225db00075" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-jm058225db00075_1"><span><span class="NLM_string-ref">Walsh, T.; Fitch, K.; Williams, D.; Murphy, K.; Nolan, N.; Pettibone, D.; Chang, R.; O'Malley, S.; Clineschmidt, B.; Veber, D.; Greenlee, W. Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III). <i>  Bioorg. Med. Chem. Lett.</i><b>1995</b>, <i>5</i>, 1155−1158.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=1158&author=T.+Walsh&author=K.+Fitch&author=D.+Williams&author=K.+Murphy&author=N.+Nolan&author=D.+Pettibone&author=R.+Chang&author=S.+O%27Malley&author=B.+Clineschmidt&author=D.+Veber&author=W+Greenlee&title=Potent+dual+antagonists+of+endothelin+and+angiotensin+II+receptors+derived+from+%CE%B1-phenoxyphenylacetic+acids+%28Part+III%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00075_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%26atitle%3DPotent%2520dual%2520antagonists%2520of%2520endothelin%2520and%2520angiotensin%2520II%2520receptors%2520derived%2520from%2520%25CE%25B1-phenoxyphenylacetic%2520acids%2520%2528Part%2520III%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00076"><div class="reference"><strong class="refLabel"><a href="#jm058225db00076" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-jm058225db00076_1"><span><span class="NLM_string-ref">Murugesan, N.; Tellew, J.; Gu, Z.; Kunst, B.; Fadnis, L.; Cornelius, L.; Baska, R.; Yang, Y.; Beyer, S.; Monshizadegan, H.; Dickinson, K.; Panchal, B.; Valentine, M.; Chong, S.; Morrison, R.; Carlson, K.; Powell, J.; Moreland, S.; Barrish, J.; Kowala, M.; Macor, J. Discovery of <i>N</i>-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. <i>  J. Med. Chem. </i><b>2002</b>,<i> 45</i>, 3829−3835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3835&author=N.+Murugesan&author=J.+Tellew&author=Z.+Gu&author=B.+Kunst&author=L.+Fadnis&author=L.+Cornelius&author=R.+Baska&author=Y.+Yang&author=S.+Beyer&author=H.+Monshizadegan&author=K.+Dickinson&author=B.+Panchal&author=M.+Valentine&author=S.+Chong&author=R.+Morrison&author=K.+Carlson&author=J.+Powell&author=S.+Moreland&author=J.+Barrish&author=M.+Kowala&author=J+Macor&title=Discovery+of+N-isoxazolyl+biphenylsulfonamides+as+potent+dual+angiotensin+II+and+endothelin+A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00076_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurugesan%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520N-isoxazolyl%2520biphenylsulfonamides%2520as%2520potent%2520dual%2520angiotensin%2520II%2520and%2520endothelin%2520A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00077"><div class="reference"><strong class="refLabel"><a href="#jm058225db00077" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-jm058225db00077_1"><span><span class="NLM_string-ref">Murugesan, N.; Gu, Z.; Fadnis, L.; Tellew, J.; Baska, R.; Yang, Y.; Beyer, S.; Monshizadegan, H.; Dickinson, K.; Valentine, M.; Humphreys, W.; Lan, S.; Ewing, W.; Carlson, K.; Kowala, M.; Zahler, R.; Macor, J. Dual angiotensin II and endothelin A receptor antagonists:  Synthesis of 2‘-substituted <i>N</i>-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics. <i>  J. Med. Chem. </i><b>2005</b>,<i> 48</i>, 171−179.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=179&author=N.+Murugesan&author=Z.+Gu&author=L.+Fadnis&author=J.+Tellew&author=R.+Baska&author=Y.+Yang&author=S.+Beyer&author=H.+Monshizadegan&author=K.+Dickinson&author=M.+Valentine&author=W.+Humphreys&author=S.+Lan&author=W.+Ewing&author=K.+Carlson&author=M.+Kowala&author=R.+Zahler&author=J+Macor&title=Dual+angiotensin+II+and+endothelin+A+receptor+antagonists%3A%E2%80%89+Synthesis+of+2%E2%80%98-substituted+N-3-isoxazolyl+biphenylsulfonamides+with+improved+potency+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00077_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurugesan%26aufirst%3DN.%26atitle%3DDual%2520angiotensin%2520II%2520and%2520endothelin%2520A%2520receptor%2520antagonists%253A%25E2%2580%2589%2520Synthesis%2520of%25202%25E2%2580%2598-substituted%2520N-3-isoxazolyl%2520biphenylsulfonamides%2520with%2520improved%2520potency%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00078"><div class="reference"><strong class="refLabel"><a href="#jm058225db00078" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-jm058225db00078_1"><span><span class="NLM_string-ref">Vane, J. R. <i>  Nat. New Biol.</i><b>1971</b>, 232−235. Dannhard, G.; Kiefer, W. Cyclooxygenase inhibitorscurrent status and future prospects. <i>Eur. J. </i><i>Med. Chem.</i><b>2001</b>, <i>36</i>, 109−126.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Vane%2C+J.+R.+Nat.+New+Biol.+1971%2C+232%E2%88%92235.+Dannhard%2C+G.%3B+Kiefer%2C+W.+Cyclooxygenase+inhibitorscurrent+status+and+future+prospects.+Eur.+J.+Med.+Chem.+2001%2C+36%2C+109%E2%88%92126.+Vane%2C+J.+R.+Nat.+New+Biol.1971%2C+232%E2%88%92235.+Dannhard%2C+G.%3B+Kiefer%2C+W.+Cyclooxygenase+inhibitorscurrent+status+and+future+prospects.+Eur.+J.+Med.+Chem.2001%2C+36%2C+109%E2%88%92126."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00078_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVane%26aufirst%3DJ.%2BR.%26jtitle%3DNat.%2520New%2520Biol.%26date%3D1971%26volume%3D232%26spage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00079"><div class="reference"><strong class="refLabel"><a href="#jm058225db00079" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-jm058225db00079_1"><span><span class="NLM_string-ref">Fosslien, E. Adverse effects of nonsteroidal antiinflammatory drugs on the gastrointestinal system. <i>  Ann. Clin. Lab. Sci.</i><b>1998</b>, <i>28</i>, 67−81.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=81&author=E+Fosslien&title=Adverse+effects+of+nonsteroidal+antiinflammatory+drugs+on+the+gastrointestinal+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00079_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFosslien%26aufirst%3DE%26atitle%3DAdverse%2520effects%2520of%2520nonsteroidal%2520antiinflammatory%2520drugs%2520on%2520the%2520gastrointestinal%2520system%26jtitle%3DAnn.%2520Clin.%2520Lab.%2520Sci.%26date%3D1998%26volume%3D28%26spage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00080"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00080_1"><span><span class="NLM_string-ref">Gilroy, D. W.; Tomlinson, A.; Willoughby, D. A. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. <i>  Eur. J. Pharmacol.</i><b>1998</b>, <i>355</i>, 211−217.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1998&pages=217&author=D.+W.+Gilroy&author=A.+Tomlinson&author=D.+A+Willoughby&title=Differential+effects+of+inhibitors+of+cyclooxygenase+%28cyclooxygenase+1+and+cyclooxygenase+2%29+in+acute+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00080_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilroy%26aufirst%3DD.%2BW.%26atitle%3DDifferential%2520effects%2520of%2520inhibitors%2520of%2520cyclooxygenase%2520%2528cyclooxygenase%25201%2520and%2520cyclooxygenase%25202%2529%2520in%2520acute%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D355%26spage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00081"><div class="reference"><strong class="refLabel"><a href="#jm058225db00081" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-jm058225db00081_1"><span><span class="NLM_string-ref">Fiorucci, S.; Meli, R.; Bucci, M.; Cirino, G. Dual inhibitors of COX and 5-LOX. A new avenue in anti-inflammatory therapy. <i>  Biochem. Pharmacol.</i><b>2001</b>, <i>62</i>, 1433−1438. De Leval, X.; Julemont, F.; Delarge, J.; Pirotte, B.; Dogne, J. M. New trends in dual 5-LOX/COX inhibition. <i>Curr. Med. </i><i>Chem.</i><b>2002</b>, <i>9</i>, 941−962. Charlier, C.; Michaux, C. Dual inhibition of COX-2 and 5-LOX as a new strategy to provide safer non-steroidal anti-inflammatory drugs. <i>Eur. J. Med. Chem.</i><b>2003</b>, <i>38</i>, 645−659.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1438&author=S.+Fiorucci&author=R.+Meli&author=M.+Bucci&author=G+Cirino&title=Dual+inhibitors+of+COX+and+5-LOX.+A+new+avenue+in+anti-inflammatory+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00081_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiorucci%26aufirst%3DS.%26atitle%3DDual%2520inhibitors%2520of%2520COX%2520and%25205-LOX.%2520A%2520new%2520avenue%2520in%2520anti-inflammatory%2520therapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D62%26spage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00082"><div class="reference"><strong class="refLabel"><a href="#jm058225db00082" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-jm058225db00082_1"><span><span class="NLM_string-ref">Swingle, K. F.; Moore, G. G. I. 2,6-Di-tert-4(2‘-thenoyl)phenol(R-830):  A novel nonsteroidal anti-inflammatory agent with antioxidant properties. <i>  Agents Actions</i><b>1982</b>, <i>12</i>, 674−683.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1982&pages=683&author=K.+F.+Swingle&author=G.+G.+I.+Moore&author=A+Di&title=novel+nonsteroidal+anti-inflammatory+agent+with+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00082_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DK.%2BF.%26atitle%3Dnovel%2520nonsteroidal%2520anti-inflammatory%2520agent%2520with%2520antioxidant%2520properties%26jtitle%3DAgents%2520Actions%26date%3D1982%26volume%3D12%26spage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00083"><div class="reference"><strong class="refLabel"><a href="#jm058225db00083" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-jm058225db00083_1"><span><span class="NLM_string-ref">Lazer, E. S.; Wong, H.-C.; Possanza, G. J.; Graham, A. G.; Farina, P. R. Anti-inflammatory 2,6-di-<i>tert</i>-butyl-4(2-arylethenyl)phenols. <i>  J. Med. </i><i>Chem.</i><b>1989</b>, <i>32</i>, 100−104.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Lazer%2C+E.+S.%3B+Wong%2C+H.-C.%3B+Possanza%2C+G.+J.%3B+Graham%2C+A.+G.%3B+Farina%2C+P.+R.+Anti-inflammatory+2%2C6-di-tert-butyl-4%282-arylethenyl%29phenols.+J.+Med.+Chem.+1989%2C+32%2C+100%E2%88%92104.+Lazer%2C+E.+S.%3B+Wong%2C+H.-C.%3B+Possanza%2C+G.+J.%3B+Graham%2C+A.+G.%3B+Farina%2C+P.+R.+Anti-inflammatory+2%2C6-di-tert-butyl-4%282-arylethenyl%29phenols.+J.+Med.+Chem.1989%2C+32%2C+100%E2%88%92104."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00083_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLazer%26aufirst%3DE.%2BS.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00084"><div class="reference"><strong class="refLabel"><a href="#jm058225db00084" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-jm058225db00084_1"><span><span class="NLM_string-ref">Unangst, P. C.; Connor, D. T.; Cetenko, W. A.; Sorenson, R. J.; Kostlan, C. R.; Sircar, J. C.; Wright, C. D.; Schrier, D. J.; Dyer, R. D. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethyl)-4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles:  Novel dual 5-LOX and COX inhibitors with anti-inflamatory activity. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 322−328.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=328&author=P.+C.+Unangst&author=D.+T.+Connor&author=W.+A.+Cetenko&author=R.+J.+Sorenson&author=C.+R.+Kostlan&author=J.+C.+Sircar&author=C.+D.+Wright&author=D.+J.+Schrier&author=R.+D+Dyer&title=Synthesis+and+biological+evaluation+of+5-%5B%5B3%2C5-bis%281%2C1-dimethyl%29-4-hydroxyphenyl%5Dmethylene%5Doxazoles%2C+-thiazoles%2C+and+-imidazoles%3A%E2%80%89+Novel+dual+5-LOX+and+COX+inhibitors+with+anti-inflamatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00084_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25205-%255B%255B3%252C5-bis%25281%252C1-dimethyl%2529-4-hydroxyphenyl%255Dmethylene%255Doxazoles%252C%2520-thiazoles%252C%2520and%2520-imidazoles%253A%25E2%2580%2589%2520Novel%2520dual%25205-LOX%2520and%2520COX%2520inhibitors%2520with%2520anti-inflamatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00085"><div class="reference"><strong class="refLabel"><a href="#jm058225db00085" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-jm058225db00085_1"><span><span class="NLM_string-ref">Barbey, S.; Goossens, L.; Taverne, T.; Cornet, J.; Choesmel, V.; Rouaud, C.; Gimeno, G.; Yannic-Arnoult, S.; Michaux, C.; Charlier, C.; Houssin, R.; Henichart, J. P. Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 779−782.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=782&author=S.+Barbey&author=L.+Goossens&author=T.+Taverne&author=J.+Cornet&author=V.+Choesmel&author=C.+Rouaud&author=G.+Gimeno&author=S.+Yannic-Arnoult&author=C.+Michaux&author=C.+Charlier&author=R.+Houssin&author=J.+P+Henichart&title=Synthesis+and+activity+of+a+new+methoxytetrahydropyran+derivative+as+dual+cyclooxygenase-2%2F5-lipoxygenase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00085_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbey%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520a%2520new%2520methoxytetrahydropyran%2520derivative%2520as%2520dual%2520cyclooxygenase-2%252F5-lipoxygenase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00086"><div class="reference"><strong class="refLabel"><a href="#jm058225db00086" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-jm058225db00086_1"><span><span class="NLM_string-ref">Corey, E. J.; Cashman, J. R.; Kantner, S. S.; Wright, S. W. <i>  J. Am. Chem. Soc.</i><b>1984</b>, <i>106</i>, 1503.</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00317a064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Corey%2C+E.+J.%3B+Cashman%2C+J.+R.%3B+Kantner%2C+S.+S.%3B+Wright%2C+S.+W.+J.+Am.+Chem.+Soc.+1984%2C+106%2C+1503.+Corey%2C+E.+J.%3B+Cashman%2C+J.+R.%3B+Kantner%2C+S.+S.%3B+Wright%2C+S.+W.+J.+Am.+Chem.+Soc.1984%2C+106%2C+1503."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00086_1&amp;dbid=16384&amp;doi=10.1021%2Fja00317a064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00317a064%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1984%26volume%3D106%26spage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00087"><div class="reference"><strong class="refLabel"><a href="#jm058225db00087" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-jm058225db00087_1"><span><span class="NLM_string-ref">Carter, G. W.; Young, P. R.; Albert, D. H.; Bouska, J.; Dyer, R.; Bell, R. L.; Summers, J. B.; Brooks, D. W. 5-LOX inhibitory activity of zileuton. <i>  J. </i><i>Pharmacol. Exp. Ther.</i><b>1991</b>, <i>256</i>, 929−937.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1991&pages=937&author=G.+W.+Carter&author=P.+R.+Young&author=D.+H.+Albert&author=J.+Bouska&author=R.+Dyer&author=R.+L.+Bell&author=J.+B.+Summers&author=D.+W+Brooks&title=5-LOX+inhibitory+activity+of+zileuton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00087_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DG.%2BW.%26atitle%3D5-LOX%2520inhibitory%2520activity%2520of%2520zileuton%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1991%26volume%3D256%26spage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00088"><div class="reference"><strong class="refLabel"><a href="#jm058225db00088" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-jm058225db00088_1"><span><span class="NLM_string-ref">Brooks, C. D. W.; Stewart, A. O.; Basha, A.; Bhatia, P.; Ratajczyk, J. D.; Martin, J. G.; Craig, R. A.; Kolasa, T.; Bouska, J. B.; Lanni, C.; Harris, R. R.; Malo, P. E.; Carter, G. W.; Bell, R. L. <i>  J. Med. Chem.</i><b>1995</b>, <i>38</i>, 4768.</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00024a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Brooks%2C+C.+D.+W.%3B+Stewart%2C+A.+O.%3B+Basha%2C+A.%3B+Bhatia%2C+P.%3B+Ratajczyk%2C+J.+D.%3B+Martin%2C+J.+G.%3B+Craig%2C+R.+A.%3B+Kolasa%2C+T.%3B+Bouska%2C+J.+B.%3B+Lanni%2C+C.%3B+Harris%2C+R.+R.%3B+Malo%2C+P.+E.%3B+Carter%2C+G.+W.%3B+Bell%2C+R.+L.+J.+Med.+Chem.+1995%2C+38%2C+4768.+Brooks%2C+C.+D.+W.%3B+Stewart%2C+A.+O.%3B+Basha%2C+A.%3B+Bhatia%2C+P.%3B+Ratajczyk%2C+J.+D.%3B+Martin%2C+J.+G.%3B+Craig%2C+R.+A.%3B+Kolasa%2C+T.%3B+Bouska%2C+J.+B.%3B+Lanni%2C+C.%3B+Harris%2C+R.+R.%3B+Malo%2C+P.+E.%3B+Carter%2C+G.+W.%3B+Bell%2C+R.+L.+J.+Med.+Chem.1995%2C+38%2C+4768."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00088_1&amp;dbid=16384&amp;doi=10.1021%2Fjm00024a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00024a004%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DC.%2BD.%2BW.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00089"><div class="reference"><strong class="refLabel"><a href="#jm058225db00089" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-jm058225db00089_1"><span><span class="NLM_string-ref">Laufer, S. A.; Augustin, J.; Dannhardt, G.; Kiefer, W. (6,7-Diarylhydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 1894−1897.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1897&author=S.+A.+Laufer&author=J.+Augustin&author=G.+Dannhardt&author=W.+Kiefer&author=+Diarylhydropyrrolizin&title=a+novel+class+of+potent+dual+inhibitors+of+both+cyclooxygenase+and+5-lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00089_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3Da%2520novel%2520class%2520of%2520potent%2520dual%2520inhibitors%2520of%2520both%2520cyclooxygenase%2520and%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00090"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00090_1"><span><span class="NLM_string-ref">Hibi, S.; Okamoto, Y.; Tagami, K.; Numata, H.; Kobayashi, N.; Shinoda, M.; Kawahara, T.; Murakami, M.; Oketani, K.; Inoue, T.; Shibata, H.; Yamatsu, I. Novel dual inhibitors of 5-LOX and TxA2S:  Synthesis and structure−activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 3062−3070.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3070&author=S.+Hibi&author=Y.+Okamoto&author=K.+Tagami&author=H.+Numata&author=N.+Kobayashi&author=M.+Shinoda&author=T.+Kawahara&author=M.+Murakami&author=K.+Oketani&author=T.+Inoue&author=H.+Shibata&author=I+Yamatsu&title=Novel+dual+inhibitors+of+5-LOX+and+TxA2S%3A%E2%80%89+Synthesis+and+structure%E2%88%92activity+relationships+of+3-pyridylmethyl-substituted+2-amino-6-hydroxybenzothiazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00090_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHibi%26aufirst%3DS.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%25205-LOX%2520and%2520TxA2S%253A%25E2%2580%2589%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25203-pyridylmethyl-substituted%25202-amino-6-hydroxybenzothiazole%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00091"><div class="reference"><strong class="refLabel"><a href="#jm058225db00091" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-jm058225db00091_1"><span><span class="NLM_string-ref">Fitzgerald, G. A.; Reilly, I. A. G.; Pederson, A. K. The biochemical pharmacology of thromboxane synthase inhibition in man. <i>  Circulation</i><b>1985</b>, <i>72</i>, 1194−1201.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1985&pages=1201&author=G.+A.+Fitzgerald&author=I.+A.+G.+Reilly&author=A.+K+Pederson&title=The+biochemical+pharmacology+of+thromboxane+synthase+inhibition+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00091_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DG.%2BA.%26atitle%3DThe%2520biochemical%2520pharmacology%2520of%2520thromboxane%2520synthase%2520inhibition%2520in%2520man%26jtitle%3DCirculation%26date%3D1985%26volume%3D72%26spage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00092"><div class="reference"><strong class="refLabel"><a href="#jm058225db00092" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-jm058225db00092_1"><span><span class="NLM_string-ref">Gresele, P.; van Houte, E.; Arnout, J.; Deckmyn, H.; Vermylen, J. Thromboxane synthase inhibition combined with thromboxane receptor blockade:  a step forward in antithrombotic strategy? <i>Thromb. Haemostasis</i><b>1984</b>, <i>52</i>, 364.</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=jm058225db00092/jm058225db00092_1&amp;dbid=8&amp;doi=10.1021%2Fjm058225d&amp;key=6099616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=jm058225db00092/jm058225db00092_1&amp;dbid=32&amp;doi=10.1021%2Fjm058225d&amp;key=1%3ACAS%3A528%3ADyaL2MXhsVaqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1984&pages=364&author=P.+Gresele&author=E.+van+Houte&author=J.+Arnout&author=H.+Deckmyn&author=J+Vermylen&title=Thromboxane+synthase+inhibition+combined+with+thromboxane+receptor+blockade%3A%E2%80%89+a+step+forward+in+antithrombotic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_jm058225db00092_1R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Thromboxane synthase inhibition combined with thromboxane receptor blockade:  a step forward in antithrombotic strategy?</span></div><div class="casAuthors">Gresele, Paolo; Van Houtte, Elisabeth; Arnout, Jef; Deckmyn, Hans; Vermylen, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">364</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    </div><div class="casAbstract">At a relatively high concn. (5 μg/mL), the thromboxane synthetase  [61276-89-9] inhibitor dazoxiben  [78218-09-4] alone did not inhibit, and the thromboxane receptor blocker BM 13.177  [72131-33-0] only slightly inhibited, platelet aggregation in whole blood.  The combination, however, was significantly more inhibitory than either drug by itself.  Aspirin-treated endothelial cells produced prostacyclin  [35121-78-9] when challenged with dazoxiben- or dazoxiben plus BM 13.177-treated platelets activated by collagen.  This indicates that BM 13.177 does not interfere with the property of dazoxiben of redirecting the platelet endoperoxide metab. towards prostacyclin in the presence of a source of prostacyclin synthase (endothelial cells, leukocytes).  To the extent that the combination of a thromboxane synthase inhibitor and a thromboxane receptor blocker results in activation of platelet adenylate cyclase selectively at the site of vascular injury, this assocn. would have major antithrombotic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmbE1rJCcG37Vg90H21EOLACvtfcHk0ljIEhIPTAWcpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhsVaqtro%253D&md5=fc08189e6d487a01400eae10abbe1815</span></div><a href="/servlet/linkout?suffix=jm058225db00092_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGresele%26aufirst%3DP.%26atitle%3DThromboxane%2520synthase%2520inhibition%2520combined%2520with%2520thromboxane%2520receptor%2520blockade%253A%25E2%2580%2589%2520a%2520step%2520forward%2520in%2520antithrombotic%2520strategy%26jtitle%3DThromb.%2520Haemostasis%26date%3D1984%26volume%3D52%26spage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00093"><div class="reference"><strong class="refLabel"><a href="#jm058225db00093" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-jm058225db00093_1"><span><span class="NLM_string-ref">De Clerck, F.; Beetens, J.; Van de Water, A.; Vercammen, E.; Janssen, P. A. R 68 070:  thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule. II. Pharmacological effects in vivo and ex vivo. <i>  Thromb. Haemostasis</i><b>1989</b>, <i>61</i>, 43−49.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1989&pages=49&author=F.+De+Clerck&author=J.+Beetens&author=A.+Van+de+Water&author=E.+Vercammen&author=P.+A.+Janssen&title=synthetase+inhibition+and+thromboxane+A2%2Fprostaglandin+endoperoxide+receptor+blockade+combined+in+one+molecule.+II.+Pharmacological+effects+in+vivo+and+ex+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00093_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClerck%26aufirst%3DF.%26atitle%3Dsynthetase%2520inhibition%2520and%2520thromboxane%2520A2%252Fprostaglandin%2520endoperoxide%2520receptor%2520blockade%2520combined%2520in%2520one%2520molecule.%2520II.%2520Pharmacological%2520effects%2520in%2520vivo%2520and%2520ex%2520vivo%26jtitle%3DThromb.%2520Haemostasis%26date%3D1989%26volume%3D61%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00094"><div class="reference"><strong class="refLabel"><a href="#jm058225db00094" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-jm058225db00094_1"><span><span class="NLM_string-ref">Kato, K.; Ohkawa, S.; Terao, S.; Terashita, Z. I.; Nishikava, K. Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of ω-pyridylalkenoic acids. <i>  J. Med. Chem.</i><b>1985</b>, <i>28</i>, 287−294.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=294&author=K.+Kato&author=S.+Ohkawa&author=S.+Terao&author=Z.+I.+Terashita&author=K+Nishikava&title=Thromboxane+synthetase+inhibitors+%28TXSI%29.+Design%2C+synthesis%2C+and+evaluation+of+a+novel+series+of+%CF%89-pyridylalkenoic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00094_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26atitle%3DThromboxane%2520synthetase%2520inhibitors%2520%2528TXSI%2529.%2520Design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520%25CF%2589-pyridylalkenoic%2520acids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00095"><div class="reference"><strong class="refLabel"><a href="#jm058225db00095" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-jm058225db00095_1"><span><span class="NLM_string-ref">Soyka, R.; Heckel, A.; Nickl, J.; Eisert, W.; Muller, T. H.; Weisenberger, H. 6,6-Disubstituted hex-5-enoic acid derivatives as combined thromboxane A2 receptor and synthetase inhibitors. <i>  J. Med. Chem.</i><b>1994</b>, <i>37</i>, 26−39.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=39&author=R.+Soyka&author=A.+Heckel&author=J.+Nickl&author=W.+Eisert&author=T.+H.+Muller&author=H.+Weisenberger&author=+Disubstituted&title=acid+derivatives+as+combined+thromboxane+A2+receptor+and+synthetase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00095_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoyka%26aufirst%3DR.%26atitle%3Dacid%2520derivatives%2520as%2520combined%2520thromboxane%2520A2%2520receptor%2520and%2520synthetase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00096"><div class="reference"><strong class="refLabel"><a href="#jm058225db00096" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-jm058225db00096_1"><span><span class="NLM_string-ref">Dickinson, R. P.; Dack, K. N.; Steele, J. Tromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonist. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>1995</b>, <i>5</i>, 3017−3022.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=3022&author=R.+P.+Dickinson&author=K.+N.+Dack&author=J+Steele&title=Tromboxane+modulating+agents.+1.+Design+of+1-%5B%28arylsulfonyl%29amino%5D+alkylindole+derivatives+as+dual+thromboxane+synthase+inhibitor%2Fthromboxane+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00096_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DR.%2BP.%26atitle%3DTromboxane%2520modulating%2520agents.%25201.%2520Design%2520of%25201-%255B%2528arylsulfonyl%2529amino%255D%2520alkylindole%2520derivatives%2520as%2520dual%2520thromboxane%2520synthase%2520inhibitor%252Fthromboxane%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00097"><div class="reference"><strong class="refLabel"><a href="#jm058225db00097" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-jm058225db00097_1"><span><span class="NLM_string-ref">Henke, B. Peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 4118−4127.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4127&author=B+Henke&title=Peroxisome+proliferator-activated+receptor+%CE%B1%2F%CE%B3+dual+agonists+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00097_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenke%26aufirst%3DB%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%252F%25CE%25B3%2520dual%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00098"><div class="reference"><strong class="refLabel"><a href="#jm058225db00098" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-jm058225db00098_1"><span><span class="NLM_string-ref">Nomua, M.; Kinoshita, S.; Satoh, H.; Maeda, T.; Murakami, K.; Tsunoda, M.; Miyachi, H.; Awano, K. (3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents. <i>  Bioorg.</i><i>Med. Chem. Lett.</i><b>1999</b>, <i>9</i>, 533−538.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=538&author=M.+Nomua&author=S.+Kinoshita&author=H.+Satoh&author=T.+Maeda&author=K.+Murakami&author=M.+Tsunoda&author=H.+Miyachi&author=K.+Awano&author=+Substituted&title=as+structurally+new+antihyperglycemic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00098_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNomua%26aufirst%3DM.%26atitle%3Das%2520structurally%2520new%2520antihyperglycemic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00099"><div class="reference"><strong class="refLabel"><a href="#jm058225db00099" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-jm058225db00099_1"><span><span class="NLM_string-ref">Oliver, W. R.; Shenk, J. L.; Snaith, M. R.; Russell, C. S.; Kelli, D.; Plunket, K. D.; Bodkin, N. L.; Lewis, M. C.; Winegar, D. A.; Sznaidman, M. L.; Lambert, M. H.; Xu, H. E.; Sternbach, D. D.; Kliewer, S. A.; Hansen, B. C.; Willson, T. M. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. <i>  Proc. Natl. Acad. Sci.</i><i>U.S.A.</i><b>2001</b>, <i>98</i>, 5306−5311.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=5311&author=W.+R.+Oliver&author=J.+L.+Shenk&author=M.+R.+Snaith&author=C.+S.+Russell&author=D.+Kelli&author=K.+D.+Plunket&author=N.+L.+Bodkin&author=M.+C.+Lewis&author=D.+A.+Winegar&author=M.+L.+Sznaidman&author=M.+H.+Lambert&author=H.+E.+Xu&author=D.+D.+Sternbach&author=S.+A.+Kliewer&author=B.+C.+Hansen&author=T.+M+Willson&title=A+selective+peroxisome+proliferator-activated+receptor+%CE%B4+agonist+promotes+reverse+cholesterol+transport"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00099_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DW.%2BR.%26atitle%3DA%2520selective%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B4%2520agonist%2520promotes%2520reverse%2520cholesterol%2520transport%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D5311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00100"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00100_1"><span><span class="NLM_string-ref">Mogensen, J. P.; Jeppesen, L.; Bury, P. S. Design and synthesis of novel PPARα/γ/δ triple activators using known PPARα/γ dual activator as structural template. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 257−260.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=260&author=J.+P.+Mogensen&author=L.+Jeppesen&author=P.+S+Bury&title=Design+and+synthesis+of+novel+PPAR%CE%B1%2F%CE%B3%2F%CE%B4+triple+activators+using+known+PPAR%CE%B1%2F%CE%B3+dual+activator+as+structural+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00100_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMogensen%26aufirst%3DJ.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520PPAR%25CE%25B1%252F%25CE%25B3%252F%25CE%25B4%2520triple%2520activators%2520using%2520known%2520PPAR%25CE%25B1%252F%25CE%25B3%2520dual%2520activator%2520as%2520structural%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00101"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00101_1"><span><span class="NLM_string-ref">Xu, Y.; Rito, C. J.; Etgen, G. J.; Ardecky, R. J.; Bean, S. J.; Bensch, W. R.; Bosley, J. R.; Broderick, C. L.; Brooks, D. A.; Dominianni, S. J.; Hahn, P. J.; Dale, S. L.; Mais, D. E.; Montrose-Rafizadeh, C.; Ogilvie, K. M.; Oldham, B. A.; Peters, M.; Rungta, D. K.; Shuker, A. J.; Stephenson, G. A.; Tripp, A. E.; Wilson, S. B.; Winneroski, L. L.; Zink, R.; Kauffman, R. K.; McCarthy, J. R. Design and synthesis of α-aryloxy-α-methylhydrocinnamic acids:  a novel class of dual peroxisome proliferator-activated receptor α/γ agonists. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 2422−2425.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2425&author=Y.+Xu&author=C.+J.+Rito&author=G.+J.+Etgen&author=R.+J.+Ardecky&author=S.+J.+Bean&author=W.+R.+Bensch&author=J.+R.+Bosley&author=C.+L.+Broderick&author=D.+A.+Brooks&author=S.+J.+Dominianni&author=P.+J.+Hahn&author=S.+L.+Dale&author=D.+E.+Mais&author=C.+Montrose-Rafizadeh&author=K.+M.+Ogilvie&author=B.+A.+Oldham&author=M.+Peters&author=D.+K.+Rungta&author=A.+J.+Shuker&author=G.+A.+Stephenson&author=A.+E.+Tripp&author=S.+B.+Wilson&author=L.+L.+Winneroski&author=R.+Zink&author=R.+K.+Kauffman&author=J.+R+McCarthy&title=Design+and+synthesis+of+%CE%B1-aryloxy-%CE%B1-methylhydrocinnamic+acids%3A%E2%80%89+a+novel+class+of+dual+peroxisome+proliferator-activated+receptor+%CE%B1%2F%CE%B3+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00101_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B1-aryloxy-%25CE%25B1-methylhydrocinnamic%2520acids%253A%25E2%2580%2589%2520a%2520novel%2520class%2520of%2520dual%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%252F%25CE%25B3%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00102"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00102_1"><span><span class="NLM_string-ref">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. <i>  Adv.</i><i>Drug Delivery Rev.</i><b>1997</b>, <i>23</i>, 3−25.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=25&author=C.+A.+Lipinski&author=F.+Lombardo&author=B.+W.+Dominy&author=P.+J+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00102_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00103"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00103_1"><span><span class="NLM_string-ref">Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 2615−2623.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2623&author=D.+F.+Veber&author=S.+R.+Johnson&author=H.+Y.+Cheng&author=B.+R.+Smith&author=K.+W.+Ward&author=K.+D+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00103_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00104"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00104_1"><span><span class="NLM_string-ref">Mah, R.; Gerspacher, M.; von Sprecher, A.; Stutzb, S.; Tschinke, V.; Anderson, G.; Bertrand, C.; Subramanian, N.; Ball, H. Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2065−2068.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2068&author=R.+Mah&author=M.+Gerspacher&author=A.+von+Sprecher&author=S.+Stutzb&author=V.+Tschinke&author=G.+Anderson&author=C.+Bertrand&author=N.+Subramanian&author=H+Ball&title=Biphenyl+derivatives+as+novel+dual+NK1%2FNK2-receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00104_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMah%26aufirst%3DR.%26atitle%3DBiphenyl%2520derivatives%2520as%2520novel%2520dual%2520NK1%252FNK2-receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058225db00105"><div class="reference"><div class="NLM_citation" id="rightTab-jm058225db00105_1"><span><span class="NLM_string-ref">Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.; Scozzafava, A.; Klebe, G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:  New pharmacological opportunities due to related binding site recognition. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 550−557.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=557&author=A.+Weber&author=A.+Casini&author=A.+Heine&author=D.+Kuhn&author=C.+T.+Supuran&author=A.+Scozzafava&author=G+Klebe&title=Unexpected+nanomolar+inhibition+of+carbonic+anhydrase+by+COX-2-selective+celecoxib%3A%E2%80%89+New+pharmacological+opportunities+due+to+related+binding+site+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058225db00105_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%26atitle%3DUnexpected%2520nanomolar%2520inhibition%2520of%2520carbonic%2520anhydrase%2520by%2520COX-2-selective%2520celecoxib%253A%25E2%2580%2589%2520New%2520pharmacological%2520opportunities%2520due%2520to%2520related%2520binding%2520site%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm058225d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2005.48.issue-21%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm058225d" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm058225d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                576KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992f687ac9195f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
